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Towards the total synthesis of L-783,277 
 
Hoàng Thanh Vy 
Resorcylic Acid Lactones (RALs) are a family of mycotoxins which share the same structural 
skeleton composed of a β-resorcylic acid core fused with a 12- or 14-membered macrolactone. 
Despite their small strutural variations, these macrolides display an astonishingly large 
spectrum of biological activities, spanning from being Hsp90 inhibitors to antimalarial and 
antifouling. Three metabolites of the cis-enone containing subfamily have been recently 
recognised as a structurally unique class of kinase inhibitors. Their inhibition of kinases with a 
Cys residue properly located in their ATP binding pocket (ca 10% of the kinome), result from 
the 1,4-adddition of the abovementioned protein thiol to the cis-enone. One of them, L-
783,277 has been recently disclosed to owe an anti-angiogenetic potential. 
This project aimed for an elegant and modular synthetic pathway towards L-783,277, extracted 
from the fruitbody of Helvella acetabulum. This thesis outlines the construction of a dialkyne 
precursor, as the pivotal stage for a ring-closing alkyne metathesis, followed by Lindlar 
reduction to incorporate the delicate cis-enone.  
The first chapter portrays a succinct biological profile of RALs over the period 1968-2014, 
which have been the target of a myriad of total syntheses. The syntheses of some chosen 
resorcylides are detailed to illustrate how early studies on structurally simple macrolides built 
the solid basement for innovative strategies and methodologies. The syntheses targeting cis-
enone containing RALs, e.g. L-783,277, elucidate our inspirations and strategies towards the 
latter. 
The second chapter exposed the preparation and tactical assembly of three fragments 
resulting from the retrosynthetic disconnection of L-783,277: an aromatic core and two 
straight-chained segments containing both a terminal substituted propyne. The synthesis of 
one of the latter led to the development of a new method for the opening one-carbon 
homologation and opening of lactones via the corresponding phosphine oxide. The key step 
resides in the direct alkylation at the benzylic position of the aromatic core as the first 
assembly. Finally, the crucial dialkyne precursor has been obtained on multigram scale, based 
on robust procedures with simple purification. The first series of assays devoted to RCAM are 
also discussed at the end of this chapter.  
The third chapter depicts the application of our synthetic blueprint to other RALs, namely two 
natural resorcylides (zeranol and (R)-(+)-lasiodiplodin) and two synthetic ones: (S)-lasiodiplodin 
and neolasiodiplodin. Their accomplishment illustrates our elegant and concise strategy, 
promising further synthetic avenues leading to more complex resorcylides with a 12- or 14-
membered ring. 
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BBN (9-BBN) 9-borabicyclo[3.3.1]nonane 
Bn benzyl 
Boc tert-butoxycarbonyl 
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Bu  butyl 
ca circa 
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CBS reduction Corey–Bakshi–Shibata reduction 
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Cy cyclohexane 
Cp cyclopentadiyl 
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DMP Dess-Martin periodinane 
DMSO dimethylsulfoxide 
DIPA diisopropylamine 
e.g. exempligratia 
EtOAc ethylacetate 
EOM ethoxymethyl 
F-oct3SnH tris (1H, 1H, 2H, 2H-perfluorooctyl)tin hydride 
HBTU 2-(1H-Benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate 
HMPA hexamethylphosphoric acid triamide (hexamethylphosphoramide) 
HOBt 1-hydroxybenzotriazole 
HPLC high-pressure liquid chromatography 
IBX o-iodoxybenzoic acid 
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LAH lithium aluminum hydride (LiAlH4) 
LDA lithium diisopropylamide 
LHMDS (LiHMDS) lithium bis(trimethylsilyl)amide 
LG leaving group 
LTMP lithium tetramethylpiperidide 
L-selectride lithium tri-sec-butylborohydride 
m meta 
mCPBA meta-chloroperbenzoic acid 
Me methyl 
MeCN acetonitrile 
MOM methoxymethyl 
m.p. melting point 
MPM or PMB para-methoxybenzyl 
MSA methanesulfonic acid 
NBS N-bromosuccinimide 
o ortho 
Oxone potassium peroxymonosulfate 
p para 
PG protecting group 
PCC pyridiniumchlorochromate 
PDC pyridinium dichromate 
Ph phenyl 
Piv pivaloyl 
PMB or MPM para-methoxybenzyl 
PMP para-methoxyphenyl 
PPTS pyridinium p-toluenesulfonate 
PTSA (TsOH) para-toluenesulfonic acid 
Py (pyr) pyridine 
RaNi Raney nickel 
RCAM ring-closing alkyne metathesis 
RCM ring-closing metathesis 
ROM ring-opening metathesis 
ROMP ring-opening metathesis polymerization 
RT or r.t. Room temperature 
Salen N,N’-ethylenebis(salicylideneiminato)bis(salicylidene)ethylenediamine 
sec secondary 
SEM 2-(trimethylsilyl)ethoxymethyl 
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SET single electron transfer 
SIMES N,N’-disubstituted 2,3-dihydro-1H-imidazol-2-ylidene 
TASF tris(diethylamino)sulfoniumdifluorotrimethylsilicate 
TBAF tetra-n-butylammonium fluoride 
TBAI tetra-n-butylammonium iodide 
TBHP tert-butyl hydroperoxide 
TBDMS (TBS) tert-butyldimethylsilyl 
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It would be erroneous to believe that Total Synthesis is either a mere copy of Mother Nature 
or an arrogant human game of creation in the name of our conceptual God and Faith. To 
scheme out the structure and an efficient approach of natural products is intrinsic to this 
discipline, as this would provide access to a multitude of analogues, in view of a better 
understanding of their biological activities. But this does not mean that all the chemically 
modified or laboratory-made substances have never existed at any moment in the world, or 
the naturally occurring products cannot meet human expectations. As there must be a 
constant union between cause and effect1, all natural substances have their inherent role in 
existence, whereas Total Synthesis chemists wish to modify these compounds to suit some 
expected biological activities, solely for the sake of humankind. Giving that human beings are 
also part of the Cosmos, chemical substances that are believed to be acquired through human 
imagination and accomplishment should be consequently fruits of the universe, either are they 
the exact reproduction of Nature or a target-oriented modification. Hence synthetic chemists 
do not pretend to surpass the efficiency or essence of Nature. We simply follow Nature’s  
evolution. 
Foreword viii 
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1 INTRODUCTION 
1.1 Resorcylic acid lactones (RALs)  
 
Little is known of the real biodiversity of the fungus kingdom which has a worldwide 
distribution, inhabiting even the extreme environments ranging from very high salt 
concentration areas to deserts or ionising radiation regions. Some of these organisms, 
commonly known as moulds, grow in the form of multicellular filaments and produce toxic 
secondary metabolites called mycotoxins. The production of mycotoxin is not indispensable for 
the intrinsic growth or development of the fungus, but may facilitate its proliferation into 
colonies, in particular by weakening the receiving host which provides organic matter. 
However, from a human point of view, these compounds have revealed a valuable research 
avenue for drug discovery. Among them are a family of mycotoxins produced via a unique 
polyketide biosynthetic pathway,2 which are named resorcylic acid lactones (RALs).   
 
One common characteristic of these natural products is the macrolactone (≥ 12), which are in 
general referred to as “macrolides”. In particular, resorcylic acid lactones (RALs) are a family of 
benzannulated macrolides.3 Their name originates from the structure containing a partially 
substituted β-resorcylic acid scaffold accolated with a 12- or 14-membered lactone. These 
naturally occurring compounds present a similar squeletal structure which differs by the 
arrangement of a limited number of functional groups, and despite only small structural 
variations, they display an astonishingly and unexpectedly wide spectrum of biological 
activities.Some examples of RALs are presented in Figure 1. 
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Figure 1: Representative members of the resorcylic acid marolactones 
 
The first isolated macrocycle of this family is radicicol (1) (monorden) in 1953 from 
Monocillium nordinii4then Nectria radicicola.5 It is at the beginning known to be an antifungal 
and a potent tranquilizer of low toxicity.6In 1962, the  anabolic, uterotrophic metabolite 
zearalenone (2) was extracted from corn infected with Gibberella zeae (which was fed to 
swine)7, followed by the isolation from unidentified fungus of LL-Z1640-2 (3) in 1978, whose 
biological activities except anabolic and estrogen-like one didn’t raise any particular interest at 
that time.8 α-zearalenol (produced by Fusarium roseum growing in cereals), which is the 
reduced form of zearalenone (2) and three to four times as estrogenically active, was initially 
identified around 19799, while hypothemycin(6) (isolated from a strain of Hypomyces 
trichothecoides) was closely reported to be an antibiotic metabolite of Pyrenomycetes in 
1980.10 However it was only in the early 1990s that these naturally occurring compounds 
started to earn awareness of organic chemistry community, who was intrigued by radicicol 
(1)’s reversal of Src-transformed morphology of fibroblasts and attribution to the inhibition of 
the oncogenic kinase Src.11 The potent and selective inhibitor effect of radicicol (1) on the 
HSP90 (heat shock protein 90)12 responsible for the maturation and stability of several 
oncogenic proteins (e.g. Src) and the belief Hsp90 be in an activated form in cancer cells 
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(clients of Hsp90 rather involve in the tumor genesis than tumour suppression)13 propelled 
radicicol to the front stage of chemotherapeutic treatment.  
 
Meanwhile, the targeted therapy entered the long-lasting cancer fights as it works by 
influencing the processes that control growth, division, and spread of cancer cells, as well as 
the signals that cause cancer cells to die naturally (the way normal cells do when they are 
damaged or old). Yet the MAP kinases, discovered approximately 27 years ago, together with 
their immediate upstream regulator,14 collaborate in transmitting various extracellular signals 
and thus control a large number of various and even opposing cellular processes such as 
proliferation, differentiation, development, stress response, survival and apoptosis.15 Four 
MAPK cascades have been identified in the last 24 years and those are usually named 
according to the MAPK components that are the central building blocks of each of the 
cascades16. In a general way, a stimulus switches on the activator which phosphorylates the 
first kinase (MAPKKK), which in turn phosporylates the second kinase (MAPKK), which repeats 
the same process on the third kinase (MAPK), that decisively activates a cytosolic protein or 
transcription factor.17 To date, three classes of mitogene activated protein kinases have been 
identified: the ERKs (extracellular signal-regulated kinases), the JNKs (c-Jun N-terminal kinases) 
and the p38 MAP kinases. While unregulated activation of these MAP kinases can result in 
oncogenesis, their tight control and specific inhibition, on the other hand, may open a 
potential therapeutic pathway against cancer.  
 
For these reasons, since 1998, when Williams et al. discovered the microbial compound RO 09-
2210 inhibits activated biochemically purified MEK in vitro (IC50= 0.06 μM),18 followed by the 
report from the Merck group of Zhao, in 1999, about the noticeably irreversible inhibition of 
MEK of L-783,277 (7) and hypothemycin (6),19 the RALs have resuscitated interest from organic 
chemists. In particular, various RALs and RALs analogues containing a cis-enone moiety are 
reported to be more effective (in comparison to the trans isomers (14))19 ATP-competitive 
irreversible inhibitors of MAP kinases, which led to the hypothesis of  a covalent interaction 
between the α,β-unsaturated ketone within the macrolactones and the active site of the 
kinases. 
 
 
 
Figure 2: L-Z1640-2 (8), L-783,277 (7) and its E-isomer 
 
Radicicol A (5), another cis-enone containing RAL was first disclosed in 1996 by the Sandoz 
group of Kastelic et al. to inhibit interleukin  (IL-1β), a major mediator of inflammation, as well 
as tumour necrosis factor (TNF-α)  secretion from THP-1 cells.20 This fungal metabolite, if 
added to cells activated by interferon gamma and lipopolysaccharide, also induced an 
extremely rapid degradation of IL-1β, IL-6 and TNF-α mRNA to undetectable levels within 5-8 
h. However no further study has identified its molecular target until 2007, when Winssinger’s 
group confirmed the necessity of the cis-enone moiety in the inhibition activity (low 
nanomolar range) against VEGF-R2, VEGF-R3, FLT3, and PDGFR-β. In this same report, none of 
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the products lacking the cis-enone showed significant activity against a panel of 24 
therapeutically relevant kinases.21 
 
Anterior to this work, in 2003, the LL-Z1640-2 (FR148083) (3), isolated from an unidentified 
fungus Lederle Culture Z1640,8 was proven to block pro-inflammatory signaling by selectively 
inhibiting TAK1 (IC50 = 8.1 nM) in an ATP-competitive way22.  In agreement with Zhao et al.’s 
1999 publication19, among the seven RALs submitted to the inhibition tests, the structurally 
related compounds but devoid of cis-enone moiety (e.g. radicicol (1)) had little inhibitory 
activity with an IC50> 10 μM. The in vivo test was carried out on picryl chloride (PC)-induced ear 
swelling undergone by mice as a model. Besides, LL-Z1640-2 (3) showed an inhibition against 
MEK1 (IC50 = 411 nM) which is 50-fold lower than that of TAK1, a MAPKKK involved in the p38 
MAP kinase signaling cascade of pro-inflammatory signals. At the end of 2006, Ohori et al. 
published the X-ray crystal structure of the ERK2/LL-Z1640-2 (3) adduct revealed that the 
compound binds to the ATP-binding site of ERK2, involving a covalent bond of ERK2 Cys166 
and the C8’ of the Z-ketone.23 This appealing basis for future inhibitor design was shortly 
preceded by an attractive modeling study focusing on another cis-enone RAL: hypothemycin 
(6).24 
 
Indeed, in March 2006, Schirmer et al. published a bioinformatic study, where  hymothemycin 
(6) was screened against  a panel of 124 kinases and 18 out of 19 putative Cys-containing RAL 
targets were inhibited.24 A structural-bioinformatics analysisidentified a Cys residue that is 
conserved in the ATP site of Ser/Thr/Tyr protein kinases reported to be inhibited by cis-enone 
RALs but absent from those that are not. This same approach also revealed that only a subset 
of 46 protein kinases (out of 510 identified from the human kinome sequence database) 
possess the Cys residue, which shed light on the specificity of the inhibitors. Additionally, 
kinetic analyses showed time-dependent inhibition, a hallmark of covalent inactivation, which 
was in line with the biochemical studies of the interaction of ERK2 with hypothemycin (6). This 
publication confirmed the hypothesis concerning the irreversible inhibition of MEK by L-
783,277 (7) earlier submitted by Zhao.19 Two years later, Rastelli et al. solidly supported the 
previous molecular modeling with the determination of the 2.5 Å resolution crystal structure 
of ERK2 covalently bound to hypothemycin (6).25 The most recent investigation by Winssinger 
et al. revealed that both LL-Z1640-2 (3) and hypothemycin (6) are competitive ligands for the 
ATP-binding pocket.26 
 
Aigialomycins A (15), B (16), C (17), D (9), E (18) and dihydrohypothemycin (19) (scheme 3) 
were first isolated in 2002, together with the known hypothemycin (6), from the mangrove 
fungus Aigialus parvus BCC 5311 by the Thailandese team of Isaka.27 They found out that both 
aigialomycin D (9) and hypothemycin (6) were moderate antimalarial (respectively, IC50 = 6.6 
μg/mL and 2.2 μg/mL against Plasmodium falciparum K1) while other structurally close 
aigiaglomycins inactive in the same assays. Recently, Winssinger et al. disclosed that 
aigiaglomycin D (9) inhibits CDK1/cyclin B and CDK5/p25 at 5.7 and 5.8 μm, respectively, as 
well as GSK-3 at 14 μm but much less PfGSK-3, the Plasmodium homologue of GSK-3.28 This 
discovery further supports the hypothesis that the RALs constitute a promising scaffold for ATP 
antagonism/kinase inhibition. 
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Figure 3: Aigialomycins A (15), B (16), C (17), D (9), E (18) and dihydrohypothemycin (19) 
 
Pochonins and in particular pochocin C(8) were isolated from cultures of the mould Pochonia 
chlamydosporia var. catenulata strain P 0297.29 Unexpectedly,pochonin C (8) which is closely 
related to radicicol (1) was found to be poor Hsp90 inhibitor, contrary to radicicol (1),12 
whereas it inhibits Herpes Simplex Virus (HSV) replication with a significant therapeutic 
window.29 This divergence could be rationalised by their different conformations in solution.30 
Interestingly, pochonin A (4), structurally closer to radicicol (1), was proven to be a competitive 
antagonist of ATP for Hsp90 (90 nM).31 
 
Recently, two new subgroups of RALs were unraveled, namely paecilomycins A-F isolated from 
Paecilomyces species SC0924 by Xu et al. in 2010 32 (scheme 4) and cochliomycins A-C (26-28) 
from the culture broth of Cochliobolus lunatus, a fungus obtained from the gorgonian 
Dichotella gemmacea collected in the South China Sea by the team of Shao in 2011 (together 
with the E-isomer of LL-Z1640-2 (3),and paecilomycin F (7)).33 Among these, paecilomycin E 
(24)exhibited antiplasmodial activity against Plasmodium falciparum line 3D7 with IC50 values 
of 20.0 nM, and paecilmycins E (24)and F (25)showed moderate activity against the 
P.falciparum line Dd2.32 As cochliomycin A (26), possessing the acetonide moiety, exhibited 
moderate antibacterial activity against S. aureus, with an inhibition zone of 11 mm in diameter 
at a concentration of 50 μg/mL, the authors suggested it be useful as environmentally benign 
antifouling agent.33 
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Figure 4: Paecilomycins A-F (20-25) and cochliomycins A-C (26-28) 
 
 
In 2013, bioassay-guided fractionation of an unidentified fungal species Neocosmospora 
allowed the isolation of three new RALs, neocosmosins A-C (29–31)34; among these, 
neocosmosin C (31) exhibited potent and full agonistic activity against the human δ-opioid 
receptor. From the same extraction also radicicol (1) was isolated and interestingly, this first-
discovered compound of the RALs family also showed potent binding affinities at the μ-opioid 
receptor. Consequently, the longstanding interest for radicicol (1) from the organic chemist 
community will contribute to the structure and activity relationship study of this class of 
compound.  
 
 
 
Figure 5: Neocosmosin A-C (29-31) 
 
To date, several bioactive natural RALs have been the targets of total syntheses, designing the 
general synthetic strategies that usually involve olefin metathesis catalysed by Grubbs catalyst 
or alkyne metathesis as the key step, together with some other classical chemical reactions 
(e.g. the Suzuki coupling reaction, the Stille coupling reaction, the Wittig reaction, the 
Mitsunobu reaction, etc). As an overview of the growing synthesis field, only some selected 
examples are described in details in this chapter to highlight the diverse chemical 
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approacheswhich imitate and confront the boundaries of human creativity with the diversity 
of natural products.  
The examples highlighted hereafter begin with the syntheses of zearalenone (2), the earliest 
synthetic target of the family. They illustrate a brief historical perspective of total synthesis of 
RALs and shed light on the competitive development of visionary synthetic strategies, at first 
applied to the “ancestral member” of the natural RALs, e.g. zearalenone (2).   
The second representative molecule of our choice is aigialomycin D (9), one of the RALs 
discovered in the 21st century. The syntheses of this metabolite give an overview of our 
modern synthetic mindset and instruments, especially the most popular among the chemists 
community. These methods emphasise how early investigations of the “simplest” natural 
products can build a solid basement for innovative concepts.          
The general numbering of the atoms composing the structural frame of RALs is illustrated in 
Figure 6 below.  
 
Figure 6: General number assignment for RALs’ structural frame    
1.1.1 Synthesis of zearalenone (2) 
 
O
O
OH
HO
O Me
 
Figure 7: zearalenone (2) 
 
Produced mainly by fungi belonging to the genus Fusarium in foods and feeds, zearalenone (2) 
has been frequently involved in reproductive disorders observed in farm animals, especially in 
swine, since the first report of its toxicity of the abovementioned agricultural damaging 
fungus.35 
With the structural identification of zearalenone (2) in 1966, the late 1960s witnessed several 
total syntheses as a response to the widespread interest in the anabolic and oestrogenic 
properties of this metabolite implicated in hyperoestrogenic syndromes in humans.  .  
Between the first total synthesis of 2, published in 196736  and the latest one in 2013,37 more 
than 11 syntheses have been accomplished. Generally, the limiting step was the formation of 
the 14-membered ring which relied on an intramolecular ring-closure, especially the cyclisation 
of the seco-acid. Several approaches have been developed, setting the stage for the 
application of conceptually innovative methodologies, namely the remarkable progresses 
made by Corey and Nicolaou 38 and independently in the same year as Masamune’s group.39 
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Scheme 1: Macrolactonisation methods by Corey and Nicolaou,38 and Masamune et al.39 
 
The first total syntheses of 2 accomplished by the Merck and Syntex groups were 
disadvantaged by a low yield for the late-stage lactonisation of the related 14-membered seco-
acid (less than 31%).36 In order to illustrate the efficiency of their newly developed 
methodology, Corey and Nicolaou preactivated the benzoic acid function of 32 as a 2-
pyridinethiol ester 34 before closing the macrocycle in refluxing benzene (scheme 1). The 
overall yield was 75% after the ultimate deprotection to release the target 2.38 Meanwhile, the 
group of Masamune also proposed a similar method transformed the corresponding acid 
chloride of 32 into tert-butyl thiol ester 35 in the presence of mercuric acetate at room 
temperature to yield the zearalenone methyl ether 36 in 90%.39 
 
 
 
Scheme 2: Macrocyclisation protocol based on olefination via ω-iodoalkyl 2-phenylthiomethyl- 
4,6-dimithoxybenzoate (39) by Tsuji et al. 
 
Four years later, the research group of Tsuji reversed the synthetic sequence by synthesising 
the intermediate 39 via the addition of the 2-phenylthiomethyl-4,6-dimethoxybenzoyl chloride 
37 to the hydroxyl iodide 38 (scheme 2). This intermolecular ester formation proved to be 
much more efficient than the related intramolecular macrolactonisation. The 14-membered 
ring was accomplished upon treatment of the iodoalkyl phenylthioacetate 39 with KHMDS 
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(85%), followed by an oxidation/ elimination to yield the corresponding macrocyclic E-alkene. 
The success of this strategy marked the first of a series of syntheses which include a late-stage 
ring-closure at either C1’-C2’ or C2’-C3’ bond as a direct application of the newly developed 
methodologies, as well as the growing concern in asymmetric synthesis. 
While the first syntheses resorted to a subsequent chiral resolution to procure the naturally 
occurring (S)-zearalenone (2), the first total syntheses of the optically active metabolite were 
reported in the early 1990s, to begin with that by Pattenden and Hitchcock.40 Their ring-closing 
strategy was based on a 14-endo-trig macrolactonisation from a cinnamyl radical intermediate. 
In the same year, the group of Solladié published their synthesis which induced the 
configuration of the C10’ by a chiral β-keto sulfoxide.41 
One year later, Stille and Hedgedus successfully applied the intramolecular Stille coupling 
between a vinylstannane and an iodide, as part of a series of carbon-carbon bond formation 
towards the cyclisation of 10- to 15-membered β-resorcylic macrolides.42 The synthetic 
approach implicated a Mitsunobu based esterification of 2-halo- or 2-trifloxybenzoic acids (e.g. 
2-iodobenzoic acid) with (E)-vinylstannyl alcohols, followed by the intramolecular coupling of 
the vinylstannane with the aryl electrophile. The (R)-propylene oxide 40 was opened by 
vinylmagnesium bromide in the presence of CuI to provide the optically pure secondary 
alcohol 41, which was subjected to the next 6 transformations leading to the obtainment the 
hydroxy vinylstannane 42 (scheme 3).  
 
 
 
Scheme 3: Stille coupling applied to the macrocyclisation in solution-phase and solid-phase 
syntheses  
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Being at the heart of the emergence of combinatorial chemistry and solid-phase synthesis in 
the late 1980s and early 1990s, Nicolaou et al. reported a novel solid-phase synthetic tool for 
the macrocyclisation that employs the Stille coupling cyclorelease (scheme 3). The E-vinyltin 
polymer 47 was prepared from the Merrifield resin 45, which was first transformed into the 
polymer-supported tin chloride (PBTC) 46. Esterification under Mitsunobu conditions between 
47 and carboxylic acid 46 gave the desired precursor 48, setting the stage for the cyclorelease 
which  smoothly took place in the presence of the polymer-supported [Pd(PPh3)4] catalyst and 
an ultimate acidic deprotection completed the total synthesis of optically pure (S)-zearalenone 
(2). As expected, the ring-closing Stille coupling did not give place to any Z-isomer of 2. 
 
In 2000, the group of Fürstner published, as part of their program on the ring-closing 
metathesis (RCM) as a general and viable tool for syntheses of natural products (since 1997), 
another synthesis of (S)-zearalenone (2) as illustrated in scheme 4 beneath.43 
 
 
 
Scheme 4: Ring-closing metathesis applied to the synthesis of (S)-zearalenone (2) by Fürstner 
et al.43 
 
The penultimate step consists in a strategically pioneer RCM to introduce the double bond at 
the benzylic position followed by the demethylation under acidic conditions. Their synthetic 
scheme included a Stille coupling to install the benzylic double-bond, which was also prepared 
by a Heck coupling for practical convenience. The diene precursor 52 was prepared from the 
commercial (R)-(+)-propylene oxide 40 which was first opened in the presence of catalytic 
CuCl(COD) and vinylmagnesium bromide. It is worth mentioning that even though the planified 
Mitsunobu based esterification to join fragment 49 with the readily prepared phloroglucinol 
acid derivative 50, as well as the subsequent Heck coupling to build the benzylic alkene and the 
crucial RCM would not interfere with the ketone function, as proven by the racemic synthesis 
of zearalenone.43 The loss of optical activity of the alcohol would have been caused by a 
reversible intramolecular hydride shift (scheme 4).44 Nonetheless, the release of the ketone 
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could be carried out by the final deprotection under acidic conditions to afford the target 
compound 7. They reported a superior reactivity of the 2nd generation Grubbs’ catalyst 54 
(91% of yield) in contrast to the complete failure in case the 1st generation Grubbs’s catalyst 
53. Moreover, the RCM catalysed by 54 provided exclusively E-isomer.  
 
The same ring-closing metathesis to build the E-alkene at C1’-C2’ featured in the biomimetic 
synthesis of (S)-zearalenone (2), among other resorcylate natural products, that was issued in 
2008 by Barrett et al. 45 Their synthetic scheme involves a late-stage aromatisation of triketo-
ester 57 which consisted in an aldol condensation under strongly basic conditions (KOMe in 
methanol) with subsequent dehydration and aromatisation assisted by strong acid (HCl in 
methanol) (scheme 5). The triketo-ester 57 resulted from the thermolysis of the dioxinone 56 
(at 110°C in toluene) to release the ketene which was then trapped in situ by alcohol 55. The 
unmasked ketone function, under acidic conditions, would not interfere with the scheduled 
RCM as described by Fürstner et al. in their racemic synthesis of zearalenone. Indeed, the RCM 
smoothly proceeded in the catalytic presence of 2nd generation Hoveyda-Grubbs catalyst 59 to 
provide the desired final product (E/Z: 8/1). Interestingly, the four-step synthetic sequence 
could also be carried out without intermediate purification, or in some cases a simple but 
yield-increasing filtration of Dowex resin, and subtle modification of the reaction conditions to 
lead to the same result. Besides, attempts of RCM with the 2nd generation Grubbs catalyst 54 
only gave unyielding mixtures containing (S)-zearalenone (2). Noteworthily, the late-stage 
aromatisation method proved to be highly compatible with fragile functions and hence 
promising for syntheses towards more complex biologically active targets. 
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Scheme 5: Biomimetic syntheses proposed by Barrett et al.45-46 
 
Two years later, the same research group proposed an alternative approach to the same 
mycotoxin, which exploited their previously developed “transannular aromatisation”, followed 
in situ by a total deprotection, as the finalising steps to achieve the target molecule 2, avoiding 
a RCM.46 The macrocycle 62 was prepared by a retro-Diels-Alder fragmentation, on heating, 
resulting in a ketene which was intramolecularly trapped by the intramolecular secondary 
alcohol.  The intermediate 61 was obtained, with good E/Z selectivity (> 20:1) by a cross-
metathesis (CM) between the alcohol 55 and keto-dioxinone 60. Though their first total 
synthesis featuring an aromatisation from a tri-ester was closely inspired from the 
biosynthesis, the very late-stage transannular aromatisation of the second approach 
remarkably mimics Nature’s pathway leading to resorcylate natural products. 
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Scheme 6: Synthesis of (S)-zearalenone (2) proposed by Murphy et al.47 
 
In the same year, Napolitano and Murphy described a synthetic sequence that involved a 
modified Horner-Wadsworth-Emmons (HWE) olefination for the macrocyclic formation, 
resulting in the enone intermediate 66 (scheme 6).47 The applicability of this novel synthetic 
strategy was first proven by the successful total synthesis of (S)-zearalenone (2), which was 
retrosynthetically disconnected at the C7’-C8’ bond, necessitating the preparation of 67a and 
67b.  
 Indeed, the latter derived from a Hoveyda-Grubbs II-assisted cross metathesis with the 
resorcylate intermediate 64 to implant the C1’-C2’ double bond as single E-isomers of the 
phosphonate. The resorcylate ester 64 resulted from a Mitsunobu based esterification 
between the optically pure alcohol 64 and resorcylate 64, obtained from 2,4,6-
trihydroxybenzoic acid 63. According to the authors, the choice of 67a (Still-Gennari 
phosphonate) and 67b (Ando phosphonate) was based on usual reporting of cis-enones when 
these reactants were used, which would extend the strategy to the preparation of other cis-
resorcylides, e.g. LL-Z1640-2 (3). Unfortunately, the intramolecular olefination, promoted by 
NaH in THF at 0°C, only gave E-isomer 68 in 77% and 62%, respectively. The subsequent 
chemoselective reduction of C7’-C8’ double bond was successfuly carried out with the 
copper(I) hydride cluster [(Ph3P)CuH]6 in THF in 82% of yield. Conceptually, as the order of 
coupling 64-67 was possible in all permutations, intermolecular olefination would prepare the 
testing field for novel ring-closing strategies. 
 
In 2011, Yadav and Murthy reported another convergent total synthesis of (S)-zearalenone (2), 
together with its unseparated congeners α-zeranol and β-zeranol, a powerful oestrogen and 
animal growth- promoting agent,48 as both proceeded via same C6’-alcohol precursor. Their 
synthetic strategy involves a Diels-Alder reaction to construct the resorcylate moiety 69, which 
was fused with the functionalised polyol alkene 72 via a Mitsunobu-based esterification, 
followed by a 2nd generation Grubbs catalysed  RCM (scheme 7). The styrene 69 was prepared 
by a Diels-Alder reaction between the diene 70 and the dienophile 71. The open chain of the 
macrocyclic backbone 72 was synthesised from 5-hexen-1-ol  73. A more detailed synthesis will 
be exposed in section 3.3.2.  
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Scheme 7: Retrosynthesis of (S)-zearalenone (2) by Yadav et al.48 
 
The latest synthesis of (S)-zearalenone (2) was reported by Baggerlaar and Minnaard in 2013.37 
Their synthetic strategy also consisted in a late-stage RCM to install the 14-membered 
macrocycle, preceded by an ester formation (scheme 8). The macrocyclic chain was prepared 
in 9 steps, starting with a copper/Taniaphos asymmetric allylic methylation by MeMgBr onto 
the commercial 74 to afford intermediate 75 in remarkable enantioselectivity (98% ee). 
Hydrolysis of 75 and protection of the released alcohol afforded 76 which underwent a 
hydroboration to give the corresponding alcohol selectively, followed by an iodination. The 
lithiation of the readily prepared dimethylhydrazone 78 allowed a regioselective addition onto 
the iodide 77 in high yield. The authors decided to protect the ketone before unmasking the 
secondary alcohol, in order to preserve the optical purity of the secondary alcohol, as it was 
described by Wendler et al. in their first total synthesis of zearalenone.44 
The starting aromatic moiety remained the same (64) as described by Napolitano and Murphy 
(scheme 6),47 however their esterification method relied on the formation of acyl fluoride in 
the presence of cyanuric fluoride, prior to the addition of potassium alkoxide derived from 
fragment 81. Due to the severely steric hindrance of the acid function, the authors have also 
noticed a fruitless esterification by means of Yamaguchi reagent or carbodiimide-based 
coupling reagents. These results had been previously mentioned by Fürstner et al. in their 
attempts towards the total synthesis of cruentaren A.49 To overcome the bulky resorcylate, 
they found out that fluoride would be the appropriate leaving group thanks to its very small 
size. The subsequent RCM smoothly provided a protected resorcylate macrolactone, which 
was first unmasked at the ketone function under acidic condition to furnish 84.  Demethylation 
was based on the procedure described by Maier and co-workers in their efforts to elucidate 
the effect of an allylic methyl group in zearalenone analogues.50 
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Scheme 8: Synthesis of (S)-zearalenone (2) proposed by Baggerlaar et al.37 
 
Since the first racemic synthesis of zearalenone (2)36 until its latest catalytic asymmetric 
synthesis in 2013,37 many of the syntheses relied on either the racemate, or kinetic resolution, 
or natural chiral pool, or on chiral auxiliaries, or enzymatic approach leading to the chiral 
building blocks, or enantioselective catalytic allylic alkylation. The macrocylic closure has also 
witnessed remarkable progresses, either based on various macrolactonisation methods or 
olefination approaches (e.g. Julia-Kocienski olefination, Stille coupling or ring-closing 
metathesis).  
 
Another member of the RALs family which also contains a trans C1’-C2’ double bond is 
aigialomycin D (9), which bears an additional trans-olefin at C7’-C8’. Through various structure-
activitie studies, it was found that the C7’-C8’ trans-configured RAL, such as radicicol (1) 
(containing a trans-epoxide) and pochonin D (containing an E-alkene), inhibit HSP90 by a 
competitive binding at the ATP-binding site.51 Behaving like an outlier among the reported 
RALs, aigialomycin D (9) does not inbibit Hsp90, in spite of its trans C7’-C8’ double bond, and 
exhibits instead moderate inhibition of kinase similar cis-enone bearing RALs.52 
 
The unsusual activities of aigialomycin D (9) and its intriguing structure have led to a series of 
novel synthetic routes towards this metabolite, as well as its analogues. 
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1.1.2 Synthesis of aigialomycin D (9) 
 
 
 
Figure 8: aigialomycin D (9) 
 
Isolated in 2002 from a mangrove fungus Aigialus parvus BCC 5311 by Thailandese 
researchers,27 the first total synthesis of this bioactive secondary metabolite was realised 2 
years later,53 and the latest total synthesis was published in 2009.54 Most of the syntheses 
developed for aigialomycin D (9) feature a RCM. 
 
The first total synthesis of aigialomycin D (9) was reported by Danishefsky et al. in 2004.53 The 
key steps feature a Diels-Alder reaction using a disiloxydiene 85 and a 14-membered “ynolide” 
86 as the dienophile, a RCM to introduce the E double bond C7’-C8’and a Martin’s sulfurane 
conditions to construct the benzylic alkene (scheme 9). 
 
 
 
Scheme 9: Synthesis of aigialomycin D (9) by Danishefsky et al.  Reagents and conditions : a) 
2-methoxypropene, p-TSA, DMF, 3 h, 62%; b) KHMDS, Ph3P+CH3I-, THF, -78°C to RT, 10 h, 68%; 
c) PivCl, Et3N, DMAP, DCM, 10 h, 90%; d) 9-BBN, THF, 0°C to RT, 4 h, then NaOH, H2O2, H2O, 2.5 
h, 88% ; e) SO3.Pyr, DMSO, DCM, Et3N, 0°C, 1 h; f) propargyl bromide, Zn, THF, 0°C, 2 h; g) 
TBSOTf, 2,6-lutidine, DCM, 10 h, 89% over 3 steps; h) NaOMe/MeOH, 10 h, 88% ; i) SO3.Pyr, 
DMSO, DCM, Et3N, 0°C, 2 h then KHMDS, Ph3P+CH3I-, THF, -78°C to RT, 10 h, 86% over 2 steps; j) 
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BuLi, dry ice, -78°C to rt, 2 h; k) 41, DIAD, PPH3, toluene, 10 h, 85% for 2 steps ; l) Co2(CO)8, 
toluene, 30 min, 94% ; m) 2nd generation Grubbs catatlyst 54 (25 mol %), DCM, 10 h; n) CAN, 
acetone, -10°C, 15 min, 95%; o) 85, neat, 140°C, 36 h, 84% ; p) MOMCl, DIPEA, DCM, 10 h, 83%; 
q) HF-pyr, pyr, THF, 10h, 87%; r) [PhC(CF3)2O]2SPh2, DCM, 0°C to RT, 2 h, 84%; s) 0.5 N HCl, 
H2O/MeOH, 2 days, 69%. 
 
The “ynolide” 86 was obtained in 15 steps from 2-deoxy-D-ribose (89) which provided the C5’-
C6’ anti-diol in the right configurations. The pentose was submitted to a sequence of 
protection, Wittig olefination, hydroboration, oxidation, propargylation then protection to 
provide the intermediate 91 bearing the much triple bond and one terminal alkene. The other 
olefin extension was built through addition of the derived alkynyl lithium of 92 onto carbon 
dioxide, followed by Mitsunobu reaction with the alcohol 4, giving rise to the R ester 93. It is 
worth noting that previous to the RCM, it was necessary to mask the ethynyl linkage as its 
dicobalt hexacarbonyl complex, which would be easily removed under oxidative reaction. This 
protection of the alkyne avoided the diversion to an ene-yne metathesis while distorting the 
alkyne geometry to favour the metathesis by bringing the carbons C7’ and C8’ closer in space. 
RCM was easily accomplished, using 2nd generation Grubbs catalyst 54. Only the E-configured 
double bond was obtained, and their decomplexation revealed the “ynolide” 86, which was 
subjected to the pivotal Diels-Alder reaction with 85. The cycloaddition turned out to be 
successful for both stereoisomers. The dehydration of C1’ alcohol under Martin’s conditions55 
smoothly proceeded to install the styrene like double bond, proving especially the useful MOM 
protection of the phenol groups. The final deprotection under acidic condition released 
aigialomycin D (9), completing the 18-step synthesis in an overall yield of approximately 8%. 
 
 
In 2006, two other total syntheses of aigialomycin D (9) were disclosed by Winssinger et al.28 In 
hope of enlarging the diversity of RAL beyond the naturally available RAL analogues, the group 
of Winssinger became interested in the aigialomycins. As described previously, the general 
synthetic blueprint was a direct alkylation at benzylic position by means of the stabilised anion 
derived from a thio- or selenoether at the benzylic position (scheme 10). The 
macrolactonisation was carried out through RCM. The trans diol was obtained through 
Sharpless asymmetric epoxidation/Sc(OTf)3-catalysed opening. 
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Scheme 10: Retrosynthesis of aigialomycin D (9) by the group of Winssinger 
 
In the same year, the third total synthesis was published by Pan et al.56 The key features are 
the use of Julia-Kocienski olefination to create both E olefins and a Yamaguchi based 
macrolactonisation (scheme 11). The polyketide fragment 87 was obtained in 10 steps from 
prop-2-yn-1-ol (103). The anti-diol was formed via Sharpless asymmetric epoxidation and a 
titanium-assisted regioselective opening. The first Julia-Kocienski coupling afforded the 
benzylic olefin 103, prior to the second one which furnished the precursor 104 containing all 
the needed functionalities. Operated under thermal conditions (refluxing during three day), 
the Yamaguchi based macrolactonisation gave rise to the macrocycle in 51% yield. This step 
fulfilled the formal synthesis of aigialomycin D (9), as the fully protected metabolite was 
identical to that reported by Danishefsky. 
 
 
 
Scheme 11: Synthesis of aigialomycin D (9) by Pan et al.56 Reagents and conditions : a) 
BnOCH2CH2CH2I, BuLi, HMPA, -78°C, 8 h, 70%; b) LiAlH4, THF, reflux, 1 h, 96%; c) Ti(O-iPr)4, 
TBHP, (-)-DIPT, cat. CaH2, DCM, -25°C, 12 h, 89%; (d) Ti(OiPr)4, PhCO2H, DCM, rt, 15 min, 75%; 
e) EtMgBr, ether, RT, 1 h, 95%; f) PivCl, Et3N, DMAP, DCM, RT, 10 h, 88%; g) 2-
methoxypropene, PPTS, DCM, RT, 5 h, 95%; h) 10% Pd/C, H2, EtOH, RT, 4 h, 95%; i) 1-phenyl-
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1H-tetrazole-5-thiol, DIAD, PPh3, THF, 0 °C to rRT, 1 h; j) m-CPBA, NaHCO3, RT, DCM, 12 h, 81% 
for two steps; k) KHMDS, DME, -60°C to RT, 3 h, 68%; l) DIBAL-H, DCM, -78 °C, 1 h, 96%; m) 
Dess–Martin periodinane, DCM, rt, 2 h, 85%; m) 100, KHDMS, DME, -60°C to RT, 3 h, 58%, n) 
TBAF, THF, RT, 8 h, 95%, o) BuLi, CO2, THF, -78 °C to RT, 2 h, 83%; p) 2,4,6-
trichlorobenzoylchloride, Et3N, THF, RT, 2 h, then DMAP, toluene, reflux, 36 h, 51%; q) 0.5M 
HCl, H2O/MeOH, RT, 2 d, 70%. 
 
From the first isolated macrolide radicicol (1) in 19534 to the polyketides cochliomycins in 
2011,33 more than 30 naturally occurring RALs have been isolated, characterised and have 
undergone extensive bioactivity screening and therefore revealed powerful biological activities 
with respect to estrogenic, antifungal, antimalarial, antiviral, cytotoxic effects and nematicidal 
properties.  
 
Historically, the high-throughput screening approach has efficiently led to the discovery of 
many type 1 ATP-competitive inhibitors out of compound libraries. Until now, most of the 
scaffolds able to serve as ATP-competitive ligands have been successfully identified, which 
leaves this method to be restrictively of use when a kinase with an unusual active site is 
screened or when allosteric inhibitors are specifically being sought.57 At the dawn of 
computational philosophy of science, combination of methods evolving analogue synthesis, 
structure-informed design and fragment-based assembly strategies, have become the 
prevailing paradigm. 
 
 
The next chapter deals with a specific subset of RALs composed of 4 metabolites which contain 
a cis-enone and have been the subject of several total syntheses. An overview of some 
significant retrosynthetic strategies for LL-Z1640-2 (3), as well as 2 detailed pathways towards 
hypothemycin (6) will precede the development of our efforts targeting the naturally occurring 
L-783,277 (7).  
  
1  INTRODUCTION 38 
  
1.2 cis-enone containing RALs 
 
Among the most extensively investigated natural polyketides is a subset of cis-enone 
containing RALs, which exhibit inhibitory activities against ATPases and kinases. The 
mechanism of inhibition is tightly linked to the Michael acceptor nature of the cis-enone 
moiety, which enables covalent binding to the cysteine residue in the ATP-binding pocket 
existing in barely 10% of kinases encoded in the human genome.58 The high potential to find 
new ATPase or kinase inhibitors among this class of natural products, paired with the interest 
of reducing their potential for toxicity as a result of rationalising of anticipated targets, has 
intrigued and challenged the synthetic chemists’ creativity.     
 
 
 
Figure 9: RALs with cis-enone 
 
LL-Z1640-2 (3) was the first isolated RAL member of the cis-enone bearing subfamily (1978),8 
followed by hypothemycin (6) (1980),59 radicicol A (1) (1996)20 and a few years later L-783,277 
(7) and its related lactones (1999).19 Since the report about the inhibition of IL1β activity by 
radicicol A (5), preceded by its identification in the same paper,20 and later the discovery of cis-
enone-containing RALs as kinase inbibitors, total syntheses of all the four naturally occurring 
resorcylides of this family (scheme 17) have been developed over the past decade.  
 
Structurally similar, with the only difference at C1’-C2’as distinctive feature (in addition to the 
meta-methoxy for radicicol A (5)), yet all the four metabolites have been the stage for 
conceptually diverse synthetic routes. Giving the eager isomerisation of the cis-enone to the 
more stable trans-isomer, all the published syntheses of RALs containing a cis-enone featured 
a late-stage oxidation of the vinylic alcohol to reveal the characteristic enone function. 
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1.2.1 Synthesis of LL-Z1640-2 (3) 
 
 
 
Figure 10: LL-Z1640-2 (3) 
 
In 2001, Tatsuta et al. reported the first synthesis of LL-Z1640-2 (3), featuring a Mukaiyama 
lactonisation to generate the macrocycle (scheme 12).60 At first, the Z-alkene C1’-C2’ came 
from a Lindlar reduction of the C1’-C2’ triple bond, which resulted from a Sonogashira coupling 
between iodoresorcylate 113 and the polyol segment 112. Following the Tsuji’s reduction to 
cleave the ethyl carbonate at C3’, the Z-alkene isomerised into its corresponding isomer E. The 
configuration at the C4’ and C5’ was established by D-ribose 111, the starting material for the 
preparation of 112, which included a Corey-Fuchs reaction, closely followed by a Lindlar 
reduction to construct the cis double bond precursor of cis-enone. Selective oxidation of the 
allylic alcohol, the last step to LL-Z1640-2 (3), was proven effective only by use of the Dess-
Martin periodinane reagent (62%), while other methods gave either very poor yield (e.g. DDQ 
gave 20% of yield) or no expected product at all.  
 
 
 
Scheme 12: Retrosynthesis of LL-Z1640-2 (3) by Tatsuta et al. 
 
One year later, Sellès and Lett accomplished the second total synthesis of LL-Z1640-2 (3), 
which suitably led to the first total synthesis of hypothemycin (6) by a tactical epoxidation of 
C1’-C2’ double bond.61 The retrosynthetic scheme ofLL-Z1640-2 (3) is illustrated hereafter 
(scheme 13), and the synthesis of hypothemycin (6) will be detailed in the paragraph 1.2.1. 
The authors performed a Mitsunobu-based esterification to achieve the 14-membered ring 
and a Suzuki coupling for the C1’-C2’ double bond. Conceptually, the order of these 2 steps 
would be permutable, yet it turned out that a Suzuki-based ring closing was far too 
unproductive. The alkene at C7’ was formed by a vinyl addition onto an aldehyde, determining 
the precursor cis-enol. It is worth mentioning that after deprotection of the allylic alcohol, only 
one diastereoisomer could be oxidised under mild conditions (PCC, 2,5-DMP in CH2Cl2), 
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whereas the other required harsher method (Jones oxidation) to be transformed into ketone. 
The anti-diol was constructed via a Sharpless asymmetric epoxidation combined with a 
carbamate-assisted opening of the epoxide. 
 
 
 
Scheme 13: Retrosynthesis of LL-Z1640-2(3) by Sellès and Lett 
 
Another total synthesis of LL-Z1640-2 (3), and consequently the second one of hypothemycin 
(6) (scheme 14), together with the second total synthesis of L-783,277 (7), were disclosed by 
the group of Winssinger in 2009.62 Their synthetic route relied on a macrocyclisation through a 
Mitsunobu-based esterification in the presence of fluorous-tagged triphenylphosphine and 
diazodicarboxylate, and a vinyl addition to introduce the cis allylic alcohol. In an ulterior step of 
the synthetic strategy, the polymer-supported IBX oxidation of the allylic acohol led to very 
interesting outcome. While one isomer cleanly gave the desired macrolactone 3, the other 
afforded a different monooxidation product, supposedly with a ketone at C5’ postion. The 
same issue was independently observed by Altmann et al. in their efforts to synthesise L-
783,277 (7). The requisite C1’-C2’ styryl bond was installed by exploiting a sequence of 
alkylation-oxidation-elimination.  This methodology could be extended to other RALs by 
substituting the selenide with a benzyl sulfide, such as L-783,277 (7) which will be detailed in 
chapter 1.2.3.  
 
 
Scheme 14: Retrosynthesis of LL-Z1640-2 (3) by Winssinger et al. 
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In 2010, Barrett’s group reported the biomimetic total synthesis of 6 without protection of 
phenol, a common point to all the reported syntheses to date.63 Instead, their approach 
features an intermolecular ketene trapping and late-stage transannular aromatisation applied 
to macrocyclic diketo-ester 125 (scheme 15), a strategy which had successfully laid foundation 
for the synthesis of (S)-zearalenone (2) (scheme 15).46 The efficacy of this methodology has 
made it a reliable alternative to the widespread RCM for macrocyclisation. The configuration 
of the anti-diol was also derived from 2-deoxy-D-ribose (89), as described by Winssinger’s 
group within their synthetic pathway. 
 
 
 
Scheme 15: Retrosynthesis of LL-Z1640-2(3) by Barrett et al. 
 
In the same year, Thomas and collaborators published a synthetic approach to LL-Z1640-2 (3) 
which is conceptually similar to that by Winssinger’s group.64  Their synthetic route notably 
made use of an intramolecular Nozaki-Hiyama-Kishi coupling with vinyl iodide for the ring-
closure (scheme 16). Like Winssinger’s group, the authors employed the same selenide 
precursor 129 to construct the benzylic double bond, as well as a Mitsunobu-based 
esterification to complete the carbon framework of 128, setting the stage for the 
macrocyclisation.  
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Scheme 16: Retrosynthesis of LL-Z1640-2 (3) by Thomas et al. 
 
In summary, among all the tactical approaches employed by the aforementioned syntheses of 
LL-Z1640-2 (3), macrolactonisation appears to be the most effective method to implant the 
core ring structure. Intriguingly, the use of RCM as ring-closure to introduce the E-alkene has 
not been reported so far. In 2007, Marquez et al. have detailed the fast and efficient synthesis 
of the triene 133 as the stage for a RCM as an alternative mode to achieve the macrocycle 
(scheme 17).65 However, no attempts of RCM on this precursor have been described so far, 
leaving this proposition an unproven method to access the ring structure of this cis-enone RAL. 
 
 
 
Scheme 17: RCM-based strategy towards LL-Z1640-2(3) proposed by Marquez et al. 
1.2.2 Synthesis of hypothemycin (6) 
 
 
 
Figure 10: hypothemycin (6) 
 
Isolated from the fermentation broth of Hypomyces trichothecoides in 198010a, hypothemycin’s 
structure was first attributed to the 14-membered RALs 2.  More than a decade later, a 
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Japanese group discovered a cytotoxic substance from the crude extract of Coriolus versicolor 
whose physico-chemical properties were identical with those from zeralenone (2).66 A 
thorough reinvestigation lead to the reassignment of hypothemycin’s structure which is the 
cis-enone RAL hypothemycin (4), an epoxide of LL-Z1640-2 (3)- discovered in 1978.8 Initially, 
the metabolite LL-Z1640-2 (3) was synthesised from D-ribose in 2001,60 yet the first total 
synthesis of hypothemycin (6) was only disclosed in 2002 by Sellès and Lett, as an epoxidised 
product of the convergently synthesised LL-Z1640-2 (3).61, 67 
The key features of the synthesis are a Suzuki coupling to form the benzylic olefin, a 
Mitsunobu based macrolactonisation and a selective epoxidation. The Z-alkene was implanted 
through a vinyl lithium derived from the vinyl iodide 117 containing readily the adapted 
absolute configuration for the methyl at C10’.   The terminal alkyne 116 needed for the Suzuki 
coupling at benzylic position was prepared from but-2-yne-1,4-diol 139 which intermediately 
underwent a Sharpless epoxidation followed by a selective epoxide opening to introduce the 
anti-diol at C4’ and C5’. The first attempts to form the 14-membered macrolide via an 
intramolecular Suzuki coupling of vinyldisiamylborane derived from 137 turned out to be 
ineffective (scheme 17). According to the authors, the major difficulty was to get a good turn-
over of the catalyst, at the minimal dilution (0.03-0.04 M) required for minimising 
intermolecular reactions and kinetically compatible with the time scale necessary to adopt the 
appropriate conformations allowing the formation of the palladamacrocycle.  
 
 
 
Scheme 17: Intramolecular Suzuki coupling  by Selles and Lett:61, 67 a) Sia2BH (3.9 equiv.), THF, 
−20°C to RT, 2 h, then addiƟon of acetone (3 equiv.) and aŌerwards 2 M aq. K3PO4 (2 equiv.) at 
−10°C to RT, further addiƟon of that mixture via cannula to a solution of 4 mol% [Pd(OAc)2 + 4 
TFP] in DME, i.e. substrate 0.034 M in DME/H2O (30/1), reflux, 6 h. 
 
The strategy was therefore changed into a Suzuki coupling between 116 and the aromatic part 
116 (scheme 18). This reaction provided the intermediate 143 in satisfactory yield, which 
underwent an orthogonal cleavage of the TBS group to set the stage for the Mitsunobu 
macrolactonisation. This step completed the 14-membered macrocyclic framework in 67% 
yield. The (Z)-allylic alcohol was selectively deprotected then oxidised to release the 
characteristic cis-enone and the acetonide was smoothly cleaved into the anti-diol, completing 
the total synthesis of LL-Z1604-2 (2). Giving the cis-olefin readily epimerises to the more stable 
trans isomer, finding an appropriate oxidising reagent was indispensable. In the synthesis of 
LL-Z1604-2 by Tatsuta et al., the best condition was found to be Dess-Martin periodinane 
reagent.60 The group of Lett opted for PCC in the presence of 2,5-dimethylpyrazole (Parish 
conditions) which afforded the ketone in excellent yield, though only one of the 
diastereoisomers reacted under these conditions.   
The final key step was a selective oxidation of the benzylic olefin. As expected, the oxidation 
proved to be arduous, due to an unusually unreactive benzylic double bond and lability of the 
product. The best result was observed for mCPBA/NaHCO3 with 17% yield, increased to 24% 
after recovering 30% of LL-Z1604-2. Gratifyingly, no other epoxides were observed in this case. 
 
1  INTRODUCTION 44 
  
 
 
Scheme 18: Synthesis of hypothemycin (6) by Sellès and Lett61, 67Reagents and conditions: a) Red-Al® 
(1.5 equiv.)/toluene, THF, 0°C to rt, overnight, 81%; b) NaH (1.03 equiv.), THF, RT, 1 h, then −78°C, 
TBSCl (1.03 equiv.), 36 h, 74%; c) MsCl (1.1 equiv.), NEt3 (1.1 equiv.), DCM, −10°C to RT, 30 min; d) 
NaI(1.5 equiv.), acetone, RT, 1 h; e) ethynyltrimethylsilane(1.5 equiv.), THF, BuLi (1.5 equiv.), −78°C, 
30 min, then 140 and HMPA (THF/HMPA=10/1), RT, 4 h; f) DDQ (5 mol%), MeCN/H2O (9/1), RT, 2 h; g) 
Ti(OiPr)4 (1 equiv.), (+)-DET (1.24 equiv.), anhydr. DCM, tBuOOH (3 M in isooctane) (2.1 equiv.), −25°C, 
overnight; h) PhNCO (2.5 equiv.), DCM/pyridine, RT, 1 h; i) BF3·Et2O (1.1 equiv.), Et2O, −20°C, 2 h, then 
1N H2SO4, RT, overnight; j) MeONa (0.35 equiv.), MeOH, RT, 8 h, then Dowex 50 WX8 column eluted 
by MeOH; k) TBSCl (1.05 equiv.), imidazole (1.05 equiv.), DMF, RT, 1 h; l) 2-methoxypropene (2 
equiv.), TsOH cat., DCM, RT, 1 h; m) BuLi/hexane (1.1 equiv.), Et2O, −30°C, 30 min, then TMSCl (1.1 
equiv.), −30 to −10°C, 98%; n) DDQ (8 mol%), MeCN/H2O (9/1), RT, 2 h, 73%; o) oxalyl chloride (1.1 
equiv.), DMSO (2.2 equiv.), DCM, −78°C, 30 min, then alcohol, 30 min and NEt3 (5.0 equiv.), −78 to 
0°C; p) 118 (n equiv.), Et2O, −78°C, then tBuLi/pentane (2n equiv.), 15 min, and further addition of 142 
in pentane, −78 to 0°C; q) K2CO3 (1.4 equiv.), MeOH, RT, 5 h; r) CH3OC6H4CH3OC(NH)CCl3(2 equiv.), 
Et2O, CF3SO3H (0.004 equiv.), RT, 4 h; s) Sia2BH (2 equiv.), THF, −25°C to RT, 2 h and then aq. 2 M 
K3PO4 (2 equiv.), further addition of that mixture via cannula at RT to a solution of 116(1.2 equiv.) and 
15 mol% [Pd(OAc)2 + 4 TFP] in DME; DME/H2O: 7/1, reflux, 8 h; t) TBAF 1 M/THF (3.5 equiv.), RT, 6 h, 
93%; u) 2M aq. NaOH (13 equiv.)/MeOH (1/3), reflux, overnight, 71%; v) hydroxy-acid 0.007 M in 
anhydr. toluene, PPh3 (2 equiv.), DEAD (2 equiv.), RT, 15 min; w) DDQ (1 equiv.), DCM/pH 7 buffer 
(9/1), RT, 30 min; x) PCC (3 equiv.), 2,5-DMP (10 equiv.), DCM, 0°C, 6 h; y) pTsOH (0.5 equiv.), 
DCM/MeOH (1/1), RT, 3 h 30 min; z) mCPBA/NaHCO3 (3 equiv.), −20°C to 0°C, 4 h, then pH 7 work-up, 
17% (24% based on recovered starting material). 
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The most recent total synthesis of hypothemycin (6) was accomplished by the group of 
Winssinger as part of their effort to broaden the diversity of the RALs family beyond naturally 
occurring products, especially those containing a cis-enone moiety.62 The synthetic route relies 
also on a late-stage epoxidation, a Mitsunobu macrolactonisation as well as a vinyl lithium 
addition onto an aldehyde to induce the Z-enol prior to the construction of the cis-enone 
(scheme 19). Interestingly, the benzylic functionalisation was addressed by using a stabilised 
anion derived from the resorcylic ester 145  bearing a sulfoxide at the benzylic position, which 
allowed a direct alkylation onto the iodide fragment 123, followed by an oxidative elimination 
to reveal the 1’,2’-alkene. The epoxidation was carried out by using DMDO (5.0 equiv.) which 
afforded hypothemycin (6) in 25% isolated yield at 50% conversion. It was mentioned that all 
attempts to drive the reaction to completion resulted in decomposition, as the epoxide was 
quite sensitive to acid and partial degradation of the final product was also observed upon 
isolation.  
 
 
Scheme 19: Retrosynthesis of hypothemycin (6) by Winssinger et al. 
 
Our interest, as synthetic chemists, was directed towards the metabolite L-783,277 (7), which 
is the latest synthetic target among all the other cis-enone RALs of this family.68 Carrying a 
saturated bond at C1’-C2’, while the other members contain an unsaturated bond at this 
position, 7 has been subject of efficiently concise and conceptually heterologous synthetic 
pathways. 
 
The coming chapter will give a summary of the intriguing biological activities of this secondary 
metabolite, followed by descriptions of different synthetic approaches realised to date. 
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1.2.3 Syntheses of L-783,277 (7) 
 
 
 
Figure 11: L-783,277 (7) 
 
The metabolite L-783,277 (7) was purified from fermentations of Phoma sp. (ATC 74403) which 
came from the fruitbody of Helvella acetabulum, together with its trans-isomer L-783,290. Its 
structure was established on the basis of NMR and MS analysis by the Merck group of Zhao in 
1999.19 The identification and fermentation of the culture that produced L-783,277 (7) and 
other related lactones, represented in figure 12, were reported by Dombrowski et al. in the 
same year.69 Anterior to this work, RO 09-2210, or L-783,278 (13) had been isolated from the 
mycelial cake of Curvularia species by Ms. K. Ilida (Nippon Roche Research Centre).18 
 
 
 
Figure 12: L-783,277 (7) and other RALs isolated and characterized in 1999 19,69 
 
In great agreement with the discovery by Zhao et al. of the potent and irreversible inhibition of 
MEK1 (4 nM) by the natural product L-783,277 (7),19 Altmann and collaborators have also 
reported this metabolite as a time-dependent, ATP-competitive irreversible inhibitor of MEK2 
(IC50= 15 nM), VEGFR2 (IC50= 2 nM),  and PDGFRα (IC50= 2.4 nM).70 Interestingly, the same 
research group mentioned that L-783,277 (7) inhibits the formation of tube during 
investigations in human umbilical vein endothelial cells (HUVEC), a common test to assess 
angiogenesis in vitro.71 Their study disclosed that 7, when added at the time of seeding, 
effectively inhibited the formation of tubes, but had no significant effect on readily formed 
capillary-like networks.  Consequently, 7 is also an inhibitor of VEGF-induced tube formation, 
at the condition of being incubated with the cells at day 0. 
 
• Synthesis by Altmann et al. 
The first total synthesis of L-783,277 (7) was disclosed by Hofmann and Altmann in 2008.68 One 
of the key features of their strategy is the ultimate introduction of the ketone moiety at C6’ 
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through a selective oxidation of allylic alcohol applied to the triol precursor 147 (scheme 20). 
The 14-membered ring was formed via Mitsunobu-based macrolactonisation, following a 
Suzuki coupling at ortho position of the aromatic part 150 and the borane resulting from 
hydroboration of the substructure 151, a strategy which was previously employed by Sellès 
and Lett in their synthesis of LL-Z1640-2 (3).67 Prior to the macrocyclic ring-closing, the Z-
alkene was formed by Lindlar reduction of the previously inserted triple bond through an 
acetylide addition of the deprotonated homopropargylic TBS-protected alcohol 153 onto the 
aldehyde fragment 152.  
 
 
 
Scheme 20: Retrosynthesis of L-783,277 (7) by Hofmann and Altmann 
 
The R configuration of C10’ was determined by the configuration of the epoxide 40 which 
underwent a regioselective attack of lithium acetylide. The released secondary alcohol was 
subsequently protected as TBS ether and provided O-TBS-protected (R)-1-pentyn-4-ol 153. 
Keeping in mind that the very same stereogenic carbon was to be subjected to a 
configurational inversion as a consequence of the late-stage Mitsunobu-based 
macrolactonisation, the resulting C10’ would have the desired S configuration for the target 
metabolite L-783,277 (7). 
On the other hand, the anti-diol configuration at C4’ and C5’ was induced by the commercially 
available chiral pool erythronolactone 155 which was submitted to a well established 
sequence of reduction, Wittig olefination and hydrogenation to provide the ester 156 (scheme 
21). The primary alcohol was silylated before the ester was reduced to primary alcohol 157, 
which underwent Grieco-Sharpless olefination, TBS removal and Swern oxidation to give 
aldehyde 152. The nucleophilic attack of the anion derived from the readily prepared O-TBS-
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protected (R)-1-pentyn-4-ol 153 onto the aldehyde led to a mixture of diastereomeric alcohol 
151.  
 
 
 
Scheme 21  Reagents and conditions: a) DIBAL-H, Et2O, -78°C, 2 h, 95%; b) Ph3PCHCOOEt, 
dioxane, reflux, 7 h, 91% (E/Z = 1.1/1); c) H2, Pd/C, EtOH, 4 h, quant.; d) TBSOTf, CH2Cl2, 93%; e) 
DIBAL-H, toluene, 2 h, 85%; f) i. 2-O2NC6H4SeCN, Bu3P; ii. NaHCO3, 30% H2O2, 19 h, 81%; g) 
TBAF, THF, 0°C to RT, 0.5 h, 90%; h) (COCl)2, DMSO, Et3N, CH2Cl2, -78°C, 1 h, 74%; i) 153, BuLi, -
78°C, 1.5 h, 87%; j) MOMCl, iPr2NEt, Bu4NI, DMF, 19 h, 87% (1:9:1 mixture of isomers) 
 
The aromatic core 160 was obtained from 4-methoxysalicylic acid 154 following ester cleavage 
with TMSOK under microwave conditions and DCC/DMAP-mediated protection of the released 
acid with 2-TMS-ethanol (scheme 22). The Suzuki coupling between 150 and 151 provided in 
high yield the precursor 149 whose triple bond was partially reduced into Z-olefin. At this 
stage, the isomers derived from 149 were separated before being submitted to the remaining 
transformations, respectively. The TMS ester and TBS ether were removed concurrently, 
leading to the precursor 162. The Mitsunobu macrolactonisation proceeded smoothly, 
followed by the deprotection with sulfonic acid resin to give the fully deprotected 
macrolactones 147 which were both submitted to oxidation with polymer-bound IBX. 
The oxidation of the major C6’-isomer of 147 gave a 1:4 mixture of L-783,277 and an unknown 
mono-oxidised product whereas the minor isomer afforded L-783,277 in 93% yield, along with 
8% of inseparable mono-oxidised product.  
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Scheme 22  Reagents and conditions:  a) TBSCl (2.5 equiv.), iPr2NEt (3.6 equiv.), DMF, RT, 2 h; 
b) oxalyl chloride (1.1 equiv.), DMF cat., CH2Cl2, −10°C to RT, overnight, then Et2NH (2.0 equiv.), 
1 h, RT; c) Et2NAlMe2 from Me3Al (4 equiv.) and Et2NH (4 equiv.), toluene, −6°C to RT, 45 min, 
then reflux, overnight; d) tBuLi/pentane (1.08 equiv.), Et2O, −78°C, 10 min, then Br2 (1.06 
equiv.); e) Me3O+, BF4- (1.3 equiv.), CH2Cl2, RT, overnight, then evaporation; f) aq. sat. 
Na2CO3/MeOH (1/1), RT, 6 h; g) TMSOK, DME, μwave, 110°C, 2 h, acidic workup, 85%; h) 
Me3SiCH2CH2OH, DCC, DMAP, CH2Cl2, 15h, 88%; i) i. 9-BBN, THF, r.t., 2 h; ii. 2 M K3PO4, 
[Pd(OAc)2+4 TFP], DME, reflux, 5.5 h, 81%; j) i. H2, Lindlar catalyst, EtOAc, 3 h, 94%; k) 
separation of isomers (1.6:1); f) TBAF, THF, RT, 15 h, quant. (major isomer); quant. (minor 
isomer); l) DIAD, Ph3P, toluene, 25 min, 59% (major isomer), 74% (minor isomer); m) sulfonic 
acid resin, MeOH, reflux, 6 h, 78% (major isomer), 46% (minor isomer); n) IBX (polymer-
supported), CH2Cl2, RT, 6 h; from major isomer of 7: 1:4 product mixture of L-783,277 and a 
second mono-oxidised species (major product), 82% (total yield); from minor isomer of 147 : 
93% of 7 (91% purity) 
 
• Synthesis by Winssinger et al. 
The second total synthesis of L-783,277 (7) was published in 2009 by the group of Winssinger, 
as a result of their efforts in broadening the diversity of the RALs family beyond naturally 
occurring compounds.62 In the first place, Winssinger and co-workers tried to address, through 
a general synthetic map, the largest spectrum of readily existing metabolites of the family 
bearing either an alkane, or an alkene, or even an epoxide at the benzylic position. Indeed, 
their major tactical step comprises a sulfide at the benzylic position of the resorcylic ester as a 
common pattern, which allows the direct attachment of another fragment (scheme 23).  
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Scheme 23: Formation of benzylic alkene 154, alkane 165 and epoxide 166 from common 
intermediate 163 by Winssinger et al. 
 
The total synthesis of L-783,277 (7), an instance of RAL whose structure is fully saturated at the 
benzylic position, embodied the tactical use of the resorcylic ester 171 bearing a benzylic 
sulfide. As illustrated above, the C1-C2 alkane bond would be built through a direct alkylation 
Retrosynthetically, the metabolite 7 was dismantled into two major parts (scheme 24): the 
aromatic core 171 and the iodide substructure 172, which was aimed to build the 
characteristic 14-membered macrocycle. Prior to the benzylic alkylation, the Z configuration of 
the alkene would be induced by the appropriate and enantiomerically pure cis-vinyl bromide 
122 which was to be lithiated in the presence of tert-butyllithium.The aldehyde fragment 121 
containing the right anti-diol configuration was synthesised from the naturally-occurring D-
form of deoxyribose (89). While the late-stage Mitsunobu macrolactonisation leading to the 
14-membered ring joined the strategy employed by Altmann and Hofmann,68 an earlier 
orthogonal deprotection combined with the oxidation of the released allylic alcohol was aimed 
to provide the cis-enone more selectively.  
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Scheme 24: Retrosynthesis of L-783,277 by Winssinger and co-workers 
 
The preparation of cis-vinyl bromide 122 was achieved in four steps from methyl 3-
hydroxybutyrate 177, using well-established procedures (scheme 25). The initial attempts of 
synthesising the corresponding cis-vinyl iodide 176 by means of a final Wittig reaction ended 
up with unpleasingly low yields (<30%), despite the appealing existence of all the involved 
reagents under immobilised versions. Alternatively, the sequence starting with the less 
expensive methyl 3-hydroxybutyrate 177, introducing compound vinyl gem-dibromide 178 was 
undertaken. The supposingly more reactive trans-isomer underwent the tributyltin hydride 
reduction catalysed by tetrakis(triphenylphosphine)palladium and afforded the desired cis-
vinyl bromide 122 in excellent yield.  
 The aldehyde 121 was, as previously reported by the same research group (scheme 14),21 
prepared in three steps: LAH mediated reduction of the corresponding hydroxyaldehyde of 2-
deoxy-D-ribose 89, mono-protection of the obtained diol and a mild oxidation of the 
unprotected alcohol. The resulting aldehyde was then submitted to an addition of the lithiated 
derived of cis-vinyl bromide 122 to provide the cis allylic alcohol 179. Benzyl protection of the 
unseparate diastereomeric mixture of 179, TBAF mediated deprotection and iodination of the 
released primary alcohol completed the synthesis of intermediate 172. As outlined in the 
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retrosynthesis, this subunit was to be bound to the aromatic core by means of the 
corresponding polymer-bound linker 171. 
 
 
 
Scheme 25:  Reagents and conditions: a) PMBOCNHCCl3 (1.0 equiv), CSA (0.1 equiv), CH2Cl2, 
23°C, 12 h, 92%; b) DIBAL-H, (1.1 equiv), toluene, 78°C, 2 h, 89%; c) CBr4 (4.0 equiv), Ph3P (8.0 
equiv), CH2Cl2, 0°C, 45 min, 90%; d) [Pd(PPh3)4] (0.2 equiv), nBu3SnH (5.1 equiv), benzene, 
23°C, 1.5 h, 95%; e) LiAlH4 (1.4 equiv), THF, 0 to 23°C, 2 h, 95%; f) TBDPSCl (1.0 equiv), 
imidazole (1.5 equiv), DMF, 23°C, 2 h, 66%; g) PS-IBX (3.0 equiv), CH2Cl2, 23°C, 2 h, quantitative; 
h) 122 (1.0 equiv), tBuLi (2.0 equiv), Et2O, -100 °C, 30 min, 88%; i) BzCl (2.5 equiv), pyridine (2.5 
equiv), TBAI (cat), CH2CH2, 0 to 23°C, 6 h, 90% ; j) TBAF (2.0 equiv), THF, 23°C, 6 h, quantitative; 
then I2 (1.5 equiv), Ph3P (1.5 equiv), imidazole (2.5 equiv), THF, 0°C, 30 min, 91%. 
 
The introduction of a selenide or sulfur at the benzylic position is compelling in spite of the 
tricky preparation of the required selenide or sulfide, in particular the compound 171. 
Commonly, if the sulfur or selenium sources are envisioned as electrophiles, the toluate 
position of the aromatic substrated can be easily deprotonated by LDA, though the reaction is 
not always reliable as for the sulfur, e.g. diphenyl disulfide, which inevitably gave the 
unwanted disubstituted compound 183 (scheme 26).62 Even solid-phase processes gave very 
modest yields. On the other hand, reactions with nucleophilic selenols or thiols revealed to be 
high yielding, with the exception of the opening of phtalide ring 186 with sodium thioxide. 
Even this least efficient transformation failed to provide passable results, access to benzyl 
halide in the presence of appropriate protecting groups (e.g. EOM phenol ether or TMSE ester) 
was undoubtedly much more tedious.  
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Scheme 26: Selenide formation through electrophilic selenium 
 
According to the authors, it was most convenient to access the polymer bound resorcylate 171 
from an acetonide protection of the acid and ortho-phenol 188, which is obtained in three 
steps from the commercially available 3,5-dihydroxybenzyl alcohol 187 (scheme 27). 
Treatment of the benzyl chloride 188 with a thiophenol resin afforded quantitatively the 
sulfide 189 which was doubly protected into the polymer bound resorcylate 171 in 93% overall 
yield. 
 
 
 
Scheme 27: Reagents and conditions: a) POCl3, DMF; b) NaClO2; c) acetone, TFA, TFAA; d) in 
solution: Ph-SH (1.0 equiv), 188 (1.0 equiv), iPr2NEt (1.0 equiv), DMF, 60°C, 12 h, 98%; on solid 
phase: PS-SH (1.0 equiv, 0.8 mmol.g-1), 188 (1.5 equiv), iPr2NEt (1.0 equiv), DMF, 60°C, 12 h, 
quantitative; e) in solution: EOM-Cl (2.0 equiv), iPr2NEt (2.0 equiv), TBAI (cat.), CH2Cl2, 23°C, 12 
h, 97%; on solid phase: EOMCl (2.0 equiv), DBU (2.0 equiv), TBAI (cat), DMF, 23°C, 12 h. 
quantitative; f) in solution: TMSEOH (1.1 equiv), NaHMDS (1.1 equiv), THF, 0°C, 2 h, 95%; on 
solid phase: TMSEOH (4.2 equiv), NaHMDS (1.1 equiv), THF, 0 to 23°C, 12 h. 
 
The resin 171 was deprotonated prior to its alkylation with 172 then submitted to DDQ and 
TBAF deprotections to release the precursor 170 required for the Mitsunobu-based 
macrolactonisation (scheme 28). The polymer-bound macrocycle 190 was released under 
reductive conditions followed by a benzoate hydrolysis. The allylic alcohol was mildly oxidised 
into cis-enone 168 by Dess-Martin periodinane. Though the group had previously 
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accomplished the total synthesis of radicicol A (5) using a selective oxidation of the triol 
precursor to introduce the desired Z-enone successfully, this method was supposedly 
unsuitable for macrolides lacking a substituent on the aromatic ring which should be ortho to 
the alkene. As for the attainment of LL-Z1640-2 (3) through the same selective oxidation 
strategy, the less polar triol isomer was cleanly transformed into enone in 86% yield, while the 
other isomer only led to the γ-enone. Interestingly, the group of Altmann also mentioned, in 
their article concerning the first total synthesis of L-783,277 (7), the same issue during their 
attempts to oxidize the precursor triol of this metabolite. Noteworthily, L-783,277 (7) is totally 
saturated at the benzylic position.  
As a consequence, in contrast with the synthetic sequence by Hofmann and Altmann, 
Winssinger and colleagues opted for an early and selective oxidation of allylic alcohol, followed 
by total deprotection of alcohol and phenol moieties upon treatment with HF. Then a 
diazomethane mediated methylation leading to a selective alkylation of the para-phenol in 
relatively high yield (63-74%), ended the total synthesis of L-783,277 (7) (scheme 36). 
 
 
 
Scheme 28  Reagents and conditions: a) 172 (3.0 equiv), LDA (6.0 equiv), THF/HMPA (10:1), -
78°C, 20 min; b) DDQ (2.4 equiv), CH2Cl2/H2O (2:1), 23°C, 4 h; c) TBAF (10 equiv), THF, 23°C, 6 h; 
d) DIAD (3.0 equiv), Ph3P (3.0 equiv), toluene, 23°C, 12 h; e) F-OctSnH (5.0 equiv), AIBN (cat), 
toluene, 150°C, μwave, 10 min, 52% over 5 steps; f)NaOH/MeOH, 23°C, 12 h, 76-80%;  g) DMP 
(3.0 equiv), CH2Cl2, 65°C, 6 h, 85-87%; h) 40% HF in CH3CN (1:10), 23°C, 7 h, 50%; i) CH2N2 (5.0-
10 equiv), Et2O, 23°C, 6 h, 63-74%. 
 
This strategy allowed an apparently more selective and reliable oxidation of allylic alcohol, 
hence higher overall yield even with an additional step (methylation of the para-phenol) to 
accomplish the total synthesis. Conceived amid the library of RAL products, the use of a sulfide 
linker followed by reductive cleavage led to a strategically concise benzylic extension of the 
macrocyclic precursor. Though the choice of benzoyl as the protecting group for the cis allylic 
alcohol was suitably orthogonal, to find the appropriate conditions to deprotect both EOM 
ethers and the acetonide revealed to be troublesome, because of the eagerly isomerisable cis-
enone into its related trans-isomer.  According to Winssinger et al., the para-EOM exhibited 
the most resistance to acidic cleavage, which constrained the reaction to be stopped before its 
completion (e.g. within 7h) in order to avoid the isomerisation of the cis-enone, affording the 
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expected L-783,277 in merely 50% yield. The other half amount was composed of the ortho-
EOM protected analogue which was once again submitted to the same acidic deprotection, 
followed by a selective para-protection in the presence of diazomethane. In accordance with 
the preceding results published by the group of Hofmann,68 the final product was, upon the 
isolation by HPLC, usually tainted with more than 5% of the supposed trans-isomer.  
 
• Synthesis by Sim et al. 
The most recent total synthesis of L-783,277 (7) was published by Sim et al. in 2010.72 The 
synthetic strategy relies on the introduction of the anti-diol configuration via the chiral pool D-
mannitol, the Yamaguchi-based macrolactonisation and the built-in triple bond which would 
be later partially reduced into Z-alkene. 
 
 
 
Scheme 29: Retrosynthesis of L-783,277 by Sim et al. 
 
The resorcylic fragment 6 was prepared from commercially available 2,4,6-trihydroxybenzoic 
acid 196, which was submitted to Danishefsky-based method to afford acetonide 3, followed 
by a regioselective methylation and the formation of the corresponding triflate in order to 
carry out a Stille coupling reaction to provide styrene 193 (scheme 29).  
 
 
 
Scheme 30  Reagents and conditions: a) TFAA, TFA, acetone, 45°C, 2d, 57%; b) MeOH, PPh3, 
DIAD, THF, 0°C to RT, 82%; c) Tf2O, pyridine, 0°C, 12h, 68%; d) Pd(PPh3)4, LiCl, (vinyl)SnBu3, 
dioxane, 110°C, 2h, 75% 
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The vinyl fragment 194 containing the anti-diol was synthesised in 6 steps starting with D-
mannitol (197) which gave according to well-known procedures enantiomerically pure D-(R)-
glyceraldehyde acetonide 201 (scheme 31). The latter was subjected to an asymmetric Brown 
allylation, acetonide deprotection, TBDPSCl protection of the released primary alcohol to give 
204, which was then subjected to the re-protection of the anti-diol to provide the 
intermediate 194.  
 
 
 
Scheme 31  Reagents and conditions: a) 2,2-dimethoxypropane, SnCl2, DME, reflux, 3 h, 36%; 
b) NaIO4, DCM, H2O, 20°C, 2 h, 94%; c) (-)-Ipc2BOMe, allylMgBr, Et2O, -78°C to r.t., 12 h; d) 
AcOH/H2O (4/1), r.t., 12 h,  56% over two steps; e) TBDPSCl, imidazole, DMF, r.t., 2 h, 74%; f) 
2,2-dimethoxypropane, PPTS, DCM, r.t., 12 h, 93% 
Reagents and conditions: g) TMS acetylene, BuLi, BF3.Et2O, THF, -78°C, 3 h, 50%; h) TBSCl, 
imidazole, DMF, r.t., 1 h; i) K2CO3, MeOH, r.t., 4 h, 93% over two steps 
 
The enatiomerically pure 195 was prepared in 3 steps from the commercial (S)-propylene 
oxide 136 (scheme 31). The sequence commenced with the selective opening of 136 by lithium 
TMS acetylene in presence of BF3.Et2O, followed by TBS protection of 205 and selective 
demethylation to provide 195.   
 
 
 
Scheme 32 Reagents and conditions: a) Grubbs II (54), toluene, 80°C, 1.5 days, 55%; b) Pd/C, 
H2, EtOAc, r.t., 3.5 h, 60%; c) NaOMe, THF, 0°C to r.t., 15 min; d) MOMCl, DIPEA, DMF, r.t., 14 
h, 59% over two steps; e) TBAF, THF, r.t., 2 h, 92% 
 
Fragments 193 and 194 were connected by Grubbs II (54) catalyst cross olefin metathesis, 
followed by hydrogenation and exposure to sodium methoxide to furnish compound 207 
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(scheme 32). MOM protection of the phenol moiety and TBAF deprotection released the 
primary alcohol 208 in 59% over 2 steps. 
The intermediate 208 was exposed to a Dess-Martin oxidation to smoothly provide aldehyde 
209, which reacted with the lithium acetylide derived from 195, furnishing a 2:1 ratio 
diastereomeric mixture of compound 210. Without further separation, both diastereomers of 
210 was partially reduced into Z-olefin. The resulting allylic alcohol 211 was transformed in 
PMB ether 212, before submission to TBAF to release the C10’ alcohol. Subsequent 
saponification released the benzoic acid required for the macrolactonisation under Yamaguchi 
conditions (23% yield over 2 steps), completing the carbon frame 213 of the target molecule. It 
is worth mentioning that the similar strategy employed by Altmann, a Mitsunobu-based 
macrolactonisation gave a relatively better yield (59%). 
 
 
Scheme 33  Reagents and conditions: a) DMP, NaHCO3, DCM, r.t., 3 h; b)BuLi, THF, -78°C, 2 h, 
42% over two steps; c) Lindlar catalyst, quinoline, H2, EtOAc, 1.5 h, 99%; d) PMB-Cl, NaI, NaH, 
DMF, 50°C, 5 h, 96%; e) TBAF, THF, r.t., 3 h, 86%; f) NaOH, EtOH/H2O, 120°C, 8 h; g) 2,4,6-
trichlorobenzoyl chloride, TEA, THF, r.t., 3 h then DMAP, toluene, reflux, 24 h, 23% over two 
steps; h) DDQ, DCM/H2O, 5 h, 93%; i) DMP, NaHCO3, DCM, r.t., 2 h, 72%; j) THF:H2O:TFA 
(2:1:2), 2 h, 93% 
 
The oxidative deprotection revealed the cis allylic enol which was successfully oxided by Dess-
Martin periodinane into the corresponding Z-enone precursor 214. Upon exposure of 214 to 
TFA, simultaneous cleavage of the acetonide and the MOM protecting groups (93% of yield) 
accomplished the third total synthesis of L-783,277 (7). Furthermore, the authors reported for 
the first time the optical rotation value of L-783,277 (7): [α]D24,5 = +8.8° (c 0.5, CHCl3). 
 
• Synthesis by Banwell et al. 
 
The latest synthesis targeting L-783,277 (7) has been disclosed by Banwell and collaborators.73 
Initially, the authors had succeeded in synthesising the co-metabolite L-783,290 (14) which 
contains a trans-enone instead of cis-enone like L-783,277 (7).74 However, after fruitless 
attempts to photoisomerise 14 into 7 (scheme 34), the synthetic framework has been slightly 
modified in order to install the desired Z-alkene in a direct way.  
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Scheme 34: Banwell’s effort to photoisomerise the trans-isomer L-783,290 (9) into L-783,277 
(7)  
 
As illustrated in scheme 35, their synthesis is a modular one that combines three fragments 
corresponding to C1-C6 + C12 aromatic structure, C1’-C6’ and C7’-O11’ of L-783,277 (7). The 
C4’-C’5 diol configuration was induced by cis-1,2-dihydrocatechol 219 . The benzaldehyde 217  
was connected to terminal alkene 218 via a Heck coupling, followed by hydrogenation of the 
C1’-C2’ double bond. A Mitsunobu-based esterification, involving homopropargylic alcohol 
153, completed the preparation of precursor 216. The ring-closure was performed by an 
intramolecular acetylide acylation and the subsequent Lindlar reduction revealed the desired 
cis-enone. 
 
 
 
 
Scheme 35: Retrosynthesis of L-783,277 (7) by Banwell et al. 
 
The benzaldehyde 217 was synthesised from the commercially available dimethoxyaniline 220, 
which was first subjected to a Sandmeyer reaction, using potassium iodide as nucleophile to 
give 221 in 71% yield (scheme 36). The resulting iodide was engaged in a Vilsmeier-Haack 
reaction to give 217 (63%).  
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Scheme 36: Synthesis of the aromatic core.Reagents and conditions: a) NaNO2, H2SO4, -15°C, 
3h; b) KI, H2O, -15°C, 3h; c) DMF, POCl3, 100°C, 5h 
 
 
The C1’-C6’ fragment was prepared from the enantiomerically pure catechol 219 (scheme 37). 
The non-chlorinated double bond was selectively hydrogenated in the presence of rhodium on 
alumina and the diol protected by dimethoxypropane. Reductive ozonolysis, followed by in situ 
sodium borohydride reduction and subjection to (MeO)MeNH.HCl in the presence of i-PrMgCl 
delivered the Weinreb amide 223, which was directly converted to o-nitrophenylselenide 224 
(89%). Oxidative elimination to reveal terminal alkene 218 was carried out in two steps, upon 
treatment of 224 with m-CPBA then O2 in diethylamine.  
 
 
 
Scheme 37: Synthesis of C7’-O11’ fragment.Reagents and conditions: a) H2, Rh on Al2O3, 
MeOH, 18°C, 25min; e) 2,2-dimethoxypropane, p-TsOH, CH2Cl2, 0°C, 0.5 h; f) O3, pyr., MeOH, -
78°C, 12 min; g) dimethylsulfur, 0°C, 2h; h) NaBH4, 0°C, 1h; i) i-PrMgCl, (MeO)MeNH.HCl, THF, -
15°C, 0.5h; j) o-NO2C6H4SeCN, Bu3P, THF, 18°C, 1h; k) m-CPBA, CH2Cl2, -78°C, 0.25h; l) O2, 
Et2NH, 18°C, 3h. 
 
 
The Heck coupling between 217 and 218 was achieved by heating a DMF solution of the 
substrates in the presence of Pd(AcO)2, K2CO3, and TBAB at 80°C for 40h, providing a 8:1 
mixture of product 225 and its Z-isomer in 56% combined yield (scheme 38). Pinnick oxidation 
and 10% palladium on charcoal assisted hydrogenation led to the saturated system 226. 
Subjection of acid 226 to a Mitsunobu-based esterification with homopropargylic alcohol 153 
gave the ester/amide 216 required for the pivotal ring-closure strategy. Intramolecular 
acetylide alkylation took place upon exposure of 216 to LiHMDS in THF at -35%, and a 
subsequent Lindlar reduction afforded the Z-enone. Protecting group removal with boron 
trichloride at -78°C, a method previously described by Winssinger’s group for the same 
target,62 accomplished the total synthesis of L-783,277 (7). However, the acid-sensitive Z-
enone was partially isomerised into the more stable E-isomer, resulting in a ca. 4:1 mixture of 
L-783,277 (7) and L-783,290 (14). 
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Scheme 38: Assembly of three fragments and completion of L-783,277 (7). Reagents and 
conditions: a) Pd(OAc)2, TBAB, K2CO3, DMF, water, 80°C, 19h; b) NaClO2, t-BuOH, NaH2PO4, 2,3-
dimethylbutene; c) 10% Pd/C, H2, 18°C, 48 h; d) DIAD, Ph3P, PhMe, 0°C, 1h; e) LHMDS, THF, -
35°C; f) Pd/CaCO3(Pb), H2, py., toluene; g) BCl3, CH2Cl2, -78°C. 
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1.3 Conclusion 
Within 3 years, 4 accomplished syntheses have been disclosed for L-732,277 (7) as a 
consequence of extensive efforts to develop economical and adjustable routes to this cis-
containing RAL and its analogues for further assessment of their biological activities. 
 
 
 
Figure 13: Retrosynthetic disconnections wielded on L-783,277 (7) in the literature 
 
All the 4 routes opted for the connection of the target metabolite into 3 keys fragments: an 
aromatic core, a straight-chained fragment containing the anti-diol C4’-C5’ and a segment 
bearing the appropriate configuration of C10’. With the exception of the approach by Banwell 
et al., the other 3 syntheses bear a number of conceptually comparable strategies. 
Macrolactonisation, either based on the classical Mitsunobu conditions or using Yamaguchi 
reagent, appears to be the most favored strategy to establish the ring structure (figure 13). 
Though the Winssinger’s group has also proven the benzylic sulfoxide represented an effective 
ring-closure tool, this method precludes L-783,277 (7) as it leads to an unsaturated C1’-C2’ 
bond. The same 3 groups also opted for a late-stage oxidation to restore the characteristic 
enone. Altmann et al. had attempted to selectively oxidize the enol, in competition with the 
C4’-C5’ anti-diol, only to obtain the desired metabolite 7 from the less abundant triol isomer. 
Interestingly, the same observation was stated by Winssinger’s group in their synthesis of LL-
Z1640-2 (8). 
 
The configuration of the cis double bond was determined by a partial reduction based on 
Lindlar’s conditions by Altmann’s, Sim’s and Banwell’s groups respectively. Nonetheless, 
Banwell and collaborators have auspiciously achieved the ring-closure via an intramolecular 
acetylide acylation followed by a Lindlar reduction, which simultaneously built the cis-enone. 
Altmann’s and Winssinger’s syntheses resorted to a Suzuki coupling and an 
alkylation/reductive elimination respectively to functionalise at the benzylic position. In a 
different manner, Sim’s and Banwell’s approaches employed an alkene metathesis and a Heck 
coupling, respectively to create first a C1’-C2’ double bond, which was subsequently reduced.   
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The intrinsic para-methoxy had been introduced in distinct manners, taking into account the 
plausible interference with the ortho-phenol of the same target. Altmann’s approach 
implicated an early orthogonal release of the ortho-phenol. Sim’s synthesis opted for the final 
step to release the phenol, together with the anti-diol, while Winssinger’s final target-releasing 
deprotection compelled a selective ortho-methylation. Banwell’s synthesis ended with the 
selective mono-deprotection. 
1.4 Research objectives 
 
• A modular and efficient synthetic route to L-783,277 (7) 
 
Our interest in L-783,277 (7) has been triggered by the anti-angiogenetic actitivity of this 
metabolite, originally disclosed by the group of Altmann in 2008.71  While hypothemycin (6) 
and LL-Z1640-2 (3) have much earlier attracted the attention of organic chemists, at the time 
of our first envisaged synthesis targeting (7) in 2009, this metabolite appeared in only 2 total 
syntheses.62, 68 
 
Figure 14: Our initial disconnections of L-783,277 (7) 
 
Retrosynthetically, it seemed to be judicious to disconnect the target molecule 7 also into 3 
fragments: one aromatic core 233, one straight-chained segment containing the C4’-C5’ anti 
diol 231 and another one bearing the asymmetric C10’ 232 (scheme 39).  
 
 
Scheme 39: Three synthons required for the construction of L-783,277 (7)  
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Conceptually different from Winssinger’s strategy, we aspired to carry out a more direct 
alkylation at the benzylic position, in view of abbreviating the final route. This approach was 
expected to be quite time-and effort-consuming to fine-tune the alkylation conditions.   
Besides, an esterification was thought to link the northern fragment to the aromatic core. 
 
Before the disclosure of the trans-isomer of L-783,277 (7) by Banwell and collaborators in 2010 
which had recourse to a RCM for the ring-closure, a late-stage macrolactonisation had 
prevailed. Independently, we aimed to achieve the cyclisation of the 14-membered ring by a 
RCAM and a subsequent partial reduction to reveal the cis double bond. A selective oxidation 
of allylic alcohol would complete the construction of the well-known acid-sensitive cis-enone, 
at the most remote step as possible. And a selective demethylation would reach the end of our 
synthetic pathway.  
 
 As a consequence of this retrosynthetic plan, the construction of the dialkyne precursor with 
strategically appropriate protecting groups was pivotal, as it would lay the foundation for 
further study of RCAM as a novel ring-closure for cis-enone containing RALs.    
 
•  Application to other natural RALs and analogues  
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Scheme 40: General synthetic scheme for RALs without cis-enone 
 
From a broader point of view, the abovementioned synthetic pattern could be exploited for 
the syntheses of other RALs, especially those bearing a saturated C1’-C2’ bond (e.g. (R)-(+)-
lasiodiplodin (10) as the most uncomplicated 12-membered macrolactone).  
 
Fundamentally based on the strategies targeting the synthesis of L-783,277 (7), the 
retrosynthesis of the simplified lactone 234, as depicted in scheme 40, encompasses the 
assembly of three separate segments: an aromatic core 236 derived from orsellinic acid, and 
two straight-chained fragments 237 and 238 containing each a terminal alkene. The first 
assembly would result from the application of our strategic direct alkylation at the benzylic 
position of 236, to which 238 would be anchored. An esterification between the resulting 
alkylation product and the last fragment 237 and a subsequent RCM would complete the 
carbon framework of the target macrolactone. 
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This synthetic approach is rather modular in various aspects, such as the insertion of either a 
double bond (resulting from the RCM) or simply a saturated bond instead, via a subsequent 
hydrogenation. Moreover, a Z-alkene would also be at reach through a RCAM followed by a 
Lindlar reduction of the newly formed triple bond, as described for the retrosynthesis of L-
783,277 (7).  
 
In case our crucial step, the direct benzylic alkylation, takes effect, the previous synthetic 
pathway would give straightforward access to various RALs, as well as their ananogues. And to 
the greatest extent, incorporating this step into a synthetic pathway would considerably 
shorten the number of transformations, and thus contribute to the elaboration of very concise 
and efficient syntheses.   
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2 TOWARDS THE TOTAL SYNTHESIS OF L-783,277 (7) 
2.1 Strategies for the synthesis of L-783,277 (7) 
All the four aforementioned syntheses were flawless proofs of highly convergent and concise 
strategies, based on modern chemistry, and propulsed by the report of the high potential 
against MEK (IC50 =4 nM) of L-783,277 (7) by Zhao et al.,.1 Like other members of the cis-enone 
containing subfamily, L-783,277 (7) owes its irreversible inhibition of kinase to the 1,4-addition 
of a properly located Cys residue inside the ATP-binding pocket to the inherent cis-enone. The 
presence of this functional group is not only crucial for the biological activities of these 
macrolides, but also stimulating from a synthetic point of view.  
The biological activity due to this cis-enone has been supported by comprehensive studies of 
the mode of action of hypothemycin (6) by Schirmer et al..2 This is in great agreement with the 
weak inhibition potential of MEK 1 (IC50 =300 nM) by the natural trans-isomer of L-783,277 
(7).3  More recently, Altmann’s group has also disclosed that the lack of C5’ alcohol does not 
deprive 7 of its inhibition of a panel of kinases, as part of an extensive study of 7 analogues 
after their discovery of the anti-angiogenetic potential of L-783,277 (7). 4 
For these reasons, several total synthesis chemists have chosen L-783,277 (7) as target, in 
quest of an elegantly efficient synthetic pattern towards 7 and its analogues for further 
assessment of their promising biological profile. So have we. 
Our first synthetic scheme for the metabolite L-783,277 (7) was devised in 2009, right after the 
publication of the second synthesis of 7 by Winssinger et al.5 
At the time, we envisioned to tackle the formal synthesis of L-783,277 (7) via the fully 
protected intermediate 239 with a convergent synthetic route, which highlights a RCAM 
combined with subsequent Lindlar reduction as a reliable macrocyclisation method. As 
previously mentioned, the cis-enone’s construction would be crucial, due to the greater 
stability of the trans-enone isomer, thus the easy isomerisation, especially by using the 
traditional alkene metathesis catalysts, e.g. 2nd generation Grubbs catalyst (54) within 
macrocycles of more than 12 members. 
Though in the synthesis of cruentaren A accomplished by Kusuma, Brandt and Blagg,6 the cis-
olefin containing macrocycle was obtained in diastereomerically pure form (2nd generation 
Grubbs catalyst (54)  5%, CH2Cl2, 0°C-RT, 3h30, 78%), the use of RCM had not been depicted in 
the literature for 14-membered macrolactones until the advent of Z-selective catalysts 
discovered by the group of Schrock in 2011.7 Besides, to preserve an early-stage, though 
masked, cis-enone throughout the synthetic sequence seemed to be risky and this would 
confine our strategies to some selectively mild conditions, due to the ready isomerisation of 
the double bond. Nevertheless, our research work had been far too advanced in the direction 
of the RCAM strategy at the time of the publication of the new Z-selective metathesis 
catalysts. Nevetheless, we considered a second way of synthesis including a selective Z-alkene 
RCM once the initial formal synthesis would have been successfully fulfilled. 
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Figure 15: Structures of radicicol A (5) and L-783,277 (7) 
Retrosynthetically, the macrolactone could be disconnected into 3 relatively similar sections: 
the aromatic core 242, the polyol 231 and the propargylic alcohol 232 (scheme 41). Given the 
highly similar structure of L-783,277 (7) to that of radicicol A (5) (figure 15), and our priority in 
attaining in the shortest way the dialkyne precursor 241, desired platform for our key step 
RCAM, the preparation of the building blocks 242 and 231 was conveniently based on some 
syntheses described by the group of Winssinger.8 The protected aromatic acid 242 would 
derive from the commercially available methylated orsellinic acid 243, while the assembly of 
intermediate 231 would start with the natural chiral pool 2-deoxy-D-ribose (89), containing the 
right configuration of the anti-diol.  
 
Scheme 41: 1st generation retrosynthesis of L-783,277 (7) 
 
The building block 232 was planned to result from the selective opening of the 
enantiomerically pure (S)-(-)-propylene oxide (136) in the presence of the commercial prop-1-
yn-1-ylmagnesium bromide 245. With all the three fragments in hand, the first connection 
would be worked out through a direct alkylation at benzylic position between the protected 
ester 242 and the polyol 231, whose leaving group was still to be fine-tuned. It was decided to 
transform the methylated orsellinic acid into TMSE ester in the first place for the 
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deprotonation at benzylic acid, for fear of a possibly competitive nucleophilic attack from the 
carboxylate onto the polyol 231. The success of this pivotal step would provide a fairly concise 
synthetic sequence, without additional steps to obtain a benzylic sulfide, in view of stabilising 
the derived anion of 242, as in the strategy of Winssinger et al.9 
 The esterification was in the first place outlined to proceed, as commonly described in the 
literature, between the acid halide derived from the earlier funtionalised orsellinic acid as 
electrophile (e.g. in the presence of cyanuric fluoride10), and the secondary alcohol 232 as 
nucleophile. This seemingly easy step then turned out to be unexpectedly troublesome, a 
point that would be discussed in more details in the next chapter.  
Since the RCAM was introduced as a pivotal step towards the total synthesis of sophorolipid 
lactone by the research group of Fürstner in 2000,11 which has led many total syntheses 
projects to accomplishment, e.g. the total synthesis of cruentaren A,10 it would be judicious to 
make use of some commercially available Fürstner’s catalysts, and contingently, the 
commercial Schrock catalyst for alkyne metathesis. The Lindlar reduction would be either 
conducted under classical conditions or under continuous conditions via automatic via H-
cube®, according to some readily defined conditions from our research group. For example, a 
standard Lindlar hydrogenation could also be conducted in the flask, using the same conditions 
described by the group of Fürstner for their successful reduction of cyclic alkynes into 
macrocyclic Z-alkenes, e.g. the last step completing the total synthesis of marine natural 
product (-)-prostaglandin E2-1,15-lactone.12 
The attainment of the Z-selective partial reduction would lead to the formation of precursor 
239, which would be totally protected. The choice of all these protecting groups was originally 
based on the readily existing precursors within the total syntheses of the same natural 
product,9, 13 and other resorcylides of the same family, namely radicicol A (5).8 Actually, the 
relatively unstable cis-enone would naturally be introduced at the very last stage of the 
synthesis, a strategy which was already accomplished by Hoffmann and Altmann.14 However, 
to carry out a direct benzylic alkylation in the presence of an appropriately strong base, the 
protection of both phenols of the aromatic core were compelling.  
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2.2 Construction of the building blocks 
2.2.1 Polyol fragment  
2.2.1.1 First generation strategy: “2-deoxy-D-ribose approach” 
 
With the objective of attaining the first series of synthon 231 (scheme 41) in mind, we opted 
for the preparation of compound 248 as a conveniently reachable intermediate to found 
basement for our synthesis of alcohol 248 (scheme 42). Indeed, this precursor intersects our 
synthetic route with the one leading to the total synthesis of radicicol A (5) by Winssinger and 
collaborators in 2007.15 
 
 
 
Scheme 42: Synthesis of fragment 3 from 2-deoxy-D-ribose (89) 
 
The synthesis of the polyketide sector commenced with the protection of 2-deoxy-D-ribose 
(89) with 2-methoxypropene catalysed by PTSA in DMF. The purification required assiduous 
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labour, due to the viscous aspect of the crude product, its low miscibility with common polar 
solvents (CH2Cl2, EtOAC), and especially the inevitable formation of several undesired by-
products. By using 2 equivalents of 2-methoxypropene and PPTS in catalytic amount (0.02 
equivalent), the reaction gave incoherent yields on larger scales (up to 5 g of starting material) 
which was occasionally due to the incompletion of the reaction. Not only the sugar 89 but also 
the acetonide 246 were difficult to handle because of their high viscosity. 
 Nonetheless, we pursued our synthesis according to the procedure described by the group of 
Winssinger,16 reducing the protected sugar with LAH (total conversion and NMR spectra 
correspond to the literature data16), followed by a mono-protection of the non-purified 
obtained diol 247 with one equivalent of TBDPSCl in the presence of imidazole at room 
temperature, giving the polyol intermediate 248. The reaction was monitored by thin layer 
chromatography and showed the disappearance of TBDPSCl while the crude diol 247 still 
remained. It was quite tricky to optimise the reaction, as the formation of both mono-
protected diols as well as the totally protected by-product was unavoidable, giving the 
structurally similar primary alcohols at both extremities. Thus the best yield obtained over 2 
steps was around 45%, which was reasonable for the next oxidation step of the primary 
alcohol under Parikh-Doering conditions: SO3.pyr complex, freshly distilled DCM, DMSO and 
DIPEA.17 
The oxidation occurred smoothly with total conversion and quantitative yield to provide the 
aldehyde 249 which was immediately employed for the nucleophilic attack of commercial 
prop-1-yn-1-ylmagnesium bromide (244) to provide a 60:40 diastereomeric mixture of alcohol 
250 in fairly good yield (90% over 2 steps). Neither the separation of each of the 
diastereoisomers nor a diastereomerically selective synthetic way were required for this step 
on account of a late stage oxidation of this alcohol to furnish the cis-enone, as described in the 
synthesis of the same metabolite by Altmann and Hofmann.13 
The protection of the alcohol function with EOMCl was promoted by TEAI at RT proceeded 
uneventfully to give the fully protected polyol 251. Since we pursued the same approach to a 
late-stage oxidation of the enol to access the cis-enone,13 both EOM ether and the acetonide 
would be quantitatively cleaved using sulfonic acid resin in MeOH, while the ortho-phenol 
could be selectively deprotected by the Lewis acid BCl3, or while closely monitored, all these 
cited protecting groups could be simultaneously cleaved by BCl3.16 As rightly programmed, the 
TBAF deprotection of the primary alcohol was unproblematic and afforded the intermediate 
252 in very high yield. Despite the common use of bromide alkyls for the direct alkylation at 
benzylic position,18 we decided to verify the compatibility of different leaving groups attached 
at the primary carbon, in view of establishing a general design  motif. Therefore, with the 
alcohol in hands, we embarked on the preparation of halogenated intermediates derived from 
252 as the first target to verify their accessibility.  
The iodination took place at first according to the Appel reaction, which necessitated the use 
of iodine in the presence of triphenyl phosphine and a mild base (e.g. imidazole).16 This 
reaction resulted in the iodide fragment 253 which was carefully purified by flash 
chromatography through neutralised silica gel (1% Et3N), taking into account the instability of 
primary iodide when confronted with slightly acidic conditions. Indeed, the yield obtained 
after purification for the iodide was clearly inferior to 80% on non-neutralised silica gel 
chromatography column. Once isolated, the resulting iodide should be conserved at low 
temperature (-20°C) and the decomposition of the product was easily detected as the initially 
obtained colourless oil turned gradually pink. Encouraged by the success of the Appel reaction, 
we applied the same strategy for the next bromination.  
2  TOWARDS THE TOTAL SYNTHESIS OF L-783,277 (7) 78 
  
The bromination was first performed under the similar conditions,19 using CBr4 as the bromine 
donor. Unfortunately, the Appel reaction only gave a complex, uncharacterised mixture, 
despite the use of freshly distilled solvents and PPh3 that was recrystallised in hot hexane and 
CBr4  recrystallised in hot ethanol and dried in the dark under vacuum.20 It was also described 
in the literature that NBS was also used as a brominating agent when combined with PPh3, 
which led us to replace CBr4 by NBS.21 Disappointedly, this reaction mainly led to products with 
either complete or partial loss of the acetal protection, as it occurred in the initials attempts. 
Later, we found out in the literature that this unexpected incident was due to the 
unpreventable cleavage of acetonides in the presence of triphenylphosphine (2 equiv.) and 
CBr4 (2 equiv.) in THF or CH2Cl2 at 0°C under inert atmosphere.22 The authors proposed a 
mechanistic explanation by a plausible coordination of the phosphonium adduct formed by 
PPh3 and CBr4 onto one oxygen of the acetonide, while the freed bromide ion liberated the 
respective carbonyl compound, in addition to the triphenylphosphine oxide commonly 
observed. These findings condemned our initial strategy to transform alcohol 252 intobromide 
254 as well as chloride derivatives. However according to the literature, other halogenation 
methods theoretically would not interfere with the existing acetonide, such as the use of the 
complex 2,4,6-trichloro[1,3,5]triazine and N,N-dimethyl formamide in the presence of 
NaHCO3.23 In the meanwhile, the sulfonation unsurprisingly proceeded to provide the 
intermediate 7 in relatively high yields (91% after isolation).  
While the direct preparation of the corresponding bromoalkane 254 from alcohol 252 by well-
known procedures, like Appel reaction, was to avoid, another method has allowed to adress 
this issue via the available tosylate 255. To our pleasure, exposure of intermediate 255 to 10 
equivalentS of LiBr in refluxing acetone has resulted in the attainment of 254 in acceptable 
yield (50 to 60 %).  
Then we decided, after the obtainment of the tosylate compound 255, to find out the right 
conditions for our key step, the direct alkylation at benzylic position, with some commercially 
available primary haloalkanes.  
With the tosylated alcohol 255, bromide 254 and iodide 253 in hands, we invested our efforts 
in benzylic alkylation which is related in detail in section 2.3.1, starting with our first attempts 
in deprotonating the ester compound 242. The series of attempts to find out the suitable 
electrophile for the subsequent alkylation consumed the available amount of the building 
blocks 253, 254 and 255. However, their preparation on a larger scale was time- and material-
consuming, due to the lack of reproducibility of the initial sequence based on the strategy 
described by Winssinger et al., starting with 2-deoxy-D-ribose (89).8 Indeed, as mentioned 
above, the starting material and the resulting products were difficult to handle and purify, not 
to mention the very low overall yield due to the non-selective monoprotection at the 
beginning of the 8-step sequence. These disadvantages of the strategy revealed to be 
unsuitable to synthesise alcohol 252 on a multigram scale. Therefore, it was necessary to 
modify our strategic approach towards the desired polyol compound. 
As a consequence, the new pathway required a more selective protecting group for the 
specific primary alcohol of diol 247, in addition to being orthogonal to the acetonide and EOM 
groups. The new starting material should contain the right configuration of the vicinal diol, 
accessible and easily handled, unlike the viscous 2-deoxy-D-ribose (89). In the literature, 
monosaccharides have been commonly employed as chiral pools, whose equilibrium between 
the heterocycle ring and the straight-chain form is commonly put to profit. One of these 
tactical syntheses consists of the one-carbone homologation operated on the open-chain 
form, e.g. via a Wittig reaction of a lactol with alkoxymethylenephosphoranes,24 directly 
followed by hydrogenation of the obtained enol ether. In our case, the lactol 257 would be 
required as substrate for this homologation method (scheme 43). 
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Scheme 43: Retrosynthesis of the homologation reaction  
 
On that account, we embarked on the second synthetic sequence which involved a Wittig 
reaction as the decisive step. This 2nd-generation approach commenced with the preparation 
of lactol 257 from D-(-)-arabinose (259), closely following the readily described procedures.25  
2.2.1.2 Second generation strategy: “D-arabinose approach” 
The first three synthetic steps of the sequence were carried out according to the literature that 
begins with the selective monoprotection of D-(-)-arabinose (259) by 2,2-dimethoxy propane 
catalysed by p-toluensulfonic acid monohydrate in DMF (scheme 44).25b 
 
 
Scheme 44: Synthesis of TMS-protected alcohol 268 from D-(-)-arabinose (259) 
 This is known to be a unique acetonating reagent for the preparation of a variety of 
isopropylidene derivatives, especially when reacting with some pentoses to give various 
products that reflect the pyranose-furanose equilibria in the reaction solution. Indeed, the 
reaction was carried out at room temperature (ca 20°C) and its completion was closely 
monitored by TLC in order to avoid the over-protection leading to the thermodynamically 
stable product 270 (scheme 45). This phenomenon is well known in the literature, especially 
when the reaction was performed at high temperature (e.g. 80°C) which gave the diacetonide 
270 almost exclusively.26 
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Scheme 45: D-(-)-arabinose (259) equilibrium. The diacetonide byproduct (270) 
The isolated 3,4-O-isopropylidene-β-D-arabinopyranose 260 was then added to a solution of 
sodium borohydride in ethanol, followed by treatment with sodium periodate to afford the 
lactol 257 in satisfactory yield. The choice of the protecting group originally depended upon 
the commercial availability of the alkoxymethylenephosphoranes, as well as its potential 
cleavage at a later stage. Therefore we opted for the commercialised triphenyl((2-
(trimethylsilyl)ethoxy)methyl)phosphonium chloride 263 to engage in the previously planified 
Wittig reaction onto lactol 257.  
As a preliminary test, the lactol 257 had been first submitted to the homologation with the 
ylide resulting from the BuLi deprotonation of methoxymethyltriphenyl phosphonium chloride 
271, affording the corresponding homologated compound 272 (scheme 46).  
 
Scheme 46: Wittig reaction involving 257 and methoxymethyltriphenylphosphonium chloride 
(271) 
Confident of the positive outcome of the previous reaction, we subjected triphenyl((2-
(trimethylsilyl)ethoxy)methyl)phosphonium chloride 263 to the same procedure. But instead 
of remaining deep red as in the case of methoxymethyltriphenylphosphonium ylide at 0°C, the 
solution mixture gradually faded into bright yellow after 2h at -30°C. Suspecting the 
butyllithium being unappropriate for the deprotonation, we tried out potassium terbutoxide to 
deprotonate the phosphonium chloride at 0°C as described by Treu and Jordis.27 Once again, 
the solution mixture’s colour changed from orange to deep yellow, blurred by a white 
precipitate.  Discouraged by the transient ylide generated by tBuOK, we carried on the 
deprotonation with KHMDS, a base that was first used by Schoenauer and Zbiral to generate 
triphenyl((2-(trimethylsilyl)ethoxy)methyl)phosphonium ylide.28 To our great delight, by adding 
KHMDS to a suspension of phosphonium salt 263 in ether at 0°C and 5 minute stirring, 
followed by the addition of lactol 257 and further stirring overnight while the temperature was 
kept between 0°C and 5°C, the awaited compound 264 was finally detained. Without further 
delay, a solution of the purified enol ether in EtOAc was delivered to the hydrogenation using a 
Thalesnano H-Cube® equipped with a 30mm CatCart filled with 10% Pd/C, at a flow rate of 0.1 
ml/min with a pressure setpoint of 50bar and the cartridge kept at 50°C. The quantitatively 
obtained primary alcohol 265 underwent the same next three steps as in the sequence starting 
with 2-deoxy-D-ribose (89), namely a Parikh-Doering oxidation successfully combined with a 
Grignard reaction, and an EOM protection of the resulting intermediate 268 without any 
incident. 
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Scheme 47: Unsuccessful TMSE deprotection 
The next step was naturally the cleavage of the silylethyl group to achieve the same compound 
252 which was earlier synthesised through the sequence based on Winssinger’s strategy “2-
deoxy-D-ribose approach” (cf. section 2.2.1.1). It is worth noting that the choice of TMSE-ether 
as protecting form was mainly fuelled by our belief in an ultimate orthogonal deprotection 
under very mild conditions, in particular by a fluoride source. In fact, trialkylsilylethyl esters 
and carbamates have been deprotected by fragmentation analogous to the β-elimination, 
expulsing the silicate and an ethylene molecule (scheme 16).29 
 
Figure 16: Example of TMSE cleavage 
 Given that the same principle is also behind the trimethylsilylethyl protecting group, we 
attempted to deprotect 268 by a fluoride source in the first place. Against all expectations, the 
several deprotecting trials via fluoride ions revealed that the collapse of the putative silicate 
intermediate is facilitated by expulsion of a good carboxylate leaving group for an ester, for 
example, while no such leaving group is available for the SEM ether, even when submitted to 
rather harsh conditions (table 1). Noting that the total synthesis of O-(methylepoxy)shikoccin 
by Paquette et al.30 embraced a TMSE ether cleavage step involving cesium fluoride in DMF at 
210°C for 6h, we carried out with high expectation the same experiment, fruitlessly. Other 
fluorine sources also turned out ineffective, leaving the starting material either fully recovered 
or totally deprotected (in acidic condition). It was also established in the literature that 
BF3.Et2O was able to cleave the TMSE ether at room temperature,31 from which we did not 
benefit as the acetonide was simultaneously removed, as in the case of Olah’s reagent HF.pyr 
(70%) or in the presence of occasionally used TsOH in combination with TBAF.32 In 2001, the 
group of Wu reported a novel method for the deprotection of 2-(trimethylsilyl)ethyl esters 
following its treatment with excess NaH (1.5 equiv.) and electrophile (2.0 equiv.) in DMF, a 
novel method next to the widespread deprotection by fluoride source. The authors favored a 
mechanism whereby the NaH reacted with adventitious moisture in the solvent to generate 
“anhydrous hydroxide” as the active species, which operated in the same manner as fluoride 
anions. However, the same method did not succeed on TMSE ether, because putative silicate 
intermediate is certainly facilitated by expulsion of a good carboxylate leaving group for the 
ester, while no such leaving group is accessible for anether. Hence also the inefficiency of LiOH 
was one of our many deprotecting trials.  
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Cleavage conditions Conversion Yield 
CsF, DMF, 210°C, 12h 30 0% 0% 
TBAF, DMF, RT, 24h33 0% 0% 
TEAF, DMF, RT, 24h34 0% 0% 
TBAF, TsOH, THF, RT, 2h35 100% 0% 
KF.Al2O3, THF, RT, 2h 0% 0% 
KF, 18-crown-ether, RT, 12h 0% 0% 
NaH, DMF, RT to 70°C, 12h36 0% 0% 
LiOH.H2O, THF/H2O, RT, 12h 0% 0% 
BF3.Et2O, CH2Cl2, 0°C to RT, 2h31 100% 0% 
HF.pyr(70%), MeCN, 50°C, 2h 100% 0% 
Table 1: Conditions used for TMSE ether cleavage trials 
 
After considerable efforts, we realised that the impracticable deprotection put an end to this 
2nd generation synthetic scheme. As a result, the homologation of the lactol/aldehyde imposed 
a customised phosphonium which would introduce a more ajustable protecting group. The 
idea of synthesizing an alkoxylidenephosphonium containing a silane 274 was deceivably 
attractive, due to the feasible retro-Brook rearrangement, once the phosphonium salt 275 was 
deprotonated (scheme 48).37 
 
Scheme 48: Retro-Brook rearrangement 
Besides the choice of fluoride-labile group (silanes) in synthetic projects, the oxidation-labile 
blocking groups are often employed though the choices are very limited. The 4-methoxybenzyl 
(PMB), 4-methoxyphenyl (PMP) and the more labile 2.4-dimethoxybenzyl (Dmpm) ethers have 
proved their worth as reagents in the synthesis of complex molecules. Both of these functions 
are easily removed under mild conditions with dichlorodicyanoquinone (DDQ) or with 
cerium(IV) ammonium nitrate (CAN).32 These conditions seemed to address the difficulties 
previously occurring and brought us to the search for a phosphonium salt containing an 
oxidation-labile protecting group. 
 
 
Scheme 49: Wittig reaction via ylide generated from phosphonium salt 280 by Paquette et al. 
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During the literature search, we came across the efficient use of phosphonium salt 280 by the 
group of Paquette in 1993, consequently included in their several years effort to design and 
develop a unique strategy for the enantiospecific synthesis of taxane diterpenes.38  The 
employed Wittig reaction is depicted in scheme 49, illustrating the initiation by BuLi 
deprotonation at very low temperature (-78°C) in a brief reaction time (7min) followed closely 
by the addition of aldehyde 279 and the completion afforded the cis and trans-vinyl ethers 5 in 
a ratio of 1:2 ('H NMR analysis) with a combined efficiency of 93%. 
 
 
Scheme 50: Unsuccessful attempts to synthesise PMP-Cl 
It was also documented that the preparation of the employed chloride had been inspired from 
an article by Masaki et al.,39 which directed our attention towards the synthesis of this PMP 
chloride as starting material. Confident with the promising preparation of 283 which had been 
so far commonly cited in the literature,39-40 our synthetic choice was first based on radical 
reactions to introduce the primary chloride from 1,4-dimethoxybenzene . As rightly described 
by Loubinoux et al.,40 the preparation of chloromethyl phenyl ether demanded either lengthy, 
energy-consumming syntheses or drastic conditions (e.g. heating up to 175°C) and one of the 
mildest option at that time was treatment with a peroxide, PCl5 and refluxing CCl4 (scheme 50). 
However, all the trials realised in the same conditions did not afford us with any of the 
expected compound 283, be it in the presence of the widely used PCl5 or NCS.41 Our attempts 
to synthesise instead a bromide via NBS in CCl4 and benzoyl peroxide also led to no expected 
results. Disappointed by the outcomes, we turned out attention to an alternative for preparing 
aromatic chloromethyl ethers which employed the corresponding aromatic methylthiomethyl 
ethers, given that the PMB protecting group was as well an oxidation-labile protecting group.  
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Scheme 51: Access to p-methoxybenzyl chloromethyl 288 via p-methoxybenzyl 
methylthiomethyl ether 287 
While the terminal chlorination in the case of (p-methoxyphenoxy)methyl chloride (283) is 
mainly carried out in a direct way (scheme 51), p-methoxybenzyl chloromethyl (288)can be 
obtained in two steps, starting from (4-methoxyphenyl)methanol (286). According to several 
articles, it was more convenient to chlorinate the sulfide 287 into the wanted product 288 
either by expposure to oxalyl chloride as described by Trost et al.42, or sulfuryl chloride by 
Corey et al.43. The p-methoxybenzyl methylthiomethyl ether 287 reportedlyresulted from the 
smooth nucleophilic attack of the hydride-deprotonated benzyl alcohol 286 onto the 
chloromethyl methyl sulfane (289). In our hands, the same reactions did not proceed in 
sufficiently high yields. Another method using radical reactions by Kyler et al.44 was also tested 
without better results. In the same printing work, the authors pointed out the major 
advantage of radical reactions which rested on a mild and non-acidic, and consequently widely 
compatible way to convert alcohols to methylthiomethyl ethers, an alternative route to 
Pummerer reaction. As a matter of fact, the Pummerer reaction has been established to 
furnish sulfides via sulfoxides in acidic conditions,45 which can be seen as an expedient means 
to obtain 288.     
Originally, the classical Pummerer recipe, treatment of a sulfoxide with a potent acylating 
agent like trifluoroacetic anhydride (TFAA) in a non-participating solvent, is sufficient to 
generate the electrophilic thionium ion.45 The traditional Pummerer reaction was thus 
performed with Ac2O and and dimethylsulfoxide 46 in the presence of 286 to generate the 
anticipated sulfide 287 in approximately 60% yield. Whereas the optimisation of the reaction 
did not exceed 65% of yield, the simple addition of AcOH to the reaction (DMSO/Ac2O/AcOH: 
15/12/3) increased the yield up to 90%.  
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Scheme 52: Synthesis of (((4-methoxybenzyl)oxy)methyl)triphenylphosphonium chloride 282 
The obtained sulfide 287 was treated with sulfuryl chloride at low temperature to give the 
desired chloride 288, a moisture sensitive product which was used in the next step without 
further purification, a decision partly due to the total conversion of the starting sulfide. The 
phosphonium 282 was successfully formed following treatment of the crude chloride 288 by 
triphenylphosphine in toluene at 80°C over 20h.  With this phosphonium salt in hand, the 
anticipated homologation of lactol 257 based on Wittig reaction could be experimented. 
Initial attempts to use KHMDS to deprotonate the freshly prepared phosphonium 282, 
following the same procedure described for the successful deprotonation of the commercial 
phosphonium 271, however, gave no predicted results. The reaction mixture turned deep red 
within 5 minutes after the addition of KHMDS at 0°C, followed by the dropwise addition of a 
solution of lactol 257 in THF. The mixture was vigorously stirred from 0°C to room temperature 
overnight. Unfortunately, no homologation product was observed and the initial lactol 257 was 
entirely recovered, while the phosphonium salt seemed to be decomposed. Suspecting the 
short-lived existence of the desired phosphonium ylide at 0°C, it was therefore evident for us 
to undertake the reaction temperature at an appropriately lower temperature, which indeed 
prolonged the deep red colour at -78°C for more than 2h right after the addition of KHMDS. 
The lactol was added at the same temperature and the reaction kept at -78°C to 10°C 
overnight. Once again, the starting material 257 was entirely recovered and the by-products 
coming from the decomposition of phosphonium were present in the crude product. NMR 
data allowed the detection of alkene, as the addition product by ylide 289 onto the resonance-
stabilised carbene 292 (scheme 53). The same undesired decomposition was earlier studied by 
Wittig and Böll24 who discovered that the higher alkoxymethylenephosphorane (e.g. 
butoxymethylene triphenylphosphorane) gave more unstable alkoxy phosphonium ylides. 
Scheme 53: Decomposition of phosphonium ylide 282 
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Given that the decomposition took place at 10°C for butoxymethylene triphenylphosphorane, 
the reaction temperature was maintained between -78°C and -15°C in several trials, without 
obtaining any trace of the homologated product. It was rather difficult to find out the 
intermediate temperature which would avoid the decomposition of the phosphorane while 
allowing the lactol-hydroxyaldehyde equilibrium to shift in favour of hydroxyaldehyde 
formation. With the purpose of favoring the hydroxyaldehyde to occur, meanwhile sparing one 
equivalent of the formed phosphorane, the lactol mixture was first treated with one 
equivalent of BuLi, before addition of the phosphorane. Nevertheless, the outcome remained 
unchanged. 
Base Temperature Conversion Yield 
KHMDS  -78°C, 1h, -78°C – 10°C, 12h 100% 0% 
KHMDS  -30°C, 15h  100% 0% 
NaHMDS -10°C, 15 min, -10°C to 0°C, 15h 100% 0% 
NaHMDS 0°C, 15 min,  RT, 15h 100% 0% 
Buli -78°C, 1h, -78 to 0°C, 15h 100% 0% 
Buli -78°C, 1h, -78°C to RT, 15h 100% 0% 
NaH 0°C, 15h 100% 0% 
 
Table 2: Conditions of Wittig reaction involving phosphonium salt 282 and lactol 257 
In the literature, several alkoxymethyltriphenylphosphorane ylides are accordingly reported to 
be quite unstable and afford low yields of substituted vinyl ethers in case the starting ketones 
are easily enolisable,24, 47 while some few have been proven to be efficient method to prepare 
substituted vinyl ethers. This lack of available methods stimulated our determination to 
synthesise and bring to application the phosphonium chloride 282. Finally, the last trials of the 
series were carried out between the phosphorane and benzaldehyde at different temperature 
combinations, unfortunately without any success, which ended our efforts to use the 
phosphonium salt 282.  
• Julia olefination 
Nonetheless, the choice for the construction of oxidation-labile substituted vinyl ethers 
through olefination was not abandoned. Besides the extensive use of phosphonium ylides in 
Wittig reactions, the construction of alkenes, in the last two decades, has also frequently been 
conducted via Julia olefination reactions.48 The first examples of modified Julia olefination 
using α-alkoxyheteroaryl sulfones to yield vinyl ethers were published only a decade earlier by 
the Canadian group of Surprenant.49 This convenient methodology might circumvent cases 
where alkoxymethyltriphenyl phosphorane ylides had failed. Their generic preparation of the 
required sulfones is reproduced in scheme 54 hereafter.   
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Scheme 54: Synthesis of α-alkoxyheteroaryl sulfones      
Syntheses of the sulfones with three electronically and sterically different alkylating agents 
were accomplished in a two-step process, namely a nucleophilic attack of the deprotonated 2-
mercaptobenzothiazole (BTSH) onto the corresponding chloromethyl ethers and an oxidation 
of the newly formed sulfides into sulfones. If the same method was to be brought into 
operation, the alkoxymethyl chloride would remain the same as previously involved in the 
synthesis of phosphonium 282 (scheme 52), but the oxidation of the corresponding sulfide 
must be sufficiently mild to accomplish the anticipated sulfonation.  
Consequently, we have in the first place synthesised the corresponding sulfur 295 from 1-
((chloromethoxy)methyl)-4-methoxybenzene 288  and 2-mercaptobenzothiazole in the 
presence of NaH in DMF (scheme 55). This reaction indeed yielded the desired precursor 295 
in gratifying yield (90%). 
 
Scheme 55: Aspiring synthesis of the PMB-sulfone 296 
With the sulfide 295 in hands, we decided first to follow closely the same oxidation conditions 
described by Surprenant et al.,49i.e. sodium tungstate in catalytic amount and hydrogen 
peroxide at 0°C in methanol and vigorously stirred overnight between 0°C and 21°C. As a 
result, neither the anticipated sulfone 296 nor the corresponding sulfoxide compound was 
observed in the crude product, while on the contrary, 4-methoxybenzaldehyde (297) was 
mainly present. This outcome did not occur in the case of benzyl group (293a)49 because of its 
lack of electron-donor methoxy group. According to the group of Noyori, the mechanism of the 
tungstate-based oxidation was explained by the rapid oxidation of Na2WO4 by hydrogen 
peroxide and aliphatic sulfides are more reactive than aromatic compounds.50 In all likelihood, 
the  oxidation-labile p-methoxybenzyl was more reactive towards the oxidising agent than the 
sulfide, even at low temperature (0°C to 5°C) leading only to the cleavage into 4-
methoxybenzaldehyde (297).  
 
Scheme 56: Decomposition of sulfone 295 into p-methoxybenzaldehyde 297 
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Other commonly described oxidising reagents have also been employed in hope of favouring a 
fast oxidation of the sulfide and hence a lower rate of decomposition into p-
methoxybenzaldehyde 297 (table 3). Unfortunately, in all cases, either the formation of 
aldehyde was inevitable or no transformation took place. 
 
Oxidation conditions Conversion Yield 
Na2WO4.2H2O, H2O2 (30 wt. % in H2O), MeOH, 0°C to 21°C, 12h 100% 0% 
Na2WO4.2H2O, H2O2 (30 wt. % in H2O), MeOH, 0°C, 12h 90% 0% 
Na2WO4.2H2O, H2O2, MeOH, 0°C to 5°C, 12h 100% 0% 
H2O2, AcOH, 0°C to 21°C, 12h 100% 0% 
mCPBA, CH2Cl2, 0°C, 6h 100% 0% 
Oxone®, MeCN/H2O: 2/1, 0°C, 4h 100% 0% 
 
Table 3: Oxidation trials of sulphur 295 into sulfone 296 
 
 
Scheme 57: Attempts to synthesis PMB-sulfone 296 
Subdued by several unsuccessful trials, the initial synthetic scheme of sulfinate 300 was 
aborted and another approach based on the nucleophilic trait of sodium benzothiazole-2-
sulfone 300 was undertaken. By following closely the conditions described by the group of 
Kouge,51 we were able to obtain 300 in a modest yield of 55% over two steps (scheme 14). The 
freshly prepared sodium salt was immediately used in the next step, as it was speculated to 
attack the in situ chloride 288 in a nucleophilic manner to provide sulfone 296. This reaction 
was first performed at 60°C in DMF and gave no trace of the expected sulfone. A higher 
temperature (70°C to 100°C) uniquely induced the disappearance of chloride 288 from the 
reaction mixture, leaving the sodium benzothiazole-2-sulfone as main compound in the final 
crude product. The negative outcome led to the used of ion exchange via TBAB and TBAI 
respectively, expecting a better electrophilic site. None of these expectations came true. 
While looking for different solutions in the literature, we learnt from Charlton et al. a feasible 
way of converting hydroxyl methyl sulfone 301 to the methoxy derivative 302 by refluxing in 
methylene chloride solution of 301 with an equivalent of methanol in the presence of a 
catalytic amount of p-toluenesulfonic acid (scheme 58).52 Unlike the methoxy derivative 302b, 
its congener 302a was formed in roughly half amount.  
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Scheme 58: Charlton et al. methylation of sulfone 301 
Mecanistically, the methylation of sulfone 301 differs from our desired alkylation. However, 
the straightforward success of such a transformation was rather inspiring for our preparation 
of sulfone 296 which, so far, had not afforded any of the anticipated result. 
 Consequently, the new sequence commenced with the synthesis of hydroxy methyl sulfone 
304 in two steps from the sodium salt 300 made beforehand (scheme 59). The sulfinic acid 
303, previously acquired by acidification of the sodium salt 300 with HCl (10 wt. %), was 
submitted to an aqueous solution of paraformaldehyde, providing hydroxy methyl sulfone 304 
in 70% of yield over 2 steps.53 With the compound 304 in hand, we applied the conditions 
described by Charlton et al., namely the addition of (4-methoxyphenyl)methanol 286 to a 
solution of 304 and catalytic amount of p-toluenesulfonic acid in refluxing THF . As no trace of 
the expected sulfone was observed, other acids were used (e.g. camphorsulfonic acid and 
triflic acid) in combination with different amount of (4-methoxyphenyl) methanol (286) (from 1 
equivalent to 10 equivalents), without formation of the desired compound. Under basic 
conditions (NaH or BuLi), 4-Methoxybenzyl chloride 305 was used instead of (4-
methoxyphenyl)methanol while the sulfone 304 was completely consumed, contrary to the 
major amount of 304 recovered from the crude product under acidic conditions.   
 
Scheme 59: Other attempts for an alternative preparation of sulfone 296 
Confronted with the fruitless trials to prepare sulfone 296 as building block for a Julia based 
olefination, our synthetic strategy took once again another direction towards an oxidation-
labile O-alkyl enol ether.  Several years ago, Kluge et al. reported the preparation of some alkyl 
enol ethers by performing a Wadsworth-Emmons olefination with 
(alkoxymethyl)phosphonates,54 and the hydroxyl protected phosphonates were obtained from 
the commercially available (hydroxymethyl)phosphonates (e.g. phosphonate 306). Convinced 
by these bibliographic results, we concentrated our efforts on the preliminary synthesis of the 
corresponding phosphonate 308.    
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• Horner-Wadsworth-Emmons olefination 
 
 
Scheme 60: Unsuccessful synthesis of phosphonate 308 
At the beginning, we tried to alkylate the commercial diethyl(hydroxymethyl) phosphonate 
306 by primary deprotonation with NaH in DMF followed by addition of  4-methoxybenzyl 
chloride (305) and 4-ethoxybenzyl bromide (307) respectively. In the meantime, the alkylation 
was also conducted under acidic conditions as described previously in the case of sulfone 296, 
involving (4-methoxyphenyl)methanol (286). One again, the results revealed only the recovery 
of starting materials under acidic conditions, whereas the commercial phosphonate 306 was 
found in an insignificant amount in the crude product following the reactions under basic 
conditions. This outcome was in accordance with the earlier results observed for sulfone 296. 
Therefore the intended alkylation of diethyl (hydroxymethyl)phosphonate 306 seemed to be 
limited to acidic conditions. This observation consequently conducted to the use of 4-
methoxybenzyl-2,2,2-trichloroacetimidate 147, a benzylating agent which could be achieved 
by submitting (4-methoxyphenyl)methanol 286 to a solution of trichloroacetonide and NaH 
(0.1 equiv.) in diethylether.55The obtained viscous yellow oil had to be kept constantly at low 
temperature. The benzylation of commercial diethyl (hydroxymethyl)phosphonate 306 
proceeded smoothly to yield the anticipated diethyl (((4-
methoxybenzyl)oxy)methyl)phosphonate 308.  
 
Scheme 61: Synthesis of diethyl (((4-methoxybenzyl)oxy)methyl)phosphonate 308 
With the phosphonate in possession, a series of conditions was tried out with several bases, 
covering different temperature levels, as we looked forward to yielding a relatively stable 
corresponding phosphonate ylide (table 4). Indeed, it was well established that while 
thioalkoxymethylenephosphonates generated stabilised ylides, their homologues 
alkoxymethylenephosphonates were difficult to metallate.56 
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Deprotonation and addition conditions Conversion Yield 
BuLi, -78°C to -60°C, 2h, then -78°C to RT, 12h 100% 0% 
sBuLi, -78°C, 2h, then -78°C to RT, 12h 100% 0% 
LiHMDS, Et2O, 0°C, 5min then 0°C to RT, 12h 100% 0% 
NaHMDS, Et2O, 0°C, 5min then 0°C to RT, 12h 100% 0% 
KHMDS, Et2O, 0°C, 5min then 0°C to RT, 12h 80% 0% 
KHMDS, Et2O, -30°C to -10°C, 1h then -10°C to RT, 12h 70% 0% 
tBuOK, HMPT, O°C to RT 100% 0% 
Table 4: Unsuccessful trials via Horner-Woodwarth-Emmons between phosphonate 308 and 
lactol 257 
Attempted metallation of diethyl (((4-methoxybenzyl)oxy)methyl)phosphonate 308 with 
butyllithium afforded a product that was presumed to be derived from substitution on 
phosphorus in the manner reported by Lavielle et al. in 1971.56 The authors observed indeed 
less than 10% of yield of the enol ether resulting from benzaldehyde and the ylide derived 
from diethyl (ethyloxymethyl)phosphonate 308.  
 
Scheme 62: Horner-Wadsworth-Emmons reaction between unstabilised ylide derived from 
diethyl (ethyloxymethyl)phosphonate 308 and benzaldehyde 297 
In the same report, the reaction initiated by deprotonation of 308 by butyllithium at -75°C 
irrefutably led to an isolated compound resulting from the substitution onto the phosphorous 
(30% of yield). This was attritubted to both the weakly acidic proton at the methylene position 
and the great electrophilicity of the phosphoryl group, an effect which would be strengthened 
by the electron-withdrawing effect of alcoxymethylene groups. As an example, diethyl 
(ethyloxymethyl) phosphonate was stated to undergo hydrolysis at a lower rate than diphenyl 
(chloromethoxymethyl) phosphonate.56 Taking into account these parameters, our choice of 
bases consisted in finding the appropriate metal (among lithium, sodium and potassium), the 
right temperature which allowed not only the deprotonation of the phosphonate as well as the 
stabilisation of the newly formed ylide, but also the equilibrium shift into the corresponding 
hydroxyaldehyde 262 of lactol 257. In spite of repeated efforts, the expected enol ether did 
not appear in the end, while the product from the substitution of  onto the phosphoryl 
depicted by Lavielle et al.56 was presumedly observed (base= BuLi). The disappointing 
performance of the anion coming from the phosphonate 331 and benzaldehyde in the 
presence of KHMDS ended our expectations of accomplishing the synthesis of enol ether 309 
via a Horner-Wadsworth-Emmons reaction. 
• Horner-Wittig olefination 
In the literature, some reports mentioned that simultaneously Kluge et al. and Warren et al. 
attained the preparation of some alkyl enol ethers by performing a Horner type reaction from 
α-alkoxy-β-hydroxydiethylphosphonates or diphenylphosphine oxides, respectively.57 Given 
that our targeted enol ether 309 remained elusive, be it via Wittig reaction, Julia reaction or 
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Horner-Wadsworth-Emmons reaction, one of the last options was to engage the recalcitrant 
lactol 257 into a Horner-Wittig reaction. 
In 1959, Horner and co-workers published the first preparation of an alkene by treatment of a 
phosphine oxide with base followed by the addition of an aldehyde.58  However, the reaction 
of a phosphorus ylide with a carbonyl, known as the so-called Wittig reaction since 195359 
remained the most widely recognised method for carbonyl olefination.  Actually, vinyl ethers 
can be made by the Wittig reaction using the alkoxy-ylides,60 a convenient way to convert 
aldehydes and ketones into the homologous aldehydes by the alkylative carbonyle 
transposition.61 This sequence worked relatively well but in some cases, the unstability of the 
ylides and the nucleophilic side reaction of enolisable aldehydes and ketones rendered the 
method unlikely reliable.56 To overcome these hurdles, some authors used phosphonic esters62 
or amides.56 As the first research group to employ alkoxymethylphosphine oxide in a Horner 
variant of Wittig reaction in 1976, Schlosser et al. have made the vinyl ether from 
cyclohexanone and the diphenyl (methoxymethyl)phosphine oxide 312 in 35% yield.63 Three 
years later, the group of Warren reported the use of the same phosphine oxide (312) to 
prepare pure samples of each geometrical isomer of a vinyl ether (scheme 63).61 
 
Scheme 63: Preparation of vinyl ethers from diphenyl (methoxymethyl)phosphine oxide 312 
according to Warren et al. 
Even though phosphine oxides can be prepared by various methods (scheme 64), it has been 
proven popular to involve the reaction of organometallic reagents with halogenophosphines 
followed by oxidation, for the simple reason of the ready availability of halogenophosphines 
such as Ph2PCl (317). This approach is not entirely suitable for our strategy due to the 
oxidation-sensitive alkoxy substituents. Another method consisted in submitting the 
corresponding phosphonium salt to an aqueous solution of hydroxide. As an example, the 
group of Warren published the formation in two steps of diphenyl(methoxymethyl)phosphine 
oxide 312 by oxidation of the corresponding phosphonium salt 271, which was previously 
synthesised by a classic addition of triphenylphosphine onto methoxymethylchloride.61 Though 
this would be a convenient way with the (((4-methoxybenzyl)oxy)methyl)triphenyl- 
phosphonium chloride 282 readily in our possession, the observed eager decomposition of this 
phosphonium salt under basic conditions made us reluctant to apply the same approach.  
On the other hand, the achievement of phosphonate 322 through an acid catalysed 
benzylation with -methoxybenzyl-2,2,2-trichloroacetimidate 174 tempted us to follow the 
same pathway towards the homologous (((4- methoxybenzyl)oxy)methyl)diphenylphosphine 
oxide 331.  
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Scheme 64: General methods to prepare phosphine oxides  
As a result, our attempts began with the preparation of (hydroxymethyl)diphenylphosphine 
oxide 330,according to a short and efficient synthetic protocol described by Kiyokawa et al.64 
(scheme 65). The sole inconvenience of this method was linked to the scale-up of the reaction, 
as a high volume of saturated solution of NaHCO3 was demanded to neutralise the excess HCl. 
This method has demonstrated its efficiency with a reproducible yield even at multigram scale, 
in addition to the easy access of the starting material. With the (hydroxymethyl)diphenyl 
phosphine oxide 330 in hands, the same benzylation, as for the (((4-methoxybenzyl)oxy) 
methyl)phosphonate 331, was performed in the presence of trichloroacetimidate 174 and a 
catalytic amount of triflic acid to accomplish the synthesis of (((4- methoxybenzyl)oxy)methyl) 
diphenylphosphine oxide 331 as a white powder. Both triflic acid and camphorsulfonic acid 
proved to be suitable catalyst, though the latter, being an anhydrous powder, would be easier 
to handle than triflic acid which is much more sensitive to moisture. 
 
Scheme 65: Synthesis of (((4-methoxybenzyl)oxy)methyl)diphenylphosphine oxide 331 
The Horner-Wittig olefination had to be initiated by a deprotonation leading to a metallated 
phosphine oxide. Initially, Horner et al. carried out their deprotonation in the presence of 
potassium tert-butoxide to produce the alkenes in a one-pot manner.58 But they quickly 
recognised the possible splitting of the olefination into two distinct steps: the first step was 
composed of the addition of a lithiated phosphine oxide to a carbonyl, providing two isolated 
and separated diastereomers, and the second step as the elimination of a phosphinic acid to 
afford the corresponding alkenes with high geometrical purity. While the 
alkyldiphenylphosphine oxides were normally deprotonated with BuLi in THF,65 researchers 
from the group of Warren referred briefly to incorporation of butyl groups upon the treatment 
of the (methoxymethyl)diphenylphosphine oxide 312 with BuLi at an array of temperatures (-
78°C, 0°C and 25°C).61 This observation prompted us to try lithium di-isopropylamide (LDA) to 
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deprotonate the newly formed α-methoxyalkylphosphine oxide 331. Especially because the 
authors reported that LDA has not only proven to provide sufficiently stable lithiated 
phosphine oxide 313 (at 0°C for 10min) but also  allowed the isolation of diastereoisomers of 
315 (scheme 63).61 
 
 
 
Scheme 66: Attempts to access the PMB enol ether 309 via the corresponding anion of                        
(((4- methoxybenzyl)oxy)methyl)diphenylphosphine oxide 331 
To a solution of LDA (prepared in situ by addition of BuLi to DIPA in THF at -78°C followed by 
vigorous stirring for at least 30 min) was added dropwise phosphine oxide 331 in THF at -78°C. 
The solution was kept at -78°C for 5 to 10 min, and allowed to warm up to -30°C within 2h, 
turning into a clear and dark red solution (as it was the case of diphenyl (methoxymethyl) 
phosphine oxide 312 in the presence of LDA at 0°C).65 According to the authors, subsequent 
addition of the carbonyl electrophile to the corresponding lithium anions of phosphine oxides 
in THF gave the best results at -78°C.61 Therefore, a solution of lactol 257 in THF was added to 
the burgundy solution of 2 equivalents of lithiated phosphine oxide 332 at -78°C. Alternatively, 
lactol  was first deprotonated by Buli at -10°C, in order to avoid the use of 2 equivalents of 
phosphine oxide 331 (synthesised in 2 steps),then added to the solution of the corresponding 
anion phosphine oxide 332 at -78°C. Afterwards, the mixture was allowed to warm up to 20°C 
under vigorous stirring overnight. Unfortunately, no trace of the expected intermediate 333 
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was observed, in both cases, within the tested array of reaction temperatures as represented 
in Table 5 below. 
Deprotonation of phosphine oxide 331 Conditions after addition of lactol 257 at -78°C
LDA, -78°C, 1h30 to 2h -78°C to 0°C, 12h 
LDA, -78°C, 1h30 to 2h -78°C to 20°C, 12h 
LDA, -78°C, 1h30 to 2h -78°C to -20°C, 3h then -20°C, 12h 
LDA, -78°C, 1h30 to 2h -78°C, 1h then 0°C, 12h 
LDA, -78°C, 1h30 to 2h -78°C, 15 min, -10 to 0°C, 12h 
Table 5: Horner-Wittig Reaction conditions applied to                                                                  
(((4- methoxybenzyl)oxy)methyl)diphenylphosphine oxide 331 and lactol 257 
Even though the group of Warren has reported reactions of lithium derivatives of 
alkyldiphenylphosphine oxides with aldehydes to make alcohols which rearranged to the 
corresponding allyl compounds,61 to the best of our knowledge, no reactions involving lactols 
have been so far mentioned in the literature. The Horner-Wittig-based reaction applied to the 
open chain form hydroxyaldehyde 262 was trickier than expected, supposedly due to the 
equilibrium far in favour of the strain-free 5-membered cyclic hemiketal 257. On the other 
hand, when the temperature exceeds 0°C, the lithium derivative of phosphine oxide 331 was 
likely to decompose into an uncharacterised PMB containing compound.  
 
Scheme 67: Addition of lithium derivative of phosphine oxide 331 onto δ-valerolactone 
In the interest of verifying the existence of the lithium derivative of phosphine oxide 331, and 
in particular its nucleophile strength, δ-valerolactone was used as testing electrophile (scheme 
67). Following closely the procedure described by Warren et al.,66 to the dark red solution of 
deprotonated phosphine oxide 331 at -78°C was added dropwise δ-valerolactone. The solution 
was vigorously stirred between -78°C and 20°C overnight, providing the expected adduct 336. 
Given the eager transformation of hemiacetals under acidic conditions, it was advisable to 
attain in the first place the hydroxyketone form of 257. In the literature, to open a γ- or δ-
lactol, one of the common methods consists in trapping the primary alcohol, which in this case 
would lead to compound 338.   
In 1985, Ditrich and Hoffmann have reported a reliable one pot procedure to convert 5-
membered and 6-membered lactones 341 into the 5-(or 6)-silyloxy-3-keto-phosphonates 
342.67Their method resides in the transformation of lactones 341 into the corresponding 
lactols 343, which upon treatment with LDA and silyl chlorides, e.g. trimethylsilyl chloride, 
provided the protected alcohol 344 (scheme 68). More recently, White and Hansen succeeded 
2  TOWARDS THE TOTAL SYNTHESIS OF L-783,277 (7) 96 
  
in obtaining the ring-opened isomer of adduct 345 as the corresponding compound 346.68 
Though there was no evidence about the equilibrium between 345 and its hydroxyketone 
isomer, exposure of 345 to trityl chloride and triethylamine in a catalytic presence of DMAP 
resulted in trityl ether 346.  
The choice of a bulky protecting group, e.g. trityl, was to avoid protection of the lactol. In spite 
of the insignificant amount at equilibrium of the hydroxyketone isomer of 347 at it 
equilibrium, its protection would remove it from the reaction mixture, and hence shift the 
equilibrium into the ring-opened form. Following the same procedure described by White and 
Hansen,68 our first attempts aimed to transform the primary alcohol of the ring-opened isomer 
of 257 as trityl ether 348 (scheme 66). The resulting crude mixture did not contain the desired 
product 348 while the adduct 336 was seemingly decomposed. Other trials using TBDPSCl or 
TMSCl in the presence of imidazole in DMF at room temperature did not provide the 
corresponding silyl ethers either.  
 
Scheme 68: Attempts to open the cyclic hemiacetal 336 
An alternative method for opening ߛ-, δ-, and ߝ-lactones was published by Lanners et al., 
which was based on the treatment of the potassium open-chain dianion 352 (resulting from 
the attack of lithium enolate of ester 351 onto lactones, e.g.δ-valerolactone 347) with 2 
equivalents of bulky silylating reagent, giving cleanly the tri-silylated compound 353 (scheme 
69).69 By exposing 347 to one equivalent of TBAF, the authors obtained silyloxy--
diketoesters 357 in quantitative amount. The same reaction sequence was also applicable to 
methylsulfoxide carbanion to afford β-ketosulfoxide 358 from the corresponding δ-
valerolactone 347. Interestingly, the addition of two equivalents of TBDMSCl, though only one 
equivalent would be required, to the hemiketal 357 directly led to the formation of -
ketosulfoxide 358 in good yield. Unfortunately, treatment of our phosphine oxide adduct 9 
with two equivalents of tBuOK, followed by two equivalents of TBDPSCl under the same 
conditions did not give the expected disilylated intermediate 359, or the -ketophosphine 
oxide 349.   
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Scheme 69: Alternative method for the opening of cyclic hemiketal 336 
Subsequent to the unsuccessful trials to trap the open-chain isomer of 336 in view of reducing 
the resulting -ketone function 349 to access the intermediate 338, we turned to another 
approach as presented in scheme 70. This was inspired by the work of Warren et al. who 
observed the formation of E-isomer 363 by diphenylphosphite (340) elimination of 
intermediate 362 resulting from the stereoselective reduction of β-ketophosphine oxide 361 
by NaBH4.70 It was hence feasible to submit hemiketal 336 to a reduction to provide the 
corresponding diol 338 which would be eliminated into enol ether 339. 
 
Scheme 70: Lactol opening by direct reduction of phophine oxide 364 
 The sequence started with the attack of the lithium anion derivative of 331 onto δ-
valerolactone, followed by submission of the crude intermediate 336 to NaBH4 reduction in 
ethanol at room temperature (scheme 71).  After the acidic workup, the resulting mixture was 
exposed to 2 equivalents of NaH in DMF at 20°C overnight. To our delight, the PMB-ether enol 
339 was obtained upon flash chromatography purification with an overall yield between 40 
and 50% over 3 steps.  
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Scheme 71: Reaction sequence transforming δ-valerolactone into enol ether 339 
 
Encouraged by this outcome, we embarked on the synthesis of the desired PMB-enol ether 
339, which initiated with the addition of lithium anion derivative of phosphine oxide 331 onto 
the corresponding lactone of the readily prepared 2,3-O-isopropylidene-d-erythronolactol 257. 
This required a prior preparation of the lactone 364 as presented in scheme 72. The first 
method was based on a simple oxidation of the available lactol 257, using pyridinium 
chlorochromate under basic conditions (NaOAc), due to the acid-labile acetonide at room 
temperature. In the absence of NaOAc, the oxidation yield remained very low in spite of the 
total conversion of lactol 257. 
  
2  TOWARDS THE TOTAL SYNTHESIS OF L-783,277 (7) 99 
  
2.2.1.3 Third generation strategy: “D-isoascorbic acid approach” 
Another synthetic procedure employing D-isoascorbic acid 365 as starting material was well-
described by Cohen et al. (scheme 72).71 The erythorbic acid 365 was subjected to hydrogen 
peroxide in the presence of sodium carbonate, and acidified by hydrochloric acid to provide D-
erythronolactone 366. Protection by 2,2-dimethoxypropane catalysed by p-toluenesulfonic 
acid  furnished the wanted lactone 364 in relatively good yields. This sequence gave a more 
direct access to lactone 364 as it required fewer intermediate purification, cheaper starting 
material and allowed a more efficient scale-up procedure.  
 
 
Scheme 72: Two synthetic methods towards 2,3-O-isopropylidene-D-erythronolactol 364 
 
With lactone 364 in hands, we applied the same reaction sequence with some subtle 
modifications that are featured in scheme 73. The first step consisted in deprotonation 
phosphine oxide 331 by a solution of LDA, prepared in situ by a solution of Buli and DIPA in THF 
at -78°C. The deep red solution was stirred between -78°C and -20°C during 2h, instead of 5 to 
10 minutes at 0°C, which gave ostensibly a cleaner resulting product. A solution of lactone 364 
in THF was added at -78°C and the mixture stirred between -78°C and 0°C overnight. As 
previously described, the reduction of 367 was carried out in the presence of NaBH4 in a 
mixture of ethanol and ether at 20°C overnight. The resulting crude intermediate 368 had to 
be dried under reduced pressure until obtainment of an opaque white powder, before being 
subjected to a NaH-assisted elimination in anhydrous DMF. Interestingly, reactions which were 
carried out in THF would not lead to any desired elimination product, but a complete 
destruction of 368. Isolation of 309 gave an average yield that fluctuated between 45 and 55% 
over 3 steps, via flash chromatography employing silicagel which was neturoalised by 
triethylamine. The subsequent hydrogenation was carried out in H-cube® through at a flow 
rate of 1 mL/min through a 10% Pt/C cartridge, at 50°C and 50 bar. The outcome hydrogenated 
solution provided without purification, up to 98% of yield the desired compound 369. On the 
other hand, the same results have been obtained by means of batch hydrogenation, using 10 
%-mol PtO2.H2O in EtOAc. The 3-phased mixture was vigorously stirred at ambient 
temperature and pressure for 12 to 24h till completion and the catalyst was carefully filtered 
off through a celite pad.  
Given the generally known instability of enol ethers, it seemed to be more appropriate not to 
purify the intermediate 309 prior to the hydrogenation. This led to a sequence that combined 
all the 4 aforementioned synthetic steps without intermediate purification. To our great 
delight, the overall yield could reach up to 85%. However, in case the resulting ether enol was 
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not isolated, hydrogenation in a flask was more convenient than continuous flow 
hydrogenation. Indeed, the crude product from NaBH4 reduction caused a more recurrent 
blockage of Pd/C cartridges, while it was less wasteful to add, 6h after the first addition, 
another 5 %-mol of PtO2.H2O to accomplish the reaction in the flask. 
 
 
Scheme 73: Reaction sequence towards PMB ether 369 
 
Convincingly, the one-carbon homologation, together with the introduction of the para-
methoxy benzyl leading to the PMB enol ether was achievable by means of diphenylphosphine 
oxide 369, whereas the corresponding triphenylphosphonium 282 as well as diethyl 
phosphonate 308 failed. Even though the Horner-Wittig reaction could not be directly 
conducted with lactol 257 as expected, the relatively high and reproducible yields over 4 
consecutive steps have proven a novel alternative pathway to open lactones. Moreover, this 
method has been proven robust by an easy scale-up to afford the desired PMB protected diol 
in multigram amount. 
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Scheme 74: Accomplishment of iodide fragment 253 
Similar to the previous route, the next step was the oxidation of the primary alcohol in the 
presence of complex SO3·pyr and N,N-diisopropylethylamine in a mixture of DMSO and CH2Cl2 
at low temperature (scheme 74). This oxidation method was mild enough to avoid the 
cleavage of acid-labile dioxolane, but the temperature had to be maintained under 0°C to 
avoid the undesired Pummerer reaction. The obtained crude mixture, containing no trace of 
Pummerer product according to NMR analysis, was directly subjected to Grignard addition of 
commercial prop-1-yn-1-ylmagnesium bromide in THF, affording intermediate 371 in 
adequately high yield (70% over 2 steps). Like in the first strategic approach (“2-deoxy-D-ribose 
approach” from section 2.2.1.1), the newly formed alcohol was protected as ethoxymethoxy 
ether 372, upon subjection of 371 to EOMCl, DIPEA and catalytic TBAI in DMF. The fully 
protected polyol 372 was then treated with a solution of DDQ in wet dichloromethane. When 
the reaction was maintained at 0°C, DDQ had to be added till total conversion, the resulting 
crude product was a very complex mixture, which gave less than 60% of the desired alcohol. 
But when stirred at 0°C for 30 minutes, then at room temperature, the reaction was 
completed within 2 hours. To our great pleasure, this oxidation cleaved 372 into p-
methoxybenzaldehyde and the anticipated alcohol 252 in very high yield (90 to 95%). This 
synthetic sequence merged with the “2-deoxy-D-ribose approach” via the achievement of this 
polyol fragment, starting with D-isoascorbic acid (365) as the chiral pool for the anti-diol at C5’-
C6’.  
The ensuing iodination under Appel conditions (I2 and PPh3 in THF at 0°C) gave comparable 
results after purification as the first synthetic approach (scheme 42).   
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• Conclusion 
 
 
Scheme 75: 2-deoxy-D-ribose approach versus D-isoisoascorbic acid approach 
In conclusion, we have succeeded in obtaining the iodide intermediate 253 as one of the three 
fragments required for convergent synthesis towards metabolite L-783,277 (7). Starting with 
D-isoascorbic acid (365), the last synthetic pathway was composed of 11 steps with 33% of 
overall yield (scheme 75). The very first synthetic approach starting with 2-deoxy-D-ribose (89) 
included 8 steps with 11% of overall yield. This low overall yield was due to the unselective and 
unrepeatable mono-protection of primary diol 247, the third step in the sequence. In addition, 
the handling of some intermediates, as well as the starting material 2-deoxy-D-ribose (89), was 
difficult on a multigram scale. Despite its longer sequence, the D-isoisoascorbic acid approach 
provided 253 in relatively higher yield, which is also reproducible on multigram scale. 
The D-arabinose approach led to compound 268, containing a TMSE-ether which proved to be 
too stable to be selectively cleaved under commonly described conditions. This was the first 
dead end of a series of attempts to attain segment 253, leading consequently to the 
preparation of PMB enol ether 309, an intermediate which was finally obtained via the D-
isoascorbic acid sequence.  
Hereafter, scheme 76 illustrates our various attempts to obtain the intermediate enol ether 
309. Notably, the success of the D-isoascorbic acid approach depended on the Horner-Wittig 
based olefination combined with intermediate reduction the preparation of PMB-enol ether 
309. Indeed, the 4 successive steps illustrated in scheme 73, without isolation of 
intermediates, have been proven to be not only concise and promising, but also very reliable 
method.  
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Scheme 76: Attempts to achieve PMB-enol ether 509 via various olefination methods 
Transforming alcohol 252 into the corresponding iodide 253 instead of another corresponding 
haloalkanes or tosylate 255 (scheme 42) resulted from previous trials targeting a direct 
alkylation at the benzylic position of the aromatic core of L-783,277 (7). The next chapter will 
deal with this key step of our synthetic scheme towards the formal synthesis of L-783,277 (7), 
and hence our choice of the appropriate leaving group for the polyol segment 231 illustrated 
in scheme 77 below.  
 
Scheme 77: Expected assembly of the three segments 
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2.2.2 Synthesis of (S)-hex-4-yn-2-ol (232)  
 
 
 
Scheme 78: First retrosynthesis of (S)-hex-4-yn-2-ol (232)  
In compliance with the disconnections of dialkyne prescursor 241 (scheme 41), the 
stereochemistry of the carbon at α position to the aromatic carbonate would originate from 
the propargylic fraction 232, whose retrosynthetic cleavage was illustrated in scheme 78. The 
required propargylic alcohol 232 appeared to be readily available from rather simple building 
blocks via a regioselective opening of (S)-2-methyloxirane(136) by an alkynyl anion. The latter 
was at first employed as the commercially available Grignard reagent 244.  
 
 
Scheme 79: Unsuccessful epoxide opening via Grignard reagent 244 
 
The magnesium bromide was added to a solution of (S)-2-methyloxirane 136 at -78°C in THF 
(scheme 79). The reaction was allowed to warm up to -20°C within 4h then stirred for further 
4h at 0°C. Isolation of the main resulting product gave evidence, unfortunately, of the 
presence of the unintended bromohydrin 375, and surprisingly, no trace of its isomer 
bromohydrin 374 was observed. Even at a constantly low temperature (-20°C) during the 
reaction time, the same product was still formed. Obviously, this phenomenon was induced by 
the Schlenk equilibrium, a well-known process which took place in the solution of Grignard 
reagent and led to the emergence of dibromide magnesium (scheme 80). 
 
 
Scheme 80: Schlenk equilibrium  
This degradation of the propargyl magnesium bromide was unavoidable and the ability of 
metal halides to open simple and functionalised epoxides has also been mentioned in the 
literature. This tendency of Grignard reagent to afford magnesium halide salt was interestingly 
tampered by the additional presence of copper halide, e.g. CuI.SMe2 or CuBr.SMe2. For 
instance, Solladié and co-workers had access to five-carbon functionalised homoallylic alcohols 
by regioselective ring opening with vinylmagnesium bromide.72 Their careful and extensive 
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study on the opening reaction of protected epoxide 378 (protecting group= Bn, MPM, TBS, 
TBDPS, respectively). They found out that Cu(I) salts alone did not open oxiranes 378, whereas 
the Grignard reagent 379 alone furnished mainly bromohydrin 381, together with a small 
amount of bromohydrin 382, but when used in combination they granted homoallylic alcohols 
380 in excellent yields (scheme 81).72  Some years later, Tanino et al. oxidised the 
commercially available allylsilane 384, then exposed the resulting epoxide to an efficient ring-
opening method where prop-1-yn-1-ylmagnesium bromide 245 was used, along with 
CuBr.SMe2 in the presence of a Lewis acid, BF3.OEt2.73 
 
Scheme 81: Attempts to open (S)-2-methyloxirane (136) by Grignard reagent and Cu(I) salts in 
the manner of Solladié’s group and Tanino’s group 
 
Convinced by the reasonable synergy of a Grignard reagent and a monohalide cupper, we 
ventured the opening of enantiomerically pure epoxide 136 with prop-1-yn-1-ylmagnesium 
bromide (244) in the presence of either CuI (1 equivalent) or CuBr (0.5 to 0.8 equivalent). The 
end result was only complex mixtures of several unidentified compounds, among those there 
was no observation of propargylic alcohol 232. In the meantime, other trials were carried out 
in the same conditions, with addition of Lewis acid BF3.OEt2, as described by Tanino et al.,73 
which, to our discontent, did not give any better result when combined with CuI. Nevertheless, 
when 0.4 equivalent of CuBr.SMe2 was employed, the desired product was formed, together 
with the bromohydrin 375 as observed when no copper salt was present, though in very low 
yields (less than 20%). These outcomes ended our intention to employ an organomagnesium 
as epoxide opening reagent and turned our attention to the corresponding organolithium.   
One decade ago, Woerpel and collaborators succeeded in opening the achiral epoxide 385, 
using prop-1-yn-1-yllithium 245, in combination with BF3.OEt2 at -78°C, overmatching the steric 
hindrance of both tertiary carbons (scheme 82).74 Typically, organolithiums have proven to be 
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more basic than Grignard reagents, and do not create any lithium salt susceptible to induce an 
acid-catalysed opening of epoxides. More recently, the Korean group of Sim had recourse to 
((trimethylsilyl)ethynyl)lithium formed in situ in the presence of BF3.OEt2 at -78°C to open 
regioselectively (S)-propylene oxide (136), as previously mentioned in section 1.2.3.75 The final 
yield was nevertheless only half amount of the expected amount. 
For these reasons, we envisaged to resort to the corresponding prop-1-yn-1-yllithium  to gain 
access to the enantiomerically pure homoallylic alcohol 1. 
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Scheme 82: Epoxide opening by prop-1-yn-1yllithium (244)  
 
The first idea for the synthesis of the related organolithium would naturally evoke the 
commonly known treatment of prop-1-yne (387) with butyllithium at low temperature, as 
described by the group of Woerpel, who engaged this reaction in situ to open epoxide 385.74 
Nonetheless, the use of prop-1-yne (387) did not appeal to us, due to its very low boiling point, 
hence impractical laboratory manipulation. Fortunately, Suffert and Toussaint developed a 
convenient method to obtain prop-1-yn-1-yllithium (245) from a E/Z mixture of bromo-1-
propene (388) upon treatment with 2 equivalents of butyllithium.76 This preparation step 
preceded the opening of oxirane 136  in the same manner detailed by Fürstner and co-workers 
as part of their innovative synthetic design of (S)-(+)-citreofuran.77 
 
Scheme 83: Synthesis of (S)-hex-4-yn-2-ol (136)  
 
Actually, the prop-1-yn-1-yllithium (245) was prepared in situ from the commercially procured 
bromo-1-propene (388) in THF at -78°C. After 2 hours, the reaction mixture was allowed to 
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warm up to -20°C over a period of 5 minutes before the addition of DMPU, and kept at this 
temperature for 30 minutes, followed by very slow addition of (S)-methyloxirane (136) in 
DMPU.78 Most of the experiments were performed in the presence of DMPU as co-solvent 
provided the desired product at 40% to 60% yields. Some other trials which were conducted in 
the same conditions, in default of DMPU, would only led to very bad yields (lower than 15%). 
On the other hand, when the temperature exceeded -20°C right after the addition of DMPU, or 
the reaction temperature remained at 0°C overnight, the overall yields also shrank 
considerably. The use of DMPU presumably was crucial for the opening process, in the same 
modus operandi as HMPA in the opening of (R)-propylene oxide (390) by pentyne anion by the 
research group of Cho.78 We were rather surprised to gain in yields while replacing DMPU with 
HMPA, which was certainly accounted as highly toxic, therefore often disfavored in 
comparison to the not yet listed as harmful DMPU. Considering the final high yields, we 
preferred though to use HMPA for the scale-up synthesis of the propargylic alcohol 3.  
 
 
Scheme 84: Synthesis of (R)-hex-4-yn-2-ol (389) 
 
To sum up, the alcohol fragment (S)-hex-4-yn-2-ol (232) could be achieved on multigram scale 
from the commercially available bromo-1-propene and (S)-propylene oxide (232), the chiral 
pool containing the right configuration for the C10’ carbon from L-783,277 (7), if the upcoming 
connection to the aromatic section ensued from an esterification. In case the esterification did 
not  the alternative connection induced an inversion of configuration at the carbon in 
question, the R-enantiomer (389) could also be obtained by the same protocol, starting this 
time with the corresponding R-propylene oxide 40 (scheme 84).  
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2.3 Assembly of the building blocks 
2.3.1 Direct benzylic alkylation  
 
 
 
Scheme 85: Expected alkylation at benzylic position as the key step of our retrosynthesis 
 
As indicated above, we envisioned that the synthon 231 would be appended to the aromatic 
moiety 243 via a direct SN2 alkylation, a major improvement in atom economy of our sequence 
if successfully achieved. Regarding the same strategic transformation from the group of 
Winssinger, where the acid function of the orsellinic acid derivatives was masked as an ester 
prior to the deprotonation at the benzylic position,1, 79 we decided to take the same 
precaution. Consequently, the preparation of the fragment 243, both as free benzoic acid 
derivative and its corresponding ester took place. The subsequent step would consist in finding 
the right conditions to deprotonate at the benzylic position of orsellinic ester 234, as well as 
the appropriate leaving group for the polyol 231. 
• Preparation of orsellinic acid (401) 
 
Orsellinic acid (392), together with orcinol (393) and penicillinic acid (394), were isolated from 
the culture of Penicillium fennelliae.80 Orsellinic acid plays an important role in the 
biochemistry of lichens, where the biosynthesis proceeds via polyketide way.  
 
Scheme 86: Orsellinic acid (392), orcinol (393) and penicillinic acid (394) 
The preparation of orsellinic acid 431 has been subject of several studies in the literature, 
involving different synthetic routes as well as various starting materials. Among these, for 
instance, the synthetic route taken by Kato and Hozumi in 1972 implicated the nucleophilic 
attack of the active methylene of β-ketoester 396 in the presence of sodium hydride onto 
diketene 398, leading to the formation of methyl orsellinic ester 399 (scheme 87).81 The 
protection of the diphenol moiety took place under the efficient treatment of 400 with 
diazomethane in ether, giving the totally protected orsellinic acid 401 in good yields (45% and 
89%).  
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Scheme 87: Preparation of orsellinic acid 401 and its methylated derivative by Kato and 
Hozumi in 1972 
Almost one decade later, Hubbard and Harris published another method yielding methyl 
orsellinate 399 which originated from the converting of the monoanion of methyl acetoacetate 
to the related dianion 405 by trianion 406, itself came from two successive deprotonations 
(scheme 88).82 As a consequence, the dianion 397 condensed with methyl acetoacetate 
monoanion to give methyl 3,5,7-trioxo-octanoate 407, which, through an aldol cyclisation 
during chromatography, provided the methyl orsellinate 399.  
 
 
Scheme 88: Preparation of methyl orsellinoate 399 by Hubbard and Harris in 1981 
Another preparative method of orsellinic acid was also reported by Nicolaou et al. as part of 
their strategic approach towards the stereocontrolled synthesis of the Everninomicin A1B(A)C 
ring framework.83 Using the relatively cheap commercially available orcinol (393) as starting 
material and the convenient, classic synthetic techniques employed by the authors, this 
approach by Nicolaou’s group seemed to be appropriate to prepare the aromatic structure of 
L-783,277 (7). Moreover, this preparative method does not result in an orsellinate derivative 
(e.g. methyl orsellinate) which necessitates a supplementary step to release the acid moiety, 
but directly afforded the desired orsellinic acid 401. 
The first step consisted in a Vilsmeier-Haack formylation of orcinol 393 which gave the 
corresponding aromatic aldehyde 409 in rather high yield (80%) (scheme 89). Exposure of 409 
to a mixture of sodium chlorite and in a NaH2PO4 buffered solution of DMSO and H2O provided 
orsellinic acid 399 in an acceptable 77% yield. This Pinnick-Lindgren oxidation has the 
advantage of using cheap, off-the-shell reactants and can take place under atmospheric 
environment, in an open flask. The resulting acid can be either purified through silica 
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chromatography or recrystallised in dichloromethane to afford white crystals in form of 
needles. The diphenol was then methylated with iodomethane under the action of K2CO3 in 
acetone (97% of yield). 
 
Scheme 89: Preparation of methylated orsellinic acid 401 
The choice of protecting the phenols as methyl ethers was inspired by the work of Winssinger 
and co-workers towards radicicol A (2), another member of RALs family.16Indeed, the ortho 
methyl ether was selectively cleaved upon treatment with boron trichloride, in the presence of 
other methyl ethers in meta and para positions (scheme 90).  
 
Scheme 90: Final deprotection of macrolide 410 as part of the total synthesis of radicicol A by 
Winssinger et al. 
 
• Protection of methylated orsellinic acid  
 
Scheme 91: TMS protection of commercial methylated orsellinic acid (399) 
The TMSE-ester was chosen as the protecting form because it could easily undergo 
fragmentation reaction in the presence of TBAF in THF to give fluorotrimethylsilane, ethylene 
and the resulting carboxylate.84 The TMSE-protected acid 412 has also been featured in the 
synthesis of radicicol A (5) by the group of Winssinger.8 Its mild deprotection would 
theoretically not interfere with other protecting groups on the intermediate resulting from the 
expected alkylation between the deprotonated 401 and an appropriately electrophilic 
derivative of polyol section. Otherwise, the use of NaH in the presence of DMF as a mild 
alternative would also be compatible.36 
The ester formation smoothly took place between the chloride acid that was formed in situ by 
submission of 401 to a solution of freshly distilled oxalyl chloride in dichloromethane, and 2-
trimethylsilyl ethanol in the presence of triethylamine and a catalytic amount of 4-DMAP. The 
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obtained ester was to be subsequently subjected to several trials of deprotonation at the 
benzylic position in the conditions described by the group of Winssinger,9 followed by addition 
of iodopropane and bromobutane as simple testing models. 
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2.3.1.1 State of the art 
 
• Deprotonation with LDA  
 
 
Scheme 92: Selenide formation via electrophilic selenium 
The synthetic strategy from Winssinger et al. consists in the protection of the acid function 
prior to the functionalisation of the benzylic carbon.79 Moreover blocking the acid function was 
principally meant to obtain a mono-lithiated species instead of dianion which would be much 
more unstable. Additionally, it would prevent the nucleophilic carboxylate from competing 
with the stabilised selenide anion following the addition of the electrophile alkyl iodide. For 
these reasons, we decided to apply the same method based on Hauser’s 
deprotonation/selenation85 (scheme 93) which used LDA (prepared in situ by adding one 
equivalent of BuLi to a stirred solution of diisopropylamine in THF at -78°C) to lithiate methyl 
2-methoxy-6-methylbenzoate 419 prior to addition of diphenylselenide. This procedure was 
also part of the total synthesis of ochratoxin A by Kraus,86 who deprotonated the diester 421 
with two equivalents of LDA (one equivalent was to deprotonate the o-phenol), before its 
successful addition onto ethanal, followed by a lactonisation (scheme 93). In both reactions, 
the presence of the carbanion was distinctly detected by the formation of a deep red solution 
in place of the initial colourless reaction mixture.  
 
Scheme 93: LDA deprotection by Kraus and the group of Hauser 
In our case, the temperature had to be constantly kept at -78°C to avoid the newly generated 
organolithium to add to unreacted starting material to give dimer 423, once the temperature 
started to rise (scheme 94).85 
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Scheme 94: Inevitable self-condensation of the ester 412 
Though the dimerisation of the aromatic compound was not mentioned by the group of 
Winssinger throughout the systematic deprotonation/addition to prepare their library of 
selenide and sulfunide aromatic building blocks, this occurrence was earlier cited in the 
literature. Indeed, in their 1980 article, Hauser et al. observed the self-condensation product 
425 of ethyl 2-methylbenzoate (424) as soon as the product organolithium formed, for it 
added to the undeprotonated starting material. 
 
Scheme 95: Self-condensation and alkylation of alkyl 2-methylbenzoates in the literature 18, 86 
Yet a substantial factor which could slow down this undesired reaction was the substitution 
within the aromatic component: the addition reaction is much slower with 2,6-distubstituted 
esters (and phenoxides), which allowed its carbanionic lithium to react with external 
electrophiles (scheme 95).85 Recent researches depicted the same unwanted side reaction that 
led to very low yield for the alkylation between 1-bromotetradecane and benzylic anion 
derived from ester 426a (28%) while the ethyl ester counterpart 426b gave a clearly higher 
yield under the same conditions. In comparison, it was reported that treatment of 243a with 
LDA and 1-bromotetradecane in the presence of HMPA provided 426a in only 5% yield.87 The 
ethyl ester function was likely more sterically hindering than the methyl ester, which favored 
the benzylic alkylation to the addition onto the non-deprotonated starting compound to form 
dimeric products. The addition of HMPA was aimed to increase the nucleophilic effect of the 
anion and turned out to be ineffective as long as the acid function was blocked by a methoxy 
group, which conferred a greater electrophilic character to the carbonyl than ethoxy group.  
2.3.1.2 First generation strategy: “TMSE-ester approach” 
Following closely the protocol by Kraus,86 the TMSE ester 424 was first deprotonated by LDA 
(resulting from the addition of BuLi to diisopropylamine) at -78°C for 1h, providing an orange 
red solution, then submitted to a slow dropwise addition of bromopropane at the same 
temperature and stirred for 4h, before the reaction was allowed to warm up to -10°C 
overnight. Accordingly, the compound 425 resulting from the previously mentioned self-
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condensation was majorly present in the final reaction mixture, observed by NMR spectrum 
analysing, though not isolated and fully characterised (scheme 96). In other trials, the reaction 
mixture was kept at -78°C for 7h following the addition of bromopropane before warming up 
to room temperature overnight, which did not prevent the undesired self-condensation. It 
seemed to us that this phenomenon was unavoidable as long as the temperature started to 
rise over -78°C, which consumed the starting material before any nucleophilic attack onto the 
bromide.   
 
Scheme 96: Unsuccessful alkylations with LDA  
On the other hand, as long as the reaction temperature did not increase, the existing lithiated 
ester 427 would not react with the added bromide. The bromide leaving group was probably 
unsuitable at very low temperature. Hence iodopropane was substituted as it was known to be 
a more reactive electrophile with the better leaving group, basing on experimentally 
determined bond enthalpies which show a higher heterolytic bond dissociation energy for the 
carbone-bromide bond (72.1 kcal.mol-1) compared to carbone-iodide bond (57.6 kcal mol-1).87 
The lithiation was carried out as previously described at -78°C and the iodopropane was added 
after 1h, then the mixture was vigorously stirred at -78°C for 12h before being quenched with 
water at 0°C. Disappointedly, the major product was once again the dimer 423.  
Given that the only two leaving groups that were successfully implanted onto the polyol 
section at that time were iodide and tosyl, we decided to test the benzylic addition directly 
onto the intermediate 255. Unfortunately, no alkylation product was detected next to the 
previously observed dimeric by-product 423. Finally, we had to give up on the benzylic 
alkylation through mono-lithiated ester 427 and find out an alternative directing group that (i) 
would not be prone to self-condensation, (ii) easily converted into an acid function to respect 
the initial retrosynthetic plan (scheme 41), and (iii) stabilising enough to leave out the use of 
benzylic selenide/sulfide like the strategy from Winssinger et al. The strategic method by 
Winssinger certainly guaranteed a well stabilised benzylic anion, the over addition of diphenyl 
disulfide caused however the formation of by-product 432 (scheme 97). 
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Scheme 97  
Considering the self-condensation as impossible to overcome in a short time assignment, we 
decided to look for another directing group in the literature which would also be easily 
removed in mild conditions.   
To this aim, amides have also been proved to be effective directing group in the literature. 
Even though laterally lithiation occurred in the presence of either secondary amide or tertiary 
amide, the latter is more prone to self-condensation like in the case of an ester, whereas the 
former requires two equivalents of base. As an example, the group of Clark has used the 
addition of both laterally lithiated secondary and tertiary amide to a Weinreb-type amide 433 
and 43588 and imine89 (scheme 98), while Schultz et al. employed a laterally lithiated tertiary 
amide 438 to add onto a series of halogenated compounds. This alternative could be attractive 
to replace the ester-directing benzylic metallation, but it would require additional steps to 
introduce the amide function then its orthogonal cleavage, in the same manner as for an 
ester.90 
 
Scheme 98: Amides as directing group for lateral lithiation by Clark et al. and the Schultz’s 
group 
It was not unusual in the literature to use a carboxylate function as directing group in lateral 
lithiation. In spite of the commonly known weaker stability of a dianion compared to an anion, 
benzylic alkylation can also be assisted by a carboxylate instead of an ester, necessitating two 
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equivalents of base instead of one, but advantageously cuts down the protection/deprotection 
when an ester or amide is chosen as directing group. Both the ability to coordinate and the 
competence to acidify are important in a lateral lithiation (scheme 98). The presence of the 
carbonyle in both cases (carboxylate vs ester) assures a good coordination, but a carboxylate 
displays a weaker inductive effect. Moreover, treatment of a methyl benzoic acid with a base 
would greatly reduce the risk of self-condensation at higher temperature than -78°C, for an 
alkyloxy group is clearly better leaving group than a lithium oxide, the decisive drawback of our 
initial strategy via an ester. We embarked then on a series of attempts to carry out the 
benzylic alkylation through 2,4-dimethoxy-6-methylbenzoic acid (401), starting with the search 
for the most appropriate base and a fine-tuned reaction temperature. 
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2.3.1.3 Second generation strategy: “Orsellinic acid approach” 
In the literature four decades earlier, the group of Creger proved that 2-methylbenzoic acid 
could be laterally lithiated with two equivalents of LDA,91 whereas the group of Thompson, 
twenty years later used instead LiTMP to achieve the same dilithiated species prior to 
successful nucleophilic addition to an aldehyde (scheme 99). To their great delight, the dilithio 
species derived from 7 was found to be stable in THF even at room temperature.92 
 
Scheme 99: Literature deprotonation/addition 
Taking into account the reduced stability of organolithium deriving from a functionalised 2-
methylbenzoic acid, our synthetic tactics would rely on the lifespan of the dianion 447 at 
different temperatures. The benzylic anion would not be as stabilised as the corresponding 
selenide/sulfide-supported anion used by the group of Winssinger, but the alkylation would 
plausibly be achievable when combined with appropriate electrophiles. Furthermore, the 
formation of the dianion 447 would shut down the self-condensation tendency, which was 
observed in the case of the corresponding ester (scheme94).     
 
Scheme 100: Dilithiation of 2,4-dimethoxy-6-methylbenzoic acid (401) with LDA 
Accordingly, preliminary attempts to deprotonate the 2,4-dimethoxy-6-methylbenzoic acid 
(401) were performed with two equivalents of LDA formed in situ at -78°C as described by 
Braun et al. in their total synthesis of (R)-(+)-lasiodiplodin  (10) (scheme 100). Unexpectedly, 
these experiences turned out to be unsuccessful, which was strongly supported by 
experimental observations. As a matter of fact, during the slow dropwise addition of the 
solution of 401 in THF to LDA at -78°C, the reaction mixture turned gradually from colorless to 
yellow then orange red. This colour change was already documented by Braun et al. as being 
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linked to the formation of benzylic anion, describing the same phenomenon when the reaction 
mixture was warmed up to -10°C.93 But the red-orange colour of the mixture gradually faded 
away before the complete addition of acid 401, even though the temperature was constantly 
maintained at -78°C. This observation could be explained either by the generation of the 
dianion, which was then reprotonated by the increasing amount of the diisopropylamine 
formed in situ. Or the deprotonation of the anion 446 was much faster than its reprotonation, 
which amounts to a small quantity of dianion 447 observed by its characteristic deep red color 
at the beginning.  
 Prior to the work of Braun et al., Coughlin and Salomon published a synthetic methodology 
which allows conversion of benzylsilanes into 4-alkylidenecyclohexenes of 4-
alkylidenecyclohexanones in good yields.94 For this aim, one entry starting with 2-
methylbenzylic acid involved the dilithiation in the presence of LDA and a mixture of THF and 
HMPA as solvent, followed by benzylic silylation and provided in rather good yield (88%) the 
compound 449. Using on the same conditions, we tried to dimetallate 2,4-dimethoxy-6-
methylbenzoic acid (401) but the reactions turned out to be fruitless, with or without HMPA as 
co-solvent. 
 
Scheme 101: Benzylic sililation by Coughlin and Salomon 
To overcome this insufficient basicity of LDA, we considered using an alkyllithium as proton 
extractor, a strong base that was often used in the literature to avoid the undesired 
competitive nucleophilic addition of the resulting diisopropyl amine.95 In 1991, the group of 
Schultz employed sBuLi to dilithiate 2-methylbenzoic acid (424) cleanly, prior to a favorable 
addition onto short-chained alkyl iodides (scheme 102).90 The use of sBuLi was meant to avoid 
addition to the carbonyl group if the temperature was not low enough.96 Secondly, the proton 
extraction by lithium amides will release amine by-products (e.g. diisopropylamine) apt to 
react with electrophiles, and consequently compete with the dilithio species originally 
generated for this purpose.  
 
Scheme 102: Dilithiation of 2,4-dimethoxy-6-methylbenzoic acid (401) with sBuLi 
Our first deprotonations with sBuLi were maintained at -78°C for 4h after its addition to the 
solution of methylated orsellinic acid 401 at the same temperature. The reaction mixture’s 
colour gradually changed from yellow to orange and did not fade back to light yellow as it 
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previously occurred because of reprotonation of the toluate. Noticing the prolonged lifetime 
of the dilithiate 447, we added in a slow dropwise way a solution of iodopropane to the bright 
orange solution, obtaining a quickly fading yellow solution. The solution was stirred overnight 
while the temperature gradually rose from -78°C to room temperature. Despite the low yields 
of the resulting propylated product after an acidic workup and purification via flash 
chromatography, we were quite optimistic about the success of the addition and boldly 
replace iodopropane for the iodide fragment 253, whose multi-gram synthesis was thoroughly 
related in the previous chapter.   
Stirring temperature/time 
after addition of sBuLi 
Addition 
temperature of 
iodide 253 
Stirring temperature/time 
until workup Yield 
-78°C over 4h -78°C -78°C over 12h X 
-78°C over 4h -78°C -78°C to RT overnight <10% 
-78°C to -50°C over 3h -50°C -78°C to -20°C overnight 10-15% 
-78°C to -30°C over 4h -30°C -30°C overnight 15-20% 
-78°C to -30°C over 4h -30°C -30°C to -5°C overnight 35-50% 
-78°C to -30°C over 3h 
then -15°C over 2h -20°C -15°C  overnight 50%-60% 
-78°C to -30°C over 3h 
then -15°C over 2h -20°C 
-20°C for 5 min 
then 0°C overnight 75%-85% 
-78°C to -30°C over 2h 
then -15°C to -10°C over 2h -15°C 
-15°C for 5 min 
then 0°C to 10°C overnight 80%-90% 
 
Table 6: The representative conditions of benzylic alkylation 
During the first experiments, by fear of causing the self-condensation reaction at higher 
temperature than -78°C, the dropwise addition of a solution of iodide fragment 253 in THF, as 
well as the subsequent stirring overnight were accomplished at the same temperature. No 
expected alkylated product was observed while 2,4-dimethoxy-6-methylbenzoic acid (401) was 
entirely recovered. Supposing the nucleophilic attack was inactive at such a low temperature, 
we allowed the reaction mixture temperature to reach room temperature overnight. The 
alkylation actually took place, yet the yield was far from satisfying. Indisputably, the success of 
the benzylic alkylation depended on the right temperature which had to be low enough to 
allow the total deprotonation without self-condensation, but also not below the favourable 
temperature for nucleophilic attack onto the iodide. Unfortunately, there was no means of 
controlling the consumption of 2,4-dimethoxy-6-methylbenzoic acid (401) during its 
deprotonation, other than its changing colour. Therefore, right after the addition of sBuLi, the 
temperature was allowed to steadily increase from -78°C to -15°C which caused the mixture 
colour to become deeper red while staying limpid for more than 2h. The subsequent addition 
of iodide 253 was performed between -20°C and -15°C and the alkylation gave the best results 
when the temperature was allowed to warm up to 0°C without further delay. Prior to this 
significant detail, in some experiments, the addition of iodide 253 proceeded at -20°C and the 
mixture temperature was maintained between -20°C and -10°C up to 2 hours before being 
warmed up to 0°C overnight. As a consequence, the expected adduct was yielded either in 
disappointing amounts (10% to 20%), or worse, none was detected. Pleasingly, when the 
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reaction mixture was directly warmed to 0°C following the iodide addition at -20°C or -15°C, 
the alkylation displayed an obvious surge in yields. Eventually the optimised yields were 
obtained for 12h of stirring between 0°C and 10°C (up to 90%).   
 
 
 
Scheme 103: Successful benzylic alkylation applied to the total synthesis of L-783,277 (7) 
The validation of direct benzylic alkylation as feasible synthetic tool, one crucial synthetic step 
of our strategy, was further confirmed by addition to the iodide 453 whose preparation is 
described in more detailed in section 3.3.2.2. The same conditions also worked fine for 
commercial 7-bromohept-1-ene (454) and 5-bromohept-1-ene (455), an application of our 
methodology to the total syntheses of (R)-(+)-lasiodiplodin (10) and its S isomer which would 
be described in further details in section 3.2. When the bromide was used in slightly higher 
excess, the yield exceeded 91% and the crude product could be used in the next step 
(Mitsunobu esterification) without any intermediate purification, for the remaining amount of 
bromide could be easily separated from the mixture by evaporation under highly reduced 
pressure.   
 
Scheme 104: Application of benzylic alkylation to other halides 
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In conclusion, despite the use of two equivalents of base (to abstract the carboxylic hydrogen) 
instead of one as in the case of the related ester, the abstraction of the supplementary 
protection/deprotection steps consequentially shortened the synthetic sequence, hence 
affording a higher overall yield. The outstanding success of the direct alkylation via 2,4-
dimethoxy-6-methylbenzoic acid (401) instead of the ester 2-(trimethylsilyl)ethyl 2,4-
dimethoxy-6-methylbenzoate (412) undeniably renders the synthetic design more attractive 
without the intermediate steps of sulfenylation or selenation, followed by alkylation then 
elimination to form related olefins. Our strategy constitutes a viable preparative entry to 
macrolactone analogues containing a saturated system at benzylic position, thanks to its 
compatibility with iodides, as well as bromides. And interestingly, this methodology has proven 
to be fairly mild, as it did not interfere with the different chemical functions of the precursor 
iodide 253, such as ethoxymethoxy ether, alkyne or the highly acid sensitive acetonide, which 
restricted the conception of new synthetic design to smaller fields.  
2.3.2 Esterification  
2.3.2.1 State of the art 
As stated in their name, the resorcylic acid lactones (RAL) consist structurally in a partially 
substituted β-resorcylic acid scaffold, which is linked to a 12 or 14-membered lactone. The 
ester moiety frequently prompted total synthesis chemists to disconnect retrosynthetically the 
carbon-oxygen bond, in view of either a late-stage macrolactonisation, or an intermediate 
connection between convergently synthesised fragments. Since the term “ester” was first 
referred to by Leopold Gmelin in 1848, numerous methods have been conceived, extending 
from the classic Fisher esterification or the commonly performed Steglich method, to cobalt 
(II) chloride hexahydrate as catalyst.97 However, aromatic esterification, such as the resorcylic 
acid core hindered to some extent at the ortho-methyl, the choice of the appropriate ester 
formation might be pivotal. Comprised in the strategic design of RALs, the ester bond synthesis 
covered a wider area than the routinely used esterification between an alcohol and an acid 
moiety, according to the steric hindrance of the substrate or the reactivity of the involved 
fractions. 
One of the convenient methods for the formation of esters is the well-known Steglich reaction 
which involves the use of DCC and DMAP to perform an esterification between an alcohol and 
a carboxylic acid. Comprised in the synthetic scheme of the total synthesis of LL-Z1640-2 (3)  by 
Sellès and Lett98 (scheme 105), the Steglich conditions allowed the polyol fragment 459 to be 
connected to the previously prepared o-bromo benzylic acid 115. The macrolatonisation 
substrate 143 was achieved at rather high yield (76%). However, the planned intramolecular 
Suzuki coupling which operated onto the vinyl borane derived from 137 did not exceed 15% of 
yield, even under optimised conditions, urging the researchers to bring in a new approach 
which involved a late-staged macrolactonisation under Mitsunobu conditions. 
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Scheme 105: Steglich esterification vs Mitsunobu-based macrolactonisation by Sellès and Lett 
 
As expected, Mitsunobu esterification implied an inversion of configuration at the carbon C10’ 
and the intramolecular Mitsunobu reaction proceeded without any incidence, providing 144 in 
67% yield. This reaction required far shorter reaction time (15min) in comparison to 5h as for a 
classic Steglich esterification. However, this intramolecular reaction is constantly in 
competition against an intermolecular reaction, which remarkably reduces the final yield. As a 
result, the Mitsunobu conditions were also reported to perform an intermolecular 
esterification onto some resorcylic acid derivatives, especially those which were highly 
substituted at the ortho benzylic position. 
Another application of this method for the total synthesis was reported by Murphy et al. as a 
connection step in their synthesis of a RAL incorporating a trans-enone and an amide in the 
macrocyclic ring (scheme 106).99 Indeed, a sequence of hydrolysis of ester 460 closely followed 
by the Mitsunobu reaction of the resulting acid with alcohol 461 provided the MPM-diether 
462. The subsequent oxidative deprotection of MPM group ended the sequence in 3 steps 
with an overall yield of 50%, i.e. on average, each step would have reached 80% yield. 
 
Scheme 106: Intermolecular Mitsunobu esterification by Murphy et al. 
One year ahead of the synthesis of LL-Z1640-2 (3) published by Sellès and Lett, the group of 
Tatsuta reported their synthetic design of the same target molecule, which comprised a late-
stage macrolactonisation through Mukaiyama lactonisation (scheme 107).100 Considering the 
highly substituted benzoate at both ortho positions, the success of this macrolactonisation 
between the secondary alcohol and the benzoic acid, which came from a saponification in situ 
of the related methyl ester 463, was greatly impressive. The yield over three successive steps 
(Lindlar reduction, saponification and Mukaiyama lactonisation) attained 47%, a very 
satisfactory result and proof of the efficiency of the tricky macrolactonisation.   
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Scheme 107: Mukaiyama lactonisation as ring-closing step by Tatsuta et al. 
Among the metabolites of the family of RALs, cruentaren A has been one of those soliciting 
much interest from the organic chemistry community. It was the inspiration for several 
innovative synthetic blueprints, and at the same time the settings for the development of 
competitive chemical tools. Each research group had recourse to a different esterification 
method, in view of an efficient and reliable ring-closing tool. The first published total synthesis 
belongs to Vintonyak and Maier101 who observed no trace of ester by using standard 
Mitsunobu, Yamaguchi or Trost esterification. Besides, attempts to synthesise ester 468, using 
the classic peptide coupling reagents like DCC/DMAP or BOP also failed. Eventually, the only 
satisfactory esterification relied on the reaction of the imidazolidine derivative 466, resulting 
from treatment of acid 465 by carbonyldiimidazol (CDI), with the sodium alkoxide formed in 
situ (scheme 108). Interestingly, this reaction produced only one regioisomer of 468 as shown 
in the following scheme. 
 
Scheme 108: Esterification via imidazolide by Vintonyak and Maier 
One year later, in view of a concise total synthesis of the same target, the group of Fürstner 
envisaged carrying out an ester formation at the same strategic position.102 In contrast to the 
former researchers, they were not convinced by the results yielded through the corresponded 
imidazolide via CDI. During the study, they confirmed that attempts to form the corresponding 
acid chloride invariably led only to the formation of a six-membered δ-lactone, a side reaction 
that Vintonyak and Maier were also confronted with while applying the same strategy. 
Surprisingly, to transform the acid moiety into the related acid fluoride 471 not only afforded 
the desired ester 473, but also prevented the intramolecular esterification. According to the 
authors, the best conditions to form the acid fluoride 471 were found to be 2,4,6-trifluoro-
1,3,5-triazene (470) in the presence of pyridine (scheme 109).    
2  TOWARDS THE TOTAL SYNTHESIS OF L-783,277 (7) 124 
  
 
Scheme 109: Esterification via acid fluoride by Fürstner et al. 
In both reports, it was not mentioned whether an acid bromide in place of acid chloride would 
have bettered the esterification approach. In 2012, the group of Blagg published the fifth total 
synthesis targeting cruentaren A, lining up a row of several successful totals syntheses and 
numerous approaches to fragments.6 Comprised within their concise synthetic route was the 
esterification step, which was performed this time through an acid bromide (scheme 110), as 
the successfully chosen methods by Fürstner and Vintonyak for the related alkynyl derivative 
failed to give the wanted product. Allegedly, the acid bromide was the most appropriate 
intermediate, which was obtained upon treatment of the acid 401 with oxalyl bromide (COBr)2, 
DIPEA, and catalytic DMF in CH2Cl2 at 0°C for 30 minutes, followed by the addition of alcohol 
475 and DMAP. The ester formation proceeded within 10 minutes in excellent yield (96%).  
 
Scheme 110: Esterification via acid bromide by Blagg et al. 
An alternative esterification method was employed by Yadav et al. within their total synthesis 
of  analogues of (R)-(+)-lasiodiplodin  (10).103 Their strategy, like those of Fürstner and 
Vintonyak, consisted in an esterification, preceded by an alkylation at benzylic position via 
Stille coupling, which rendered this position much bulkier than a simple methyl, as mentioned 
in the esterification by Blagg and co-workers. The employed method was quite appealing, as it 
did not require any transformation of the acid moiety into a more reactive derivative (e.g. acyl 
imidazole, acid halide), but a previous formation of the acetonide which framed both the acid 
function and the ortho phenol. Thanks to a transesterification in the presence of the alkoxylate 
derived from an in situ deprotonation of alcohol 486, the desired ester 479 was obtained in 
sufficiently high yield (scheme 111). 
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Scheme 111: Esterification via transesterification by Yadav et al. 
Another representative method of esterification is illustrated by the Yamaguchi esterification 
realised within the total synthesis of L-782,277 (7) by Choi et al as detailed in section 1.2.3.104 
According to the authors, this esterification was a crucial step allowing the macrolactonisation 
leading to the 14-membered ring. To their relief, this reaction was successfully carried out, 
involving a saponification of methyl ester 480 prior to the submission of the resulting acid to a 
modified version of Yamaguchi esterification described by Evans and collaborators (scheme 
112). Contrary to the higher yield attained by the similar macrolactonisation at a late stage by 
Tatsuta et al. towards the total synthesis of LL-Z1640-2 (3),100 where the Mukaiyama 
conditions met their demands, the Yamaguchi reagent obviously gave much lower yield 
(merely 23%) over 2 consecutive steps (saponification, esterification). 
 
Scheme 112: Evans’ modified version of Yamaguchi esterification by Choi et al. 
It is noteworthy that two years earlier, in the course of the synthesis of the same metabolite L-
783,277 (7), Hofmann and Altmann achieved the macrolactonisation of their pivotal 
intermediate 149 via a Mitsunobu esterification in 59% yield (scheme 113).13 In comparison to 
the prior example of macrolactonisation with Yamaguchi reagent, this result obviously seems 
to be more promising. 
 
Scheme 113: Macrolactonisation under Mitsunobu based esterification by Hofmann and 
Altmann 
Despite all the methods mentioned so far do not constitute a comprehensive list of all the 
discovered esterifications by this time, they provided us, to some extent, a good overview, 
which would serve for the next step of our predefined synthetic scheme: attachment of the 
propargylic alcohol 232 tothe orsellinic acid fragment 452. This procedure, apparently simple, 
turned out to be far more tricky and challenging than expected. 
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2.3.2.2 First generation strategy: “Orsellinic acid derivative (241) as electrophile” 
 
 
Scheme 114: 1st generation retrosythetic esterification   
Our first approach relied on the formation of an acyl imidazole, a classic method which has 
proven to be an efficient brick for Vintonyak’s genuine construction of cytotoxic macrolide 
cruentaren A.101 
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Scheme 115: Esterification via carbonyldiimidazole (CDI) 
At the beginning, we tried to obtain an acyl imidazole upon treatment of the benzylic alkylated 
orsellinic acid derivative 483 with CDI in THF at room temperature. After 3 to 4 hour stirring, a 
solution of NaH deprotonated propargylic alcohol 232 was slowly added and the mixture 
stirred over night. The obtained crude product showed major presence of the starting material 
401, while the propargylic alcohol amount was much more reduced, probably due to its high 
volatility during the evaporation of the crude solution at reduced pressure. Even by increasing 
the reaction temperature up to 50°C right after the addition at room temperature of CDI and 
stirring for 4 hours before the addition of alkoxide in DMF, we did not succeed in synthesising 
the decisive RCAM intermediate 241. We were rather surprised by the outcome, given the 
bright success of the same reaction performed on intermediates of the cruentaren A’s 
sequence by Vintonyak and Maier, though aware of the structural difference of the alkyl chain 
at benzylic position in both substituted orsellinic acid intermediates. For this reason, the same 
procedure was tested on the simple orsellinic acid 401, which displays less hindrance at the 
benzylic position. The outturn was once again very disappointing, yet in total agreement with 
the statement by the group of Blagg during their effort towards the esterification of the same 
commercially available benzoic acid 401 (scheme 115).6 
According to these researchers, the synthesis of ester through the transformation of the 
commercial acid 401 into acyl imidazole 484 turned out to be quite challenging and only gave 
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unsuccessful results, in spite of its apparently unhindered structure at the benzylic position. 
The esterification was though successfully carried out via an acid bromide, we were tempted 
to synthesise an acid chloride from the laboratory made orsellinic acid derivative 401.  
Instead of using the Ghosez chlorinating reagent like the group of Fürstner,10 we opted for the 
2,4,6-trichloro-1,3,5-triazine (470), applying the procedure described by Venkatamaran and 
Wagle while modifying some experimental parameters.105 Due to the elaborate multi-step 
synthesis of the aromatic fragment 452, the esterification method was first attempted 
between the simple orsellinic derivative 401 and the freshly prepared propargylic alcohol 232.  
The related acid chloride was prepared upon treatment of aromatic acid 401 with cyanuric 
chloride 470 in acetonitrile, in the presence of DIPEA. After stirring for 3 hours when the initial 
heterogeneous solution turned into a clear yellowish mixture, it was evaporated till total 
dryness before addition of THF, followed by slow introduction of a solution of alcohol 232 in 
THF at 0°C. Unfortunately, the resulting crude product revealed, according to NMR analysis, 
only trace of the more simple ester 485, which was not worth isolating.  
In order to optimise the reaction, we decided to put at use the lithiated alkoxide resulting from 
the deprotonation of 232 by butyllithium. As a result, the ester 485 was obtained in less than 
30% yield, which prompted us to apply the same conditions to the esterification between the 
precursor 452 and the enantiomerically pure 232. Despite our intensive efforts, the yield did 
not exceed 20%.  
 
Scheme 116: Esterification via 2,4,6-trichloro-1,3,5-triazine (470) 
The presence of acid sensitive functions incorporated at the benzylic alkyl chain restrained the 
esterification conditions, preventing us from using some published methods that successfully 
contributed to the syntheses of some RALs, such as (COBr)2 used by Blagg et al., or (COCl)2 
introduced by Winssinger and collaborators.16 
In the literature, a classical esterification based on DCC was successfully carried out by 
Marquez and collaborators as part of their concise synthesis of the complete L-Z1640-2 (3) 
framework (scheme 117).106 This incited us to try out the same procedure, which unluckily 
ended with no significant result. However, inspired by the use of DCC, we decided to test by 
the same occasion the Steglich esterification, a relatively mild procedure, which allows the 
transformation of sterically demanding and acid labile substrates.   
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Scheme 117: DCC-mediated esterification by Marquez et al. 
Once again, the Steglich esterification was first performed with methylated orsellinic acid 401, 
using DCC and DMAP in DMF at 0°C for 10 minutes then at ambient temperature overnight 
(scheme 118). 
 
Scheme 118: Steglich esterification 
We succeeded in obtaining the anticipated ester, though the yield remained low with less than 
30%. By raising the reaction time up to 24 hours, and especially the use of stoichiometric (1.2 
equiv.) rather than catalytic (0.1 equiv.) amount of DMAP, the yield was somehow increased to 
around 40%. With this moderately encouraging result, the acid fragment 452 was involved as 
substrate in the next Steglich based esterification trials. Unfortunately, the crude product 
contained no detectable amount of the desired dialkyne 241, even after two days of stirring at 
a gradually increasing temperature from 20°C to around 50°C. Substituting dichloromethane 
by DMF did not give any better result, either.  
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2.3.2.3 Second generation strategy: “Orsellinic acid derivative (241) as nucleophile” 
At this stage of the synthetic sequence, the achievement of the dialkyne was of great 
consequence, as it would allow us to test out one of the crucial steps of the strategy depiction: 
the ring-closing alkyne metathesis. In the end, the Mitsunobu based esterification, which was 
twice used as the ultimate method of esterification by both groups of Altmann14 and 
Winssinger9 respectively within their successful syntheses of our taget molecule L-783,277 (7) 
(cf. section 1.2.3) was investigated the Mitsunobu reaction to determine its feasibility (scheme 
119).   
 
Scheme 119: Mitsunobu esterification  
Nonetheless, given that a Mitsunobu-based esterification mechanistically induces inversion of 
stereochemistry of the involved alcohol, it was indispensable to prepare the enantiomer of (R)-
hex-4-yn-2-ol 389. As a consequence, as it was previously described in section 2.1.2, the (R)-
hex-4-yn-2-ol 232 was accordingly synthesised from the stereochemically related expoxide (R)-
propylene oxide 40 in the same manner as its S-isomer 136. As anticipated, the preparation of 
the alcohol 232 proceeded uneventfully. With the propargylic alcohol 232 in hand, we 
embarked on the following trials, which exploited the well-established Mitsunobu reaction.  
In the first attempts, the simple orsellinic acid 401 was chosen as substrate to carry out the 
Mitsunobu reaction. By using the standard conditions described in the literature, we were very 
pleased to observe not only the formation of the anticipated ester 485, but also its isolation in 
85% of yield. Without further needless delay, the same procedure was applied to the 
precursor 452. To our great delight, the desired dialkyne precursor 241 was smoothly attained 
at very gratifying yield (87%). The Mitsunobu reaction, in great accordance with the two first 
publications of the synthesis of L-783,277 (7), has proven to be a powerful and robust method 
to circumvent the obstacles encountered while using other standard esterification methods. 
In summary, the construction of the dialkyne precursor 241, the pivotal intermediate required 
for the key step RCAM, turned out to be very challenging, and hence more effort- and time- 
consuming than expected. Nevertheless, all the abandoned methods (e.g. the use of acid 
derivatives like acyl imidazole via CDI or acid chloride through cyanuric chloride, the DCC-
based esterification or Steglich peptide coupling) are in agreement with the observations by 
other researchers during their respective studies concerning the esterification of related 
alkynyl derivatives.6, 101, 107 Obviously, before tackling this synthetic step, we were aware of the 
relatively weak electrophilicity of aromatic acid derivatives in comparison to other acid ones, 
though not thoroughly prepared to be confronted to so many difficulties. Especially, the highly 
unpredictable conformational of the substituted orsellinic acid 452 and the counter-intuitive 
reactivity correlation between the latter and the structurally simple acide 401. However, the 
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crucial intermediate 241 was finally achieved in rather high yield via a Mitsunobu 
esterification. With the dialkyne 241 in hands, the next step consisted in a ring-closing alkyne 
metathesis to complete the carbon framework of the target molecule. The coming paragraph 
will give a detailed description of our efforts and extensive experimentation dedicated to this 
synthetic step. 
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2.3.3 Ring Closing Alkyne Metathesis (RCAM)  
2.3.3.1 State of the art 
Alkene and alkyne metatheses are among the most known and convenient tools for the 
synthesis of a wide range of complex, organic molecules. In accordance with the impact of 
such a powerful synthetic method, progress in this field is constantly growing at remarkable 
pace, overcoming tough challenges and giving rise to numerous breakthroughs. The 
contributions of Grubbs, Schrock and Chauvin to the alkene metathesis were rewarded with 
Nobel prize in 2005. Alongside their efforts, many research groups contributed, since decades, 
to the discovery of new and more efficient catalysts, in terms of activity and tolerance to 
different functional groups.  
The most studied reaction in this context has been so far olefin metathesis. Alkene metathesis 
profits from an invaluable substrate basis as long as humankind relies on crude oil. 
Consequently, olefins are relatively common chemical functions and both terminal and 
disubstituted olefin metathesis catalysts are readily available. Though alkene and alkyne 
metatheses are mechanistically very similar, the latter has the advantage of not involving 
stereochemical problems, contrary to alkene metathesis due to the resulting E/Z-configuration 
of the resulting olefins. More interestingly, alkyne metathesis can be closely followed by 
stereoselective reduction, giving either E or Z alkenes.11 
Investigated to a far less extent, alkyne metathesis has been, nonetheless, known almost since 
the advent of alkene metathesis, starting with the discovery by Mortreux and Blanchard in 
1974 about the amazing reactivity of a catalytic amount of structurally unidentified species 
which are generated in situ from [Mo(CO)6] or related molybdenum source combined with 
phenol additives.108 This method is very attractive in use because all the involved substances 
are commercially available at relatively cheap prices, shelf-stable and the solvents do not need 
to be rigorously anhydrous. However, the required temperature often has to exceed 130°C, 
harsh conditions which limit its application to high temperature robust substrates. Above all, 
as the active species formed in situ have not yet been identified, the (molybdenum/phenol) 
system still remains ill-defined, and has been reported to be undeniably less active than other 
modern catalysts.109Succeeding the discovery of this “instant catalyst”, Schrock’s research and 
development of 12-electron metal-alkylidyne idyne complexes, e.g. the commercial 
neopentylidyne complex [Me3CC≡ W(OCCMe3)3], has popularised the alkyne metathesis 
among organic chemists.110 Indeed, this prototype is able to catalyse ring-closing alkyne 
metathesis (RCAM) reactions under rather mild conditions and its behavior at molecular level 
is well understood.111 Nevertheless, the metal alkylidyne [Me3CC≡W(OCCMe3)3] and its 
congeners are highly air and moisture sensitive, thus requiring a strictly inert atmosphere. 
Moreover, though they have proven to be appreciably efficient in challenging ring-closing 
alkyne metathesis reactions (RCAM), and tolerate many functional groups, their tolerance 
towards thioethers, amines and crown ether segments has been reported to be 
problematic.112 
The research group of Fürstner supposed the previously mentioned incompatibility stems from 
the plausible coordination of these donor sites to the high-oxidation-state tungsten center, 
hence rendering the catalyst inactive.111 In order to enlarge the scope of alkyne metathesis, 
Fürstner and collaborators have embarked on an impressive programme searching for 
alternative catalysts. Recent progress in alkyne metathesis has been published by the latter, 
which outlined the excellent (pre)catalysts for alkyne metathesis reactions of all types. These 
catalysts are nitride- and alkylidyne complexes of molybdenum of the general type 
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[(Ar3SiO)3Mo≡X] where X= N, CR and R= aryl, alkyl and Ar= aryl, endowed with triarysilanolate 
ligands, which combine high activity with striking tolerance towards polar and sensitive 
substrates (figure 17).113 According to the authors, these catalysts can become air-stable with 
the aid of 1,10-phenanthroline or derivatives thereof, hence clearly more user-friendly 
precursors than other catalysts in the literature, e.g. Schrock alkyne metathesis catalysts.  
 
 
Figure 17: Catalysts for alkyne metathesis in the literature110 
Historically, despite of the availability of well-defined tungsten-based alkyne metathesis 
catalysts by the group of Schrock since 1981,114 their application was simply restricted to 
dimerisation or cross-metathesis of some acetylene derivatives and mainly the preparation of 
a few special polymers.115 
Shortly before the turn of the millenium, the scope of ring-closing alkyne metathesis (RCAM), 
catalysed by Schrock’s tungsten alkylidyne complex [W(≡CtBu3)(OtBu)3], was first explored by 
Seidel and Fürstner, who pioneered the indirect but stereoselective approach to macrocyclic Z 
alkenes.115 As briefly described at the beginning of this chapter, although medium-sized and 
macrocyclic rings could be forged by ring-closing metathesis (RCM), the resulting olefins are 
often obtained as mixtures of E and Z isomers with neither predictable nor controllable ratio. 
This inherent issue constitutes a significant drawback in many total syntheses, as it was for 
example reported from the epothilone case by Nicolaou and co-workers in the same year.116 
To circumvent the stereoselectivity problem of RCM, Fürstner and collaborators disclosed an 
elegant and efficient way that combines ring-closing metathesis of diyne substrates with a 
subsequent partial reduction of the cycloalkyne molecules, using conventional methodology 
(e.g. Lindlar hydrogenation or hydroboration/protonation) to provide (Z) macrocyclic alkenes.  
More than one decade later, a concise and stereoselective entry macrocyclic (E)-alkenes were 
developed by the group of Fürstner which was based on trans-selective hydrosilylation 
catalysed by [Cp*Ru(MeCN)3]PF6, followed by protodesilylation with AgF in THF/MeOH.117 
Recently, in 2011, Schrock and Hoveyda’s respective groups finally succeeded collectively in 
synthesising the first molybdenum-based catalyst which is effective in Z-selective olefin cross-
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metathesis (CM), which involved terminal alkenes with either allylic amides, or, for the first 
time in the literature known to date, terminal enol ethers.7 These researchers not only found 
out the appropriate design of the complexes 496 that give rise to exceptional reactivity, in 
comparison to other previously described Mo- and Ru-based complexes (498-500), but also the 
use of reduced pressure to enhance stereoselectivity in catalytic cross-metathesis (CM). The 
highly Z-selective olefin metathesis reactions of terminal alkenes catalysed by 496 is supposed 
to come from the structural flexibility of the stereogenic-at-metal complexes 496a and 496b, 
and free rotation around the molybdenum-oxygen bond of these alkylidenes. Moreover, their 
approach took into account the relationship between efficiency and stereoselectivity, as the 
conversion values portray a balance struck between the highest attainable yields and maximal 
Z selectivity with minimal substrate amount, together with inevitable formation of the 
homocoupling side-product. Indeed, time-dependent studies carried out by both groups 
indicated the stereoselectivities suffered with lengthened reaction times.  
 
Figure 18: Design of catalysts capable of Z-selective cross-metathesis of terminal alkenes 
 
Although among the alkyne metathesis catalysts published by the group of Fürstner, many are 
those proven to be thermally quite robust and fairly stable on exposure to Lewis acid as 
activator of the pre-catalysts (e.g. ZnCl2 or MnCl2), rigorously anhydrous conditions are still 
compulsory for productive alkyne metathesis.113 Next to the bimolecular collision which 
caused the decomposition of the (pre)catalysts, the new alkylidynes supported by silanolate 
ligands, just like Schrock alkylidyne complexes, are still known to degrade in presence of 
terminal alkynes as substrates. According to Schrock and co-workers, terminal alkynes could 
not be metathesised by alkylidynes of type [W(CR)(OCMe3)3] due to the ready loss of one 
proton from a carbon atom in a tungstenacyclobutadiene complex.118 This critical step is 
believed to occur after metallacycle formation, which consists of a transannular carbon-
hydrogen bond activation with formation of a deprotio-metallacyclobutadiene (scheme 120) 
and concurrent loss of one alkoxide, a drawback that also none of Fürstner’s catalysts can 
overcome.113 
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Scheme 120: Formation of deprotio-metallacyclobutadiene (DMS)  
Recently, in 2012, there are a few examples of terminal alkynes metathesis recently reported 
in the literature by the group of Tamm, mediated by the new catalyst 
[MesC≡Mo{OC(CF3)2Me}3], which is represented as 495 in figure 17 above.119 In the 1980s, the 
group of Schrock has already succeeded in synthesising the closely related neopentylidyne 
complexes [Me3CC≡Mo{OC(CF3)2Me}3(dme)] and its congener [Me3CC≡Mo{OC(CF3)2Me}3], 
which exhibited, according to the authors, one of the best catalytic capability, yet no terminal 
alkyne metathesis (TAM) was realisable in their presence. The sparkling idea of introducing the 
mesityl group instead of methyl by Tamm and co-workers has led to the remarkable discovery 
of the first class of TAM catalysts, whose rate of alkyne metathesis is appreciably faster than 
that of deactivation caused, for instance, by formation of deprotiometallacyclobutadiene 503 
(scheme 120). This class of catalysts promises certainly a better atom economy, though it still 
remains a fairly recent domain, with the impossible metathesis of terminal aromatic alkynes as 
the vivid proof of its remaining obscure facet. 
  Prior to the disclosure of Tamm’s catalysts, in 1993, terminal alkyne metathesis was first 
reported by the group of Mortreux on a few aliphatic alkynes, e.g. 1-pentyne, 1-hexyne and 1-
heptyne, following their initial attempts at homogeneous metathesis catalysed by well defined 
(tBuO)3W≡CtBu complex.120 Nevertheless, they observed little metathesis activity in diethyl 
ether, while competing polymerisation tended to predominate, a rather discouraging effect 
that resulted in no further investigation of the neopentylidyne complex (tBuO)3W≡CtBu as 
prominent TAM catalyst. 
• RCAM as a crucial step in our synthesis towards L-783,277 (7) 
 
In the course of the initial conception of the synthesis of L-783,277 (7), we decided to 
investigate the reactions catalysed by one of these Fürstner’s catalysts to contrive to perform 
the ring-closing of the 14-membered macrocyclic section. At that time, the (Z)-selective alkene 
metathesis catalyst had not been published by Schrock and co-workers, which left Fürstner’s 
method, a RCAM combined with partial reduction as the best alternative. Consequently, the 
introduction of internal alkynes (e.g. propynyl) at both extremities of the precursor 241 was 
mandatory, in order not to induce the undesired decomposition of the catalyst. Had the 
promising terminal alkyne metathesis catalyst system [MesC≡Mo{OC(CF3)2Me}3] been readily 
available at the time of our strategy conception, we would still not have opted for a TAM, 
given that the terminal propynyl would be prone to deprotonation, especially during the 
benzylic alkylation key step (cf.section 2.2.1).  Some of Fürstner’s catalysts are a fortiori less 
oxygen and moisture sensitive, compared to the widely used Schrock alkylidyne 489 and other 
alkyne metathesis catalysts known to date, e.g. the exceptionally air stable nitride complex 
509, which can be handled by conventional benchtop techniques.  
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Scheme 121: Retrosynthetic macrocyclisation of dialkyne 3 
As a result of our previously described efforts, the dialkyne intermediate 241, conceived as the 
testing ground for a RCAM, was finally available. This compound can be prepared on 
multigram scale, following a reliable synthetic route, which involves rather inexpensive and 
easily accessible reagents. With the precursor 3 in hands, we ventured to test the RCAM 
process. 
For all that has been described as drawbacks of the Mortreux’ catalytic system, we were yet 
tempted to carry out a series of trials in the presence of the “instant catalyst” 
(phenol+Mo(CO)6), at first under the original conditions described by the authors.108De facto, 
since 1974, considerable improvements based on the Mo0/ArOH in situ catalytic system have 
been made to extend its scope to more sensitive molecules.109 
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2.3.3.2 First generation strategy: “instant catalyst” of Mortreux and variations 
 
Conceived as a model substrate, given its somewhat simpler structure, the di(pent-3-yn-1-yl) 
adipate 506 has also been prepared in our laboratory, involving an esterification of adipoyl 
chloride 504 by pent-3-yn-1-ol (505) in the presence of DIPEA and catalytic DMAP in CH2Cl2 
(scheme 122).  
 
 
Scheme 122: Preparation of di(pent-3-yn-1-yl) adipate 506 
This dialkyne has been used as a substrate, within an array of alkynes, in the previously 
mentioned study realised by Fürstner and Seidel in 1998, which upheld the efficiency of 
Schrock’s alkylidyne complex [W(≡CCMe3)(OCMe3)3].115 
 
 
Scheme 123: RCAM performed on 506 and 241 
The first attempt using “instant catalyst” by Mortreux and Blanchard108 (10% Mo(CO)6 
activated by resorcinol in decaline at 160°C) has not led to the cyclisation of any of both 
dialkyne substrates(entry 0). As rightly anticipated, this very harsh condition only ended up in 
the total decomposition of precursor 241.  
 While the experiments in the presence of the modified “instant system” (Mo(CO)6/4-
chlorophenol) by Mori et al. have given 507 at very low yeal (entries 1 to 4),121 those 
employing the most recent fine-tune in situ catalyst (Mo(CO)6/2-fluorophenol) by Grela et al. 
allowed higher yields, ranging from 20 to 30% after purification (entries 5 and 6 ).109 
Encouraged by this outcome, we have undertaken a series of trials catalysed by 10% of 
Mo(CO)6 and 1 equivalent of 2-fluorophenol (entries 5 to 8) with the precursor 241 as 
substrate. Unfortunately, these conditions have not led to the desired product. Even by 
decreasing the reaction temperature to around 80°C for a longer period, no trace of 
macrolactone 240 was observed.  
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Since the beginning of this century, many reactions with transition metal complexes have been 
reported to be accelerated by microwave irradidation. Among them is the successful alkyne 
metathesis catalysed by (Mo(CO)6/silanol) under microwave conditions, reported  by the group 
of Villemin.122 
We decided to use the same procedure described by the authors: octane as solvent and 
silanol, e.g. triphenylsilanol, instead of the commonly used co-catalyst p-chlorobenzene. The 
mixture (dialkyne/ Mo(CO)6/silanol : 20/1/2) was submitted to microwave irradiation during a 
time interval varying from 10 minutes to 1 hour (entries 9 to 11). The dark black, 
heterogeneous mixture did not result in the macrocyclisation of the substrates. However, in 
contrast with the previous results, these conditions were milder, in the sense that almost half 
of the initial amount of precursor 241 could be recovered, as well as the entire initial amount 
of the model dialkyne. Other experiments based on the same reagents used for microwave 
reaction were also operated at high temperature, without radiation and only ended in the 
total decomposition of the substrates (entries 13 and 14). 
 
Entry Catalyst Co-catalyst  (1 equiv.) 
Reaction 
conditions 
Yield 
507 
Conversion 
241 
Yield 
240 
0 Mo(CO)6  (10 mol%) resorcinol (6:1) 
Decaline, 
160°C, 5h 0% 100% 0% 
1 Mo(CO)6  (5 mol%) 4-chlorophenol 
Chlorobenzene, 
120-130°C, 3-7h 
< 5% 
 
 
100% 0% 
2 Mo(CO)6  (5 mol%) 4-chlorophenol 
Chlorobenzene, 
100°C, 12h 
< 5% 
 >80% 0% 
3 Mo(CO)6  (10 mol%) 4-chlorophenol 
Chlorobenzene, 
120-130°C, 3-7h 
< 10% 
 100% 0% 
4 Mo(CO)6  (10 mol%) 4-chlorophenol 
Chlorobenzene, 
100°C, 12h 
< 10% 
 >80% 0% 
5 Mo(CO)6  (10 mol%) 2-fluorophenol 
Chlorobenzene, 
135°C, 3h 
< 30% 
 100% 0% 
6 Mo(CO)6  (10 mol%) 2-fluorophenol 
Chlorobenzene, 
135°C, 6h 
< 20% 
 100% 0% 
7 Mo(CO)6  (10mol%) 2-fluorophenol 
Toluene,  
110°C, 6-12h 
< 15% 
 >70% 0% 
8 Mo(CO)6  (10 mol%) 2-fluorophenol 
Dichloroethane, 
84°C, 6-12h 
< 5% 
 100% 0% 
9 Mo(CO)6  (10 mol%) 2-fluorophenol 
Chlorobenzene,  
reflux, 8 to 16h 
< 20% 
 >100% 0% 
10 Mo(CO)6  (10 mol%) 2-fluorophenol 
Chlorobenzene, 
Microwave, 170W, 
135°C, 1-2h 
0% 
 >60% 0% 
11 Mo(CO)6  (5 mol%) 
Silanol  
(10 mol%) 
Octane,  
Microwave, 170W, 
150°C, 10 to 60 min
0% 
 >70% 0% 
12 Mo(CO)6  (5 mol%) 
Triphenylsilanol 
(10 mol%) 
Octane, 
Microwave, 170W, 
150°C, 10 to 60 min
0% 
 >70% 0% 
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13 Mo(CO)6  (5 mol%) 
Silanol (10 
mol%) 
Octane,  
reflux, 8 to 16h 
0% 
 100% 0% 
14 Mo(CO)6  (5 mol%) 
Triphenylsilanol 
(10 mol%) 
Octane, 
 reflux, 8 to 16h 
0% 
 100% 0% 
 
Table 7: Attempts of RCAM catalysed by Mortreux’s “instant catalyst” and other variations 
Despite the cyclisation of the model substrated 506 in the presence of the improved catalytic 
system (Mo(CO)6/phenol), for example the fine-tune (Mo(CO)6/2-fluorophenol), the same 
conditions applied to the more complicated dialkyne 241 did not result in any ring-closure. 
The use of (Mo(CO)6/phenol) systems is very attractive, as their constituents are often quite 
stable and off-the-shelf reagents, yet the very high temperature and long reaction time which 
caused the decomposition of dialkyne 241 remains the main drawback. Besides, all the 
systematic studies of these Mo(CO)6 –based catalytic systems to extend their scope to more 
elaborate and fragile substrates have not yet elucidated the entire action mechanism and the 
active species.  
From our point of view, it would not be erroneous to believe in the existence of the optimal 
phenolic co-catalyst for the ring-closure of our precursor 241. This assumption implies the 
screening of a library of phenols, from the best ones known (e.g. 4-trifluoromethylphenol) to 
those supposed to be less activating in the literature, in sight of a tailor-made catalytic system 
for the substrate of our interest. Unfortunately, due to lack of time, we could not devote 
further efforts to this end. 
Under the circumstances, we turned back to our initially conceived strategy for the pivotal 
RCAM step, which envisages the use of Fürstner’s catalysts, the RCAM catalysts on the rise. 
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2.3.3.3 Second generation strategy: catalysts of Fürstner 
 
Among all the modern RCAM catalysts,  the highly active species prepared by Fürstner from 
[Ar(tBu)N]3Mo and methylene chloride has contributed to the accomplishment of numerous 
challenging total syntheses projects.123 
Therefore, our second-generation strategy embraced the use of Fürstner’s catalysts, to begin 
with the CH2Cl2-activated precursor complex 508 (figure 19). 
 
Figure 19: Commercially available Fürstner catalysts  
One of the first commercially available Fürstner catalysts is the complex 508, a sterically 
hindered trisamido molybdenum (II) complex which possesses remarkable application profile, 
a novel catalyst disclosed in 2001, which featured in the total synthesis of epothilone A and 
C.124 
Originally the authors were impressed by the results published by the group of Cummins some 
years earlier, who found out the notable capacity of monomeric Mo (III) complexes to react 
with elemental sulfur, selenium, phosphorous, dinitrogen, CO, NO, etc… Quickly, Fürstner and 
co-workers succeeded in developing the strikingly air sensitive molybdenum complex 508 
which, following its activation in the presence of CH2Cl2 (scheme 124), was reported to exhibit 
noteworthy competence in alkyne metathesis, especially in ring-closing alkyne metathesis 
applied to all ring sizes≥ 12. Being the first catalyst of the type [Mo{(OtBu)(Ar)N}3] which 
outperformed all the existing catalysts at the time in all aspects, in particular by its 
extraordinary tolerance towards an impressive array of polar groups (e.g. unprotected 
aldehyde, ester, ether, ketone, sulfone, silyl ether, acetal, nitrile, sulfonamide, glycoside, alkyl 
chloride, and trifluoromethyl) though limits still reside in acidic protons, for instance from 
alcohols or acids.  
The excellent profile of the combination 508/CH2Cl2 has been validated, in the first decade of 
our century, by several accomplished total syntheses, which incorporate a decisive RCAM step 
applied to highly functionalised and bulky precursors.    
Convinced by these results, we started a new series of experiments based on a well-described 
procedure by the Fürstner’s group,125 involving at first the less structurally complicated model 
dialkyne 506 in the presence of the precatalyst 508.   
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Scheme 124: Activation of the sterically demanding trisamido molybdenum 508 to form 
metathesis active components 
Despite its very favourable characteristics, complex 508 is strikingly sensitive and requires very 
careful handling. In addition to its sensitivity vis-à-vis oxidation and hydrolysis, this compound 
is active enough to cleave molecular nitrogen.126 Accordingly, all the involved solvents were 
not only freshly distillated, but also submitted to freeze-pump-thaw cycles. Weighing and 
addition of the catalyst took place inside a glove box under argon atmosphere.  
A 10-3 mol.L-1 solution of the commercial molybdenum complex 508 (10 mol%) in toluene was 
first activated by rigorous stirring, at room temperature, with CH2Cl2 (0.04 mL per mole of 
precatalyst). After 5 to 10 minutes, the solution of the activated catalyst was added to a 
3.6x10-3 mol.L-1 solution of the model substrate 506 and powdered molecular sieve (MS) 5Å (1 
g) in toluene. The heterogeneous mixture stirred at 80°C for 1 hour before being cooled to 
ambient temperature (entry 15). The solvents were totally evaporated and the crude product 
analysed. Unfortunately, there was no observation of the macrocycle 507.  The reaction time 
has also been extended in some trials (entry 16), or/and the temperature was decreased 
below reflux point (entry 17) in others, yet the resulting mixture remained devoid of any ring-
closure product. 
Additional trials have also been performed under similar conditions, continuously flushed 
through by an argon flow, following the addition of the CH2Cl2-activated catalyst (entry 16). 
However, the resulting mixture did not contain any trace of the expected ring-closing product.      
As rightly predicted, the ring-closure also did not take place in the case of the more 
complicated dialkyne when exposed to similar conditions (entry 15 to 20).  
 
Entry Catalyst (5 to 10 mol%) Reaction conditions Yield 507 
Conversion 
241 
Yield 
240 
15 Fürstner pre-catalyst 508/ CH2Cl2 
Toluene, 5-10 min, 20°C, 
MS 5A, 80°C, 1h 0% > 30% 0% 
16 Fürstner catalyst 508/ CH2Cl2 
Toluene, 5-10min, 20°C, 
MS 5A, 80°C, 1h, 80 to 
20°C, 12h 
0% > 60% 0% 
17 Fürstner pre-catalyst 508/ CH2Cl2 
Toluene, 5-10 min, 20°C, 
MS 5A, 80°C, 20 min, 
80°C to 50°C, 40min 
0% > 20% 0% 
18 Fürstner pre-catalyst 508/ CH2Cl2 
Toluene, 5-10 min, 20°C, 
MS 5A, 80°C, 1h, 
continuous argon flow 
0% > 20% 0% 
19 Fürstner pre-catalyst 508/ CH2Cl2 
Toluene, 5-10 min, 20°C, 
MS 5A, 80°C, 1h, 80 to 
20°C, 12h, continuous 
flow 
0% > 30% 0% 
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20 Fürstner pre-catalyst 508/ CH2Cl2 
Toluene, 5-10 min, 20°C, 
MS 5A, 80°C, 20 min, 
80°C to 50°C, 40min 
continuous argon flow 
0% > 30% 0% 
 
Table 8: Attempts of RCAM catalysed by the molybdenum complex 508 
Discouraged by the outcome, we gave up on this exceedingly sensitive and unpractical pre-
catalyst. Indeed, the failure of RCAM in the presence of the commercial molybdenum complex 
508 could be explained by its eager decomposition, which could be caused by inappropriate 
storage during the transport to our laboratories. Therefore, it would be more reasonable to 
use this pre-catalyst as freshly prepared to verify its reactivity.  
Consequently, we embarked on another series of probes usingthe molybdenum alkylidyne 
endowed with triarylsilanolate ligands 510 (figure 17) as pre-catalyst. This compound is 
commercially available and can be activated by MnCl2 at 80°C in toluene to deliver the active 
species 24 (scheme 125), which is reported by the authors to be one of the most active 
metathesis catalysts known to date, but still less active in comparison to its nitrogen-sensitive 
congener 508.127 In addition, the phenanthroline adduct 510 has been reported to be 
surprisingly stable to the point of being handled in air without instantaneous decomposition, 
though still requires to be stored under argon. Practically, this precatalyst could be rapidly 
weighed in the air without instantaneous decomposition. Furthermore, the catalytic mixture 
containing the molybdenum alkylidyne 513 restored in situ from the pre-catalyst 510 (scheme 
125) is so active that the metathesis can be carried out at ambient temperature. 
 
Scheme 125: Activation of Fürstner pre-catalyst 510 
Following the procedure by Fürstner and collaborators,127 a solution containing precatalyst 510 
(5 mol%) and MnCl2 (mol%) in toluene was stirred at 80°C for 30 min. After this activation 
phase, the mixture was allowed to reach ambient temperature before it was added to a 
suspension of dialkyne 506 (1.0 mmol) and powdered MS 5Å (2 mg of MS 5Å per μmol of 
released 2-butyne) in toluene. The resulting mixture was stirred at ambient temperature for 2 
to 3h before being filtered through a short plug of silica. The residue after evaporation of the 
solvent was purified by flash chromatography. To our great pleasure, the macrocycle 507 was 
obtained in very good yield (65%).  
 
 
Encouraged by this outcome, the precursor 241 was subjected to the same conditions (entry 
21), which did not provide any expected ring-closing product 240. 
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Entry Catalyst Activation conditions 
Reaction 
conditions 
Yield 
507 
Conversion 
241 
Yield
240 
21 
510 (5 to 10 
mol%)/MnCl2 (5 to 
10 mol%) 
30 min, 80°C MS 5A, 20°C, 3 to 4h 
< 
40% > 30% 0% 
22 510/MnCl2 (5 mol%) 30 min, 80°C
MS 5A, 35 to 40°C, 
3 to 4h 
< 
40% > 30% 0% 
23 510/MnCl2 (5 to 10 mol%) 30 min, 80°C
MS 5A, 35°C to 
20°C, 12h 
< 
50% > 30% 0% 
24 510/MnCl2 (10 mol%) 
30 to 45 
min, 80°C 
MS 5A, 20°C, 3 to 
4h continuous 
argon flow 
< 
70% > 30% 0% 
25 510/MnCl2 (10 mol%) 
30 to 45 
min, 80°C 
MS 5A, 20°C, 
continuous argon 
flow,  12h 
< 
75% > 30% 0% 
26 510/MnCl2 (5 to 10 mol%) 
30 to 45 
min, 80°C 
MS 5A, 35°C, 
continuous argon 
flow,  12h 
< 
50% > 30% 0% 
 
Table 10: Attempts of RCAM catalysed by the pre-catalyst 510 
 
Some other experiments have been carried out with small modifications, such as longer 
reaction time (entries 22 and 23), or additional argon flow, following the addition of the 
CH2Cl2-activated catalyst (entries 24-26). However, tried as hard as we could, like all the 
previous trials, no trace of the desired intermediate 240 was detected in any case. On the 
other hand, analogous metathesis reactions have been simultaneously performed, involving 
the simple dialkyne 506 as model. In opposition to those previously described, these 
experiments unchangingly provided the RCAM product in acceptable yield, spanning from 50% 
to 60% (entry 22 to 23). Extensive studies have prevailed upon the assistance of molecular 
sieve, in particular the MS 5Å, in liberating the required free coordination site at molybdenum, 
and additionally, activated MS 5Å is capable of absorbing C4-hydrocarbons, e.g. the liberated 
2-butyne.127 For these reasons, despite the stated absorption of 2-butyne by MS 5Å by the 
authors, it is worth mentioning that continuous flushing of the reaction mixture by argon until 
completion resulted in somewhat better yields which lay within 65-75% (entry 24-26). 
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• Conclusion 
 
Regardless of the cheap and easy availability of the constituents of the catalytic systems 
comprising Mo(CO)6 and resorcinol (or other phenols), these simple and user-friendly systems 
have not yet reached the level of activity, nor selectivity offered by better-defined catalysts or 
precatalysts at this point in time. The harsh conditions, often due to the activation in high 
boiling solvents, render these heterogenous mixtures unsuitable for structurally complex, and 
thus labile targets, which includes our strategic dialkyne precursor 241. 
 
Nevertheless, substantial enhancement of the catalytic performance of the combination 
[Mo(CO)6, ArOH] has been rationalized in terms of decarbonylation of Mo(CO)6, as a 
consequence of extensive experimental studies. The phenolic activator is still to be 
investigated, as it would be simplistic to believe in a linear correlation between the acidity of 
the involved phenols and the activity of the resulting combination. Moreover, each target 
substrate is very like to influence the catalytic activity of the entire system, whose precise 
mechanism is still unknown.  
 
The unexpected inefficiency of the crucial RCAM in the presence of Fürstner’s catalysts was 
very likely, in the first place, linked to the excessive sensibility of the chosen pre-catalysts 
towards oxygen, moisture, and even molecular nitrogen in the extreme case of trisamido 
molybdenum 508. There was unfortunately no warranty of the quality and intactness of the 
purchased pre-catalyst, supplied by the very few commercial sources. Nevertheless, the 
unsuccessful metathesis trials implicating the uncomplicated, and relatively robust compound 
507 have discarded the presumption of conformational constrains in the cyclisation precursor 
as major source of failure. In all likeliness, the handle and employment of such an extremely 
sensitive compound requires the expert’s know-how and specific techniques, a prerequisite 
condition which has turned into a limitation in our case. 
Besides, the rather high reaction temperature (80°C) mandatory for the metathesis reaction in 
the presence of 508/CH2Cl2, which is supposed to be the best compromise found by the 
authors for an optimal metathesis, ironically constitutes a major cause for decomposition of 
the catalyst formed in situ. A competition between the life-time and sustainability of the active 
species and the rate of metathesis renders the use of the combination 508/CH2Cl2 problematic. 
For these reasons, to replace the unstable pre-catalyst 508, the authors have developed other 
alternatives, e.g. the partially air-stable p-methoxybenzylidyne species 510.  To our great 
pleasure, when applied to model dialkyne 506, this precatalyst, once activated by MnCl2, 
delivered the ring-closure product in comparatively high yields (60 to 75%). And to our great 
dismay, the same procedure did not result in any trace of the desired compound 240.This 
outcome clearly annulated the hypothesis of possible lack of expertise skills and equipment, or 
the decomposition of the commercially procured pre-catalyst 510 due to its inappropriate 
storage and handling. However, in correlation with the statement of the authors concerning 
the inefficiency of the active species 513 released from the activation of 510, in cases of very 
bulky compounds, the conformational constrains in the target substrate 241 might be at the 
origin of our fruitless RCAM trials. 
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2.4 Conclusion 
 
The major work of this thesis is rooted in the search for a formal synthesis targeting L-783,277 
(7), a pathway studded with numerous stumbling blocks and detours. Our work has been 
based on the initial desire to realise the ring-closure by a RCAM, while securing the 
characteristic cis-enone with a Lindlar reduction to induce the Z-configuration. 
To this end, the synthesis of the dialkyne precursor 241 was of priority, which has engendered 
the key step employing a direct alkylation at the benzylic position. Extensive experimentation 
has been required to achieve operationally efficient alkylation conditions, e.g. the use of sec-
butyllithium at -78°C to generate the lithium dianion derived from 401 and the appropriate 
choice of electrophilic function for the polyol section. Initial attempts to synthesise a series of 
corresponding electrophiles were mainly based on a similar synthesis in the literature (cf. “2-
deoxy-D-ribose approach”),8 which have resulted in the preparation of iodide segment 253 
and tosylate 255. However, the very low yields caused by unreliable procedures, together with 
the tricky handling and purification of the some intermediates prompted us to find another 
route. The second sequence, the “D-arabinose approach”, ended in a fully protected polyol 
fragment, whose (tri-methylsilyl)ethyl ether resistant to all attempts of orthogonal 
deprotection to release the corresponding primary alcohol 369 as the intersecting point with 
the first “2-deoxy-D-ribose approach”.  This synthetic route sadly led to the impasse due to the 
highly tricky orthogonal deprotection of TMS group on the precursor 268, as briefly illustrated 
in scheme 75 below. This unexpected incident has embarked us onto a long journey to find out 
the most appropriate one-carbon homologation to forge the (para-methoxy)benzyl enol ether 
309.  
 
Scheme 75: 2-deoxy-D-ribose approach versus D-isoisoascorbic acid approach 
 
To our great relief, the use of phosphine oxide 351 to carry out a modified Horner-Wittig 
reaction with lactone 364 has finally led to the synthesis of intermediate 257 via a very short 
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and reliable route. Besides, phophine oxide 331 which has not been mentioned in the 
literature so far can be obtained in 2 steps starting from chlorodiphenylphosphine (329) on a 
multigram scale. This turning point of the pathway has bridged the “D-isoascorbic acid 
approach” unto the achievement of iodide segment 253 with an average yield for each 
synthetic step exceeding 75%. This short and efficient route has allowed us to attain a 
multigram amount of iodide 253 without further complication. Noteworthily, our tactical 
sequence of modified Horner-Wittig alternated with sodium borohydride assisted reduction 
and final NaH elimination to release the corresponding ether enol is interestingly promising for 
opening other highly functionalised lactones. Further investigations with an array of lactones 
have also been carried out within our group. 
 
Scheme 76: Attempts to achieve PMB-enol ether 509 via various olefination methods 
 
Even though the first approach towards tolsylate 255 and iodide 253 from 2-deoxy-D-ribose 
(89) has not been conclusive on a multigram scale, it has allowed us to find out iodide 6 as the 
best reactant for our key step: the direct benzylic alkylation. The target was to achieve the 
intermediate 12 without additional functionnalisation to enhance the nucleophicity of the 
anion derivative at the benzylic position. The original scheme of protecting the benzylic acid 
function before generating the lithium benzylic anion turned out to be inefficient and very 
lengthy. Meticulous and extensive experiments have led to the use of lithium dianion derived 
from orsellinic acide 401, as well as an iodide as the best electrophile in this case. With the 
iodide fragment 253 in hands, we have identified the best conditions thus far for the direct 
attachment of 253 to 401, affording the desired intermediate 452 in remarkable yield (up to 
85%). To our great pleasure, the riskily speculated direct alkylation has been substantiated and 
optimised to the point of being a very reliable and efficient tool.  
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Indeed, the very same procedure can be extended to the synthesis of other RALs which also 
carry a single bond C1’-C2’. The most representative example is the succinct and accomplished 
synthesis of the naturally occurring macrolide (R)-(+)-lasiodiplodin (10), the first resorcylide, 
along with other natural and analogue RALs synthesised according to the designing blueprint 
outlined in section 3.1.  
The last fragment coupling took place between 452 and the enantiomerically pure propargylic 
alcohol 389 (scheme 126) resulting from the selective opening of the commercially available 
(R)-2-methyloxirane 41. Starting from 1-bromopropene 388, alcohol 389 was obtained in 2 
steps with an average yield of 60 to 70%. The same procedure has been initially applied to the 
preparation of the other enantiomer (S)-2- methyloxirane 136, which has been involved in the 
first trials of esterification described in section 2.2.2.2. Due to their very low boiling point, it is 
advisable not to store this compound and instead to use the propargylic alcohol directly after 
its preparation.   
 
Scheme 126: Synthesis of (R)-hex-4-yn-2-ol (389) and (S)-hex-4-yn-2-ol (232) 
 
In the literature, it has been observed that the esterification involving the benzoic acid of the 
aromatic core of the target RAL was not as straightforward as expected, especially when the 
latter was implicated as electrophilic center. Nonetheless, we have, in the first place, 
submitted the simple orsellinic acid 401 to various esterification procedures which have been 
formerly used in the syntheses of RALs and are sufficiently mild for notably acid-sensitive 
substrates. These methods include the use of carbonyldiimidazole (CDI), cyanuric chloride 470 
and Steglich conditions, all of which aim to transform the carboxylic acid into the 
corresponding electrophilic site. Various metal anions derived from (S)-hex-4-yn-2-ol (232) 
have been employed as nucleophiles. While some of these procedures worked out for the 
model orsellinic acid derivative 401, they have not led to any trace of the expected precursor 
241. This outcome might be explained by the exceedingly weak electrophilicity of the carbonyl 
carbon due to the presence of two methoxy functions, and in particular the sterically hindered 
ortho position, which is lacking in the case of the more simple orsellinic acid 401. Finally, the 
Mitsunobu reaction has allowed us to overcome this substrate barrier by transforming instead 
(R)-hex-4-yn-2-ol (389) into the related electrophile. This method has gratifyingly yielded the 
dialkyne precursor 241 in comparably high yield (75 to 85%) upon flash chromatography 
purification.  Hereafter, our most concise and efficient route towards the pivotal precursor 241 
is presented in scheme 127. 
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Scheme 127: Our most concise and efficient route towards dialkyne 241 
As our granted time for this thesis work reached the end, the last intramolecular metathesis 
envisaged to connect both alkyne ends of precursor 241 has not been substantiated. However, 
a number of well-known catalysts have been tested onto the aforementioned 241, as well as 
the adipoyl ester 506 as the model substrate, which represents a more simple structure and 
hence less conformational constrains.   
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The first attempts using the most-known variants of the classic “instant catalystic system” 
(Mo(CO)6/phenol), originally disclosed by Mortreux108 have definitely given the ring-closing 
product from the model substrate 506, though at very  low yields. Due to their harsh 
conditions (e.g. high boiling solvents) and ill-defined mechanism, these catalytic systems are 
unsuitable for more decorated, and thus labile substrates like precursor 241. However, it 
seems feasible to screen for the optimal phenol, i.d. the fine-tune of the combination 
(Mo(CO)6/ArOH) to attain the expected RCAM.  
 
 
Scheme 123: RCAM performed on model substrate 506 and dialkyne 241 
However, the use of the combination 508/CH2Cl2 (scheme 124), which has been developed by 
Fürstner’s group and remains one of the most powerful metathesis catalyst known to date, did 
not lead to any anticipated ring-closing product for the model dialkyne 506 and the more 
complex substrate 241. This outcome is very likely linked to the excessive sensitivity of 508 
towards oxygen, moisture and even molecular nitrogen, which demands expert knowledge 
and skills, as well as specific equipment for its manipulation. Therefore, the fruitless trials 
catalysed by the CH2Cl2-activated complex 508 do not validate any assumption about the 
compatibility of the latter with our precursor 241, concerning either the activity profile of the 
precatalyst 6, or the structural hindrance of the substrate.    
 
Figure 20: Commercially available Fürstner catalysts involved in our attempts of RCAM  
Our last series of experiments carried out in the presence of p-methoxybenzylidyne 510 
activated by MnCl2 resulted in the achievement of the macrolactone 507 in rather high yields 
(50 to 75%). And against all expectations, similar conditions involving the crucial precursor 241 
have not led to any ring-closure. After several attempts with some slight modifications of the 
original procedure by the authors, such as longer reaction time or higher reaction 
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temperature, even higher loading of the precatalyst 510, we have come to the conclusion of a 
possible structural barrier of the highly functionalised tested substrate. Indeed, all the 
experiments which involved the simple adipoyl diester 506 gave the corresponding 
macrolactone, did not give the anticipated product when performed in the presence of the 
more structurally complex dialkyne 241.  
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3 APPLICATION OF OUR SYNTHETIC ROUTE TO OTHER 
RALs 
3.1 Conception and strategy 
The second objective of this thesis targets the application of the modular synthetic strategy 
which was first devised for the total synthesis of the cis-containing L-783,277 (7). Initially, the 
strategic disconnections feature a direct alkylation at the benzylic position, followed by a 
Mitsunobu-based esterification and ended with a RCAM combined to a partial reduction to 
reveal the cis-enone moiety. 
 
Figure 21: From the cis-enone containing RALs to other RALs 
In spite of an on-going study of the RCAM to complete the carbon framework of L-783,277 (7), 
the concise and scalable synthesis of the dijjalkyne precursor 241 has substantiated our 
synthetic strategies. To a greater extent, this synthetic concept could be applied to other RALs 
than the restrictive subset of cis-enone containing RALs, in particular those bearing a single 
C7’-C8’ bond instead.  
From a synthetic point of view, the ring-closing method would be based on a RCM, followed by 
a hydrogenation. In terms of substrates, this transformation would imply the installation of a 
terminal alkene at both extremities of the ring-closure precursor. Consequently, we have 
dedicated the second part of the project to the syntheses of natural RALs that have been 
reported in the literature, as well as their rjelated unnatural compounds, on the basis of our 
strategies which are represented in scheme 40 beneath.    
 
Scheme 40: General synthetic scheme for RALs without cis-enone 
Our synthetic strategy is composed of 5 general steps: direct alkylation at the benzylic 
position/Mitsunobu-based esterification/ RCM/ hydrogenation/demethylation and 
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deconvolutes the target molecule into 3 separate fragments. While the aromatic core remains 
the same orsellinic acid dimethyl ether 401, the other fragments 237 and 238 would vary in 
function of the functional groups decorating the macrocyclic backbone. However, it was 
already clear to us that the allylic alcohol C could be quite convenient for the installation of the 
appropriate configuration of the asymmetric carbon C10’.   
In the first instance, it was advisable to apply the strategy to a relatively simple target, with 
respect to the presence of a C7’-C8’ saturated bond. And consistently, the 12-membered ring 
resorcylide (R)-(+)-lasiodiplodin (10) seemed to be the most relevant macrolactone as the first 
candidate.   
3.2 Synthesis of 12-membered RALs 
3.2.1 Synthesis of (R)-(+)-lasiodiplodin (10): naturally occurring RAL 
 
 
Figure 22: (R)-(+)-lasiodiplodin (10) 
(R)-(+)-lasiodiplodin (10) was first isolated from Lasiodiplodia theobromae, a plant pathogen 
which causes rotting and dieback in most species it infects.1 Numerous synthetic investigations 
of this metabolite were carried out, due to its purported ability to operate as a plant growth 
inhibitor,2 an inhibitory activity which was later discovered to be linked to another metabolite 
from the culture filtrates of the same fungus: jasmonic acid.3 Some years later, in vivo P-388 
assay-directed fractionation of an active extract from Euphorbia splendens has also led to the 
isolation of lasiodiplodin (10).4 Since then, lasiodiplodin (10) and its family were identified to 
be very efficient inhibitors of prostaglandin biosynthesis, exhibit anti-leukemic activities and 
reported to be potato micro-tuber inducing substances.5 Lately, the Chinese group of Yang 
reported for the first time the antimicrobial activities of lasiodiplodin (10), this time isolated 
from the mycelium extracts of a brown alga endophytic fungus (No. ZZF36) obtained from the 
South China Sea.6 
 
3.2.1.1 State of the art 
 
The first racemic synthesis of lasiodiplodin was reported by Gerlach et al. in 1977,2 followed at 
one-year interval by two other racemic syntheses from the groups of Takahashi7 and 
Danishefsky.8 In the nineties, several enantioselective routes have been reported, requiring 
either a chiral pool precursor,9 or the stoichiometric use of an asymmetric controller group and 
subsequent purification of a diastereomeric mixture.10 The first catalytic asymmetric synthesis 
was reported by Jones and Huber, 11 which outlined the enantioselective addition of Me2Zn to 
an aldehyde, mediated by a tricarbonyl(η6 arene)chromium(0) catalyst. The 21st century 
witnessed the expansion of the catalytic toolbox for the preparation of lasiodiplodin and its 
congeners, featuring the first ring-closing metathesis approach by the group of Fürstner.12 This 
strategy turned out to be superior in all relevant preparative aspects (in comparison to 
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McMurry coupling) and became one of the crucial steps in other synthetic routes, namely in 
the first stereo selective total synthesis of (3R),(5R)-5-hydroxy-de-O-methyllasiodiplodin and 
its epimer by Yadav et al.,13the enantioselective formal synthesis of lasiodiplodin (10) by the 
group of Feringa,14 depicting a highly stereoselective Cu-catalysed allylic alkylation, or the 
chemeoenzymatic asymmetric total synthesis of (R)-(+)-lasiodiplodin  methyl ether (529)  by 
Fuchs et al.15 
 
 
 
Scheme 128: Syntheses of (±)-lasiodiplodin (10) by Gerlach et al 
 
In the first synthesis of (±)-lasiodiplodin (10), the group of Gerlach’s strategy started with a 
Claisen condensation, followed by treatment with benzyl alcohol to obtain the 1,3-
dioxygenated benzoic acid derivative 516 as the basic framework (scheme 128).2 The 
aromatisation was initiated by a selenylation/oxidation/elimination sequence and subsequent 
protection as the methyl ether yielded the related orsellinic ester. The primary alcohol was 
subjected to a partial oxidation prior to the Grignard reaction with MeMgI, followed by the 
releasing of the benzoic acid under basic condition to provide the seco-acid 518 required for 
the macrocyclisation. The lactonisation was effected in the presence of 1,2-di(pyridin-2-
yl)disulfane and triphenylphosphine and completed by a AgClO4 assisted cyclisation, a method 
which was previously described by the same group. Hydrogenolysis of the para benzyl ether 
accomplished the first total synthesis of the target macrolide (10) as a racemic mixture in 12 
steps.  
 
The second total synthesis of (R)-(+)-lasiodiplodin (10) published by the same group implicated 
an interesting order alteration of the final synthetic sequence, opting for an early formation of 
the macrocycle and a late-staged aromatisation (scheme 128).16 Their approach began with 
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the preparation of the acyclic carbon framework 521 from tert-butyl 9-hydroxydecanoate. 
Acetylation with bromoacetyl bromide and addition of triphenylphosphine afforded the 
stabilised Wittig reagent 520, followed by transformation of the tert-butyl ester into the 
related acyl chloride 521, providing the required substrate for the novel macrocyclisation step. 
Upon treatment under basic condition, an intramolecular Wittig condensation took place, prior 
to an immediate loss of HCl to provide allenic lactone 522 in 42% of yield. The ensuing [4+2] 
cycloaddition of protected diene 523 with 12-membered cyclic dienophile 522 resulted in the 
macrolactone 524 (55% yield). The final aromatization in the presence of sodium methanolate 
procured 50% yield of (±)-lasiodiplodin (10).    
 
 
Scheme 129: O-methyl lasiodiplodin by Tsuji et al 
 
Though the natural analog O-methyl lasiodiplodin 529 has not yet been discovered in nature, 
its synthetic pathway towards this macrolactone is closely related to that of the natural 
congener 10, which would necessitate an ultimate selective demethylation of the para ether. 
 
In their synthesis of O-methyl lasiodiplodin 529, the group of Tsuji constructed the aromatic 
core through a condensation between the β-ketoester 528 and ketene 388.7 The resulting 
orsellinic ester 399 was then transformed into the acyl chloride 530, bearing a phenyl sulfide at 
the benzylic position (scheme 129).The secondary alcohol 527 was linked to the acyl chloride 
530 to set the stage for the intramolecular macrocyclisation, a methodology developed by the 
same laboratory. 
The ring-closure was initiated by a KHMDS deprotonation at the benzylic position to allow the 
intramolecular alkylation of the ω-haloalkyl 2-phenylthiomethylbenzoate 528 in 41% of yield. 
The desulfurisation was effected through heating with Raney Nickel in ethanol to furnish 
lasiodiplodin dimethyl ether 529 in 70% of yield.  
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Scheme 130: Synthesis of (±)-lasiodiplodin (10) by Danishefsky et al.Reagents and conditions: 
a) THF/HMPA, -15 to RT, 18h; b) MeI, K2CO3, DMF, RT, 12h; c) xylene, 141°C, 18h; d) NaH, THF, 
benzyl chloride, NaI, reflux, 16h, 35% over two steps; e) i. diborane, THF, 0°C to RT, 30 min; ii. 
NaOH, H2O2, 50°C, 30 min, 80%. 
 
One year later, Danishefsky and collaborators developed a formal synthesis of (±) lasiodiplodin 
(10),8 targeting the tetrasubstituted aromatic system 535 which had appeared in the first 
synthesis of the same macrolide by Gerlach and Thalmann.2 Their approach relied on the 
construction of the tetrasubstituted aromatic system using Diels-Alder cycloaddion of methyl 
undec-10-en-2-ynoate (533) with 1,1-dimethoxy-3-trimethylsilyloxy-1,3-butadiene (534). The 
required dienophile (532) was easily obtained the dianion of propiolic acid 530 by the 
commercial 1-bromo-7-octene (531),17 employing the alkylation of, followed by methylation to 
give 533. The compound 533 was heated with 534 at 140°C within 18h to provide the arene 
535 which was then benzylated to merge conveniently with the Gerlach’s first synthesis.2 
Despite the rapid access to the aromatic core, the overall yield of 535 over 2 steps was 
expectedly low, in comparison to those encountered in other models carried out between the 
same nucleophilic diene 533 and more electrophilic dienophiles.18 
 
 
Scheme 131: Synthesis of (R)-(+)-lasiodiplodin  by Braun et al. Reagents and conditions: a) 
LDA, THF, -78°C, 5min, -15°C to -10°C, 3h; b) 12, THF, -30°C, RT, 12h, 34%; c) 1,2-di(pyridin-2-
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yl)disulfane, AgClO4, toluene, reflux, 30 min, 49%; d) NaH, EtSH, DMF, RT, 30 min, then 130°C 
to 140°C, 3h, 29%. 
 
On the other hand, conventional retrosynthesis of lasiodiplodin or its methyl ether analogs 
invites macrolactonisation of precursor 538, as featured in the synthesis Braun et al. (scheme 
131).9a The stereogenic centre was incorporated via the chiral pool poly-β-hydroxybutyrate 
(536), which underwent seven well-established transformations to afford the enantiomerically 
pure building block 537. A direct alkylation proceeded in high yield (67%) between the lithio 
dianion derived from the methylated orsellinic acid 401 after deprotonation by LDA, and the 
chloride 537, followed by an acidic work-up to afford the precursor 538. This direct alkylation 
was earlier published by the group of Creger in 1970,19 who opted for a wide range of 
bromides instead (cf. section 2.2.1). The intramolecular macrolactonisation was performed 
according to a method previously decribed by Gerlach et al.,2 involving the activation of the 
carboxylic acid with (S)-2-pyridyl thioester assisted by silver perchlorate. The synthesis was 
finalised by the selective demethylation at para position, using in situ sodium ethanethiolate in 
DMF. The somehow tricky reaction gave only 29% of isolated (R)-lasiodiplodin (10), and 34% of 
its isomer 539, prompting the development of alternative syntheses with more appropriate 
protecting group of the aromatic starting material. 
 
 
Scheme 132: Chiral sulfoxide used in the total synthesis of (±)-lasiodiplodin (10) by Solladié 
et al. 
 
Solladié et al. initiated their synthesis of (R)-(+)-lasiodiplodin  (10) with the preparation of the 
achiral diester 540 was the testing stage for the introduction of the chiral carbinol part via a β-
ketosulfoxdide functionality (scheme 132), in view of obtaining both configurationq of the 
macrolide (132).20 Reduction of the sulfoxide by two different pathways, either in the presence 
of DIBAL-H alone or with ZnCl2 yielded (R,R)-β-ketosulfoxide 543 or its (R,S) isomer 544. 
Following the Raney-Ni assisted desulfinylation, the cyclisation was carried out according to 
the method described by Gerlach’s group for their own synthetic pathway towards (±)-
lasiodiplodin (10)  (scheme 128).2 
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Scheme 133: Synthesis of (R)-(+)-lasiodiplodin  dimethyl ether (529) by Jones et al.Reagents 
and conditions: a) TBDPSCl, imidazole, 74%; b) Dess-Martin periodinane, CH2Cl2, 93%; c) 
(CH3)2Zn, toluene, -5°C, 0.05 eq. catalyst 547, 90% (>84% e.e.); d) TBSOTf, 2,6 lutidine (96%); e) 
NaH, HMPA, 60%; f) methylacetoacetate, NaH, 45%; g) CH2CN2, Et2O, 89%; h) LDA, THF, Ph2S2, 
84%; i) LDA, 552, THF/HMPA, 74%; j) RaNi, EtOH, 100%; k) TBAF, THF, 87%; l) KOH, ethylene 
glycol, 165°C, 91%; m) (2-pyridyl) disulfide, PPh3, AgClO4, CH3CN, 160°C, 70%. 
 
 
As previously mentioned, the first catalytic enantioselective formal  synthesis of (R)-(+)-
lasiodiplodin  (10) was completed by Jones and Huber.11b The intermediate 553 resulted from 
the coupling between a stabilised lithiated anion derived from 529 with C8 chiral bromide 553, 
a fragment which was prepared via different enantioselective routes (scheme 133). In both 
presented preparative ways, the strategic enantioselective methylation using dimethyl zinc in 
the presence of catalyst 547 proceeded in high yields, though the enantiomeric excess 
attainable for the unmasked alkynyl substrate(< 80% e.e) was far below that for substrate 548 
(> 89% e.e). Hence the carbinol 529 was easily prepared on large scale in 6 steps from the diol 
546.  
 
The arene 401 was synthetised from diketene 388 according to a well-known procedure, 
followed by connection of the phenylsulfide group prior to the formation of the stabilised 
anion essential for attachment of 552 at benzylic position.  Desulfenilation and saponification 
released the precursor 554, which then smoothly underwent a lactonisation under usual 
conditions to give (R)-(+)-lasiodiplodin methyl ether 529. The para-demethylation successfully 
proceeded by use of ethylthiolate, as described in the strategy from Braun and Houben.9a Since 
the enantiomeric form of the alcohol could be easily achieve by appropriate choice of the 
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catalyst and the method fitting for multigram scale, this strategy proved to be favorable for 
related macrolides. 
 
In line with the rising interest for olefin metathesis catalysts since the first defined ruthenium 
catalyst in 1992,21 the group of Fürstner applied the ring closing metathesis to their synthetic 
scheme for lasiodiplodin (10) as reported in 1996.9b  The macrocyclisation was conducted at a 
late stagevia a RCM, using the ruthenium carbene 557, introduced by Grubbs et al. in 1993.22 
As one of the pioneers in the field, this catalyst was noteworthily insensitive towards moisture 
and oxygen, while remaining highly     reactive in metathetic reactions of monosubstituted 
olefins. At that time, macrolactonisation via RCM was still believed to successfully operate on 
conformationally restricted subtrates only, a tendency that did not convince the group of 
Fürstner. Therefore they reported a concise total synthesis of (R)-(+)-lasiodiplodin (10), 
shedding light on the efficiency of RCM to access macrocyclic systems, even if the diene 
precursor was devoid of conformational constraints. This metabolite’s synthesis was a 
protruding proof for the concept, among other previously synthesised odoriferous macrolides 
by the same group.  
In the first synthesis of lasiodiplodin (10) by the same group, the stereogenic center was 
induced by commercially available (S)-propylene oxide (136), which was subjected to a 
CuCl(COD)-catalysed reaction with 4-pentenylmagnesium bromide 555 to yield the building 
block 556. The RCM precursor 561 was obtained by a Mitsunobu-based esterification between 
the methylated orsellinic acid 558 (readily prepared from cheap commercialised 3,5-
dimethoxyphenol) and the enantiomerically pure alkenol 556, followed by  Stille cross coupling 
with allyltributylstannane using Pd2(dba)3/tris(2-furyl)phosphane as catalyst in the presence of 
LiCI. The RCM was performed onto 15 in the presence of the Grubbs’ catalyst 557, a process 
which turned out to be viable and quantitative (94% yield), affording the macrolactone 562S as 
a mixture of the (E) and (Z) isomers ((E)/(Z): 2.3/1). Demethylation according to the literature9a 
accomplished the total synthesis of the naturally occurring (R)-(+)-lasiodiplodin  (10). 
 
 
Scheme 134:  Synthesis of (R)-(+)-lasiodiplodin  dimethyl ether (529) by Fürstner et al.Reagents 
and conditions: a) CuCI(COD) (10 mol%), THF, -78°C to RT, 81%; b) DEAD, PPh3, Et20, RT, 83%; c) 
(CF3SO2)2, pyridine, 0°C to RT, 91%; d) allyltributylstannane, LiCl (3 equiv.), Pd2(dba)3 (3 mol%), 
tris(2-furyl)phosphane (12 mol%), N-methyl-2-pyrrolidinone, 40°C, 93%; e) 557 (6 mol%), 
CH2Cl2, RT, 94%, (E)/(Z)=2.3/1 (GC); f) H2 (1 atm), Pd/C, EtOH, RT, 94%. 
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Encouraged by the outcomes, Fürstner et al. went on with a program on the application of 
RCM to the synthesis of biologically active natural products, occasionally employing the 
Grubbs ruthenium carbene catalyst 557 in similar total syntheses of (S)-zearalenone and (R)-
(+)-lasiodiplodin (10) in 2000 (cf. section 1.1.1).12  In the same study, an alternative approach 
via reductive coupling of carbonyl compounds mediated by low-valent titanium [Ti] “McMurry 
coupling” was employed to synthesise the same natural compound. This key transformation 
turned out to be fairly problematic with somewhat variable yield and in contrast to RCM, the 
cyclised product was obtained in a mixture of both stereoisomers E/Z: 3.5/1. Furthermore, the 
McMurry coupling required dialdehyde as precursor, which led to a far less concise synthesis. 
The comparison ended therefore in favor of the RCM-based approach which is superior in all 
relevant preparative aspects, notably accessibility of substrates, total number of steps, 
reproducibility, stereoselectivity, and handling of the reagents.  
 
In 2011, Minnaard et al. published a formal synthesis of (R)-(+)-lasiodiplodin methyl ether 
(529), whose enantioselective synthesis is represented in scheme 135. This catalytic approach 
employed the stereoselective Cu-catalysed allylic alkylation, a methodology developed in their 
laboratories in 2006,23 as the key step to install the asymmetric centre C8’ via optically pure 
alcohol 564.14 The synthesis started with the formylation of commercially available iodide 565 
into the benzaldehyde scaffold 566, which was subjected to an AsPh3-promoted Suzuki cross-
coupling with the related 7-bromohept-1-ene to afford intermediate 567. Their attempts of 
esterification by Yamaguchi method or carbodiimide reagents between the corresponding acid 
of 567and optically pure 564 turned out to be unsuccessful wherease the use of acyl fluoride 
568, according to the method described by Fürstner et al.24  provided the ester 569 in very 
good yield. The obtained dialkene was submitted to a RCM using Hoveyda-Grubbs 2nd 
generation catalyst (59), furnishing an unseparated E:Z/1:2 mixture of 570. The macrolactone 
underwent a hydrogenation to release methylated macrolide 529 in quantitative yield and 
accomplished the formal synthesis of (R)-(+)-lasiodiplodin (10).   
 
 
Scheme 135: Formal synthesis of (R)-(+)-lasiodiplodin  methyl ether 529 by Minnaard et al. 
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In the same year, Jiang et al. achieved the synthesis of the naturally occurring (R)-de-O-
methyllasiodiplodin (577),25 which was recently reported as a potent inhibitor of pancreatic 
lipase (IC50= 4.73 µM).26  Their synthesis began with lithiation of the bromo derivative of 
orcinol 571 prior to the addition of isobutyl chloroformate to give ester 572 (scheme 136). 
Treatment of 572 with LDA followed by addition of 3-chloropropene afforded 573 which, upon 
saponification, released acid 574. The readily prepared (S)-hept-6-en-2-ol was linked to 574 via 
a Mitsunobu esterification, setting the stage for the macrocyclisation. The RCM was effected 
under classical conditions in the presence of 2nd generation Grubbs catalyst 54 (3 mol%) to 
provide macrolactone 570 as an unseparated mixture of geometrical isomers (E):(Z) = 1.5:1 in 
80% yield. The hydrogenation of 570 provided O-methyllasiodiplodin 529, an intermediate 
which intercepted with previously described syntheses in the literature. The final 
demethylation in the presence of BBr3 accomplished the total synthesis of (R)-de-O-
methyllasiodiplodin 577 in nine steps with 28.3% overall yield.  
 
Scheme 136: Synthesis of (R)-de-O-methyllasiodiplodin (10) by Jiang et al.Reagents and 
conditions: a) BuLi, isobutyl chloroformate, THF, -78°C to 0°C, 3h, 89%;b) LDA, 3-
chloropropene, THF, -78 to 0°C, 3 h, 90%; d) KOH, 90% EtOH, reflux, 12 h, then 10% HCl, 98%; 
e) DEAD, PPh3, (S)-hept-6-en-2-ol, THF, RT, 1.5 h, 85%; f) 54 (3 mol %), CH2Cl2, reflux, 1 h, 80%; 
g) H2 (1 atm), 10% Pd/C, EtOH, RT, overnight, 94%; h) BBr3, dry CH2Cl2, 0°C, 15 min, 57%. 
 
Recently, the Austrian group of Faber applied a chemoenzymatic deracemisation process 
based on inverting alkyl sulfatases to the formal synthesis of (R)-(+)-lasiodiplodin methyl ether 
(529).15 Indeed, the recently identified sulfatase “Pisa 1” from Pseudomonassp. DSM 6611 was 
capable of inverting the (R)-enantiomer of 578 (> 99% ee of 579 at 50% conversion), leaving 
579 untouched (scheme 137). The enzymatically formed 580 was subsequently obtained by 
extractive separation, prior to acidic hydrolysis of 579. With the enantiomerically pure alcohol 
580 in hands, a Mitsunobu-based esterification was employed followed by Negishi coupling to 
provide the precursor 512 aimed for Hoveyda-Grubbs II-catalysed RCM. The crude E/Z isomers 
(65:35) mixture was directly engaged into a palladium catalysed hydrogenation to afford 
lasiodiplodin methyl ether 529 in 93% e.e. in 94% isolated yield in two steps. The title 
compound was obtained in seven linear steps in 44% overall yield, a performance which, 
according to the authors, could be easily improved by one-pot fashion without intermediate 
product isolation.  
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Scheme 137: Formal synthesis of (R)-(+)-lasiodiplodin  methyl ether (529) by Fuchs et 
al.Reagents and conditions: a) PPh3, DIAD, THF, RT, 16h, 64% starting from 578; b) Tf2O, 2,6-
lutidine, CH2Cl2, 30 min, 95%; c) PdCl2dppf, 583, THF, 45°C, 30 min, 98%; d) Hoveyda-Grubbs II 
(59), toluene; e) Pd/C, H2 (1 atm), 94% over 2 steps. 
 
3.2.1.2 Our synthesis of (R)-(+)-lasiodiplodin (10) 
 
Despite the structural simplicity of  (R)-(+)-lasiodiplodin (10) in comparison to other members 
of the same RAL family, 10 displays an interesting profile of biological activities.3,4a,5a, 6 In order 
to validate our synthetic strategies mentioned in section 3.1, this resorcylide was the first 
chosen candidate.  
Retrosynthetically, the target molecule results from the assembling of three separate 
fragments which would be connected via a Mitsunobu-based esterification, a direct benzylic 
alkylation and a RCM (scheme 139). The stereochemistry of the carbon C3’ would be induced 
by the readily existing and commercially procurable homoallylic alcohol 488, taking into 
account the inversion of configuration induced by a Mitsunobu reaction. Devoid of other 
functionalities, the benzylic alkylation involved simply an alkenyl halide.   
 
Scheme 139: Retrosynthesis of (R)-(+)-lasiodiplodin (10) 
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The first synthetic step involved the alkylation at the benzylic position of the readily prepared 
methylated orsellinic acid 401. This key step has been successfully carried out in the presence 
of the alcohol fragment 253 (cf. section 2.2.1). Retrosynthetically, 5-iodopent-1-ene would 
likely be a good alkylating reagent. However, in order to extend the scope of our benzylic 
alkylation to bromoalkanes, the commercially available 5-bromopent-1-ene (454) has been 
chosen as a building block for the synthesis of (R)-(+)-lasiodiplodin (10).   
 
Figure 23: Iodide fragment 253 previously involved in our benzylic alkylation methodology 
The synthesis of (R)-(+)-lasiodiplodin (10), as depicted in scheme 140, commenced with the 
deprotonation of orsellinic derivative 401 by a solution of sBuLi, followed by the addition of 5-
bromopent-1-ene (454). Alternatively, sec-butyllithium could be replaced by a solution of 
butyllithium, with the condition that the reaction temperature should be raised from -78°C to -
20°C over 2 hours. To our delight, the expected intermediate 602 was obtained in very good 
yield (up to 90%). In the contrary, the alkylation involving the more complex iodide fragment 
253 and the dianion derived from deprotonation of 401 by butyllithium would give much lower 
yield (below 40%). Besides, when the crude product of 602 was engaged to the next step 
(Mitsunobu-based esterification), the yield over 2 steps still remained very satisfying (75 to 
80%).   
 
Scheme 140: Our synthesis of (R)-(+)-lasiodiplodin (10) 
Initially, the ring closing metathesis was effected in the presence of 2nd generation Grubbs 
catalyst (54), as it has been shown that the strongly electron-donating and sterically 
encumbered SIMES ligand imparts stability to the active species in solution, in comparison to 
the PCy3 ligand in the 1st generation Grubbs catalyst (53).22 The yields span from 40% to 65%, 
depending on the solvent. The average yield of the first attempts, employing refluxing 
dichloromethane overnight, stayed below 50% with a significant amount of unconsumed diene 
603, yet higher amount of catalyst (10 mol %) tended to favor the formation of homo-coupling 
product. By replacing dichloromethane with toluene, the yield could be increased to 70%. But 
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the catalyst had to be added in several small portions to avoid its degradation at high 
temperature (100°C to 110°C). The macrocyclisation afforded E isomer of 604 as the major 
product, as previously denoted in the literature.12   
Alternatively, the 1st generation Grubbs catalyst could also be used to carry out the RCM (60-
70%).  
 
Figure 24: 1st generation and 2nd generation Grubbs catalysts 
Hydrogenation of the macrolactone 604 was accomplished in quantitative yield via the H-
Cube®, where the reactions took place on CatCard Pd/C 10% at a flow rate of 0.1 mL/s, under 
high pressure (50 bar) and high temperature (50°C). The solution of 604 in ethyl acetate was 
diluted at a concentration between 0.2 and 0.3 mol/L. Similar conditions were previously 
chosen for the hydrogenation of the crude product of 309 (cf. section 2.1.1.2). Hydrogenation 
under more classical conditions was also accomplished in the presence of Pd/C (5 to 10%) in 
ethyl acetate at room temperature, leading to comparable yields. Even though the resulting 
product could be engaged in the next step without any further purification, the catalyst had to 
be carefully and totally filtered off through a pad of silica gel, as its remaining traces seemed to 
decrease remarkably the yield of the subsequent demethylation.  
The methoxy para to the EWG could be selectively demethylated to deliver (R)-(+)-
lasiodiplodin, employing in situ sodium ethanethiolate in DMF,27 a relatively mild method to 
cleave this highly stable functionality. Nevertherless, the low yield (20 to 30%) was to be 
expected, as it has been observed previously by Braun et al. within their synthetic pathway 
towards the same metabolite.9a Indeed, when the reaction temperature was maintained 
between 130 and 140°C for 3h, according to the procedure by Feutrill and Mirrington,27 the 
intermediate 605 was likely to decompose. Therefore, the temperature was kept below 100°C 
and with significantly longer reaction time (12 to 20h), which seemed to give the best result 
(up to 35% yield), but the resulting mixture contained the unconsumed 605 and O-de-
methyllasiodiplodin 577.     
In conclusion, we have accomplished the total synthesis of the naturally occurring (R)-(+)-
lasiodiplodin (10) in 5 steps as a white solid, with an overall yield of 40%. In all evidence, the 
direct benzylic alkylation is the pivotal procedure which has considerably shortened the 
synthetic route. Moreover, the ring-closure by RCM, combined with hydrogenation at C5’-C6’ 
was highly efficient and versatile. Consequently, we have also embarked on the synthesis 
targeting (S)-(-)-lasiodiplodin (545), following the same synthetic path. 
3.2.2 Synthesis of (S)-lasiodiplodin (545): synthetic 12-membered RAL 
The macrocycle (S)-(-)-lasiodiplodin (545) has not been isolated or identified from any culture 
of fungus so far, even though from a synthetic point of view, The macrocycle (S)-(-)-
lasiodiplodin (545) has not been isolated or identified from any culture of fungus so far, even 
though from a synthetic point of view, 545 differs from its naturally occurring enantiomer 10 
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by a single carbon C8’. Scheme 141 below depicts the synthesis of (S)-(-)-lasiodiplodin (545), 
which is identical to that of its natural enantiomer 10.  
 
Scheme 141: Our synthesis of (S)-lasiodiplodin (545) 
 As previously described, the pathway is composed of five steps, starting from the orsellinic 
derivative 401. While the final demethylation remained identical to those for (R)-(+)-
lasiodiplodin (10), some alternative synthetic conditions have been applied for the 
intermediate steps. The Mitsunobu-based esterification carried out between the crude 
product of 602 and (R)-pent-4-en-2-ol (41) provided the dialkene 603 (80% over 2 steps) 
required for the pivotal ring-closure step. The RCM was performed in the presence of 10% 1st 
generation Grubbs catalyst 53 in refluxing toluene. The yield fluctuated from 55% to 65%, 
depending on the addition of the catalyst. Indeed, when added in two times (5% + 5%) at 4-
hour intervals, the macrocycle 605 was obtained in the best isolation yield (65%). 
Hydrogenation of 12 was performed under classical conditions, catalysed by 10% Pd/C in 
anhydrous ethyl acetate at 19°C within 2 days. The resorcylide 545 was achieved in almost 
quantitative yield after careful filtration over a celite/silica pad (97%). The optical activity 
reported in the literature by Fürstner’s group for 529 was +8.7 for a concentration of 1.63 in 
chloroform, while the optical activity measured for its enantiomer 605 is -8.0 for a 
concentration of 1.7 in chloroform. The final demethylation at para position by in situ sodium 
ethylthiolate in DMF gave similar results as formerly described for (R)-(+)-lasiodiplodin  (10) 
(30-37%). The straightforward achievement of the “unnatural” (S)-(-)-lasiodiplodin (545) is a 
further argument for the efficiency of our initial strategic pattern for C1’-C2’saturated 
macrocylides of the RALs family. 
In spite of its “unnatural” label by several total synthesists nowadays,9b (S)-(-)-lasiodiplodin 
(545) might exist as well in the nature, as the presence of a carbon with the S configuration has 
been elucidated for other members of the same family. Prior to this discovery, all the natural 
compounds from the same family in the literature have been reported to bear solely R 
configuration at C8’ for 12-membered ring RALs and C10’ for 14-membered resorcylides. 
3.2.3 Synthesis of neolasiodiplodin (606): synthetic 14-membered RAL 
In order to extent the scope of our synthetic pathway to 14-membered RALs, it was 
appropriate to opt, in the first place, for a target which does not contain a highly decorated 
macrocycle, as it is the case for the two previously described RALs (R)-(+)-lasiodiplodin (10) and 
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(S)-(-)-lasiodiplodin (545). As there was no 14-membered RAL isolated so far with a comparably 
simple structure as (S)-lasiodiplodin (545), we chose to address the issue by synthesising in the 
first place the simple resorcylide 606, named “neolasiodiplodin” in respect to its unnatural 12-
membered homologous (S)-lasiodiplodin (545). 
 
Figure 25: neolasiodiplodin (606) 
To this end, the same modular synthesis was drawn upon, disconnecting 606 retrosynthetically 
into three fragments (scheme 142). It was convenient to realise a RCM at C7’-C8’ bond, 
allowing to keep the same homoallylic alcohol 488 as in the synthesis of (S)-lasiodiplodin (545), 
as well as the aromatic core 401 readily prepared by our group.  The remaining part of the 
macrocyclic backbone would be completed by 7-bromohept-1-ene 455, easily accessible from 
commercial sources, which was required for the decisive benzylic alkylation with orsellinic acid 
401. 
 
Scheme 142a: Retroynthesis of “neolasiodiplodin” (606) 
Following the same strategic scheme, the reaction sequence commenced with the benzylic 
alkylation between the dilithiated dianion derived from 401 and 7-bromo-pent-1-ene 488 
(scheme 142a), which resulted in a clear crude product of the expected dialkyne 608.  The 
crude product of 608 was directly engaged to the subsequent Mitsunobu-based esterification 
with the optically pure alcohol 488, affording the precursor 608 in 88% of yield.  
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Scheme 142b: Synthesis of “neolasiodiplodin” (606) 
The RCM was performed in the presence of 2nd generation Grubbs catalyst 54 in refluxing 
toluene over 12h to provide an unseperated E/Z :2/1 mixture of macrolactone 610 in 
acceptable yield (60-70%). Hydrogenation of 607 was carried out via  H-Cube®, under the same 
conditions described for the syntheses of both enantiomers of lasiodiplodin 10 and 545. The 
crude product of macrolide 610 was clear enough to be involved in the next step without 
further purification. Treatment of 610 with an in situ solution of sodium ethanethiol in DMF 
furnished the title compound 606 in slightly higher yield than previously observed for 
lasiodiplodin 10 and its unnatural enantiomer 545 (up to 40%). The demethylation completed 
the synthesis of the analogue “neolasiodiplodin” 606 in 5 steps with an overall yield of 25%. 
The straightforward accomplishment of this novel 14-membered RAL has prompted us to 
extent the synthetic scope to a more structurally complex metabolite. As a consequence, the 
next chapter will describe the synthesis of zeranol (611) 
3.2.4 Synthesis of zeranol (611): naturally occurring RAL 
Encouraged by the successful synthesis of the macrolide “neolasiodiplodin” (6) as a direct 
application of our synthetic strategy, initially targeting L-783,277 (7), we ventured in the 
achievement of zeranol 611, a 14-membered metabolite which is one of the most widely used 
chemicals in the U.S. beef industry.  
 
 
Figure 26: zeranol (611) 
The two diastereoisomers α- and β-zeranol (α-611 and β-611) were in the first place obtained 
as reduced products of zearalenone (2),28 before the isolation from Fusarium roseum 
“Gibbosum” in rice culture in 1979,29 closely followed by its discovery, by the same research 
group of Mirocha30, in the mycelium of the fungus Gibberella zeae (Fusarium graminearum) 
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growing as a mould on corn. Researchers have proven very low residues of zeranol were 
present in edible tissues from animals fed with implants of this metabolite. Being approved by 
the FDA (based on its toxicity information) to be employed as a growth promoter, this RAL 
member is widely employed in the beef cattle in the United States, being one of the 
compounds causing the European Union to refuse the import of beef products with any 
growth promoter implantation from the U.S., concerned about the potentially adverse health 
associated with the contaminant metabolite.  Given its activities as a non-steroidal estrogen 
agonist,beingreported to be three to four times more active than its close relativezearalenone 
(2),31 it is also under clinical trials as a potential treatment against menopausal and post-
menopausal syndrome. Yet the main use of zeranol as growth promoter still raises skepticism 
about its biological consequences in humans and has been subjected to controversial debates 
for decades. Epidemiological studies have suggested that there are many risk factors 
associated with breast cancer. Therefore, greater concrete evidence experimental led to 
results implying the potential adverse health effect of zeranol in breast cancer development, 
while further study is still under progress.32 
In 2013, Hongkong researchers demonstrated that zeranol upregulated CRH mRNA expression 
through increased CRE binding in the JEG-3 placental cells.33 Although the physiological 
significance is not yet determined, this report may help defining the exposure limit to human 
or the limitation of agricultural application. 
 
More than 40 years have witnessed the rushing research in biological and chemical fields 
regarding this controversial, yet widely used metabolite (under various trade names: Ralgro®, 
Ralabol®, etc.). However, besides the achieved efforts to selectively reduce zearalenone (2) 34 
and consequently separate the diastereomeric mixture of zeranol (611),35 its relatively simple 
structure (compared to e.g. more functionalised hypothemycin (6) or aigialomycin D (9)), its 
total synthesis has not raised considerable interest from the organic chemist community. 
Hereafter are two detailed total syntheses disclosed by the group of Fürstner in 1999,36 and 
Yadav et al. in 2011.37 
 
3.2.4.1 State of the art 
 
• Synthesis by Fürstner et al. 
 
As part of the remarkable studies on RCM by the group of Fürstner since the early nineteen 
nineties, leading to the synthesis of naturally occurring macrolactones family,9b a chemical 
approach based on RCM as the key step was materialised in 1999, accomplishing on one hand 
the total synthesis of zeranol and on the other hand, a closer understanding of the essential 
parameters for successful macrocyclisation.36 
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Scheme 143: Formal synthesis of zeranol (611) by Fürstner et al.Reagents and conditions:a) 
HS(CH2)3SH, BF3.Et2O, MeOH, 87%; b) i. sec-BuLi (2 equiv.), THF,-15°C, 4h; ii. 4-bromo-1-butene, 
16h, 85%; c) PCC, CH2Cl2, 51-62%; d) MeMgI, Et2O, -30°C, 97%; e) DEAD,PPh3, Et2O, 84%; f) 
(CF3SO2)2O, pyridine/CH2Cl2, 0°C to RT, 91%; g) 9-allyl-9-BBN, KOMe, PdCl2(dppf) (3 mol%), THF, 
reflux, 86%; h) (CF3CO2)2IPh, MeOH/H2O (9/1), 84%; i) 557 (19 mol%), CH2Cl2, reflux, 73%; j) H2 
(1 atm), Pd/C, EtOH, quant. 
In close analogy to the synthesis of lasiodiplodin (10) outlined in the same paper and 
previously described in section 3.2.1.1, the double bond of the macrocycle was chosen as the 
strategic site of disconnection. The synthesis began with 3,4-dihydro-2H-pyrane (612) as 
starting material, which upon treatment with propane-1,3-dithiol in the presence of BF3.Et2O 
provided the dithioacetal 613. Deprotonation by sec-BuLi and quenching with 4-bromo-1-
butene cleanly afforded the primary alcohol which was oxidised by PCC, the best conditions 
found by the authors at the time. The resulting aldehyde was then methylated, giving a 
racemic mixture of alcohol 615 which was submitted, together with the phloroglucinic acid 
derivative 616 to a Mitsunobu-based esterification to the salicy. A first coupling under Stille 
conditions was successfully carried out, as in the reported lasiodiplodin synthesis. Nevertheless 
the reaction proceeded somehow slowly in reasonable yields (40°C, 48h, 41% or 60°C, 24h, 
60%), which demanded the recourse of a modified Suzuki cross coupling, resulting in the 
preparation of the precursor 619 on a multigram scale in 86% isolated yield after only 30 min 
reaction time.   
To the great dismay of the authors, the cyclisation of diene 619 bearing dithioacetal moiety by 
Grubbs catalyst 557 failed to provide the expected 626. The recovery of unchanged substrate 
was accounted by the likely chelation of emerging ruthenium carbene by the neighboring 
sulphur atoms, which sequesters the catalyst in an unproductive structure (scheme 144). 
Indeed, it had been reported that substrates containing sulphur (II) donor sites were generally 
incompatible with ruthenium based metathesis catalysts.38 
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Scheme 144: Proposed chelate structure causing the uncessful RCM. [M]= Ru (II) template 
To circumvent this problem, the use of (trifluoroacetoxy)iodobenzene released the 
corresponding ketone 620, enabling the cyclisation of the diene in reasonable yield (73%) to 
provide 622. Hydrogenation over Pd/C followed by well-described reduction in the literature 
completed the racemic total synthesis of zeranol (611). The seemingly trivial isomerisation of 
macrolactone 622 in view of obtaining the thermodynamically more stable alkene isomer 
required tricky conditions which deterred the authors’ efforts to perform a formal total 
synthesis of zearalenone (2) itself. The successful total synthesis of zeranol (611) contributed 
to the promising avenues to large ring systems, especially those properly adjusted. 
• Synthesis by Murthy et al. 
 
Recently, Yadav and Murthy have disclosed a total synthesis of zeranol, which involved an 
intermolecular Diels-Alder reaction to build the resorcylic acid moiety 630, containing a 
terminal alkene at the benzylic position, an esterification under Mitsunobu conditions to 
functionalise the acid, allowing the incorporation of both the stereogenic center bearing the 
methyl group and the second terminal alkene needed for the RCM-based macrolactonisation.37 
 
Scheme 145: Synthesis of zeranol (10)  by Yadav and Murthy Reagents and conditions: a) 
TBSCl, imidazole, DMAP, CH2Cl2, RT, 95%; b) BuLi, ClCO2Me, THF, –78 °C, 80%; c) 70, neat, N,N-
dimethylaniline (cat.), 180 °C, 48 h, 40%; d) HF·Py, MeCN, RT, 90%; e) I2, Ph3P, MeCN–Et2O 
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(1:2), RT, 95%; f) t-BuOK, THF, RT, 90%; g) LiOH, MeOH, reflux, 85%; h) DHP, PPTS, CH2Cl2, RT, 
95%; (i) MCPBA, CH2Cl2, RT, 90%; j) (S,S)-Jacobsen catalyst, AcOH, H2O, toluene, 40%; k) LAH, 
THF, 0 °C to RT, 90%; l) TBDPSCl, imidazole, CH2Cl2, 90%; m) PPTS, EtOH, 94%; n) IBX, DMSO, 
CH2Cl2, 89%; o) 4-pentenyl bromide, Mg, THF, 0 °C to RT, 80%; p) DHP, PPTS, CH2Cl2, 90%; q) 
TBAF, THF, 90%; r) DEAD, Ph3P, Et2O, RT, 90%; s) PPTS, EtOH, 85%; t) [(PCy)3Cl2Ru=CHPh] (53), 
toluene, reflux, 80%; u) Pd/C, H2, EtOH, RT, 80%; v) AlI3, TBAI, benzene, 70%. 
 
The synthesis of the aromatic core began from the commercially available homopropargylic 
alcohol 627, which was first protected then treated with Buli to react with 
methylchloroformate to give 71. The Diels-Alder reaction between diene 70 and acetylenic 
dienophile 71 at 180°C gave the aromatic product 628. The protected primary alcohol was 
released, before being submitted to a clean iodination, followed by a treatment with tBuOK to 
afford 630. Demethylation smoothly proceeded to give in high yield the expected precursor 
631. 
The preparation of the chiral segment 636 started with the protection of the commercial 5-
hexen-1-ol (632), followed by epoxidation to give a racemic mixture of 635. A kinetic resolution 
with (S,S)-Jacobsen catalyst, followed by reductive opening in the presence of LAH and the 
protection of the released alcohol led to compound 635. An orthogonal deprotection followed 
by IBX-based oxidation and nucleophilic addition with a Grignard reagent (previously formed 
by 4-pentenyl bromide and Mg) provided the diastereomeric mixture of alcohol 636.  
The two fragments 631 and 636 were successfully assembled by a Mitsunobu-based 
esterification. Deprotection of the alcohol preceded the RCM assisted by 1st generation Grubbs 
catalyst (53) to give the macrolactone 639, which was submitted to a hydrogenation over Pd/C 
and a subsequent demethylation by AlI3 to complete the total synthesis of zeranol (611). In the 
same paper, it was also reported that the strategy was harmoniously applicable for the 
synthesis of (S)-zeralenone (2), the oxidised form of zeranol (611). Among the methods 
designing resorcylic acid macrolactones, this synthetic scheme is the first method that made 
use of the hydrolytic kinetic resolution of Jacobsen, a fairly modern synthetic tool to acquire 
enantiomerically pure epoxides. Another advantage comes from the commercially available 
starting materials that are commonly cheap. 
3.2.4.2 Our synthesis of zeranol (611) 
Our initial synthetic target was to achieve zeranol as an unseparated mixture of 
diastereoisomers α and β-zearalenol (α-611 and β-611). Closely analogous to the synthesis of 
neolasiodiplodin (606), the retrosynthetical scheme consists in disconnecting the macrolide 
into 3 fragments, as depicted in scheme 146.  One of them remained orsellinic acid derivative 
401 required for the key step direct alkylation with the functionalised iodoheptene 453. Similar 
to the syntheses mentioned above,36-37 an esterification under standard Mitsunobu conditions 
would provide diene 643, setting the stage for the macrocyclisation via a RCM, closely 
followed by a hydrogenation to release the fully protected macrolide. 
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Scheme 146: Our retrosynthesis of zeranol (611) 
 
Though the retrosynthesis remained analogous to that of “neolasiodiplodin” (606), the 
synthesis of zeranol 611 demanded in the first place the preparation of the iodide 453. The 
first synthetic scheme opted for pentane-1,5-diol 633 as starting material, giving its easy 
accessibility, aiming to reach the fragment 456 in 6 steps (scheme 147). 
 
Scheme 147: 1st synthesis attempt towards iodide fragment 456 
Consequently, the sequence began with a monoprotection of symmetrical diol 633 as TBDMS 
ether 634, in the presence of imidazole in DMF at room temperature for 2h.39 As expected, the 
resulting mixture of monoprotected/diprotected/unprotected alcohols could not provide more 
than 40% of 634, after purification. However, the monoprotection could be favored by 
engaging 3 to 4 equivalents of the diol 633, giving its cheap commercial availability and easy 
elimination through aqueous workup, providing 45% of yield. From a practical point of view, 
the obtained amount of ether 634 was sufficient to be engaged in the next 2 steps to construct 
the allylic alcohol 636. The subsequent Parikh-Döring oxidation in the presence of SO3·py in 
DMSO/CH2Cl2 smoothly afforded the aldehyde 635. Due to the unstability of the resulting 
aldehyde, the crude mixture was subjected to the next addition of vinyl magnesium bromide 
without further purification. The Grignard reaction involving aldehyde 635 in THF gave access 
to allylic alcohol 636. Unfortunately, the yield over the last two steps was very low (20-30%), 
prompting us to undertake the second preparative way as illustrated in scheme 148 beneath.  
This alternative pathway is conceptually close to the one described by Yadav et al. (cf. section 
3.3.2.1) which starts with the protection of hex-5-en-1-ol (632).  
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Scheme 148: Synthesis of the iodide 456 
 
The preparation of iodoalkane 456 began with the protection as TBS ether of hex-5-en-1-ol 
632, under standard conditions using imidazole and TBSCl, affording ether 639 in very good 
yield (93 to 95%) (scheme 148). Epoxidation of the terminal alkene in the presence of mCPBA 
(1.5 equiv) under buffered conditions gave a racemic mixture of 640, which was used in the 
next step without further purification. The one carbon homologation to provide the allylic 
acohol 636 was performed by exposure of of epoxide 640 to Me3SIand BuLi. The first attempts 
of epoxide opening closely followed the procedure described by the group of Nicolaou.40 
Accordingly, the trimethylsulfonium iodide (4 equiv.) was deprotonated by nBuLi (6 equiv.) at -
30°C for 30 minutes before addition of the crude product of epoxide 640. The mixture was first 
stirred at the same temperature for 1h before being allowed to warm up to 20°C over 3h. 
However the yields stayed below 50% with a conversion of less than 70%. 
As a consequence, the Corey-Chaykovsky-based reaction was then carried out under the 
conditions described by Mioskowski et al.41 Both Me3SIand BuLi were engaged in lesser 
amount (3 equiv.) and the deprotonation temperature was maintained between -15°C and -
10°C until the milky suspension became colorless, followed by addition of the solution of 
epoxide 640. This procedure allowed the attainment of the desired alcohol 636 in distinctly 
better yields than previously described for the sequence starting with diol 633. The secondary 
alcohol 636 was then uneventfully protected as EOM ether, allowing an orthogonal TBAF-
promoted deprotection to release alcohol 638 (97% of yield). The iodination under Appel 
conditions afforded the desired iodide segment 456 in 85% of yield. This transformation 
completed the synthesis of iodide fragment 456 in 6 steps, with an overall yield of 49%. 
Employing the same route as previously described, the iodide 456 was subjected to the direct 
benzylic alkylation with 2,4-dimethoxy-6-methylbenzoic acid 401 (scheme 149). Conformed to 
our expectation, this key step proceeded once again without any complication and resulted in 
the acquirement of the intermediate 640, which underwent a Mitsunobu-based esterification 
in the presence of the optically pure allylic alcohol 488 to smoothly provide the diene 643 in 
87% of yield. 
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Scheme 149: Final steps of the synthesis of zeranol (611) 
Accordingly, the sequence benzylic alkylation/esterification without intermediate purification 
also provided the desired compound 643 in rather high yields (75%). A highly diluted solution 
of diene 634 in toluene (less than 6.10-3 M) was then subjected to a ring-closing metathesis 
using the second-generation Grubbs catalyst 54 (5 mol%) to give the macrolactone 644 in 70% 
of yield, completing the carbon framework of zeranol (611). Other attempts of RCM under the 
same conditions, using first-generation Grubbs catalyst (53) instead, did not yield the same 
results (yield ≤ 50%), unless the amount of catalyst was increased to 15 mol%. The resulting 
macrocycle underwent a continuous-flow hydrogenation under the same conditions as 
previously described in section 3.3.1, employing the H-Cube® reactor and a 10% Pd/C 
cartridge. Alternatively, the hydrogenation could also take place under standard conditions 
(10% Pd/C catalyst in AcOH at atmospheric pressure and temperature), though the reaction 
time was clearly longer (up to 24h). Both methods gave acceptably high yields (≥ 97%). Unlike 
the deprotection used by the group of Yadav in their latest total synthesis of the same 
molecule which employed an solution of AlI3 in benzene,37 our demethylation was carried in 
the presence of boron tribromide in dichloromethane, following the procedure described by 
McOmie et al.42 The authors observed the best results for demethylation when an extra 
equivalent of boron bromide was added per basic O-containing group.42It was therefore 
advisable to add at least 4 equivalents of BBr3 to cleave both methyl ethers, together with the 
EOM ether of intermediate 642. To our joy, this procedure smoothly released the fully 
deprotected macrolide 611 in 80% of yield, completing our synthesis of the zeralenol (611).  
De novo, our synthetic strategy, a sequence which is composed of 5 general steps alkylation/ 
esterification/ RCM/ hydrogenation/ deprotection has proven its suitability for designing RALs 
analogues, especially those containing a saturated macrocyclic backbone. Accordingly, the 
applicability of the reaction sequence for natural and unnatural 12-membered RALs has been 
extended to 14-membered analogues.      
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3.3 Conclusion 
As previously detailed in all the four syntheses described in this chapter, the general pattern 
(direct alkylation/ Mitsunobu-based esterification/ RCM/ hydrogenation) has provided a very 
short way to access their carbon backbones, respectively.     
 
 
Scheme 150: From the conception to the molecules 
The first assembly of 401 and 237 via the well-studied direct benzylic alkylation has been 
uneventfully efficient and reproducible. The alkylation can be performed in the presence of a 
bromoalkanes, as well as iodoalkanes (scheme 150). Interestingly, the deprotonation of 401 by 
butyllithium did not lead to any expected product when submitted to the iodide segment 453. 
While in the cases of the 4 syntheses abovementioned, the results are comparable following 
the deprotonation of 401 by either butyllithium or sec-butyllithium. Despite the use of 2 
equivalents of base is required to engender the lithiated dianion 401, this key step represents 
a remarkable shortcut for future syntheses. Indeed, the alkylation does not require the 
protection of the benzylic acid, and hence an ulterior deprotection step, nor additional 
functionalisation at the benzylic position to stabilise the benzylic anion. The fragment 238 can 
be as well bromoalkanes or iodalkanes, offering a large range of operational choices. 
Moreover, the direct benzylic addition results in a highly clear product that it can be involved 
in the next step without further purification.  
The Mitsunobu esterification has proven to be very mild and efficient, in comparison to the 
common methods mentioned in section 2.2.2.1, especially those generating an electrophilic 
derivative of the corresponding benzoic acid. Indeed, this method is not hampered by the 
weak electrophilicity of the benzoyl carbon by transforming the alcohol fragment 237 into the 
corresponding electrophile instead. The configuration of C8’ for 12-membered RALs and C10’ 
for 14-membered RALs can be conveniently induced through the configuration of the 
homoallylic alcohol 237. Consequently, both enantiomers of lasiodiplodin, the naturally 
occurring (10) and its unnatural enantiomer (545) have been achieved in 5 steps with a 
virtually similar overall yield which reaches ca. 17%. 
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The RCM is not only suitable for macrocycles composed of 12 to 14 members, but also 
reconcilable with a large spectrum of functionalities. The catalysts required for this ring-
closure offer relatively easy accessibility and handling (e.g. Grubbs 1st generation catalyst 53), 
rendering this method a convenient synthetic tool. Besides, the macrocyclic framework can be 
easily disconnected at different positions, offering various options for the chain size of 237 and 
238, with respect to the functional groups decorating the macrocyle. 
Given that our target molecules’ macrocyclic frames do not include any double bond, we have 
not investigated the impact of the catalysts, and other parameters on the ratio of E/Z-alkene 
resulted from the RCM. However, in case the RCM is applied to the synthesis of cis-enone 
containing RALs, the  formation of the corresponding trans-isomer is inevitable.43 In 
consequence, our initial synthetic approach towards L-783,277 (7) has recourse to the 
combination RCAM/ Lindlar reduction to install the Z configuration of the double bond.  
The validation of our conception and strategy from section 3.1 is illustrated by the highly 
efficient and step-economic syntheses of the four RALs represented in scheme 151. 
 
Scheme 151: The four syntheses based on our strategic route 
Apart from zeranol (611) which was obtained in 11 steps with an overall yield of 22%, all the 
other total syntheses were completed within 5 steps with an over yield of ca. 15-20%. It is 
worth noting that the selective demethylation (30 to 40% of yield), which ends the syntheses 
of (R)-(+)-lasiodiplodin (10), its unnatural isomer 545 and neolasiodiplodin (606) have 
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considerably decreased the overall yield (below 30%), which would reach up to 43% without 
demethylation.  
In order to overcome this, it is wiser to devise an aromatic core, which contains a different 
protecting group at para which is orthogonal to the ortho methyl ether, for example a silyl 
group. According to the choice of the protecting group at para, extensive studies concerning 
the electronic effects could be carried out for our key step, the direct alkylation at the benzylic 
position, in view of extending the scope of this reaction to macrolactones with a more 
decorated phenolic core.  
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4 CONCLUSION AND OUTLOOK 
4.1 Conclusion 
 
• Towards the synthesis of L-783,277 (7): achievement of the pivotal dialkyne 
precursor 3 
 
 
Scheme 152: Our most accomplished route leading to precursor 241 
The main topic of this thesis resides in the search for a succinct and reliable route towards a 
formal synthesis of L-783,277 (7). Tenacious efforts and long-hour laboratory work have 
conducted to the achievement of the pivotal precursor 241, setting the stage for further 
advancement on our synthetic pathway. As briefly illustrated in scheme 152 above, the three 
building blocks had been first synthesised in very satisfying overall yields. 
The aromatic core, though commercially available at a high price, was prepared from the 
classical and cheap orcinol (93) according to well-described procedures in the literature. The 
overall yield is comparatively high (up to 75%). 
The propargylic alcohol 389 has demanded more intensive research to find out the optimal 
conditions for the stereoselective opening of the enantiomerically pure propylene oxide 40. 
The best experimental conditions have led to the attainment of alcohol 389 in acceptable 
overall yield (50 to 60%). 
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The major work has evolved around the preparation of the iodide fragment 253 in a reliable 
way, starting from easily and/or commercially available starting material. During the synthesis 
of this fragment, we have been confronted with several experimental issues (e.g. tricky 
purification of the intermediates, unreliable procedures, difficult handling of the starting 
materials) which led to dead-ends, and hence revision of strategies. Finally, the synthesis of 
this troublesome compound has been accomplished from D-isoascorbic acid (365) in 11 steps 
with an overall yield of 33%, following a very efficient and concise route.     
As a recurrent theme from total synthesis research, the detours taken with respect to the 
initial synthetic itinerary often resulted in the development of innovative strategies and 
working tools. The best examples in our case are the use of phosphine oxide as a powerful 
method for the opening and homologation of lactones (e.g. erythronolactone 364 represented 
in scheme 153) based on a modified Horner-Wittig reaction. To date, there has been no 
publication disclosing the homologation of lactones to achieve the corresponding p-
methoxybenzyl ether enols, which opens to this novel method a promising alley towards the 
preparation of more complex compounds.   
 
Scheme 153: Phosphine oxide as powerful method for opening and homologation of 
lactones 
 
Finally, the crucial direct alkylation at the benzylic position between orsellinic acid derivative 
401 and iodocalkanes has turned out to be greatly efficient, yielding the intermediate 452 in 
good yield, ranging from 80 to 85% (scheme 154).   
 
Scheme 154: Direct alkylation at the benzylic position  
 
The reliability of this key step has clearly been validated by its major contribution to the 
accomplishment of 4 other natural and synthetic RALs, following a very concise and efficient 
pathway. 
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• From the strategic disconnection to the 4 successful syntheses of RALs 
Scheme 155: General strategic route of RALs bearing a single C1’-C2’ bond 
 Finally, the envisaged synthetic route towards the syntheses of other RALs (scheme 155) has 
turned out to be very efficient and concise. The common building block remains the orsellinic 
acid derivative 401, the main core to which were appended the remaining fragments to 
complete the carbon frame of the target molecules. The key step, direct alkylation at the 
benzylic position, has proven to be tactically powerful and versatile. This transformation is 
unprecedented in the field of total synthesis of RALs, making it a new and viable tool among 
the classic synthetic toolkit. 
 The validation of our concepts and strategies are illustrated by the accomplishment of the 2 
naturally occurring macrolides, (R)-(+)-lasiodiplodin  (10) and zeranol (611), as well as 2 other 
unnatural  resorcylic acid lactones, (S)-(-)-lasiodiplodin (545) and neolasiodiplodin (606), 
presented in figure 27  below. 
 
Figure 27: The natural RALs and RALs-inspired molecules achieved  
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4.2 Outlook 
 
• Construction of the cis-enone by RCAM/Lindlar reduction 
 
The next step towards the synthesis of L-783,277 (7) consists in the RCAM followed by a 
Lindlar reduction as featured in scheme 156. 
 
Scheme 156: RCAM/Lindlar reduction step towards the formal synthesis of L-783,277 (7) 
 
The ineffective RCAM trials using two of Fürstner’s commercially available pre-catalysts (figure 
19) have raised the plausible issue of structural constrictions due to the significantly decorated 
carbon frame of the readily prepared precursor 241.  This hypothesis can only be verified by 
future modifications of the structure of intermediate 241, particularly the adjustment of the 
protecting groups at C4’ and C5’. In all likeliness, one of the structural obstacles comes from 
the somewhat rigid acetonide (induced by the starting material erythronolactone 364). In 
consequence, it might be expected that incorporation of less conformational constrains in the 
cyclisation precursor may lead to the ring-closing of dialkyne 241. One of the potentially 
appropriate protecting groups is TBS (figure 28), which would have the advantage of being 
orthogonal to the coexisting EOM protecting group. This would presumably avoid the tricky 
selective oxidation of allylic alcohol of the triol precursor, previously mentioned by Altmann’s 
and Winssinger’s respective group.1 
645
MeO
MeO
O
Me
EOMO
OTBS
OTBS
O
MeMe
 
Figure 28: New dialkyne precursor for RCAM/Lindlar reduction strategy  
 
On the other hand, it would be also relevant to employ other well-known alkyne metathesis 
catalysts on the market to try out anew the RCAM onto the readily prepared precursor 241. 
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Among all the well-defined and commercially available alkyne metathesis catalysts, the 
crystalline complex 509 is thought to be the next candidate, giving its reported indefinite 
stability on the benchtop without any precautions whatsoever (scheme 157).2 
 
Scheme 157: Reactions and conditions: (a) Ph3SiOH (3 equiv), toluene; (b) 1,10-phenanthroline, 
82%; (c) MnCl2, toluene, 80-100 °C. 
 
 
• Construction of the cis-enone by Z-selective RCM 
 
 
Scheme 158: RCAM/Lindlar reduction step towards the formal synthesis of L-783,277 
(7) 
 
As  previously mentioned in section 2.1, the assembly of the carbon framework of our target 
molecule 239 might be based on a Z-selective RCM, exploiting one of the newly disclosed 
catalysts by Schrock and Hoveyda (scheme 158).3 To date, there has been no report yet in the 
literature about the use of any of the Z-selective olefin catalysts for ring-closing alkene 
metathesis for the syntheses of RALs. If successfully carried out, this would constitute an 
influential tool for the syntheses of naturally occurring RALs, their analogues and beyond. 
 
• From the “direct benzylic acylation” to the synthesis of neocosmosin A (29) 
 
Convinced by the usefulness of our key step, the direct alkylation at benzylic position, we have 
directed our attention to the extending of its reaction scope to the construction of other type 
of C1’-C2’ bond, in particular the ketone carbonyl group at C3’ in several members of the vast 
RALs family. 
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Figure 29: Some representative RALs which bear a ketone carbonyl group at C3’ 
The development of a reliable method for acylation at the benzylic position, based on our well 
established “direct alkylation at benzylic position” methodology, will enable access to the RALs 
illustrated in scheme 29 above. In addition, a feasible direct benzylic acylation combined with 
the immediate application of our synthetic blueprint (scheme 155) would allow the 
achievement of neocosmosin A (2), which diplays in vitro binding affinity for human opioid and 
cannabinoid receptors.4 
Retrosynthetically, neocosmosin A (29) might be disconnected, following our previously 
described synthetic strategy, into three separate segments: the aromatic core 401, the 
optically pure allylic alcohol 488 and the terminal alkene 650. Scheme 159 depicts the 
assembly of these fragments by a benzylic acylation, followed by a Mitsunobu-based 
esterification and a RCM to complete the carbon framework 648. A selective demethylation 
would release the ortho-phenol, finalising the total synthesis of neocosmosin A (29).  
 
Scheme 159: Proposed retrosynthetic disconnection of neocosmosin A (29) 
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Undoutedly, before embarking on the synthesis of this modestly decorated and hence 
structurally simple macrolide, it is mandatory to investigate the best leaving group X attached 
to the carbonyl C2’ of 650. In a broader perspective, if successfully carried out, this reaction 
sequence would be a short route to other analogues of neocosmosin A (29), the principal 
actors for further investigation of the biological activities of this newly discovered metabolite. 
In consequence, the first attempts to find the best electrophilic candidate for the 
abovementioned acylation have been undertaken in our laboratories. In the first place, we 
have opted for an imidazoyl, e.g. 1-(1H-imidazol-1-yl)hept-6-en-1-one (652), with respect to 
the synthon 650 (scheme 159). However, extensive experimentation is required in order to 
find operationally useful conditions of acetylation.  
Lastly, while there is no way to predict the E:Z/ 1:1 ratio of 648 by a RCM which has been 
observed by the first total synthesis of neocosmosin (29) by Das et al. in 2014,5 the group of 
Fürstner has lately reported a reliable method to access the E configuration of alkenes within 
macrocycles. Their paper outlined the entry to macrocyclic E alkenes by using a sequence of 
ring-closing alkyne metathesis (RCAM), trans-selective hydrosilylation of the resulting 
cycloalkynes catalyzed by [CppRu(MeCN)3]PF6, and a protodesilylation of the ensuing 
vinylsilanes with AgF in aqueous THF/MeOH. 
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5 EXPERIMENTAL 
5.1 Devices and materials 
5.1.1 General methods 
 
Reagents and solvents were bought from ABCR, Acros, Aldrich, Fluka, VWR at ACS grade and 
used without purification, unless otherwise indicated. All absolute solvents had HPLC quality 
and were stored over molecular sieves. 
Reactions were performed within dry solvents obtained by refluxing (dichloromethane and 
acetonitrile over calcium hydroxide, toluene over sodium, tetrahydrofuran and diethyl ether 
over sodium and benzophenone) followed by distillation.  
All non-aqueous reactions were carried out using heatgun-dried glassware under a gas flow of 
dry argon unless otherwise indicated, reactions were magnetically stirred and monitored by 
thin layer chromatography (TLC) using Merck Silica Gel 60 F254 plates and visualized by 
fluorescence quenching under UV light, then dipping inside a vanillin preparation (5 g vanillin, 
100 mL ethanol, 0.4 mL H2SO4) followed by heatgun drying to reveal the subsequent spots. 
Retention factors (Rf) are indicated with the used solvent mixture in brackets. 
Chromatographic purification of products (flash chromatography) was performed on Davisil® 
LC60A (particle size 40 - 63 μm or particle size 70-200 μm) using a forced flow of eluant at 1- 3 
bar. Purifications on preparative layer chromatography were performed on silica gel coated 
glasses (Davisil® LC60A, 60 PF254, 1.5 mm thick) which were prepared by our department.   
 
NMR measurements 
 
NMR spectra were recorded either on an JEOL (FNM EX-400) with a 400 MHz magnet for 1H, 
101 MHz for 13C and 162 MHz for 31P acquisitions  or on a JEOL (JMN EX-270) with a 270 Hz 
magnet for  1H acquisitions. The spectra were resolved with the Delta program. Chemical shifts 
(δ) are given in ppm relative to the TMS with the solvent resonance as internal standard 
relative to chloroform (δ 7.26), methanol (δ 3.31), dimethyl sulfoxide (δ 2.50), 
dichloromethane (δ 5.32), benzene  (δ 7.16) and acetone (δ 2.05) for 1H and chloroform (δ 
77.16), methanol (δ 49.00), dimethyl sulfoxide (δ 39.52), dichloromethane (δ 53.8), benzene  
(δ 128.06) and acetone (δ 29.84) for 13C. All 13C and 31P measurements were obtained with 
hydrogen decoupling and the coupling constants J with 31P nucleus are given in Hertz. Data are 
reported as followed: s = singlet, bs = broad singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet and their combinations. Assignment of protons and carbons were respectively 
accomplished by 1H-1H COSY correlation, 135DEPT and 1H- 13C HMQC correlation experiments. 
The chemical shifts of 31P spectra are uncorrected. 
NMR data of diastereomeric mixtures are generally described for the major isomer, unless 
otherwise stated. 
 
Melting Points 
All the measurements were performed on a Büchi B-540 apparatus, in open capillaries. 
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Optical Rotations 
 
The specific rotations were measured on a Perkin-Elmer 241 polarimeter operating at the 
sodium D line with a 1.0 dm long cell. The specific rotations of solutions were calcd according 
to the Biot law: 
[α]DT = ఈ஼.௟ 
α: measured value by the polarimeter 
T: ambient temperature, automatically assumed at 20°C  
C: concentration of the sample (g/100 ml) 
l: the length of the cell (1.0 dm) 
 
and are reported as followed:  
[α]D20 (concentration, solvent) 
 
 
 
Mass spectrometry (MS) and High Resolution Mass Spectrometry (HRMS) 
 
LC-MS measurements were carried out on an Agilent 6200 series TOF mass spectrometer 
operating in either positive or negative mode. The analyte solutions were delivered to the ESI 
source by an Agilent 1200 series LS system at a 0.25 mL.min -1 flow rate. The gradient was from 
10 % to 20 % eluent acetonitrile in water within 20 min. 
 
General ESI and APCI conditions : capillary voltage (2.0 kV), cone voltage (65 kV), source 
temperature (250°C), desolvation temperature (350°C), drying gas (5 L.min -1), nebulizer (60 
psig). 
 
For the recording of the single-stage ESI-MS spectra, all ions are transmitted into the pusher 
region of the TOF analyzer where they are mass-analysed with 1 second integration time. 
 
Dry nitrogen was used for ESI and APCI methods. All ions were transmitted into the pusher 
region of the TOF analyser, where they were mass-analysed with one-second integration time 
for the recording of the single-stage ESI-MS. 
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5.2 Towards the synthesis of L-783,277 (7) 
5.2.1 Construction of the polyol fragment  
5.2.1.1 First generation strategy: “2-deoxy-D-ribose approach” 
 
 
Chemical Formula: C8H14O4 
Molecular Weight: 174.19 g.mol-1 
 
(3aR,7aS)-2,2-dimethyltetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-6-ol (246) 
 
To a solution of (3S,4S)-tetrahydro-2H-pyran-2,3,4-triol (89) (10.0 g, 74.6 mmol, 1.0 equiv.), 
PTSA (128 mg, 0.746 mmol, 0.01 equiv.) and  previously heatgun-dried under vacuum MgSO4 
(2.5 g) in DMF at 0°C was added 2-methoxypropene (14.3 mL, 149.2 mmol, 2.0 equiv.). The 
solution was stirred at 0°C for 3h30 then allowed to warm to RT before Na2CO3 (ca 10 g) was 
added.  The resulting mixture was filtered and the organic layer was evaporated to afford a 
crude product which was purified via silica flash chromatography (Cy/EtOAC: 9/1  6/1  4/1) 
to provide 73/28 anomeric mixture of (3aR,7aS)-2,2-dimethyltetrahydro-3aH-
[1,3]dioxolo[4,5-c]pyran-6-ol (246) as a white solid (6.1 g, 47%). 
 
Rf= 0.38 (Cy/EtOAc: 2/3)   
 
The analytical are identical to those from the literature.1 
 
mp= 97-99°C 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.34 (s, 6H, H-6 or H-7), 1.49 (s, 6H, H-7 or H-6), 1.77-1.81 (m, 
1H, H-2A), 2.21-2.27 (m, 1H, H-2B), 3.66-3.73 (m, 1H, H-5A), 3.92-3.98 (m, 1H, H-5B), 4.12-4.21 
(m, 2H, H-3), 4.39-4.50 (m, 2H, H-4), 5.24-5.28 (m, 1H, H-1) 
 
13C NMR (100 MHz, CDCl3): δ= 25.5 (C-6 or C-7), 28.1 (C-7 or C-6), 35.5 (C-2), 63.0 (C-5), 75.5 
(C-3), 77.9 (C-4), 97.7 (C-1), 107.9 (C-8) 
 
HRMS (ESI+): calcd for (M-H)-: 173.0814, found: 173.0807 
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Chemical Formula: C8H16O4 
Molecular Weight: 176.21 g.mol-1 
 
2-((4R,5R)-5-(hydroxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)ethanol (247) 
 
To a suspension of LAH (1.99 g, 52.5 mmol, 1.5 equiv.) in THF (70 mL) at 0°C was added 
dropwise a solution of (3aR,7aS)-2,2-dimethyltetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-6-ol 
(246) (6.1 g, 35.0 mmol, 1.0 equiv.) in THF (70 mL). The mixture was stirred at RT for 5h then 
quenched at 0°C respectively with distillated water (1.99 mL), NaOH (15 w/v%, 1.99 mL) and 
distillated water (5.97 mL). The resulting mixture was then poured into Et2O (40 mL) and 
stirred for 30 min before being filtrated via a Celite pad and the solvents were evaporated 
under reduced pressure. The slightly yellow crude product was purified through silica flash 
chromatography (Cy/EtOAC: 4/1  1/1  1/2) to afford 2-((4R,5R)-5-(hydroxymethyl)-2,2-
dimethyl-1,3-dioxolan-4-yl)ethanol (247) (5.6 g, 90%)as a yellow oil. 
 
Rf= 0.50 (Cy/EtOAc: 1/3)   
 
The analytical are identical to those from the literature.1 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.34 (s, 3H, H-6 or H-7), 1.49 (s, 3H, H-7 or H-6), 1.77-1.81 (m, 
2H, H-2), 2.00 (bs, 1H, OH), 2.22 (bs, 1H, OH), 3.53-359 (m, 2H, H-5), 3.66-3.75 (m, 2H, H-1), 
4.18-4.23 (m, 2H, H-3), 4.33-4.38 (m, 2H, H-4) 
 
13C NMR (100 MHz, CDCl3): δ= 25.5 (C-6 or C-7), 28.1 (C-7 or C-6), 32.5 (C-2), 61.0 (C-1), 63.0 
(C-5), 75.5 (C-3), 77.9 (C-4), 107.9 (C-8) 
 
HRMS (ESI+): calcd for (M-H)+: 177.1126, found: 177.1120 
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Chemical Formula: C24H34O4Si 
Molecular Weight: 414.61 g.mol-1 
 
((4R,5R)-5-(2-((tert-butyldiphenylsilyl)oxy)ethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)methanol 
(248) 
 
To a stirred solution of 2-((4R,5R)-5-(hydroxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)ethanol 
(247) (5.5 g, 31.2 mmol, 1.0 equiv.) in DMF (25 mL) at RT was added imidazole (3.2 g, 46.8 
mmol, 1.5 equiv.). The reaction was stirred at RT for 15 min before the dropwise addition of 
TBDPSCl (8.9 mL, 34.3 mmol, 1.1 equiv.) and the stirring was maintained at this temperature 
for 2h30. The mixture was diluted with EtOAc (200 mL), washed with a solution of K2CO3 (10 
w/v%, 100 mL) and brine (150 mL), dried over MgSO4 and concentrated under reduced 
pressure. The crude product was purified by silica flash chromatography (Cy/EtOAC: 9/1  5/1 
 4/1) to provide ((4R,5R)-5-(2-((tert-butyldiphenylsilyl)oxy)ethyl)-2,2-dimethyl-1,3-
dioxolan-4-yl)methanol (248) (5.7 g, 44%) as a colorless oil. 
 
Rf= 0.26 (Cy/EtOAc: 3/1)   
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.04 (s, 9H, H-8), 1.35 (s, 3H, H-6 or H-7), 1.44 (s, 3H, H-7 or H-
6), 1.77-1.91 (m, 2H, H-2), 3.56-3.61 (m, 2H, H-1), 3.77-3.81 (m, 1H, H-5), 4.09-4.18 (m, 1H, H-
3), 4.37-4.43 (m, 1H, H-4), 7.36-7.45 (m, 6H, arom), 7.65-7.69 (m, 4H, arom) 
 
13C NMR (100 MHz, CDCl3): δ= 20.2 (C-11), 25.5 (C-6 or C-7), 26.7 (C-9), 28.1 (C-7 or C-6), 32.7 
(C-2), 61.0 (C-1), 63.0 (C-5), 73.5 (C-3), 77.9 (C-4), 107.9 (C-8), 127.7 (arom), 127.9 (arom), 
129.7 (arom), 133.3 (arom), 133.5 (arom), 135.3 (arom), 135.9 (arom)    
 
HRMS (ESI+): calcd for (M-H)+: 415.2305, found: 415.2311 
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Chemical Formula: C24H32O4Si 
Molecular Weight: 412.59 g.mol-1 
 
(4S,5R)-5-(2-((tert-butyldiphenylsilyl)oxy)ethyl)-2,2-dimethyl-1,3-dioxolane-4-carbaldehyde 
(248) 
 
To a solution of ((4R,5R)-5-(2-((tert-butyldiphenylsilyl)oxy)ethyl)-2,2-dimethyl-1,3-dioxolan-4-
yl)methanol (247) (5.7 g, 13.7 mmol, 1.0 equiv.) in DMSO/DCM (10 mL/20 mL) at -10°C was 
added DIPEA (7.1 mL, 41.2 mmol, 3.0 equiv.) and the reaction mixture was stirred at this 
temperature for 15 min. To the latter solution was added via cannula a solution of SO3.pyr (6.6 
g, 41.2 mmol, 3.0 equiv.) in DMSO (10 mL) over 15 min and the mixture was stirred between -
10°C and -5°C for 4h before being diluted at 0°C with Et2O (200 mL) and washed with distillated 
water (3 x 200 mL), CuSO4  (10 w/v%, 2 x 100 mL) and brine (200 mL), respectively, dried over 
MgSO4 and highly concentrated under reduced pressure. The slightly yellow crude product 248 
(6.0 g) was employed in the next step without further purification. 
 
Rf= 0.65(Cy/EtOAc: 3/1)   
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.04 (s, 9H, H-8), 1.35 (s, 3H, H-6 or H-7), 1.44 (s, 3H, H-7 or H-
6), 1.77-1.91 (m, 2H, H-2), 3.56-3.61 (m, 2H, H-1), 4.09-4.16 (m, 1H, H-3), 4.43-4.46 (m, 1H, H-
4), 7.36-7.45 (m, 6H, arom), 7.65-7.69 (m, 4H, arom), 9.79 (d,  J= 2.97, 1H, H-5) 
 
13C NMR (100 MHz, CDCl3): δ= 20.2 (C-11), 25.5 (C-6 or C-7), 26.7 (C-9), 28.1 (C-7 or C-6), 32.7 
(C-2), 61.0 (C-1), 73.5 (C-3), 77.9 (C-4), 107.9 (C-8), 127.7 (arom), 127.9 (arom), 129.7 (arom), 
133.3 (arom), 133.5 (arom), 135.3 (arom), 135.9 (arom), 200.21 (C-5) 
 
 
Chemical Formula: C27H36O4Si 
Molecular Weight: 452.66 g.mol-1 
 
1-((4R,5R)-5-(2-((tert-butyldiphenylsilyl)oxy)ethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)but-2-yn-1-
ol (250) 
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The crude product of (4S,5R)-5-(2-((tert-butyldiphenylsilyl)oxy)ethyl)-2,2-dimethyl-1,3-
dioxolane-4-carbaldehyde (249) (6.0 g)was diluted in THF (50 mL) at RT then cooled down to -
5°C before a  0.5 M solution of prop-1-yn-1-ylmagnesium bromide (41.4 mL, 20.7 mmol, 1.5 
equiv.) was added dropwise. The mixture was vigorously stirred between -5°C and 0°C for 3h, 
then allowed to warm up to 0°C before getting diluted by Et2O (70 mL) and quenched with a 
saturated solution of NH4Cl (100 mL). The aqueous phase was extracted with Et2O (2 x 30 mL). 
The combined organic phase was washed with a saturated solution of brine (100 mL), dried 
with anhydrous MgSO4 and concentrated under reduced pressure. The crude product was 
purified via silica flash chromatography (Cy/EtOAC: 9/1  6/1  4/1) to provide a 55/45 
diastereomeric mixture of 250 (5.8 g, 93% over 2 steps) as a colorless oil.  
 
Rf= 0.31 (Cy/EtOAc: 3/1)   
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.04 (s, 9H, H-9), 1.37 (s, 3H, H-7 or H-8), 1.48 (s, 3H, H-8 or H-
7), 1.85 (d, 3H, J= 2.1 Hz, H-6), 1.93-2.17 (m, 2H, H-2), 3.78-3.87 (m, 2H, H-1), 4.06-4.11 (m, 2H, 
H-3), 4.24-4.39 (m, 2H, H-4), 4.46-4.52 (m, 2H, H-5), 7.36-7.43 (m, 6H, arom), 7.65-7.69 (m, 4H, 
arom) 
 
13C NMR (100 MHz, CDCl3): δ= 3.89 (C-8), 19.30 (C-16), 25.48 (C-9 or C-10), 27.56 (C-10 or C-9), 
32.25 (C-2), 61.26 (C-5), 64.64 (C-1), 71.63 (C-6 or C-7), 74.09 (C-3), 79.94 (C-4), 83.00 (C-7 or C-
6), 108.55 (C-13), 127.72 (arom), 129.82 (arom), 135.67 (arom) 
 
 
HRMS (ESI+): calcd for (M-H)+: 453.2461, found: 453.2455 
 
 
Chemical Formula: C30H42O5Si 
Molecular Weight: 510.74 g.mol-1 
 
tert-butyl(2-((4R,5S)-5-(1-(ethoxymethoxy)but-2-yn-1-yl)-2,2-dimethyl-1,3-dioxolan-4-
yl)ethoxy)diphenylsilane (251) 
 
To a stirred solution of 1-((4R,5R)-5-(2-((tert-butyldiphenylsilyl)oxy)ethyl)-2,2-dimethyl-1,3-
dioxolan-4-yl)but-2-yn-1-ol (250) (5.8 g, 12.8 mmol, 1.0 equiv.) in DMF (30 mL) at RT was 
added TBAI (0.13 mmol, 47.8 mg, 0.01 equiv.), DIPEA (11.0 mL, 64.0 mmol, 5.0 equiv.), 
respectively. The solution was stirred for 5 min at RT before the dropwise addition of EOMCl 
(5.7 mL, 64.0 mmol, 5.0 equiv.). The mixture was stirred at RT for 4h. The slightly orange 
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solution was diluted with Et2O (150 mL) quenched at 0°C with a saturated solution of NH4Cl 
(100 mL). The aqueous phase was extracted with Et2O (3 x 50 mL). The combined organic 
phase was washed with a saturated solution of brine (150 mL), dried with anhydrous MgSO4 
and concentrated under reduced pressure. The crude product was purified via silica flash 
chromatography (Cy/EtOAC: 95/5 8/1  6/1) to provide 55/45 diastereomeric mixture of 
251 as a colorless oil (10.4 g, 97%). 
 
Rf= 0.62 (Cy/EtOAc: 3/1)   
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.04 (s, 9H, H-12), 1.19 (t, 3H, H-8), 1.36 (s, 3H, H-10 or H-11), 
1.84 (d, 3H, J= 2.1Hz, H-9), 1.90-2.04 (m, 2H, H-2), 3.49-3.77 (m, 2H, H-7), 3.78-3.90 (m, 2H, H-
1), 4.11-4.24 (m, 1H, H-3), 4.30-4.37 (m, H-4), 4.42-4.52 (m, 2H, H-5), 4.84 (AB, JAB = 6.9 Hz, Δν= 
120 Hz, 2H, H-6), 7.35-7.43 (m, 6H, arom), 7.65-7.70 (m, 4H, arom) 
 
13C NMR (100 MHz, CDCl3): δ= 3.93 (C-11), 15.20 (C-8), 19.32 (C-16), 25.51 (C-12 or 13), 26.93 
(C-15), 27.58 (C-13 or 12), 32.20 (C-2), 60.93 (C-1), 64.24 (C-7), 66.08 (C-5), 73.68 (C-3), 74.87 
(C-9 or C-10), 79.00 (C-4), 84.04 (C-10 or C-9), 92.55 (C-6), 108.46 (C-14), 127.72 (arom), 129.82 
(arom), 135.68 (arom) 
 
HRMS (ESI+): calcd for (M-H)+: 511.2879, found: 511.2885 
 
 
Chemical Formula: C14H24O5 
Molecular Weight: 272.34 g.mol-1 
 
2-((4R,5S)-5-(1-(ethoxymethoxy)but-2-yn-1-yl)-2,2-dimethyl-1,3-dioxolan-4-yl)ethanol (252) 
 
To a stirred solution of tert-butyl(2-((4R,5S)-5-(1-(ethoxymethoxy)but-2-yn-1-yl)-2,2-
dimethyl-1,3-dioxolan-4-yl)ethoxy)diphenylsilane (251) (10.2 g, 19.6 mmol, 1.0 equiv.) in THF 
(70 mL) at RT was added in one portion tetrabutylammonium fluoride hydrate (12.8 g, 49.0 
mmol, 2.5 equiv.). The reaction mixture was stirred at RT overnight. The yellowish solution was 
diluted with EtOAc (100 mL), washed with a saturated solution of NH4Cl (2 x 70 mL) then with 
brine (100 mL). The organic layer was dried with anhydrous MgSO4 and concentrated under 
reduced pressure. The crude product was purified via silica flash chromatography (Cy/EtOAC: 
9/1 6/1  4/1) to provide 55/45 diastereomeric mixture of 252 as a colorless oil (5.2 g, 98%) 
 
Rf= 0.30 (Cy/EtOAc: 1/1)   
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Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3) :  δ = 1.21 (t, J= 7.1 Hz, 3H, H-9), 1.43 (s, 3H, H-10 or H-11), 1.47 (s, 
3H, H-11 or H-10),  1.86 (d, J = 2.29 Hz, 3H, H-6), 1.97-2.07 (m, 2H, H-2), 3.50-3.75 (m, 2H, H-8), 
3.81-3.89 (m, 2H, H-5 and H-4), 4.18-4.22 (m, 1H, H-3), 4.45-4.85 (m, 1H H-1), 4.84 (AB, JAB = 
6.9 Hz, Δν= 120 Hz, 2H, H-7) 
 
13C NMR (400 MHz, CDCl3) :   δ = 3.86 (C-8), 15.14 (C-14), 25.52 (C-9 or C-10), 27.55 (C-10 or C-
9), 31.55 (C-2), 61.33 (C-3), 64.29 (C-13), 65.87 (C-5), 75.00 (C-6 or C-7), 76.52 (C-1), 79.04 (C-
4), 84.10 (C-7 or C-6), 92.47 (C-12), 108.75 (C-11) 
 
HRMS (ESI+): calcd for (M-H)+: 273.1702, found: 273.1710 
 
 
 
Chemical Formula: C14H23IO4 
Molecular Weight: 382.23 g.mol-1 
 
(4S,5R)-4-(1-(ethoxymethoxy)but-2-yn-1-yl)-5-(2-iodoethyl)-2,2-dimethyl-1,3-dioxolane (253) 
 
To a solution of 2-((4R,5S)-5-(1-(ethoxymethoxy)but-2-yn-1-yl)-2,2-dimethyl-1,3-dioxolan-4-
yl)ethanol (252) (1.0 g, 3.7 mmol, 1.0 equiv.), PPh3 (1.4 g, 5.5 mmol,1.5 equiv.) and imidazole ( 
0.37 g, 5.5 mmol, 1.5 equiv.) in THF (50 mL) at 0°C was added I2 ( 1.4 g, 5.5 mmol, 1.5 equiv.) in 
one portion. The brown-yellow reaction mixture was vigorously stirred at 0°C until until TLC 
indicated total consumption of starting material (2h30). The reaction mixture was warmed to 
room temperature then diluted with Et2O (70mL) quenched with aqueous saturated Na2S2O5 
(100 mL). The aqueous layer was extracted with Et2O (2 x 30mL) and the combined organic 
layer was washed with brine (100 mL). The crude product was subjected to previously 
neutralised silica gel (in cyclohexane containing 0.1% TEA over 10 min) flash chromatography 
(Cy/AcOEt: 97/395/590/10) to afford 55/45 diastereomeric mixture of 247as a colorless oil 
(1.3 g, 91%) 
 
Rf = 0.80 (Cy/EtOAC : 2/1) 
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Numbering for the hydrogens                   Numbering for the carbons 
1H NMR (400 MHz, CDCl3) :  δ = 1.21 (t, J= 7.10 Hz, 3H, H-9), 1.43 (s, 3H, H-10 or H-11), 1.47 (s, 
3H, H-11 or H-10),  1.87 (d, J = 2.3 Hz, 3H, H-6), 2.13-2.27 (m, 2H, H-2), 3.20-3.42 (m, 2H, H-1), 
3.50-3.75 (m, 2H, H-8), 4.18-4.22 (m, 1H, H-3), 4.23-4.33 (m, 1H, H-4), 4.34-4.38 (m, 1H, H-5), 
4.84 (AB, JAB = 7 Hz, Δν= 120 Hz, 2H, H-6) 
 
13C NMR (100 MHz, CDCl3) :   δ = 3.25 (C-1), 3.75 (C-8), 15.14 (C-14), 25.52 (C-9 or C-10), 27.55 
(C-10 or C-9), 33.45 (C-2), 63.47 (C-13), 65.08 (C-5), 66.04 (C-3),  75.00 (C-6 or C-7), 79.04 (C-4), 
84.11 (C-7 or C-6), 92.49 (C-12), 108.76 (C-11) 
 
HRMS (ESI+): calcd for (M-H)+: 383.0719, found: 383.0726 
 
 
 
Chemical Formula: C21H30O5 
Molecular Weight: 362.46 g.mol-1 
 
(4S,5R)-4-(1-(ethoxymethoxy)but-2-yn-1-yl)-2,2-dimethyl-5-(2-(p-tolyloxy)ethyl)-1,3-
dioxolane (255) 
 
To a solution of 2-((4R,5S)-5-(1-(ethoxymethoxy)but-2-yn-1-yl)-2,2-dimethyl-1,3-dioxolan-4-
yl)ethanol (252) (1.0 g, 3.7 mmol, 1.0 equiv.) in DCM (50 mL) at 0°C was added pyridine (3.0 
mL, 36.7 mmol, 10.0 equiv.) then TsCl(3.5 g, 18.4 mmol,5.0 equiv.) in DCM (50 mL). The 
reaction mixture was vigorously stirred at 0°C for 1h and at RT overnight before being 
quenched with saturated aqueous NH4Cl (100 mL) at 0°C. The aqueous layer was extracted 
with DCM (2 x 30mL) and the combined organic layer was washed with brine (100 mL), dried 
with MgSO4. The solvents were evaporate and the crude product was subjected to silica gel 
flash chromatography (Cy/AcOEt: 97/395/590/10) to afford 255 as a colorless oil (1.3 g, 
99%). 
 
Rf = 0.84 (Cy/EtOAC: 2/1) 
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Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.18 (t, 3H, J=7.1 Hz, H-8), 1.26 (s, 3H, H-10 or H-11), 1.40 (s, 3H, 
H-11 or H-10), 1.81 (d, 3H, J= 2.1 Hz, H-9), 1.96-2.20 (m, 2H, H-2), 2.40 (s, 3H, H-16), 3.42-3.69 
(m, 2H, H-7), 4.06-4.31 (m, 5H, H-3, H-4, H-5 and H-1), 4.76 (AB, JAB = 6.9 Hz, Δν= 120 Hz, 2H, H-
6), 7.03 (d, 2H, J= 8.0 Hz, H-14 and H-15), 7.75 (d, 2H, J= 8.0 Hz, H-12 and H-13) 
 
13C NMR (100 MHz, CDCl3): δ= 3.81 (C-11), 15.12 (C-8), 21.66 (C-21), 25.36 (C-12 or C-13), 
27.46 (C-13 or C-12), 29.22 (C-2), 64.26 (C-7), 65.70 (C-3), 68.16 (C-1), 72.86 (C-5), 78.59 (C-4), 
92.47 (C-6), 108.78 (C-14), 127.98 (C-16 and C-18), 129.94 (C-15 and C-19), 133.11 (C-17), 
44.79 (C-20) 
 
HRMS (ESI+): calcd for (M-H)+: 363.2171, found: 363.2177 
 
 
Chemical Formula: C14H23BrO4 
Molecular Weight: 335.23 g.mol-1 
 
(4R,5S)-4-(2-bromoethyl)-5-(1-(ethoxymethoxy)but-2-yn-1-yl)-2,2-dimethyl-1,3-dioxolane 
(254) 
 
To a solution of (4S,5R)-4-(1-(ethoxymethoxy)but-2-yn-1-yl)-2,2-dimethyl-5-(2-(p-
tolyloxy)ethyl)-1,3-dioxolane (252) (95.5 mg, 0.22 mmol, 1.0 equiv.) in acetone (7 mL) at 25°C 
was added LiBr(19.44 mg, 2.24 mmol,10.0 equiv.).The brown-yellow reaction mixture was 
under refluxing for 16h. The reaction mixture was allowed to reach the ambient temperature 
over 1 hour before being filtered over a pad of Celite. The solvents totally evaporated and the 
crude product was subjected to previously neutralised silica gel (in cyclohexane containing 
0.1% TEA over 10 min) flash chromatography (Cy/AcOEt: 97/390/1080/20) to afford a 
55/45 diastereomeric mixture of 254 as a colorless oil (44.3 mg, 60%) 
 
Rf = 0.73 (Cy/EtOAC: 2/1) 
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Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3) :  δ = 1.21 (t, J= 7.1 Hz, 3H, H-8), 1.37 (s, 3H, H-10 or H-11), 1.47 (s, 
3H, H-11 or H-10),  1.85 (d, J = 2.3 Hz, 3H, H-9), 2.05-2.32 (m, 2H, H-2),3.47-3.64 (m, 4H, H-7 
and H-1), 3.66-3.73 (m, 1H, H-3), 4.29-4.40 (m, 2H, H-4 and H-5), 4.84 (AB, JAB = 6.9 Hz, Δν= 120 
Hz, 2H, H-6) 
 
13C NMR (100 MHz, CDCl3) :   δ = 3.90 (C-11), 15.19 (C-8), 25.54 (C-12 or C-13), 27,68 (C-13 or 
C-12), 30.74 (C-2), 32.78 (C-1), 64.38 (C-7), 65.72 (C-5), 74.98 (C-9 or C-10), 75.20 (C-3), 78.67 
(C-4), 84.15 (C-10 or C-9), 92.48 (C-6), 108.82 (C-14) 
 
HRMS (ESI+): calcd for (M-H)+: 335.0858, found: 335.0867 
 
 
5.2.1.2 Second generation strategy: “D-arabinose approach” 
 
 
Chemical Formula: C8H14O5 
Molecular Weight: 190.19 g.mol-1 
 
(3aR,7S,7aS)-2,2-dimethyltetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-6,7-diol (260) 
 
To a stirred solution of D-arabinose (259) (8.2 g, 54.6 mmol, 1.0 equiv.) and PTSA (94.0 mg, 
0.55 mmol, 0.01 equiv.) in DMF at RT was added dropwise 2,2-dimethoxypropane (20.3 mL, 
164 mmol, 3.0 equiv.). The white opaque mixture was stirred at RT for 2h30 before becoming 
limpid and quenched by addition of Amberlite A-410 (the reaction evolution was followed by 
TLC and stopped before the formation of the thermodynamic product diacetonide). After 15 
min of vigorous stirring, the mixture was filtered through a Celite® pad, evaporated under 
reduced pressure. The obtained crude product was purified via silica flash chromatography 
(Cy/EtOAC: 4/1  2/11/2) to afford 260 (9.0 g, 87%) as a white solid. 
 
Rf= 0.41 (Cy/EtOAc: 1/3)    
 
The analytical are identical to those from the literature.2 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
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1H NMR (400 MHz, CDCl3): δ= 1.36 (s, 3H, H-6 or H-7), 1.52 (s, 3H, H-7 or H-6), 3.83-3.87 (m, 
2H, H-5A), 4.14-4.30 (m, 4H, H-2, H-3, H-4 and H-5B), 5.19 (d, 1H, J= 2.9 Hz, H-1)  
 
13C NMR (100 MHz, CDCl3): δ= 24.96 (C-6 or C-7), 26.97 (C-7 or C-6), 67.70 (C-5), 72.04 (C-2), 
80.02 (C-3), 85.21 (C-4), 101.93 (C-1), 112.40 (C-8) 
 
HRMS (ESI+): calcd for (M-H)-: 189.0763, found: 189.0770 
 
 
 
Chemical Formula: C7H12O4 
Molecular Weight: 160.07 g.mol-1 
 
(3aR,6aR)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-ol (257) 
 
To a stirred solution of (3aR,7S,7aS)-2,2-dimethyltetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-
6,7-diol (260) (9.0 g, 47.4 mmol, 1.0 equiv.) in Et2O (90 mL) was added carefully a solution of 
NaBH4 (3.6 g, 94.7 mmol, 2.0 equiv.) in absolute ethanol (70 mL). Once the gas evolution 
stopped, the mixture was stirred for 2h at RT then acidified with glacial acetic acid at 0°C to 
obtain a neutral pH. The newly formed white solid was filtered and the filtrate evaporated to 
eliminate Et2O before the addition of distillated water (70 mL), followed by NaIO4 (15.2 g, 71.1 
mmol, 1.5 equiv.). The colorless limpid mixture was stirred at RT for 30 min before the fine 
white solid was filtered and the solvents evaporated under reduced pressure. The obtained 
white viscous product was dissolved in Et2O (50 mL), washed with a saturated solution of 
NaHCO3 (2 x 50 mL) then with brine (100 mL). The organic fraction was dried with anhydrous 
MgSO4 and concentrated under reduced pressure. The resulting crude product was purified via 
silica flash chromatography (Cy/EtOAC: 7/1  5/14/1) to provide 257 (6.2 g, 85%)as a white 
solid. 
 
Rf= 0.60 (Cy/EtOAc: 1/4)   
 
The analytical data are identical to those from the literature.2 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.32 (s, 3H, H-5 or H-6), 1.47 (s, 3H, H-6 or H-5), 4.05 (ABX, 2H, 
JAX= 0.7 Hz, JBX= 3.7 Hz, JAB= 10.3 Hz, Δν= 7 Hz), 4.82-4.85 (ABX, 1H, H-3), 4.58 (d, J= 5.7 Hz, H-2), 
5.42 (d, J= 1.8 Hz, H-1) 
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13C NMR (100 MHz, CDCl3): δ= 24.73 (C-5 or C-6), 26.29 (C-6 or C-5), 72.04 (C-4), 80.02 (C-3), 
85.20 (C-2), 101.93 (C-1), 112.40 (C-7) 
 
HRMS (ESI+): calcd for (M-H)-: 159.0657, found: 159.0662 
 
 
 
Chemical Formula: C13H26O4Si 
Molecular Weight: 274.43 g.mol-1 
 
((4R,5S)-2,2-dimethyl-5-((E)-2-(2-(trimethylsilyl)ethoxy)vinyl)-1,3-dioxolan-4-yl)methanol 
(264) 
 
To a stirred suspension of triphenyl(((trimethylsilyl)methoxy)methyl)phosphonium chloride 
(263) (36.5 g, 85.3 mmol, 2.2 equiv.) in Et2O (230 mL) at 0°C was added dropwise a 0.5 M 
solution of KHMDS in toluene (162.8 mL, 81.4 mmol, 2.1 equiv.). The solution was vigorously 
stirred at 0°C between 10 and 15 min while becoming gradually dark red, followed by the 
addition of (3aR,6aR)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-ol (257) (6.2 g, 38.8 
mmol, 1.0 equiv.) in Et2O (50 mL). The mixture was stirred between 0°C and 5°C for 12h, 
turning limpidly bright yellow, before being carefully quenched at 0°C with a saturated solution 
of NH4Cl (150 mL). The aqueous phase was extracted by Et2O (2 x 50 mL). The combined 
organic solution is washed with brine (20 mL), dried with anhydrous MgSO4 and concentrated 
under reduced pressure to give a viscous yellow substance. The crude product of 264 (43 g) 
was involved in the next step without further purification. 
 
 
 
Chemical Formula: C13H28O4Si 
Molecular Weight: 276.44 g.mol-1 
 
((4R,5S)-2,2-dimethyl-5-(2-(2-(trimethylsilyl)ethoxy)ethyl)-1,3-dioxolan-4-yl)methanol (265) 
 
The crude product of 264 (43 g) was diluted in dry EtOAc (200 mL) and run through H-cube® at 
a flow rate of 0.1 mL/min, the temperature was set at 50°C and 50 bar of pressure. The 
colorless mixture was evaporated under reduced pressure, then purified via silica flash 
chromatography (Cy/EtOAC: 9/1  7/14/1) to afford 265 (8.9 g, 83% over 2 steps) as a 
colorless oil. 
 
Rf= 0.58 (Cy/EtOAc: 1/2)   
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Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 0 (s, 9H, H-8), 0.91-0.96 (m, 2H, H-7), 1.35 (s, 3H, H-9 or H-10), 
1.43 (s, 3H, H-10 or H-9), 1.86 (dt, JH4-H3= 5.9 Hz, JH4-H5= 2.8 Hz, H-4), 3.44-3.68 (m, 6H, H-1, H-5 
and H-6), 4.17 (dt, JH3-H4= 5.9 Hz, JH3-H2= 7.1 Hz, H-3), 4.28 (dt, JH2-H3= JH2-H1= 5.9 Hz, H-2) 
 
13C NMR (100 MHz, CDCl3): δ= -1.34 (C-8), 18.26 (C-7), 25.60 (C-9 or C-10), 28.27 (C-10 or C-9), 
29.50 (C-4), 61.69 (C-1), 67.39 (C-5), 68.56 (C-6), 75.20 (C-3), 78.08 (C-2) 107.75 (C-11) 
 
HRMS (ESI+): calcd for (M-H)+: 277.1835, found: 277.1843 
 
 
 
Chemical Formula: C13H26O4Si 
Molecular Weight: 274.43 g.mol-1 
 
(4S,5S)-2,2-dimethyl-5-(2-(2-(trimethylsilyl)ethoxy)ethyl)-1,3-dioxolane-4-carbaldehyde (266) 
 
To a stirred solution of ((4R,5S)-2,2-dimethyl-5-(2-(2-(trimethylsilyl)ethoxy)ethyl)-1,3-
dioxolan-4-yl)methanol (265) (8.9 g, 32.2 mmol, 1.0 equiv.) in DMSO/DCM (40 mL/80 mL) at 
RT was added triethylamine (13.4 mL, 96.6 mmol, 3.0 equiv.). The solution was cooled down to 
-10°C over 15 min before a solution of SO3.pyr (15.4 g, 96.6 mmol, 3.0 equiv.) in DMSO (40 mL) 
was added dropwise via cannula over a period of 1h. The mixture was stirred between -10°C 
and -5°C for 3h30 before being warmed up to 0°C and diluted with Et2O (80 mL) then 
quenched with a saturated solution of brine (100 mL). The aqueous phase was extracted with 
Et2O (3 x 50 mL) and the combined organic phase was washed with a solution of CuSO4 (10% 
w/v, 3 x 100 mL), then with a saturated solution of brine (100 mL), dried with anhydrous 
MgSO4 and concentrated under reduced pressure to give a bright yellow oil (9.1 g). The crude 
product of 266 was involved into the next reaction without further purification. 
Rf = 0.61 (Cy/EtOAc: 2/1)   
 
 
Numbering for the hydrogens                   Numbering for the carbons 
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1H NMR (400 MHz, CDCl3): δ= 0 (s, 9H, H-8), 0.91-0.96 (m, 2H, H-7), 1.35 (s, 3H, H-9 or H-10), 
1.43 (s, 3H, H-10 or H-9), 1.84-1.86 (m, 1H, H-4), 3.44-3.68 (m, 6H, H-5 and H-6), 4.24-4.26 (m, 
1H, H-3), 4.45-4.49 (m, 1H, H-2), 9.67 (d, 1H, J= 2.97 Hz, H-1) 
 
13C NMR (100 MHz, CDCl3): δ= -1.34 (C-8), 18.26 (C-7), 25.60 (C-9 or C-10), 28.27 (C-10 or C-9), 
29.50 (C-4), 67.39 (C-5), 68.56 (C-6), 75.20 (C-3), 78.08 (C-2) 107.75 (C-11), 202.18 (C-1) 
 
 
 
 
 
Chemical Formula: C16H30O4Si 
Molecular Weight: 314.49 g.mol-1 
 
1-((4S,5R)-2,2-dimethyl-5-(2-(2-(trimethylsilyl)ethoxy)ethyl)-1,3-dioxolan-4-yl)but-2-yn-1-ol 
(267) 
 
The crude product of (4S,5S)-2,2-dimethyl-5-(2-(2-(trimethylsilyl)ethoxy)ethyl)-1,3-dioxolane-
4-carbaldehyde (266) was diluted in THF (80 mL) at RT then cooled down to -5°C before a  0.5 
M solution of prop-1-yn-1-ylmagnesium bromide (96.6 mL, 48.3 mmol, 1.5 equiv.) was added 
dropwise. The mixture was vigorously stirred between -5°C and 0°C for 3h, then allowed to 
warm up to 0°C before getting diluted by Et2O (100 mL) and quenched with a saturated 
solution of NH4Cl (100 mL). The aqueous phase was extracted with Et2O (2 x 30 mL). The 
combined organic phase was washed with a saturated solution of brine (150 mL), dried with 
anhydrous MgSO4 and concentrated under reduced pressure. The crude product was purified 
via silica flash chromatography (Cy/EtOAC: 90/10  85/15  80/20) to provide a 56/44 
diastereomeric mixture of 267 as a colorless oil (9.1 g, 90% over 2 steps). 
 
Rf= 0.46 (Cy/EtOAc: 3/1)   
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 0 (s, 9H, H-9), 0.79-0.95 (m, 2H, H-8), 1.36 (s, 3H, H-10 or H-11), 
1.47 (s, 3H, H-11 or H-10), 1.87 (d, J= 2 Hz, H-1), 1.93-2.18 (m, 2H, H-5), 3.45-3.62 (m, 5H, H-4, 
H-6 and H-7), 4.03-4.09 (m, 1H, H-3), 4.28-4.39 (m, 1H, H-2) 
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13C NMR (100 MHz, CDCl3): δ= -1.29 (C-11), 3.99 (C-1), 18.24 (C10), 25.60 (C-12 or C-13), 27.77 
(C-13 or C-12), 29.51 (C-7), 62.19 (C-4), 67.28 (C-8), 68.57 (C-9), 75.67 (C-6), 78.19 (C-2 or C-3), 
80.06 (C-5), 82.50 (C-3 or C-2), 108.06 (C-14)  
 
HRMS (ESI+): calcd for (M-H)+: 315.1992, found: 315.1999 
 
Chemical Formula: C19H36O5Si 
Molecular Weight: 372.57 g.mol-1 
 
(2-(2-((4R,5R)-5-(1-(ethoxymethoxy)but-2-yn-1-yl)-2,2-dimethyl-1,3-dioxolan-4-
yl)ethoxy)ethyl)trimethylsilane (268) 
 
To a stirred solution at RT of 1-((4S,5R)-2,2-dimethyl-5-(2-(2-(trimethylsilyl)ethoxy)ethyl)-1,3-
dioxolan-4-yl)but-2-yn-1-ol (267) (9.0 g, 28.6 mmol, 1.0 equiv.) in DMF (40 mL) was added 
TBAI (0.26 mmol, 95.6 mg, 0.01 equiv.), DIPEA (24.9 mL, 143.0 mmol, 5.0 equiv.), respectively. 
The solution was stirred for 5 min at RT before the dropwise addition of EOMCl (13.3 mL, 143.0 
mmol, 5.0 equiv.). The mixture was stirred at RT for 3h and turned orange. The solution was 
diluted with Et2O (200 mL) quenched at 0°C with a saturated solution of NH4Cl (150 mL). The 
aqueous phase was extracted with Et2O (3 x 50 mL). The combined organic phase was washed 
with a saturated solution of brine (200 mL), dried with anhydrous MgSO4 and concentrated 
under reduced pressure. The crude product was purified via silica flash chromatography 
(Cy/EtOAC: 95/5  90/10  85/15) to provide 268 as a colorless oil (10.4 g, 98%). 
 
Rf= 0.62 (Cy/EtOAc: 3/1)   
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ=0 (s, 9H, H-9), 0.79-0.95 (m, 2H, H-8), 1.20 (t, 3H, J= 7.1 Hz, H-
14), 1.36 (s, 3H, H-10 or H-11), 1.47 (s, 3H, H-11 or H-10), 1.87 (d, J= 2.1 Hz, H-1), 1.93-2.08 (m, 
2H, H-5), 3.45-3.76 (m, 5H, H-6, H-7 and H-13), 4.14-4.23 (m, 1H, H-3), 4.29-4.40 (m, 2H, H-2 
and H-4), 4.84 (AB, 2H, J= 6.9 Hz, H-12) 
 
13C NMR (100 MHz, CDCl3): δ= -1.28 (C-11), 3.93 (C-1), 15.19 (C-17), 18.27 (C10), 25.51 (C-12 
or C-13), 27.49 (C-13 or C-12), 29.79 (C-7), 64.11 (C-4), 65.17 (C-16), 67.48 (C-8), 68.24 (C-9), 
74.36 (C-6), 75.19 (C-2 or C-3), 79.11 (C-5), 83.96 (C-3 or C-2), 92.47 (C-15), 108.06 (C-14) 
 
HRMS (ESI+): calcd for (M-H)+: 373.2410, found: 373.2420 
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Chemical Formula: C16H15 NO2S2 
Molecular Weight: 317.43 g/mol 
 
2-((((4-methoxybenzyl)oxy)methyl)thio)benzo[d]thiazole (296) 
 
To a stirred solution of 2-mercaptobenzothiazole (299) (378 mg, 2.26 mmol, 1.0 equiv.) in DMF 
(7 mL) at 0°C was added carefully NaH (60% in mineral oil, 100 mg, 2.49 mmol, 1.1 equiv.). 
After 10 min stirring at 0°C was added dropwise a solution of 1-((chloromethoxy)methyl)-4-
methoxybenzene (465 mg, 2.49 mmol, 1.1 equiv.) in DMF (4 mL). The yellow mixture was 
stirred between 0°C and RT overnight before being diluted by EtOAc (40 mL), washed by NH4Cl 
(30 mL). The aqueous phase was extracted by EtOAc (2 x 20 mL). The combined organic layers 
were washed by brine (70 mL), dried over MgSO4, filtered then concentrated under reduced 
pressure. The crude product was subjected to silica gel flash chromatography (Cy/AcOEt: 
97/395/590/10) to afford 296 as a yellow oil (750 mg, 95%). 
 
Rf = 0.44 (Cy/EtOAC: 4/1) 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ = 3.80 (s, 3H, H-7), 4.68 (s, 2H, H-2), 5.43 (s, 2H, H-1), 6.87 (d, 2H, 
J= 8.7 Hz, H-4 and H-5), 7.28 (d, 2H, J= 8.7 Hz, H-3 and H-6), 7.29-7.34 (m, 2H, H-9 or H-10), 
7.41-7.45 (m, 2H, H-10 or H-9), 7.77 (d, 1H, J= 9.2 Hz, H-8), 7.91 (d, 1H, J= 12.4 Hz, H-11) 
 
13C NMR (100 MHz, CDCl3): δ = 55.38 (C-9), 70.57 (C-2), 73.58 (C-1), 114.04 (C-5 and C-7), 
121.09 (C-12 and C-15), 124.64 (C-13 or C-14), 126.25 (C-14 or C-13), 130.16 (C-4 and C-8), 
130.44 (C-3), 135.77 (C-11), 153.08 (C-16), 157.67 (C-6), 165.27 (C-10)  
 
HRMS (ESI+): calcd for (M-H)+ : 317.0544, found 317.0555 
 
 
 
Chemical Formula: C13H21O5P 
Molecular Weight: 288.28 g/mol 
 
diethyl (((4-methoxybenzyl)oxy)methyl)phosphonate (308) 
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To a stirred solution of diethyl (hydroxymethyl)phosphonate (356) (177 mg, 1.05 mmol, 1.0 
equiv.) in cyclohexane/DCM (4 mL/2 mL) at RT was added slowly 4-methoxybenzyl 2,2,2-
trichloroacetimidate (174) (356 mg, 1.26 mmol, 1.2 equiv.) and the mixture was vigorously 
stirred at RT for 16h. The reaction solution was diluted with DCM (15 mL), quenched with a 
saturated aqueous solution of Na2CO3 (20 mL). The aqueous phase was extracted with DCM (2 
x 7 mL). The combined organic solution is washed with brine (20 mL), dried with anhydrous 
MgSO4 and concentrated under reduced pressure. The crude product was purified by silica gel 
chromatography (Cy/EtOAC: 4/1 1/4 EtOAc) to afford 308 (257 mg, 86%) as a yellow oil. 
 
Rf = 0.23 (EtOAc) 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.32 (t, 6H, J= 7.1 Hz, H-9), 3.71 (d, 2H, J= 8.7 Hz, H-1), 3.80 (s, 
3H, H-7), 4.15 (q, 4H, J= 7.1 Hz, H-8), 4.56 (s, 2H, H-1), 6.86 (d, 2H, J= 8.7 Hz, H-5 and H-6), 7.15 
(d, 2H, J= 8.7 Hz, H-4 and H-7) 
 
13C NMR (100 MHz, CDCl3): δ= 16.53 (C-11), 55.38 (C-9), 62.51 (d, J= 7 Hz, C-10), 64.94 (C-10), 
74.59 (C-2), 113.95 (C-5 and C-7), 129.01 (C-3), 129.89 (C-4 and C-8), 159.62 (C-6) 
 
31P NMR (CDCl3): δ= 22.44 
 
HRMS (ESI+): calcd for (M-H)+: 289.1205, found: 289.1212 
 
 
 
Chemical Formula: C10H14O2S 
Molecular Weight: 198.28 g/mol 
 
(((4-methoxybenzyl)oxy)methyl)(methyl)sulfane (287) 
 
To a solution of DMSO/Ac2O/AcOH (15/12/3: 30 mL/24 mL/6 mL) was added (4-
methoxyphenyl)methanol (286) (3.53 g, 25.6 mmol) at RT and the mixture was stirred for 17h. 
The resulting mixture was carefully quenched with NaHCO3 powder until pH= 7. The aqueous 
phase was extracted with Et2O (3 x 50 mL). The combined organic solution is washed with 
brine (100 mL), dried with anhydrous MgSO4 and concentrated under reduced pressure. The 
crude product was purified by silica gel flash chromatography (Cy/EtOAC: 97/3  95/5) to 
afford 287 (4.4 g, 87%) as a lightly yellow oil. 
 
Rf = 0.64 (Cy/EtOAc: 5/1) 
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Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 2.17 (s, 3H, H-1), 3.81 (s, 3H, H-8), 4.53 (s, 2H, H-2), 4.64 (s, 2H, 
H-3), 6.86 (d, 2H, J= 8.5 Hz, H-5 and H-6), 7.15 (d, 2H, J= 8.5 Hz, H-4 and H-7) 
 
13C NMR (100 MHz, CDCl3): δ= 13.98 (C-1), 55.38 (C-10), 69.12 (C-2), 74.13 (C-3), 113.96 (C-5 
and C-9), 129.59 (C-4), 129.91 (C-6 and C-8), 159.42 (C-7) 
 
HRMS (ESI+): calcd for (M-H)+: 199.0793, found: 199.0789 
 
 
Chemical Formula: C9H11ClO2 
Molecular Weight: 186.63 g/mol 
 
1-((chloromethoxy)methyl)-4-methoxybenzene (288) 
 
To a solution of (((4-methoxybenzyl)oxy)methyl)(methyl)sulfane (286) (3.94 g, 17.9 mmol, 1.0 
equiv.)in DCM (50 mL) at -78°C was added dropwise a solution of SO2Cl2 (1.45 mL, 17.9 mmol, 
1.0 equiv.) in DCM (10 mL). The yellow mixture was stirred at this temperature for 1h30. The 
solvent was totally evaporated at RT and under reduced pressure to provide 288 (3.5 g) as a 
bright yellow oil which was used in the next steps without further purification. 
 
The analytical date are identical to those from the literature.3 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 3.81 (s, 3H, H-7), 4.68 (s, 2H, H-2), 5.49 (s, 2H, H-2), 6.86 (d, 2H, 
J= 8.5 Hz, H-5 and H-6), 7.15 (d, 2H, J= 8.5 Hz, H-4 and H-7) 
 
13C NMR (100 MHz, CDCl3): δ= 55.40 (C-9), 71.04 (C-2), 81.54 (C-1), 114.09 (C-4 and C-8), 
127.57 (C-3), 130.34 (C-5 and C-7), 159.88 (C-6)  
 
 
Chemical Formula: C27H26ClO2P 
Molecular Weight: 448.92 g/mol 
 
(((4-methoxybenzyl)oxy)methyl)triphenylphosphonium chloride (282) 
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To a solution of freshly prepared 1-((chloromethoxy)methyl)-4-methoxybenzene  (288) (1.55 
g, 8.32 mmol, 1.0 equiv.) in toluene (1.8 g, 5.5 mmol at RT was added PPh3 (2.18  g, 8.32 
mmol,1.0 equiv.). The solution was vigorously stirred between 80°C and 90°C for 24h then 
allowed to warm up to RT over 1h. The heterogeneous mixture was filtered and the solid 
residue was washed by ether (3 x 25 mL) then boiling cyclohexane (3 x 20 mL) to afford 282 as 
a white solid (3.73 g, 80% over two steps). 
 
The analytical data are identical to those from the literature.4 
 
mp= 98-100°C 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 3.76 (s, 3H, H-7), 4.88 (s, 2H, H-1), 5.86 (bs, 2H, H-2), 6.86 (d, 2H, 
J= 8.5 Hz, H-3 and H-6), 7.15 (d, 2H, J= 8.5 Hz, H-4 and H-5), 7.60-7.65 (m, 4H, arom), 7.72-7.77 
(m, 6H, arom) 
 
13C NMR (100 MHz, CDCl3): δ= 54.51 (C-9), 62.54 (C-2), 75.85 (d, J= 12 Hz, C-1), 113.81 (C-4 
and C-8), 116.41 (arom), 117.28 (arom), 127.77 (C-3), 130.16 (C-5 and C-7), 130.28 (arom), 
133.88 (arom), 133.98 (arom), 135.37 (arom), 160.22 (C-6) 
 
31P NMR (CDCl3): δ= 19.06 
 
HRMS (ESI+): calcd for (M-H)+: 449.1437, found: 449.1444 
 
5.2.1.3 Third generation strategy: “D-isoascorbic acid approach” 
 
Chemical Formula: C6H10O 
Molecular Weight: 98.14 g/mol 
 
(3aR,6aR)-2,2-dimethyldihydrofuro[3,4-d][1,3]dioxol-4(3aH)-one (364) 
 
To a vigorously stirred solution of erythorbic acid (365) (35.2 g, 0.20 mol, 1.0 equiv.) in 
distillated water (500 mL) at 0°C was added in small portions anhydrous sodium carbonate 
(42.4 g, 0.40 mol, 2.0 equiv.). The resulting yellow solution was kept at 0°C while aqueous 
hydrogen peroxide (31.3 w/v%, 44 mL) was added dropwise over a 10-min period. The solution 
was stirred between 0°C and 27°C for 15 min then warmed up to 42°C and stirred at this 
temperature for further 30 min. Darco® activated charcoal (8 g) was added in portions over 10 
min to decompose the excess peroxide and the mixture was heated at 100°C for 45 min before 
being poured through a Celite® pad. The obtained filtrate was carefully acidified by 6 M 
aqueous hypochloric acid until pH= 1 and concentrated under reduced pressure to give a light 
5  EXPERIMENTAL 224 
  
yellow solid. To this residue was added acetone (170 mL) and MgSO4 (50 g) and the mixture 
was stirred at RT for 5 min before the addition of 2,2-dimethoxypropane (350 mL, 2.70 mol, 
14.0 equiv.) and PTSA (0.40 g, 2.0 mmol, 0.01 equiv.). The mixture was stirred at RT for 20h 
then slowly diluted with a mixture of Et20 (500 mL) and TEA (61.3 mL, 0.44 mol, 2.2 equiv.) at 
0°C. After 15-min of stirring, the suspension was filtered and the filtrate reduced under 
pressure, giving a pale yellow crude product, which was purified by silica gel chromatography 
(Cy/EtOAc: 6/14/1) to afford 364 (27 g, 85%) as a white solid. 
 
Rf = 0.43 (Cy/EtOAc: 2/1) 
 
The analytical data are identical to the literature.5 
 
[α]D20 = -118° (c = 1.0, H2O) 
 
mp= 65-67 °C 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.39 (s, 3H, H-4 or H-5), 1.48 (s, 3H, H-5 or H-4), 4.42 (ABX, 2H, 
JAX= 3.7 Hz, JBX= 11.2 Hz, JAB= 4 Hz, Δν= 7 Hz), 4.74 (d, 1H, J= 5.7 Hz, H-3), 4.87 (ABX, 1H, H-2) 
 
13C NMR (100 MHz, CDCl3): δ= 25.73 (C-5 or C-6), 26.86 (C-6 or C-5), 70.29 (C-1), 74.71 (C-2), 
75.54 (C-3), 114.15 (C-7), 174.14 (C-4) 
 
HRMS (ESI+): calcd for (M-H)+: 97.0653, found: 97.0660 
 
 
Chemical Formula: C13H13O2P 
Molecular Weight: 232.21 g/mol 
 
(hydroxymethyl)diphenylphosphine oxide (330) 
 
To a stirred solution of chlorodiphenylphosphine (329) (12.0 g, 67.0 mmol, 1.0 equiv.) in 37% 
aqueous HCl (120 mL) was added slowly 37% aqueous formaldehyde (120 mL). The limpid 
colorless mixture was stirred at 100°C for 20h then allowed to warm up to RT. The solution was 
carefully neutralised with a saturated solution of NaHCO3 (400 mL) then with Na2CO3 until 
neutral pH. The aqueous phase was extracted with DCM (3 x 100 mL). The combined organic 
phases were washed with H2O (3 x 150 mL), a saturated solution of NH4Cl (200 mL) then with 
brine (300 mL), dried with anhydrous MgSO4 and concentrated under reduced pressure to give 
a white viscous solid. To this residue was added boiling EtOAC (100 mL) and the mixture was 
stirred for 20 min until the inner temperature reached 20°C, then filtered to afford 330 (13 g, 
85%) as a white solid.  
5  EXPERIMENTAL 225 
  
The analytical date are identical to those from the literature.6 
 
mp = 128-130°C 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.85 (OH), 4.41 (bs, 2H, H-1), 7.44-7.56 (m, 6H, arom), 7.73-7.77 
(m, 4H, arom) 
 
13C NMR (100 MHz, CDCl3): δ= 61.42 (d, J= 81 Hz, C-1), 128.81 (arom), 128.89 (arom), 130.00 
(arom), 130.96 (arom), 131.40 (arom), 131.49 (arom), 132.34 (arom), 132.36 (arom) 
 
31P NMR (CDCl3): δ= 31.58 
 
HRMS (ESI+): calcd for (M-H)+: 202.0993, found: 202.1007 
 
 
 
Chemical Formula: C10H10Cl3NO2 
Molecular Weight: 282.55 g/mol 
 
4-methoxybenzyl 2,2,2-trichloroacetimidate (174) 
 
To as stirred solution of (4-methoxyphenyl)methanol (286) (8.0 g, 58.2 mmol, 1.0 
equiv.) in Et2O (50 mL) at 0°C was added in small portions NaH (60% in mineral oil, 232 
mg, 5.82 mmol, 0.1 equiv.). The mixture was stirred at 0°C for 15 min then cooled 
down to -10°C. To the solution was added dropwise CCl3CN (5.83 mL, 58.19 mmol, 1.0 
equiv.) and the mixture turned gradually yellow-orange after stirring between -10°C 
and RT for 3h. The solvent was totally evaporated and to the dark orange viscous 
residue was added pentane (70 mL). The mixture was stirred at RT for 15 min and the 
dark brown gluing residue was filtered through a Celite pad, giving a bright yellow 
filtrate which was concentrated under reduced pressure to provide 174 (16 g, 99%) as 
a yellow liquid.  
 
The analytical data are identical to the literature.7 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
5  EXPERIMENTAL 226 
  
 
1H NMR (400 MHz, CDCl3): δ= 3.81 (s, 3H, H-6), 5.27 (s, 2H, H-1), 6.90 (d, 2H, J= 8.9 Hz, H-3 and 
H-4), 7.37 (d, 2H, J= 8.9 Hz, H-2 and H-5), 8.35 (bs, 1H, NH) 
 
13C NMR (100 MHz, CDCl3): δ= 55.37 (C-10), 70.80 (C-3), 91.58 (C-1), 114.00 (C-5 and C-7), 
127.58 (C-9), 129.83 (C-4 and C-8), 159.79 (C-6), 162.69 (C-2)  
 
HRMS (ESI+): calcd for (M-H)+: 281.9855, found: 281.9845 
 
 
 
 Chemical Formula: C21H21O3P 
Molecular Weight: 352.36 g/mol 
 
(((4-methoxybenzyl)oxy)methyl)diphenylphosphine oxide (331) 
 
To a stirred suspension of (hydroxymethyl)diphenylphosphine oxide (330) (1.1  g, 4.61 mmol, 1 
equiv.) in a mixture of cyclohexane/ CH2Cl2 (2/1 : 8 mL/4 mL) at room temperature  was added 
in once portion 4-methoxybenzyl 2,2,2-trichloroacetimidate  (1.56  g, 5.53 mmol, 1.2 equiv.). 
The clear mixture was cooled down to 0°C prior to the addition of triflic acid (0.04 mL, 0.46 
mmol, 0.1 equiv.). After a few minutes, a white precipitate appeared. The suspension was 
stirred at 0°C for 3h and warmed to room temperature. The precipitate was filtered, washed 
with 4mL of CH2Cl2  and the filtrate washed with saturated aqueous Na2CO3 (10 mL). The 
aqueous phase was extracted with CH2Cl2 (2 x 5 mL). The combined organic layers was washed 
with brine (20 mL), dried with anhydrous MgSO4, filtered and concentrated under reduced 
pressure. The crude product was purified by silica gel chromatography (Cy/EtOAC : 4/1  
2/11/4 EtOAc) to afford 331 (1.2 g, 85% yield) as a white solid. 
 
Rf = 0.45 (EtOAc) 
 
mp = 87-90°C 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 3.79 (s, 3H, H-7), 4.18 (d, 2H, J P-H1= 6.6 Hz, H-1), 4.53 (s, 2H, H-
2), 6.82 (d, 2H, J=8.70 Hz, H-4 and H-5), 7.11 (d, 2H, J= 8.70 Hz, H-3 and H-6), 7.43-7.48 (m, 4H, 
Ph), 7.51-7.57 (m, 2H, Ph), 7.75-7.80 (m, 4H, Ph). 
 
5  EXPERIMENTAL 227 
  
13C NMR (100 MHz, CDCl3): δ= 55.07 (C9), 67.52 (d, JP-C1= 88.2 Hz, C-1), 75.21 (C2), 113.89 (C4 
and C6), 128.52 (Ph), 128.63 (Ph), 129.90 (C5 and C7), 130.83 (C8), 131.56 (Ph), 131.65 (Ph), 
131.83 (Ph), 132.18 (Ph), 159.57 (C5)   
 
31P NMR (CDCl3): δ=28.57 
 
HRMS (ESI+): calcd for (M-H)+: 353.1306, found: 353.1343 
 
 
Chemical Formula: C16H24O5 
Molecular Weight: 296.36 g/mol 
 
((4R,5S)-5-(2-((4-methoxybenzyl)oxy)ethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)methanol (369) 
 
To a stirred solution of DIPA (2.85 mL, 20.19 mmol, 1.1 equiv.) in THF (5mL) at -78°C was added 
dropwise a 1.6 M solution of BuLi in hexanes (13.2 mL, 21.11 mmol, 1.15 equiv.). The reaction 
mixture was vigorously stirred at -78°C over 1h, followed by dropwise addition of (((4-
methoxybenzyl)oxy)methyl)diphenylphosphine oxide (331) (8.41 g, 23.86 mmol, 1.3 equiv.) in 
THF (15 mL). The gradually dark orange reaction mixture was stirred at the same temperature 
for 1.5 h. A solution of (3aR,6aR)-2,2-dimethyldihydrofuro[3,4-d][1,3]dioxol-4(3aH)-one (364) 
(2.9 g, 18.35 mmol, 1 equiv.) in THF (10 mL) was added dropwise at -78°C and the mixture was 
stirred between -78°C and -60°C over a period of 3h, then allowed to warmed up to 0°C until 
TLC indicated consumption of starting material (20 min). The reaction mixture was diluted with 
Et2O (70 mL) and carefully quenched with NaHCO3 (50 mL). The aqueous layer was extracted 
with Et2O (3 x 30 mL) and the combined organic layer was washed with brine (150 mL), dried 
over MgSO4, concentrated under reduced pressure to afford the crude product of 367 as a 
yellow gum which was first dried over night under vacuum then used directly in the next step.  
 
To a carefully stirred solution of 367 in Et2O (150 mL) at 0 °C was added dropwise a solution of 
NaBH4 (1.48 g, 39.18 mmol, 2 equiv.) in EtOH (150mL) over a period of 20 minutes. The 
resulting mixture was vigorously stirred at room temperature over night then carefully 
quenched with glacial acetic acid (6.7 mL, 3 equiv.) at 0°C, followed by a filtration upon Celite 
pad. Ethanol was totally evaporated under reduced pressure. The resulting viscous mixture was 
diluted withEt2O (150 mL), washed with aqueous saturated Na2CO3 (100 mL) and extracted 
with Et2O (2 x 50 mL). The combined organic layer was washed with brine (150 mL), dried with 
MgSO4, concentrated under reduced pressure. The resulting colorless gum was then dried 
under vacuum to provide 368 as a white solid which was then used in the following step 
without purification. 
 
To a stirred solution of 368 in DMF (20 mL) at 0°C was added carefully in small portions NaH 
(60% in mineral oil, 1.03 g, 2 equiv.). When the exothermic evolution stopped, the resulting 
mixture was vigorously stirred from 0°C to room temperature over night. The reaction mixture 
was carefully quenched with NaHCO3 (200 mL) at 0°C then extracted with Et2O (3 x 100 mL). 
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The combined organic layer was washed with brine (250 mL), dried with MgSO4, concentrated 
under reduced pressure, providing 309 The resulting yellow gum was directly used in the next 
step without further purification. 
A solution of 309 in ethyl acetated (1g/10mL) was subjected to H-Cube® through a 10% Pt/C 
Cartridge with a 1.5 mL/min flow rate at 50°C and 50 bar. The resulting crude product was 
purified by flash chromatography (Cy/EtOAC: 3/12/11/1) to afford 369 as a colorless oil 
(4.5g, 80%) 
 
Rf = 0.36 (Cy/EtOAC: 2/1) 
 
[α]D20 = + 4.8° (c = 0.25, CDCl3) 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3):  δ = 1.34 (s, 3H, H-12 or H-13), 1.43 (s, 3H, H-13 or 12), 1.82-1.88 
(m, 2H, H-4), 3.64-3.50 (m, 4H, H-1 and H-5), 3.79 (s, 3H, H-11), 4.12-4.16 (m, 1H, H-3), 4.26 to 
4.31 (m, 1H, H-2), 4.43 (s, 2H, H-6), 6.74 (d, 2H, J= 8.5 Hz, H-8 and H-9), 6.89 (d, 2H, J= 8.5 Hz, 
H-7 and H-10) 
 
13C NMR (400 MHz, CDCl3) :   δ = 25.60 (C-13 or C-14), 28.91 (C-14 or C-13), 55.35 (C-15), 61.73 
(C-1), 67.16 (C-5), 73.15 (C-6), 74.70 (C-2), 78.00 (C-3), 107.93 (C-16), 113.90 (C-9and C-11), 
129.15 (C-8 and C-12),  130.16 (C-7), 159.32 (C-10)   
 
HRMS (ESI+): calcd for (M-H)+: 297.1702, found: 297.1723 
 
 
 
Chemical Formula: C16H22O5 
Molecular Weight: 294.34 g/mol 
 
(4S,5S)-5-(2-((4-methoxybenzyl)oxy)ethyl)-2,2-dimethyl-1,3-dioxolane-4-carbaldehyde (370) 
 
To a stirred solution of ((4R,5S)-5-(2-((4-methoxybenzyl)oxy)ethyl)-2,2-dimethyl-1,3-dioxolan-
4-yl)methanol (369) (303 mg, 1.02 mmol, 1 equiv.) in a mixture of freshly distilled DMSO/DCM 
(1/2 : 3 mL/6 mL) at -10°C was added slowly (iPr)2NEt (0.53 mL, 3.07 mmol, 3 equiv.). After 10 
5  EXPERIMENTAL 229 
  
min at -10°C, a solution of SO3·pyr  (489 mg, 3.07 mmol, 3 equiv.) in DMSO (3 mL) was added 
dropwise per cannula to the solution. The resulting mixture was vigorously stirred at -10°C for 
2h, warmed to 0°C and stirred at this temperature until TLC indicated consumption of starting 
material (20 min). The reaction mixture was diluted with Et2O (15 mL) and quenched with  
brine (15mL). The organic layer was washed with 10% aqueous CuSO4   (3 x 20 mL) then 
thoroughly with distilled water (2 x 20 mL) and brine (20 mL). The solution was dried over 
MgSO4 and concentrated under reduced pressure. The crude product of 370 was a yellow oil 
which was subjected to the next step without further purification. 
 
Rf = 0.62(Cy/EtOAC : 2/1) 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3):  δ = 1.34 (s, 3H, H-12 or H-13), 1.43 (s, 3H, H-13 or 12), 1.82-1.88 
(m, 2H, H-4), 3.64-3.54 (m, 4H and H-5), 3.79 (s, 3H, H-11), 4.27-4.29 (m, 1H, H-3), 4.48 to 4.52 
(m, 1H, H-2), 4.43 (s, 2H, H-6), 6.74 (d, 2H, J= 8.5 Hz, H-8 and H-9), 6.89 (d, 2H, J= 8.5 Hz, H-7 
and H-10), 9.67 (d, 1H, J= 2.98 Hz, H-1) 
 
13C NMR (400 MHz, CDCl3):  δ = 25.60 (C-13 or C-14), 28.91 (C-14 or C-13), 55.35 (C-15), 66.43 
(C-5), 72.76 (C-6), 75.61 (C-3), 81.88 (C-2), 107.93 (C-16), 113.90 (C-9and C-11), 129.15 (C-8 and 
C-12),  130.16 (C-7), 159.32 (C-10), 202.20 (C-1) 
 
 
Chemical Formula: C19H26O5 
Molecular Weight: 334.41 g/mol 
 
1-((4S,5R)-5-(2-((4-methoxybenzyl)oxy)ethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)but-2-yn-1-ol 
(371) 
 
To a stirred solution of 4S,5S)-5-(2-((4-methoxybenzyl)oxy)ethyl)-2,2-dimethyl-1,3-dioxolane-
4-carbaldehyde (370) (597 mg, 2,02 mmol, 1 equiv.) in THF (4mL) at 0°C was added dropwise a 
0.5 M solution of prop-1-yn-1-ylmagnesium bromide (4.0  mL, 2.02 mmol, 1 equiv.). The 
reaction mixture was vigorously stirred at 0°C for 2h then at room temperature until TLC 
indicated consumption of starting material (30 min).  The reaction mixture was diluted with 
Et2O (10 mL), quenched with saturated aqueous NaHCO3 (10mL). The aqueous layer was 
extracted with Et2O (2 x 7 mL). The combined organic solution was washed with brine (15 mL), 
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dried over anhydrous MgSO4, concentrated under reduced pressure. The crude product was 
purified by silica gel chromatography (Cyclohexane/EtOAc : 3/1  2/1) to afford 371 as a 
yellow oil (285 mg, 95% over 2 steps). 
 
Rf = 0.4(Cy/EtOAC : 2/1) 
 
 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): (Major isomer)δ = 1.36 (s, 3H, H-13 or H-14), 1.47 (s, 3H, H-14 or 
13), 1.86 (s, J= 2.3 Hz, 3H, H-1), 1.87-2.18 (m, 2H, H-5), 3.53-3.567 (m, 3H, H-2 and H-6), 3.79 (s, 
3H, H-12), 4.03-4.08 (m, 1H, H-3), 4.30 to 4.37 (m,  1H, H-4), 4.45 (s, 2H, H-7), 6.87 (d, 2H, J= 
8.7 Hz, H-9 and H-10), 7.31 (d, 2H, = 8.7 Hz, H-8 and H-11) 
 
13C NMR (400 MHz, CDCl3): (Major isomer)δ = 3.84 (C-1), 25.49 (C-17 or C-18), 27.54 (C-18 or C-
17), 29.44 (C-7), 55.35 (C-16), 62.40 (C-6), 67.29 (C-8), 72.75 (C-9), 75.13 (C-3 or C-2), 78.19 (C-
4), 79.97 (C-5), 82.74 (C-2 or C-3), 108.22 (C-19), 113.91 (C-12 and C-14), 129.30 (C-11 and C-
15), 130.17 (C-10), 159.32 (C-13)   
 
HRMS (ESI+): calcd for (M-H)+: 335.1858, found: 335.1896 
 
 
Chemical Formula: C22H32O6 
Molecular Weight: 392.49 g/mol 
 
(4R,5R)-4-(1-(ethoxymethoxy)but-2-yn-1-yl)-5-(2-((4-methoxybenzyl)oxy)ethyl)-2,2-dimethyl-
1,3-dioxolane (372) 
 
To a stirred solution of 1-((4S,5R)-5-(2-((4-methoxybenzyl)oxy)ethyl)-2,2-dimethyl-1,3-
dioxolan-4-yl)but-2-yn-1-ol (371) (574 mg, 1.72 mmol, 1 equiv.) and TBAI (63.5 mg, 0.17 
mmol, 0.1 equiv.) in anhydrous DMF (4mL) at room temperature was added in one portion 
(iPr)2NEt (2.36  mL, 13.8 mmol, 8 equiv.) followed by dropwise addition of 
(chloromethoxy)ethane (1.23  mL, 13.8 mmol, 8 equiv.).  The reaction mixture was vigorously 
stirred at room temperature over night then diluted with Et2O (10 mL), quenched with 
saturated aqueous NH4Cl(10mL). The aqueous layer was extracted with Et2O (2 x 7 mL). The 
combined organic solution was washed with brine (15 mL), dried over anhydrous MgSO4, 
concentrated under reduced pressure. The crude product was purified by silica gel 
chromatography (Cyclohexane/EtOAc : 9/17/1 ) to afford 372 as a yellow oil (654 mg, 97%). 
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Rf = 0.47(Cy/EtOAC : 3/1) 
 
 
 
 
 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): (Major isomer)δ = 1.18 (t, J= 7.1 Hz, 3H, H-14), 1.35 (s, 3H, H-16 or 
H-17), 1.56 (s, 3H, H-17 or H-16),  1.86 (d, J = 2.1 Hz, 3H, H-1), 1.97-2.07 (m, 2H, H-5), 3.48-3.75 
(m, 5H, H-2, H-6 and H-13), 3.79 (s, 3H, H-15), 4.11-4.15 (m, 1H, H-3), 4.32-4.39 (m, 1H, H-4), 
4.44 (s, 2H, H-7), 4.84 (AB, JAB = 6.9 Hz, Δν= 120 Hz, 2H, H-12), 6.86 (d, J= 8.5 Hz, 2H, H-8 and H-
11), 7.23 (d,  J= 8.5 Hz, 2H, H-9 and H-10) 
 
13C NMR (400 MHz, CDCl3) : (Major isomer) δ =  3.93 (C-1), 15.17 (C-22), 25.49 (C-17 or C-18), 
27.47 (C-18 or C-17), 29.70 (C-7), 55.37 (C-16), 64.08 (C-21), 67.37 (C-8), 72.84 (C-9), 74.70 (C-
4), 75.09 (C-3 or C-2), 79.07 (C-5), 83.96 (C-2 or C-3), 92.45 (C-20), 108.47 (C-19), 113.84 (C-12 
and C-14), 129.30 (C-11 and C-15), 130.63 (C-10), 159.24 (C-13) 
 
HRMS (ESI+): calcd for (M-H)+ : 393.2277, found: 393.2275 
 
 
Chemical Formula: C14H24O5 
Molecular Weight: 272.16 g/mol 
 
2-((4R,5R)-5-(1-(ethoxymethoxy)but-2-yn-1-yl)-2,2-dimethyl-1,3-dioxolan-4-yl)ethanol (252) 
 
To a stirred solution of (4R,5R)-4-(1-(ethoxymethoxy)but-2-yn-1-yl)-5-(2-((4-
methoxybenzyl)oxy)ethyl)-2,2-dimethyl-1,3-dioxolane (372) (335 mg, 0.883 mmol, 1 equiv.) in 
CH2C2 /H2O (9 mL/0.5mL) at 0°C was added in one portion DDQ (240  mL, 1.058 mmol, 1.2 
equiv.). The yellow- orange colour of the reaction changed into dark brown after 10 minutes. 
The reaction mixture was vigorously stirred at 0°C for 2h then at room temperature until TLC 
indicated consumption of starting material (30 min). A solution of  aqueous NaHCO3 (10mL) 
was added and the resulting mixture was stirred at room temperature for 10 minutes then 
extracted with DCM (2 x 7 mL). The combined organic solution was washed with brine (20 mL), 
dried over anhydrous MgSO4, concentrated under reduced pressure. The crude product was 
purified by silica gel chromatography (Cyclohexane/EtOAc: 3/11/1) to afford 252 as a 
colorless oil (236 mg, 98%). 
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Rf = 0.14 (Cy/EtOAC : 2/1) 
 
 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): (Major isomer)δ = 1.21 (t, J= 7.1 Hz, 3H, H-9), 1.43 (s, 3H, H-10 or H-
11), 1.47 (s, 3H, H-11 or H-10),  1.86 (d, J = 2.29 Hz, 3H, H-6), 1.97-2.07 (m, 2H, H-2), 3.50-3.75 
(m, 2H, H-8), 3.81-3.89 (m, 2H, H-5 and H-4), 4.18-4.22 (m, 1H, H-3), 4.45-4.85 (m, 1H H-1), 
4.84 (AB, JAB = 6.9 Hz, Δν= 120 Hz, 2H, H-7) 
 
13C NMR (400 MHz, CDCl3): (Major isomer)δ = 3.86 (C-8), 15.14 (C-14), 25.52 (C-9 or C-10), 
27.55 (C-10 or C-9), 31.55 (C-2), 61.33 (C-3), 64.29 (C-13), 65.87 (C-5), 75.00 (C-6 or C-7), 76.52 
(C-1), 79.04 (C-4), 84.10 (C-7 or C-6), 92.47 (C-12), 108.75 (C-11) 
 
HRMS (ESI+): calcd for (M-H)+: 273.1702, found: 273.1818 
 
 
Chemical Formula: C14H23IO4 
Molecular Weight: 382.23 g/mol 
 
(4R,5R)-4-(1-(ethoxymethoxy)but-2-yn-1-yl)-5-(2-iodoethyl)-2,2-dimethyl-1,3-dioxolane (253) 
 
To a stirred solution of (4R,5R)-5-(1-(ethoxymethoxy)but-2-yn-1-yl)-2,2-dimethyl-1,3-
dioxolan-4-yl)ethanol (252) (77 mg, 0.29 mmol, 1 equiv.),  PPh3 (113 mg, 0.43 mmol,1.5 equiv.) 
and imidazole (29 mg, 0.43 mmol, 1.5 equiv.)  in THF (5 mL) at 0°C was added I2 (108 mg, 0.67 
mmol, 1.5 equiv.) in one portion. The brown-yellow reaction mixture was vigorously stirred at 
0°C until until TLC indicated consumption of starting material (2h). The reaction mixture was 
warmed to room temperature then diluted with Et2O (10mL) quenched with aqueous 
saturated Na2S2O5 (15 mL). The aqueous layer was extracted with Et2O (2 x 10mL) and the 
combined organic layer was washed with brine (20 mL). The crude product was subjected to 
silica gel flash chromatography (Cyclohexane/AcOEt: 97/395/590/10) to afford 253 as a 
colorless oil (100 mg, 91%) 
 
Rf = 0.8 (Cy/EtOAC : 2/1 
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Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): (Major isomer)δ = 1.21 (t, J= 7.10 Hz, 3H, H-9), 1.43 (s, 3H, H-10 or 
H-11), 1.47 (s, 3H, H-11 or H-10),  1.87 (d, J = 2.3 Hz, 3H, H-6), 2.13-2.27 (m, 2H, H-2), 3.20-3.42 
(m, 2H, H-1), 3.50-3.75 (m, 2H, H-8), 4.18-4.22 (m, 1H, H-3), 4.23-4.33 (m, 1H, H-4), 4.34-4.38 
(m, 1H, H-5), 4.84 (AB, JAB = 7 Hz, Δν= 120 Hz, 2H, H-6) 
 
13C NMR (100 MHz, CDCl3): (Major isomer) δ = 3.25 (C-1), 3.75 (C-8), 15.14 (C-14), 
25.52 (C-9 or C-10), 27.55 (C-10 or C-9), 33.45 (C-2), 63.47 (C-13), 65.08 (C-5), 66.04 (C-
3),  75.00 (C-6 or C-7), 79.04 (C-4), 84.11 (C-7 or C-6), 92.49 (C-12), 108.76 (C-11) 
 
HRMS (ESI+): calcd for (M-H)+ : 383.0719, found 383.0733 
 
5.2.2 Preparation of the propargylic alcohol fragment  
 
 
Chemical Formula: C6H10O 
Molecular Weight: 98.14 g/mol 
 
(R)-hex-4-yn-2-ol (389) 
 
To a stirred solution of 1-bromopropene (388) (3.00 mL, 24.8 mmol, 1.5 equiv.) in THF (18 mL) 
at -78°C was added dropwise a 2.5 M solution of BuLi in hexanes (19.8 mL, 49.6 mmol, 3.0 
equiv.). The colorless, limpid mixture was vigorously stirred between -78°C and -35°C for 2h 
before the addition of HMPA (7 mL) at -25 and the white opaque mixture was stirred for 20 
min at this temperature. Afterwards, a solution of (S)-2-methyloxirane (1.16 mL, 16.5 mmol, 
1.0 equiv.) in HMPA (7 mL) was added dropwise at -25°C and the mixture was stirred for 2h at 
this temperature before being allowed to warm up to 0°C overnight. The yellow opaque 
solution was first diluted at 0°C with Et2O (30 mL) then quenched with a saturated solution of 
NH4Cl (50 mL). The aqueous phase was extracted with Et2O (2 x 20 mL). The combined organic 
solution is washed with brine (50 mL), dried with anhydrous MgSO4 and concentrated under 
reduced pressure (500 mbar, 0°C) as the alcohol was quite volatile. The crude product was 
purified by silica gel chromatography (Pentane/Et2O: 9/1  6/1) to afford 389 (1.2 g, 80% 
yield) as a colorless oil. 
 
Rf = 0.43 (Cy/EtOAc: 2/1) 
 
[α]D20 = +21.5° (c = 1.1, CDCl3) 
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Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.23 (d, 3H, J= 6.2 Hz, H-1), 1.80 (t, 3H, J= 2.5 Hz, H-4), 2.19-2.27 
(m, 1H, H-3A), 2.31-2.38 (m, 1H, H-3B), 3.85-3.93 (m, 1H, H-2) 
 
13C NMR (100 MHz, CDCl3): δ= 3.56 (C-1), 22.28 (C-4), 29.73 (C-3), 66.61 (C-2), 75.44 (C-5), 
78.41 (C-4) 
 
HRMS (ESI+): calcd for (M-H)+: 99.0810, found: 99.0998 
 
 
 
Chemical Formula: C6H10O 
Molecular Weight: 98.14 g/mol 
 
(S)-hex-4-yn-2-ol (232) 
 
[α]D20 = -20.7° (c = 1.0, CDCl3) 
 
1H NMR (400 MHz, CDCl3): δ= 1.23 (d, 3H, J= 6.2 Hz, H-1), 1.80 (t, 3H, J= 2.5 Hz, H-4), 2.19-2.27 
(m, 1H, H-3A), 2.31-2.38 (m, 1H, H-3B), 3.85-3.93 (m, 1H, H-2) 
 
13C NMR (100 MHz, CDCl3): δ= 3.56 (C-1), 22.28 (C-4), 29.73 (C-3), 66.61 (C-2), 75.44 (C-5), 
78.41 (C-4) 
 
HRMS (ESI+): calcd for (M-H)+: 99.0810, found: 99.0827 
 
5.2.3 Assembly of the three fragments 
 
 
Chemical Formula: C24H34O8 
Molecular Weight: 450.52 g/mol 
 
2-(3-((4S,5R)-5-(1-(ethoxymethoxy)but-2-yn-1-yl)-2,2-dimethyl-1,3-dioxolan-4-yl)propyl)-4,6-
dimethoxybenzoic acid (452) 
 
To a solution of 2,4-dimethoxybenzoic acid (401) (0.6 g, 3.40 mmol, 1.0 equiv.) in THF (50 mL) 
at -78°C was added dropwise a 1.4 M solution of sBuLi in hexanes (5.1 mL, 7.14 mmol, 2.1 
5  EXPERIMENTAL 235 
  
equiv.). The initially colorless solution gradually turned orange then dark red after 2h between 
-78°C and -60°C before being warmed up to -20°C. To the clear red solution at -20°C was added 
dropwise a solution of (4R,5R)-4-(1-(ethoxymethoxy)but-2-yn-1-yl)-5-(2-iodoethyl)-2,2-
dimethyl-1,3-dioxolane (253) (1.3 g, 3.40 mmol, 1.0 equiv.) in 30 mL of THF. The solution’s 
color lightened at the end of the addition and was stirred for the next 15 min at -20°C before 
allowed to warm up to 0°C in 20 min and stirred for 6h at 0°C, then from 0°C to RT overnight. 
The bright yellow solution was quenched with a saturated solution of NH4Cl (70 mL) at 0°C, the 
first organic phase was extracted with Et2O (50 mL). The obtained aqueous phase was acidified 
with a solution of HCl (10% w/v) until pH = 1-2, then extracted once again with Et2O (30 mL) 
and EtOAc (2 x 30 mL). The combined organic phases were washed by a saturated solution of 
NaHCO3 (100 mL) then brine (150 mL), dried over anhydrous MgSO4, filtered and concentrated 
under reduced pressure. The crude product was purified by silica gel flash chromatography 
(Cy/EtOAC/AcOH: 80/20/1  60/40/1) to afford 452 (1.3 g, 83% yield) as a colorless oil. 
 
Rf = 0.57 (Cy/EtOAC/AcOH: 10/10/0.05) 
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Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3) : (Major isomer)δ = 1.20 (t, J= 7.1 Hz, 3H, H-12), 1.33 (s, 3H, H-15 or 
H-16), 1.49 (s, 3H, H-16 or H-15), 1.74-1.89 (m, 2H, H-6), 1.85 (d, J = 2.3 Hz, 3H, H-1), 2.79-2.95 
(m, 2H, H-7), 3.52-3.78 (m, 2H, H-10), 3.82 (s, 3H, H-14), 3.89 (s, 3H, H-13), 4.12-4.27 (m, 2H, H-
3 and H-4), 4.31-4.37 (m, 1H, H-2), 4.84 (AB, JAB = 6.9 Hz, Δν= 120 Hz, 2H, H-11), 6.35 (s, 2H, H-8 
or H-9), 6.43 (s, 2H, H-9 or H-8) 
 
13C NMR (400 MHz, CDCl3): (Major isomer)δ = 3.93 (C-1), 15.12 (C-19), 25.46 (C-22 or C-23), 
26.98 (C-23 or C-22), 28.91 (C-8), 30.23 (C-7), 34.76 (C-9), 55.51 (C-20 or C-21), 56.52 (C-21 or 
C-20), 64.23 (C-18), 66.13 (C-5 or C-6), 76.83 (C-2 or C-3), 79.11 (C-6 or C-5), 83.93 (C-3 or C-2), 
92.38 (C-17), 96.63 (C-11 or 13), 107.65 (C-13 or 11), 108.72 (C-24), 146.35 (C-10), 159.14 (C-
12), 162.17 (C-15), 169.17 (C-16) 
 
HRMS (ESI+): calcd for (M-H)- : 449.2175, found 449.2182 
 
 
Chemical Formula: C30H42O8 
Molecular Weight: 530.65 g/mol 
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(S)-hex-4-yn-2-yl 2-(3-((4S,5S)-5-(1-(ethoxymethoxy)but-2-yn-1-yl)-2,2-dimethyl-1,3-dioxolan-
4-yl)propyl)-4,6-dimethoxybenzoate (241) 
 
To a solution of 2-(3-((4S,5R)-5-(1-(ethoxymethoxy)but-2-yn-1-yl)-2,2-dimethyl-1,3-dioxolan-
4-yl)propyl)-4,6-dimethoxybenzoic acid (452) (1.70 g, 3.77 mmol, 1.0 equiv.) in THF (25 mL) 
were added respectively triphenylphosphine ( 1.97 g, 7.55 mmol, 2.0 equiv.) and (R)-hex-4-yn-
2-ol (488) (0.55 g, 5.65 mmol, 1.5 equiv.) at 0°C. The solution was stirred for 5 min at 0°C 
before the addition of DIAD (1.67 g, 8.29 mmol, 2.2 equiv.). The colorless solution turned 
yellow-orange after 10 min at 0°C then stirred at RT overnight. The solvent was completely 
evaporated and the crude product purified by silica gel flash chromatography (Cy/EtOAC: 98/2 
 97/3 90/10) to afford 241 (1.74 g, 87% yield) as a light yellow oil. 
 
Rf  = 0.57 (Cy/EtOAC : 5/1) 
 
 
 
 
 
 
 
 
 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): (Major isomer)δ = 1.20 (t, J= 7.10 Hz, 3H, H-16), 1.33 (s, 3H, H-18 or 
H-19), 1.41 (d, 3H, J= 6.2 Hz, H-20), 1.49 (s, 3H, H-19 or H-18), 1.51-1.75 (m, 4H, H-5 and H-6), 
1.77 (s, 3H, H-12), 1.85 (d, J = 2.29 Hz, 3H, H-1), 2.53-2.67 (m, 2H, H-7 and H-11), 3.46-3.63 (m, 
2H, H-14), 3.76 (s, 3H, H-18 or H-19), 3.78 (s, 3H, H-19 or H-18), 4.11-4.18 (m, 2H, H-3 and H-4), 
4.28-4.32 (m, 1H, H-2), 4.67 (dd, ABX, JAB = 6.87 Hz, JAX = 1.37 Hz, 1H, H-7), 4.99 (dd, ABX, JAB = 
6.87 Hz, JAX = 1.37 Hz, 1H, H-7), 5.19 (m, 1H, H-10), 6.29 (d, J= Hz, 2H, H-8 or H-9), 6.32 (d, J= Hz, 
2H, H-9 or H-8) 
 
13C NMR (400 MHz, CDCl3): (Major isomer)δ = 3.59 (C-21), 3.87 (C-1), 15.17 (C-24), 19.20 (C-
29), 21.79 (C-27 or C-28), 25.45 (C-28 or C-27), 28.91 (C-8), 30.23 (C-22), 33.44 (C-9), 33.61 (C-
18), 55.43 (C-25 or C-26), 55.92 (C-26 or C-25), 64.10 (C-23), 65.91 (C-4), 70.14 (C-17), 77.29 (C-
5 or C-6), 77.44 (C-19 or C-20), 79.81 (C-2 or C-3), 79.81 (C-6 or C-5), 83.93 (C-3 or C-2), 84.01 
(C-20 or 19), 92.41 (C-22), 96.34 (C-11 or 13), 105.83 (C-13 or 11), 108.39 (C-30), 142.16 (C-10), 
158.10 (C-14), 161.74 (C-12), 167.67 (C-16) 
 
HRMS (ESI+): m/z [M + H]+ calcd for C30H43O8: 531.2957, found 531.2943 
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5.3 Synthesis of other RALs 
5.3.1 Synthesis of (R)-(+)-lasiodiplodin (10) 
 
 
Chemical Formula: C15H20O4 
Molecular Weight: 264.32 g.mol-1 
 
2-(hex-5-en-1-yl)-4,6-dimethoxybenzoic acid (602) 
 
To a solution of 2,4-dimethoxybenzoic acid 401 (3.0 g, 15.30 mmol, 1.0 equiv.) in THF (70 mL) 
at -78°C was added dropwise a 1.4 M solution of sBuLi in hexanes (22.9 mL, 32.11 mmol, 2.1 
equiv.). The initially colorless solution gradually turned orange then dark red after 2h between 
-78°C and -60°C before being warmed up to -20°C. To the clear red solution at -20°C was added 
dropwise a solution of 6-bromopent-1-ene (454) (2.28 g, 15.30 mmol, 1.0 equiv.). The 
solution’s color lightened at the end of the addition and was stirred for the next 15 min at -
20°C before allowed to warm up to 0°C in 20 min and stirred for 6h at 0°C, then from 0°C to RT 
overnight. The bright yellow solution was quenched with a saturated solution of NH4Cl (70 mL) 
at 0°C, the first organic phase was extracted with Et2O (50 mL). The obtained aqueous phase 
was acidified with a solution of HCl (10% w/v) until pH = 1-2, then extracted once again with 
Et2O (30 mL) and EtOAc (2 x 30 mL). The combined organic phases were washed by a saturated 
solution of NaHCO3 (100 mL) then brine (150 mL), dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. The crude product was purified by silica gel flash 
chromatography (Cy/EtOAC/AcOH: 80/20/1  60/40/1) to afford 602 (6.3 g, 83% yield) as a 
colorless oil. 
 
Rf = 0.61 (Cy/EtOAC/AcOH: 10/10/0.05) 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.41-1.49 (m, 2H, H-3), 1.58-1.66 (m, 2H, H-2), 2.07 (td, 2H, J= 
7.5 Hz, J= 7.1 Hz, H-4), 2.80 (t, 2H, J= 7.7 Hz, H-1), 3.82 (s, 3H, H-9), 3.88 (s, 3H, H-10), 4.95 
(ABX, 2H, JAX= 17.0 Hz, JBX= 10.3 Hz, JAB= 2.0 Hz, Δν=  26 Hz, H-6), 5.74-5.84 (ABX, 1H, H-5), 6.39 
(AB, 2H, JAB= 2.4 Hz, Δν=  10 Hz, H-9 and H-10) 
 
13C NMR (100 MHz, CDCl3): δ= 28.82 (C-3), 30.91 (C-2), 33.61 (C-4), 34.34 (C-1), 55.44 (C-15), 
56.55 (C-14), 96.37 (C-10), 106.98 (C-8), 114.17 (C-12), 114.51 (C-6), 138.88 (C-5), 145.24 (C-7), 
158.90 (C-11), 162.04 (C-9), 172.47 (C-13) 
 
HRMS (ESI+): m/z [M + H]+ calcd for C15H21O4: 265.1439; found: 265.1433. 
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Chemical Formula: C20H28O4 
Molecular Weight: 332.43 g.mol-1 
 
(R)-pent-4-en-2-yl 2-(hex-5-en-1-yl)-4,6-dimethoxybenzoate (601) 
 
To a solution of 2-(6-(ethoxymethoxy)oct-7-en-1-yl)-4,6-dimethoxybenzoic acid (602) (3.3 g, 
12.48 mmol, 1.0 equiv.) in THF (50 mL) were added respectively triphenylphosphine (6.55 g, 
25.0 mmol, 2.0 equiv.) and (S)-pent-4-en-2-ol (488) (1.61 g, 18.73 mmol, 1.5 equiv.) at 0°C. The 
solution was stirred for 5 min at 0°C before the addition of DIAD (5.55 g, 27.47 mmol, 2.2 
equiv.). The colorless solution turned yellow-orange after 10 min at 0°C then stirred at RT 
overnight. The solvent was completely evaporated and the crude product purified by silica gel 
flash chromatography (Cy/EtOAC: 98/2  97/3 90/10) to afford 601 (3.7 g, 90% yield) as a 
light yellow oil. 
 
Rf = 0.52 (Cy/EtOAC: 5/1) 
 
[α]D20= - 0.88° (c = 1.13, CHCl3) 
 
 [α]D20= - 18.7(c= 1.0, acetone) 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ = 1.32 (d, 3H, J= 6.2 Hz, H-15), 1.38-1.45 (m, 2H, H-3), 1.55-1.63 
(m, 2H, H-2), 2.07 (td, 2H, J= 7.5 Hz, J= 7.1 Hz, H-4), 2.31-2.38 (m, 1H, H-12A), 2.43-2.50 (m, 1H, 
H-12B), 2.56 (t, J= 7.3 Hz, H-1), 3.77 (s, 3H, H-9), 3.79 (s, 3H, H-10), 4.95 (ABX, 2H, JAX= 17.0 Hz, 
JBX= 10.3 Hz, JAB= 2.0 Hz, Δν=  26 Hz, H-6), 5.21 (tq, 1H, J= 6.2 Hz, J= 6.4 Hz, H-11), 5.75-5.89 
(ABX, 1H, H-5 and H-13), 6.30 (AB, 2H, JAB= 2.2 Hz, Δν= 3.8 Hz, H-9 and H-10) 
 
13C NMR (100 MHz, CDCl3): δ= 19.58 (C-20), 28.91 (C-3), 29.05 (C-3 or C-4 or C-5), 30.87 (C-2), 
33.73 (C-1 and C-4), 40.30 (C-17),  55.39 (C-15), 55.80 (C-14), 71.02 (C-16), 96.24 (C-10), 105.81 
(C-8), 114.55 (C-6), 117.00 (C-12), 117.66 (C-19), 133.96 (C-18), 133.81 (C-5), 142.48 (C-7), 
157.98 (C-11), 161.30 (C-9), 167.97 (C-13)   
 
HRMS (ESI+): m/z [M + Na]+ calcd for C20H28NaO4: 355.1880; found: 355.1871. 
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Chemical Formula: C18H24O4 
Molecular Weight: 304.38 g.mol-1 
 
(R,E)-12,14-dimethoxy-3-methyl-3,4,7,8,9,10-hexahydro-1H-benzo[c][1]oxacyclododecin-1-
one (600) 
 
To a solution of (R)-pent-4-en-2-yl 2-(hex-5-en-1-yl)-4,6-dimethoxybenzoate (601) (0.92 g, 
2.77 mmol, 1.0 equiv.) in degassed dry toluene (250 mL) at RT was added the 2nd  Grubbs’ 
catalyst (117.8 mg, 0.14 mmol, 0.05 equiv.). The colorless solution became orange then brown 
after 4h at 80°C then allowed to cool down to 40°C. Another portion of catalyst (117.8 mg, 
0.14 mmol, 0.05 equiv.) was added at this temperature and the solution stirred at 80°C 
overnight. The reaction was cooled to RT before the filtration on a Celite® pad to separate the 
residual solid and washed with toluene (15 mL). The solvent was completely evaporated and 
the crude product purified by silica gel flash chromatography (Cy/EtOAC: 97/3 90/10) to 
afford a E/Z ≈ 2/1 mixture 600 as a colorless solid in 55% yield. The E/Z mixture was not 
separated and the following analyses are noted for only one isomer. 
 
Rf = 0.45 (Cy/EtOAC: 3/1) 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.13-1.48 (m, 2H, H-3), 1.36 (d, 2H, J= 6.2 Hz, H-11), 1.60-1.67 
(m, 2H, H-2), 1.83-1.91 (m, 2H, H-4), 2.28-2.32 (m, 2H, H-7), 2.51-2.63 (m, 2H, H-1), 3.77 (s, 3H, 
H-13 or H-12), 3.79 (s, 3H, H-12 or H-13), 5.39-5.43 (m, 2H, H-5 and H-6), 6.30 (d, J= 2.1 Hz, H-
11 or H-10), 6.32 (d, J= 2.1 Hz, H-10 or H-11)   
 
13C NMR (100 MHz, CDCl3): δ= 20.63 (C-9), 25.61 (C-3), 30.46 (C-2), 30.62 (C-1), 31.65 (C-4), 
41.05 (C-7), 55.45 (C-18), 55.90 (C-17), 70.07 (C-8), 96.17 (C-15), 105.89 (C-13), 117.26 (C-11), 
127.86 (C-6), 132.38 (C-5), 142.96 (C-12), 157.48 (C-16), 161.13 (C-14), 168.45 (C-10) 
 
MS: m/z [M + H]+ calcd for C18H25O4: 305.1752; found: 305.1671.  
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Chemical Formula: C18H26O4 
Molecular Weight: 306.40 g.mol-1 
 
(R)-12,14-dimethoxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-1H-benzo[c][1]oxacyclododecin-1-
one (529) 
 
To a solution of (R,E)-12,14-dimethoxy-3-methyl-3,4,7,8,9,10-hexahydro-1H-benzo[c][1] 
oxacyclododecin-1-one (600) (0.77 g, 2.53 mmol, 1.0 equiv.) in degassed dry EtOAc (180 mL) 
was added PtO2.H2O (51.2 mg, 0.25  mmol, 0.1 equiv.). The solution was continuously 
submitted to a bubbling source of hydrogen overnight at RT. The residual solid was filtrated 
through a Celite® pad and washed with EtOAc (20 mL) and the obtained filtrate evaporated 
under reduced pressure. The resulting mixture was purified by silica gel flash chromatography 
(Cy/EtOAC: 97/3 90/10) to afford afford 529 (0.70 g, 90%) as  a colorless oil. 
 
Rf = 0.71 (Cy/EtOAC: 3/1) 
 
The analytical data are identical to those from the literature.8 
 
[α]D20+7.13° (c = 1.0, CHCl3) 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.22-1.27 (m, 2H, H-6), 1.32 (d, 3H, J= 6.2 Hz, H-9), 1.35-1.57 (m, 
6H, H-3, H-4 and H-5), 1.59-1.70 (m, 4H, H-2 and H-7), 2.56-2.42 (m, 1H, H-1A), 2.61-2.71 (m, 
1H, H-1B), 3.75 (s, 3H, H-13 or H-12), 3.79 (s, 3H, H-12 or H-13), 5.21-5.31 (m, 1H, H-8), 6.30 (d, 
J= 2.1 Hz, H-11 or H-10), 6.32 (d, J= 2.1 Hz, H-10 or H-11)   
 
13C NMR (100 MHz, CDCl3): δ= 19.54 (C-9), 21.21 (C-6), 24.29 (C-4), 25.49 (C-3), 26.57 (C-5), 
30.26 (C-2), 30.62 (C-1), 32.39 (C-7), 55.36 (C-18), 55.90 (C-17), 70.07 (C-8), 96.17 (C-15), 
105.89 (C-13), 117.26 (C-11), 127.86 (C-6), 132.38 (C-5), 142.96 (C-12), 157.48 (C-16), 161.13 
(C-14), 168.45 (C-10) 
 
HRMS (ESI+): m/z [M + H]+ calcd for C18H27O4: 307.1904;  found: 307.1911. 
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Chemical Formula: C17H24O4 
Molecular Weight: 292.37 g.mol-1 
 
(R)-12-hydroxy-14-methoxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-1H-
benzo[c][1]oxacyclododecin-1-one (10) = (R)-lasiodiplodin (10) 
 
To a stirred suspension of NaH (60% in mineral oil, 0.63 g, 15.70 mmol, 15.0 equiv.) in THF (30 
mL) at 0°C was added dropwise ethanethiol (0.98 g, 15.70 mmol, 15.0 equiv.). The biphasic 
mixture was warmed up to RT and stirred for 20 min until turning into a clear colorless 
solution. To the obtained solution was added dropwise a solution of (R)-12,14-dimethoxy-3-
methyl-3,4,5,6,7,8,9,10-octahydro-1H-benzo[c][1]oxacyclodode cin-1-one (529) (0.32 g, 1.05 
mmol, 1.0 equiv.) in HMPA (4 mL). The mixture was vigorously stirred at 70°C overnight. The 
dark red solution was carefully neutralised at 0°C with an aqueous solution of 10% w/v HCl 
until pH= 6-7 and became dark yellow. The aqueous layer was extracted with Et2O (30 mL) and 
dichloromethane (2 x 30 mL). The combined organic layers were washed with a saturated 
solution of NH4Cl (70 mL) then with brine (100 mL), dried with anhydrous MgSO4, filtered and 
concentrated under reduced pressure. The crude product was purified by silica gel 
chromatography (Cy/EtOAC : 9/1  7/1 4/1) to afford 10 (0.11 g, 35% yield) as a white solid. 
 
Rf =  0.27 (Cy/EtOAC: 3/1) 
 
The analytical data are identical to those from the literature.9 
 
[α]D20 = +9.0° (c = 0.5, MeOH) 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.22-1.27 (m, 2H, H-6), 1.32 (d, 3H, J= 6.2 Hz, H-9), 1.35-1.57 (m, 
6H, H-3, H-4 and H-5), 1.59-1.70 (m, 4H, H-2 and H-7), 2.53-2.64 (m, 2H, H-1), 3.77 (s, 3H, H-13 
or H-12), 3.79 (s, 3H, H-12 or H-13), 5.39-5.43 (m, 1H, H-8), 6.30 (d, J= 2.1 Hz, H-11 or H-10), 
6.32 (d, J= 2.1 Hz, H-10 or H-11)   
 
13C NMR (100 MHz, CDCl3): δ= 19.54 (C-9), 21.21 (C-6), 24.29 (C-4), 25.49 (C-3), 26.57 (C-5), 
30.26 (C-2), 30.62 (C-1), 32.39 (C-7), 55.90 (C-17), 70.07 (C-8), 96.17 (C-15), 105.89 (C-13), 
117.26 (C-11), 127.86 (C-6), 132.38 (C-5), 142.96 (C-12), 157.48 (C-16), 161.13 (C-14), 168.45 
(C-10) 
 
MS (LC-MS): m/z [M + H]+ calcd for C17H25O4: 293.1753;  found: 293.1991. 
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5.3.2 Synthesis of (S)-lasiodiplodin (545) 
As the procedures for the synthesis of (S)-lasiodiplodin (545) are identical to those described in 
the paragraph 5.3.1, only the experimental data of the intermediates are presented in this 
section. 
 
 
Chemical Formula: C20H28O4 
Molecular Weight: 332.43 g.mol-1 
 
(S)-pent-4-en-2-yl 2-(hex-5-en-1-yl)-4,6-dimethoxybenzoate (603) 
 
Rf = 0.52 (Cy/EtOAC: 5/1) 
 
[α]D20+ 0.90° (c = 1.0, CHCl3) 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ = 1.32 (d, 3H, J= 6.2 Hz, H-15), 1.38-1.45 (m, 2H, H-3), 1.55-1.63 
(m, 2H, H-2), 2.07 (td, 2H, J= 7.5 Hz, J= 7.1 Hz, H-4), 2.31-2.38 (m, 1H, H-12A), 2.43-2.50 (m, 1H, 
H-12B), 2.56 (t, J= 7.3 Hz, H-1), 3.77 (s, 3H, H-9), 3.79 (s, 3H, H-10), 4.95 (ABX, 2H, JAX= 17.0 Hz, 
JBX= 10.3 Hz, JAB= 2.0 Hz, Δν=  26 Hz, H-6), 5.21 (tq, 1H, J= 6.2 Hz, J= 6.4 Hz, H-11), 5.75-5.89 
(ABX, 1H, H-5 and H-13), 6.30 (AB, 2H, JAB= 2.2 Hz, Δν= 3.8 Hz, H-9 and H-10) 
 
13C NMR (100 MHz, CDCl3): δ= 19.58 (C-20), 28.91 (C-3), 29.05 (C-3 or C-4 or C-5), 30.87 (C-2), 
33.73 (C-1 and C-4), 40.30 (C-17),  55.39 (C-15), 55.80 (C-14), 71.02 (C-16), 96.24 (C-10), 105.81 
(C-8), 114.55 (C-6), 117.00 (C-12), 117.66 (C-19), 133.96 (C-18), 133.81 (C-5), 142.48 (C-7), 
157.98 (C-11), 161.30 (C-9), 167.97 (C-13)   
 
HRMS (ESI+): m/z [M + Na]+ calcd for C20H28NaO4: 355.1880; found: 355.1969 
 
 
 
Chemical Formula: C18H24O4 
Molecular Weight: 304.38 g.mol-1 
 
(S,E)-12,14-dimethoxy-3-methyl-3,4,7,8,9,10-hexahydro-1H-benzo[c][1]oxacyclododecin-1-
one (604) 
5  EXPERIMENTAL 243 
  
 
Rf = 0.45 (Cy/EtOAC: 3/1) 
E/Z : 2/1 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.13-1.48 (m, 2H, H-3), 1.36 (d, 2H, J= 6.2 Hz, H-11), 1.60-1.67 
(m, 2H, H-2), 1.83-1.91 (m, 2H, H-4), 2.28-2.32 (m, 2H, H-7), 2.51-2.63 (m, 2H, H-1), 3.77 (s, 3H, 
H-13 or H-12), 3.79 (s, 3H, H-12 or H-13), 5.39-5.43 (m, 2H, H-5 and H-6), 6.30 (d, J= 2.1 Hz, H-
11 or H-10), 6.32 (d, J= 2.1 Hz, H-10 or H-11)   
 
13C NMR (100 MHz, CDCl3): δ= 20.63 (C-9), 25.61 (C-3), 30.46 (C-2), 30.62 (C-1), 31.65 (C-4), 
41.05 (C-7), 55.45 (C-18), 55.90 (C-17), 70.07 (C-8), 96.17 (C-15), 105.89 (C-13), 117.26 (C-11), 
127.86 (C-6), 132.38 (C-5), 142.96 (C-12), 157.48 (C-16), 161.13 (C-14), 168.45 (C-10) 
 
MS (LC-MS): m/z [M + H]+ calcd for C18H25O4: 305.1752; found: 305.1713 
 
 
 
Chemical Formula: C18H26O4 
Molecular Weight: 306.40 g.mol-1 
 
(S)-12,14-dimethoxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-1H-benzo[c][1]oxacyclododecin-1-
one (605) 
 
Rf = 0.71 (Cy/EtOAC: 3/1) 
 
[α]D20= - 6.87° (c = 1.2, CHCl3) 
 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.22-1.27 (m, 2H, H-6), 1.32 (d, 3H, J= 6.2 Hz, H-9), 1.35-1.57 (m, 
6H, H-3, H-4 and H-5), 1.59-1.70 (m, 4H, H-2 and H-7), 2.56-2.42 (m, 1H, H-1A), 2.61-2.71 (m, 
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1H, H-1B), 3.75 (s, 3H, H-13 or H-12), 3.79 (s, 3H, H-12 or H-13), 5.21-5.31 (m, 1H, H-8), 6.30 (d, 
J= 2.1 Hz, H-11 or H-10), 6.32 (d, J= 2.1 Hz, H-10 or H-11)   
 
13C NMR (100 MHz, CDCl3): δ= 19.54 (C-9), 21.21 (C-6), 24.29 (C-4), 25.49 (C-3), 26.57 (C-5), 
30.26 (C-2), 30.62 (C-1), 32.39 (C-7), 55.36 (C-18), 55.90 (C-17), 70.07 (C-8), 96.17 (C-15), 
105.89 (C-13), 117.26 (C-11), 127.86 (C-6), 132.38 (C-5), 142.96 (C-12), 157.48 (C-16), 161.13 
(C-14), 168.45 (C-10) 
 
HRMS (ESI+): m/z [M + H]+ calcd for C18H27O4: 307.1904;  found: 307.1979 
 
 
 
Chemical Formula: C17H24O4 
Molecular Weight: 292.37 g.mol-1 
 
(S)-12-hydroxy-14-methoxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-1H-
benzo[c][1]oxacyclododecin-1-one (545) = (S)-lasiodiplodin (545) 
 
Rf =   0.27 (Cy/EtOAC: 3/1) 
 
[α]D20= - 8.6° (c = 0.7, MeOH) 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.22-1.27 (m, 2H, H-6), 1.32 (d, 3H, J= 6.2 Hz, H-9), 1.35-1.57 (m, 
6H, H-3, H-4 and H-5), 1.59-1.70 (m, 4H, H-2 and H-7), 2.53-2.64 (m, 2H, H-1), 3.77 (s, 3H, H-13 
or H-12), 3.79 (s, 3H, H-12 or H-13), 5.39-5.43 (m, 1H, H-8), 6.30 (d, J= 2.1 Hz, H-11 or H-10), 
6.32 (d, J= 2.1 Hz, H-10 or H-11)   
 
13C NMR (100 MHz, CDCl3): δ= 19.54 (C-9), 21.21 (C-6), 24.29 (C-4), 25.49 (C-3), 26.57 (C-5), 
30.26 (C-2), 30.62 (C-1), 32.39 (C-7), 55.90 (C-17), 70.07 (C-8), 96.17 (C-15), 105.89 (C-13), 
117.26 (C-11), 127.86 (C-6), 132.38 (C-5), 142.96 (C-12), 157.48 (C-16), 161.13 (C-14), 168.45 
(C-10) 
 
MS: m/z [M + H]+ calcd for C17H25O4: 293.1753;  found: 293.1762 
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5.3.3 Synthesis of neolasiodiplodin (606) 
 
 
Chemical Formula: C17H24O4 
Molecular Weight: 292.37 g.mol-1 
 
2,4-dimethoxy-6-(oct-7-en-1-yl)benzoic acid (609) 
 
To a solution of 2,4-dimethoxybenzoic acid (401) (3.0 g, 15.30 mmol, 1.0 equiv.) in THF (70 mL) 
at -78°C was added dropwise a 1.4 M solution of sBuLi in hexanes (22.9 mL, 32.11 mmol, 2.1 
equiv.). The initially colorless solution gradually turned orange then dark red after 2h between 
-78°C and -60°C before being warmed up to -20°C. To the clear red solution at -20°C was added 
dropwise a solution of 7-bromopent-1-ene (603) (2.71 g, 15.30 mmol, 1.0 equiv.). The 
solution’s color lightened at the end of the addition and was stirred for the next 15 min at -
20°C before allowed to warm up to 0°C in 20 min and stirred for 6h at 0°C, then from 0°C to RT 
overnight. The bright yellow solution was quenched with a saturated solution of NH4Cl (70 mL) 
at 0°C, the first organic phase was extracted with Et2O (50 mL). The obtained aqueous phase 
was acidified with a solution of HCl (10% w/v) until pH = 1-2, then extracted once again with 
Et2O (30 mL) and EtOAc (2 x 30 mL). The combined organic phases were washed by a saturated 
solution of NaHCO3 (100 mL) then brine (150 mL), dried over anhydrous MgSO4,filtered and 
concentrated under reduced pressure. The crude product was purified by silica gel flash 
chromatography (Cy/EtOAC/AcOH: 80/20/1  60/40/1) to afford 609 (3.7 g, 83% yield) as a 
light yellow solid. 
 
Rf = 0.27 (Cy/EtOAC/AcOH: 7/14/0.05) 
 
 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.28-1.43 (m, 6H, H-3, H-4 and H-5), 1.55-1.64 (m, 2H, H-2), 
2.00-2.50 (m, 2H, H-6), 2.88 (t, 2H, J= 7.8 Hz, H-1), 3.84 (s, 3H, H-12 or H-11), 3.93 (s, 3H, H-11 
or H-12), 4.95 (ABX, 2H, JAX= 16.9 Hz, JBX= 10.1 Hz, JAB= 2.0 Hz, Δν= 26 Hz, H-8), 5.74-5.85 (ABX, 
1H, H-7), 6.39 (AB, 2H, JAB= 2.3 Hz, Δν=  21 Hz, H-9 and H-10) 
 
13C NMR (100 MHz, CDCl3): δ= 28.94 (C-3 or C-4 or C-5), 29.02 (C-3 or C-4 or C-5), 29.56 (C-3 or 
C-4 or C-5), 31.46 (C-2), 33.86 (C-6), 34.76 (C-1), 55.49 (C-17), 56.38 (C-16), 96.43 (C-11), 
107.34 (C-9), 113.58 (C-14), 114.24 (C-8), 139.26 (C-7), 146.41 (C-14), 159.02 (C-12), 162.10 (C-
10), 170.90 (C-15) 
 
MS (ESI+): m/z [M + H]+ calcd for C17H25O4: 293.175285; found: 293,1671. 
 
5  EXPERIMENTAL 246 
  
 
 
Chemical Formula: C22H32O4 
Molecular Weight: 360.49 g.mol-1 
 
(S)-pent-4-en-2-yl 2,4-dimethoxy-6-(oct-7-en-1-yl)benzoate (608) 
 
To a solution of 2,4-dimethoxy-6-(oct-7-en-1-yl)benzoic acid (609) (3.3 g, 11.29 mmol, 1.0 
equiv.) in THF (50 mL) were added respectively triphenylphosphine (5.92 g, 22.57 mmol, 2.0 
equiv.) and (R)-pent-4-en-2-ol (41) (1.46 g, 16.93 mmol, 1.5 equiv.) at 0°C. The solution was 
stirred for 5 min at 0°C before the addition of DIAD (5.02 g, 24.84 mmol, 2.2 equiv.). The 
colorless solution turned yellow-orange after 10 min at 0°C then stirred at RT overnight. The 
solvent was completely evaporated and the crude product purified by silica gel flash 
chromatography (Cy/EtOAC: 98/2  95/5 90/10 85/15) to afford 608 (3.7 g, 90% yield) as 
a light yellow oil. 
 
Rf = 0.54 (Cy/EtOAC: 3/1) 
 
[α]D20 = -1.3° (c = 1.0, CHCl3) 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.27-1.42 (m, 6H, H-3, H-4 and H-5), 1.32 (d, 3H, J= 6.2 Hz, H-
17), 1.53-1.60 (m, 2H, H-2), 2.02 (dt, 2H, J= 6.6 Hz, J= 7.6 Hz, H-6), 2.31-2.38 (m, 1H, H-14A), 
2.43-2.49 (m, 1H, H-14B), 2.55 (t, 2H, J= 7.1 Hz, H-1), 3.77 (s, 3H, H-14 or H-15), 3.79 (s, 3H, H-
15 or H-14), ), 4.95 (ABX, 2H, JAX= 16.9 Hz, JBX= 10.1 Hz, JAB= 2.0 Hz, Δν=  26 Hz, H-8), 5.07-5.16 
(m, 2H, H-16), 5.74-5.88 (m, 2H, H-15 and H-7), 6.30 (AB, J= 2.1 Hz, Δν= 5 Hz, H-9 and H-10) 
 
13C NMR (100 MHz, CDCl3): δ= 19.58 (C-20), 28.91 (C-3 or C-4 or C-5), 29.05 (C-3 or C-4 or C-5), 
29.54 (C-3 or C-4 or C-5), 31.37 (C-2), 33.84 (C-6), 33.89 (C-1), 40.31 (C-17),  55.41 (C-22), 55.81 
(C-21), 71.02 (C-16), 96.22 (C-11), 105.78 (C-9), 114.28 (C-8), 117.01 (C-13), 117.67 (C-19), 
133.97 (C-18), 139.16 (C-7), 142.66 (C-14), 157.95 (C-12), 161.28 (C-10), 168.00 (C-15)   
 
HRMS (ESI+): m/z [M + Na]+ calcd for C22H32NaO4: 383.2198; found: 382.2190. 
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Chemical Formula: C20H28O4 
Molecular Weight: 332.43 g.mol-1 
 
(S,Z)-14,16-dimethoxy-3-methyl-3,4,7,8,9,10,11,12-octahydro-1H-
benzo[c][1]oxacyclotetradecin-1-one (607) 
 
To a solution of (S)-pent-4-en-2-yl 2,4-dimethoxy-6-(oct-7-en-1-yl)benzoate (608) (1.0 g, 2.77 
mmol, 1.0 equiv.) in degassed dry toluene (230 mL) at RT was added the 2nd  Grubbs’ catalyst 
(117.8 mg, 0.14 mmol, 0.05 equiv.). The colorless solution became orange then brown after 4h 
at 80°C then allowed to cool down to 40°C. Another portion of catalyst (117.8 mg, 0.14 mmol, 
0.05 equiv.) was added at this temperature and the solution stirred at 80°C overnight. The 
reaction was cooled to RT before the filtration on a Celite® pad to separate the residual solid 
and washed with toluene (15 mL). The filtrate was evaporated under reduced pressure and 
purified by silica gel flash chromatography (Cy/EtOAC: 90/10  85/15) to afford a E/Z : 2.5/1 
mixture of 607 (0.75 g, 81%) as a colorless oil. The following NMR spectrum analysis is 
described for the major isomer. 
 
Rf = 0.76 (Cy/EtOAC: 4/1) 
 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.13-1.48 (m, 6H, H-3, H-4 and H-5), 1.36 (d, 2H, J= 6.2 Hz, H-
11), 1.60-1.67 (m, 2H, H-2), 1.83-1.91 (m, 1H, H-6A), 2.06-2.13 (m, 1H, H-6B), 2.28-2.32 (m, 2H, 
H-9), 2.53-2.64 (m, 2H, H-1), 3.77 (s, 3H, H-14 or H-15), 3.79 (s, 3H, H-15 or H-14), 5.12-5.20 
(m, 1H, H-10), 5.39-5.43 (m, 2H, H-7 and H-8), 6.32 (AB, J= 2.2 Hz, Δν= 28 Hz, H-12 and H-13) 
 
13C NMR (100 MHz, CDCl3): δ= 20.53 (C-11), 26.35 (C-3 or C-4 or C-5), 26.65 (C-3 or C-4 or C-5), 
26.72 (C-3 or C-4 or C-5), 29.04 (C-2), 31.51 (C-1), 39.37 (C-9),  55.40 (C-20), 55.86 (C-19), 71.93 
(C-10), 96.22 (C-14), 104.80 (C-12), 117.94 (C-16), 126.59 (C-8 or C-7), 133.72 (C-7 or C-8), 
142.11 (C-17), 157.90 (C-15), 161.22 (C-13), 168.71 (C-18)   
 
HRMS (ESI+): m/z [M + H]+ calcd for C20H28O4: 332.1987; found: 332.1991. 
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Chemical Formula: C20H30O4 
Molecular Weight: 334.45 g.mol-1 
 
(S)-14,16-dimethoxy-3-methyl-3,4,5,6,7,8,9,10,11,12-decahydro-1H-
benzo[c][1]oxacyclotetradecin-1-one (610) 
 
To a solution of (S,Z)-14,16-dimethoxy-3-methyl-3,4,7,8,9,10,11,12-octahydro-1H-
benzo[c][1]oxacyclotetradecin-1-one (607) (0.75 g, 2.26 mmol, 1.0 equiv.) in degassed dry 
EtOAc (180 mL) was added PtO2.H2O (51.2 mg, 0.26  mmol, 0.1 equiv.). The solution was 
continuously submitted to a bubbling source of hydrogen overnight at RT. The residual solid 
was filtrated through a Celite® pad and washed with EtOAc (20 mL) and the obtained filtrate 
evaporated under reduced pressure. The resulting mixture was purified by silica gel flash 
chromatography (Cy/EtOAC: 90/10  85/15 80/20) to afford afford 610 (0.74 g, 99%) as a 
colorless oil. 
 
Rf = 0.34 (Cy/EtOAC: 4/1) 
 
[α]D20 = -14,8° (c = 0.1, CHCl3) 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.13-1.48 (m, 6H, H-3, H-4 and H-5), 1.33 (d, 2H, J= 6.4 Hz, H-
11), 1.60-1.67 (m, 2H, H-2), 2.41-2.49 (m, 1H, H-1A), 2.65-2.74 (m, 1H, H-1B), 3.77 (s, 3H, H-14 
or H-15), 3.79 (s, 3H, H-15 or H-14), 5.28 (tq, J= 6.4 Hz, J= 6.2 Hz, 1H, H-10), 6.32 (AB, J= 2.2 Hz, 
Δν= 28 Hz, H-9 and H-10) 
 
13C NMR (100 MHz, CDCl3): δ= 20.26 (C-11), 20.05 (C-3 or C-4 or C-5 or C-6 or C-7 or C-8), 
24.25 (C-3 or C-4 or C-5 or C-6 or C-7 or C-8), 25.20 (C-3 or C-4 or C-5 or C-6 or C-7 or C-8), 
25.69 (C-3 or C-4 or C-5 or C-6 or C-7 or C-8), 26.05 (C-3 or C-4 or C-5 or C-6 or C-7 or C-8), 
27.34 (C-3 or C-4 or C-5 or C-6 or C-7 or C-8), 29.91 (C-2), 32.64 (C-1), 35.05 (C-9), 55.44 (C-20), 
55.91 (C-19), 70.74 (C-10), 96.38 (C-14), 105.56 (C-12), 117.44 (C-16), 142.72 (C-17), 157.90 (C-
15), 161.23 (C-13), 168.69 (C-18)  
 
HRMS (ESI+): m/z [M + H]+ calcd for C20H30O4: 334.2144; found: 334.2147. 
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Chemical Formula: C19H28O4 
Molecular Weight: 320.42 g.mol-1 
 
(S)-16-hydroxy-14-methoxy-3-methyl-3,4,5,6,7,8,9,10,11,12-decahydro-1H-
benzo[c][1]oxacyclotetradecin-1-one (606) 
 
To a stirred suspension of NaH (60% in mineral oil, 0.63 g, 15.70 mmol, 15.0 equiv.) in THF (30 
mL) at 0°C was added dropwise ethanethiol (0.98 g, 15.70 mmol, 15.0 equiv.). The biphasic 
mixture was warmed up to RT and stirred for 20 min until turning into a clear colorless 
solution. To the obtained solution was added dropwise a solution of (S)-14,16-dimethoxy-3-
methyl-3,4,5,6,7,8,9,10,11,12-decahydro-1H-benzo[c][1]oxacyclotetradecin-1-one (610) (0.35 
g, 1.05 mmol, 1.0 equiv.) in HMPA (3 mL). The mixture was vigorously stirred at 70°C overnight. 
The dark red solution was carefully neutralised at 0°C with an aqueous solution of 10% w/v HCl 
until pH= 6-7 and became dark yellow. The aqueous layer was extracted with Et2O (30 mL) and 
dichloromethane (2 x 30 mL). The combined organic layers were washed with a saturated 
solution of NH4Cl (70 mL) then with brine (100 mL), dried with anhydrous MgSO4, filtered and 
concentrated under reduced pressure. The crude product was purified by silica gel 
chromatography (Cy/EtOAC : 9/1  7/1 4/1) to afford 606 (0.25 g, 75% yield) as a white 
solid. 
 
Rf = 0.30 (Cy/EtOAC: 3/1) 
 
[α]D20 = -10° (c = 0.1, CHCl3) 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.20-1.61 (m, 14H, H-2, H-3, H-4, H-5, H-6, H-7 and H-8), 1.30 (d, 
2H, J= 6.4 Hz, H-11), 1.63-1.68 (m, 2H, H-9), 2.36-2.44 (m, 1H, H-1A), 2.62-2.71 (m, 1H, H-1B), 
3.75 (s, 3H, H-14 or H-15), 5.28 (tq, J= 6.0 Hz, J= 6.2 Hz, 1H, H-10), 6.26 (AB, J= 2.1 Hz, Δν= 11 
Hz, H-9 and H-10) 
 
13C NMR (100 MHz, CDCl3): δ= 20.26 (C-11), 20.05 (C-3 or C-4 or C-5 or C-6 or C-7 or C-8), 
24.24 (C-3 or C-4 or C-5 or C-6 or C-7 or C-8), 25.15 (C-3 or C-4 or C-5 or C-6 or C-7 or C-8), 
25.63 (C-3 or C-4 or C-5 or C-6 or C-7 or C-8), 26.05 (C-3 or C-4 or C-5 or C-6 or C-7 or C-8), 
27.28 (C-3 or C-4 or C-5 or C-6 or C-7 or C-8), 29.73 (C-2), 32.28 (C-1), 36.03 (C-9), 55.88 (C-19), 
70.93 (C-10), 96.96 (C-12), 107.89 (C-14), 117.00 (C-16), 142.95 (C-17), 157.45 (C-15), 158.14 
(C-13), 168.96 (C-18)  
 
HRMS (ESI+): m/z [M + H]+ calcd for C20H30O4: 334.2144; found: 334.2147. 
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5.3.4 Synthesis of zeranol (611) 
 
 
Chemical Formula: C12H26OSi 
Molecular Weight: 214.42 g.mol-1 
 
tert-butyl(hex-5-en-1-yloxy)dimethylsilane (639) 
 
To a solution of hex-5-en-1-ol (632) (5.0 g, 49.9 mmol, 1.0 equiv.) in dry DMF (15 mL) at RT was 
added TBDMSCl (7.5 g, 49.9 mmol, 1.0 equiv.). The solution was stirred overnight at RT then 
quenched with a solution of saturated K2CO3 (30 mL). The aqueous phase was extracted with 
Et2O (3 x 20 mL) then the gathered organic phases were washed by brine (60 mL), dried with 
anhydrous MgSO4 and concentrated under reduced pressure. The crude product was purified 
by silica gel flash chromatography (Cy/EtOAC : 95/5) to afford 639 (10.6 g, 99% yield) as a 
colorless oil. 
 
Rf = 0.64 (Cy/EtOAc: 5/1) 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 0.04 (s, 6H, H-7), 0.88 (s, 9H, H-8), 1.38-1.46 (m, 2H, H-3), 1.48-
1.53 (m, 2H, H-2), 2.02-2.08 (m, 2H, H-4), 3.60 (t, 2H, J= 6.4 Hz, H-1), 4.96 (2H, ABX, JAB= 1.6 Hz, 
JAX = 15.1 Hz, JBX = 10.1 Hz, Δν= 60 Hz, H-6A and H-6B), 5.80 (m, 1H, ABX, H-5) 
 
13C NMR (100 MHz, CDCl3): δ= -5.17 (C-7), 18.48 (C-8), 25.27 (C-3), 26.07 (C-9), 32.42 (C-2), 
33.66 (C-4), 63.16 (C-1), 114.46 (C-6), 139.00 (C-5) 
 
HRMS (ESI+): calcd for (M-H)+: 215.1831, found: 215.1817 
 
 
 
Chemical Formula: C12H26O2Si 
Molecular Weight: 230.42 g.mol-1 
 
tert-butyldimethyl(4-(oxiran-2-yl)butoxy)silane (640) 
 
To a solution of tert-butyl(hex-5-en-1-yloxy)dimethylsilane (639) (10.6 g, 49.4 mmol, 1.0 
equiv.) in dry DCM (50 mL) at 0°C was added NaHCO3 (8.3 g, 98.9 mmol, 2.0 equiv.). The 
solution was stirred at 0°C for 5 min then mCPBA (12.8 g, 74.2 mmol, 1.5 equiv.) was added in 
one portion. The biphasic solution was stirred at 0°C for 1h then allowed to warm to RT over 
another 2h. The resting mCPBA was neutralised by a saturated solution of Na2S2O3 at 0°C. The 
aqueous phase was extracted with Et2O (3 x 20 mL) then the gathered organic phases were 
washed by NaHCO3 (3 x 70 mL), then by brine (100 mL), dried with anhydrous MgSO4 and 
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concentrated under reduced pressure. The crude product was purified by silica gel flash 
chromatography (Cy/EtOAC: 95/5  8/1) to afford 640 (9.5 g, 83% yield) as a colorless oil. 
 
Rf = 0.6 (Cy/EtOAC: 3/1) 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 0.04 (s, 6H, H-7), 0.88 (s, 9H, H-8), 1.39-1.59 (m, 6H, H-2, H-3 
and H-4), 2.60 (2H, ABX, JAB= 5.0 Hz, JAX = 4.1 Hz, JB = 2.8 Hz, Δν= 110 Hz, H-6A and H-6B), 2.91 
(m, 1H, ABX, H-5), 3.60 (t, 2H, J= 6.2 Hz, H-1) 
 
13C NMR (100 MHz, CDCl3): δ= -5.25 (C-7), 18.39 (C-8), 22.40 (C-3), 26.01 (C-9), 32.32 (C-2), 
32.61 (C-4), 47.07 (C-6), 52.32 (C-5), 62.97 (C-1) 
 
 
Chemical Formula: C13H28O2Si 
Molecular Weight: 244.45 g.mol-1 
 
7-((tert-butyldimethylsilyl)oxy)hept-1-en-3-ol (636) 
 
To a solution of trimethylsulfonium iodide (25.2 g, 123.7 mmol, 3.0 equiv.) in suspension in 
THF (50 mL) at -15°C was added dropwise a 2.5M solution of BuLi (47.8 mL, 119.6 mmol, 2.9 
equiv.). After being vigorously stirred between -15°C and -10°C for 45min, the solution turned 
limpid and colorless, to which was added slowly dropwise a solution of tert-butyldimethyl(4-
(oxiran-2-yl)butoxy)silane (640) (9.5 g, 41.2 mmol, 1.0 equiv.) in dry THF (20 mL). The solution 
was stirred between -10°C and RT over 1h and became lightly yellow, containing a white solid. 
It was continuously stirred for another 2h at RT before being cooled down to 0°C, prior to the 
careful addition of distillated water (100 mL). The aqueous phase was extracted with Et2O (3 x 
50 mL) then the combined organic phases were washed by brine (100 mL), dried with 
anhydrous MgSO4 and concentrated under reduced pressure. The crude product was purified 
by silica gel flash chromatography (Cy/EtOAC: 97/3  95/5 90/0) to afford 636 (9.0 g, 90% 
yield) as a yellow oil. 
 
Rf = 0.65 (Cy/EtOAC: 3/1) 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3) : δ= 0.04 (s, 6H, H-7), 0.87 (s, 9H, H-8), 1.31-1.59 (m, 6H, H-2, H-3 
and H-4), 3.60 (t, 2H, J= 6.4 Hz, H-1), 4.09 (dt, 1H, JH5-H4 = 6.4 Hz, JH5-H6 = 6.2 Hz, H-5), 5.15 (2H, 
ABX, JAB= 1.2 Hz, JAX = 17.2 Hz, JB = 10.3 Hz, Δν= 50 Hz, H-7A and H-7B), 5.87 (m, 1H, ABX, H-6) 
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13C NMR (100 MHz, CDCl3): δ= -5.25 (C-8), 18.45 (C-9), 21.73 (C-3), 26.06 (C-10), 32.71 (C-2), 
36.81 (C-4), 63.17 (C-1), 73.29 (C-5), 114.70 (C-7), 141.29 (C-6) 
 
HRMS (ESI+): calcd for (M-Na)+: 267.1756, found: 267.1890 
 
 
 
Chemical Formula: C16H34O3Si 
Molecular Weight: 302.52 g.mol-1 
 
2,2,3,3-tetramethyl-9-vinyl-4,10,12-trioxa-3-silatetradecane (637) 
 
To a solution of 7-((tert-butyldimethylsilyl)oxy)hept-1-en-3-ol (636) (9.0 g, 36.8 mmol, 1 
equiv.) in dry DMF (40 mL) at RT were added respectively TBAI (0.14 g, 0.37 mmol, 0.01 
equiv.), DIPEA (42 mL, 258 mmol,7.0 equiv.) and the solution was stirred for 5 min before 
being cooled down to 0°C. To this yellow solution was added dropwise EOMCl (23.1 mL, 258 
mmol, 7.0 equiv.) which instantly triggered a white smoke. The solution was stirred for 30 min 
at 0°C then 6h after reaching RT.  The dark orange solution was quenched by a saturated 
solution of NaHCO3 (30 mL) and the acqueous phase was extracted by Et2O (3 x 70 mL). The 
combined organic phases were washed by a saturated solution of NH4Cl (150 mL) then brine 
(150 mL), dried over anhydrous MgSO4 and concentrated under reduced pressure. The crude 
product was purified by silica gel flash chromatography (Cy/EtOAC: 90/10  85/15) to afford 
637 (10.8 g, 97% yield) as a yellow oil. 
 
Rf = 0.82 (Cy/EtOAC: 3/1) 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 0.03 (s, 6H, H-11), 0.87 (s, 9H, H-12), 1.20 (t, ABX3, 3H, JAX= JBX= 
7.1 Hz), 1.31-1.65 (m, 6H, H-2, H-3 and H-4), 3.59 (t, 2H, J= 6.4 Hz, H-1), 3.59 (ABX3, 2H, JAB= 9.7 
Hz, JAX= JBX= 7.1 Hz, Δγ= 75 Hz, H-9A and H-9B), 4.09 (m, 1H, H-5), 4.48 (AB, 2H, JAB= 6.9 Hz, Δν= 
40 Hz, H-8A and H-8B), 5.17 (2H, ABX, JAB= 1.2 Hz, JAX = 17.2 Hz, JB = 10.3 Hz, Δν= 14 Hz, H-7A 
and H-7B), 5.64 (m, 1H, ABX, H-6) 
 
13C NMR (100 MHz, CDCl3): δ= -5.24 (C-11), 15.71 (C-10), 18.4 (C-12), 21.69 (C-3), 26.01 (C-13), 
32.75 (C-2), 35.26 (C-4), 63.12 (C-1), 63.28 (C-9), 76.79 (C-5), 92.29 (C-8), 117.07 (C-7), 138.57 
(C-6) 
 
MS (ESI+): calcd for (M-H)+: 303.2355, found: 303.2155 
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Chemical Formula: C10H20O3 
Molecular Weight: 188.26 g.mol-1 
 
5-(ethoxymethoxy)hept-6-en-1-ol (638) 
 
To a solution of 2,2,3,3-tetramethyl-9-vinyl-4,10,12-trioxa-3-silatetradecane (637) (10.8 g, 
35.7 mmol, 1 equiv.) in THF (30 mL) at RT was added at once TBAF.3H2O (28.1 g, 89.3 mmol, 
2.5 equiv.). The yellow solution was stirred overnight at RT and become red-brown. The 
solvent was totally evaporated and the crude product purified through silica gel flash 
chromatography (Cy/EtOAC: 80/20  75/25 60/40) to afford 638 (6.7 g, 99%) as a yellow oil. 
 
Rf = 0.43 (Cy/EtOAC: 1/1) 
 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.20 (t, ABX3, 3H, JAX= JBX= 7.1 Hz), 1.34-1.67 (m, 6H, H-2, H-3 
and H-4), 3.59 (ABX3, 2H, JAB= 9.7 Hz, JAX= JBX= 7.1 Hz, Δγ= 75 Hz, H-9A and H-9B), 3.64 (t, 2H, J= 
6 Hz, H-1), 4.01 (m, 1H,  H-5), 4.48 (AB, 2H, JAB= 6.9 Hz, Δν= 40 Hz, H-8A and H-8B), 5.17 (ABX, 
2H, JAB= 1.2 Hz, JAX = 17.2 Hz, JB = 10.3 Hz, Δν= 14 Hz, H-7A and H-7B), 5.66 (m, 1H, ABX, H-6) 
 
13C NMR (100 MHz, CDCl3): δ= 14.97 (C-10), 21.64 (C-3), 32.45 (C-2), 35.03 (C-4), 62.07 (C-1), 
63.34 (C-9), 76.77 (C-5), 92.09 (C-8), 117.07 (C-7), 138.26 (C-6) 
 
HRMS (ESI+): calcd for (M-H)+: 189.1491, found: 189.1475 
 
 
 
Chemical Formula: C10H19IO2 
Molecular Weight: 298.16 g.mol-1 
 
3-(ethoxymethoxy)-7-iodohept-1-ene (456) 
 
To a solution of 5-(ethoxymethoxy)hept-6-en-1-ol (638) (6.7 g, 38.6 mmol, 1.0 equiv.) in THF 
(70 mL) at RT were added respectively triphenylphosphine (14.9 g, 56.9 mmol, 1.6 equiv.) and 
imidazole (3.6 g, 53.4 mmol, 1.5 equiv.). The solution was cooled down to 0°C before the 
addition of I2 (13.5 g, 53.4 mmol, 1.5 equiv.). The solution turned progressively to a dark brown 
color after stirring at 0°C for 3h. The solution was quenched with a saturated solution of 
Na2S2O5 (50 mL) and the acqueous phase extracted by Et2O (3 x 50 mL). The combined organic 
phases were washed by a saturated solution of NH4Cl (100 mL) then brine (150 mL), dried over 
anhydrous MgSO4 and concentrated under reduced pressure. The crude product was purified 
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by silica gel flash chromatography (Cy/EtOAC: 97/3  95/5) to afford 456 (6.2 g, 93% yield) as 
a yellow oil. 
 
Rf = 0.75 (Cy/EtOAC: 6/1) 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (C6D6): δ= 1.16 (t, ABX3, 3H, JAX= JBX= 7.1 Hz), 1.23-1.37 (m, 3H, H-3 and H-4A), 1.40-
1.55 (m, 3H, H-2 and H-4B), 2.73 (t, 2H, J= 7.1 Hz, H-1), 3.54 (ABX3, 2H, JAB= 9.4 Hz, JAX= JBX= 7.1 
Hz, Δν= 75 Hz, H-9A and H-9B), 3.99 (m, 1H, H-5), 4.67 (AB, 2H, JAB= 7 Hz, Δν= 40 Hz, H-8A and 
H-8B), 5.08 (ABX, 2H, JAB= 1.8 Hz, JAX = 17.2 Hz, JB = 10.3 Hz, Δν= 28 Hz, H-7A and H-7B), 5.60 (m, 
1H, ABX, H-6) 
 
13C NMR (C6D6):δ= 6.21 (C-1), 15.14 (C-10), 26.22 (C-3), 33.29 (C-2), 34.31 (C-4), 63.10 (C-9), 
76.55 (C-5), 92.23 (C-8), 116.48 (C-7), 138.70 (C-6) 
 
MS (ESI+): calcd for (M-H)+: 299.0508, found: 299.1852 
 
 
Chemical Formula: C20H30O6 
Molecular Weight: 366.45 g.mol-1 
 
2-(6-(ethoxymethoxy)oct-7-en-1-yl)-4,6-dimethoxybenzoic acid (640) 
 
To a solution of 2,4-dimethoxybenzoic acid (401) (5.1 g, 26.0 mmol, 1.0 equiv.) in THF (50 mL) 
at -78°C was added dropwise a 1.4 M solution of sBuLi in hexanes (25.7 mL, 35.9 mmol, 2.1 
equiv.). The initially colorless solution progressively turned orange then dark red after 2h 
between -78°C and -60°C. To the limpid red solution at -20°C was added dropwise a solution of 
3-(ethoxymethoxy)-7-iodohept-1-ene (456) (6.2 g, 20.8 mmol, 0.8 equiv.). The solution’s color 
lightened at the end of the addition and was stirred for the next 15 min at -20°C before 
allowed to warm up to 0°C in 20 min and stirred for 6h at 0°C, then from 0°C to RT overnight. 
The bright yellow solution was quenched with a saturated solution of NH4Cl (70 mL) at 0°C, the 
first organic phase was extracted with Et2O (30 mL). The obtained acqueous phase was 
acidified with a solution of HCl (10% w/v) until pH = 1-2, then extracted once again with Et2O 
(30 mL) and EtOAc (2 x 30 mL). The combined organic phases were washed by a saturated 
solution of NaHCO3 (100 mL) then brine (150 mL), dried over anhydrous MgSO4, filtered and 
concentrated under reduced pressure. The crude product was purified by silica gel flash 
chromatography (Cy/EtOAC/AcOH: 80/20/1  60/40/1) to afford 640 (6.3 g, 83% yield) as a 
colorless oil. 
 
Rf = 0.47 (Cy/EtOAC/AcOH: 10/10/0.05) 
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Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.16 (t, ABX3, 3H, JAX= JBX= 7.1 Hz), 1.34-1.67 (m, 8H, H-2, H-3, H-
4 and H-5), 2.83-2.92 (m, 2H, H-1), 3.61 (ABX3, 2H, JAB= 10.3 Hz, JAX= JBX= 6.9 Hz, Δν= 70 Hz, H-
9A and H-9B), 3.83 (s, 3H, H-14), 3.92 (m, 3H, H-15), 3.97-4.02 (m, 1H, H-6), 4.67 (AB, 2H, JAB= 
6.9 Hz, Δν= 30 Hz, H-9A and H-9B), 5.17 (ABX, 2H, JAB= 0.9 Hz, JAX = 17.4 Hz, JB = 11.2 Hz, Δν= 18 
Hz, H-8A and H-8B), 5.66 (m, 1H, ABX, H-7), 6.38 (AB, 2H, JAB= 72Hz, Δν= 7 Hz, H-12 and H-13) 
 
13C NMR (100 MHz, CDCl3): δ= 15.14 (C-10), 24.96 (C-4), .29.43 (C-3), 31.28 (C-2), 34.61 (C-5), 
35.19 (C-1), 55.45 (C-19), 56.29 (C-20), 63.63 (C-10), 77.46 (C-6), 92.25 (C-9), 96.41 (C-12 or C-
14), 107.26 (C-14 or C-12), 113.96 (C-16), 117.12 (C-8), 138.53 (C-7), 145.97 (C-17), 158.89 (C-
15), 161.95 (C-13), 170.08 (C-18) 
 
HRMS (ESI+): calcd for (M-H)+: 367.2121, found: 367.2116 
 
 
Chemical Formula: C25H38O6 
Molecular Weight: 434.57 g.mol-1 
 
(S)-pent-4-en-2-yl 2-(6-(ethoxymethoxy)oct-7-en-1-yl)-4,6-dimethoxybenzoate (643) 
 
To a solution of 2-(6-(ethoxymethoxy)oct-7-en-1-yl)-4,6-dimethoxybenzoic acid (640) (6.3 g, 
17.2 mmol, 1.0 equiv.) in THF (75 mL) were added respectively triphenylphosphine (9.0 g, 34.4 
mmol, 2.0 equiv.) and (R)-pent-4-en-2-ol (41) (2.22 g, 25.8 mmol, 1.5 equiv.) at 0°C. The 
solution was stirred for 5 min at 0°C before the addition of DIAD (7.6 g, 37.8 mmol, 2.2 equiv.). 
The colorless solution turned yellow-orange after 10 min at 0°C then stirred at RT overnight. 
The solvent was completely evaporated and the crude product purified by silica gel flash 
chromatography (Cy/EtOAC: 98/2  95/5 90/10 85/15) to afford a 59/41 diastereomeric 
mixture of 643 (6.7 g, 90% yield) as a light yellow oil. 
 
Rf = 0.48 (Cy/EtOAC: 4/1) 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3): δ= 1.19 (t, ABX3, 3H, JAX= JBX= 7.1 Hz, H-11), 1.28 (d, J= 6.8 Hz, H-18), 
1.27-1.51 (m, 6H, H-3, H-4 and H-5), 1.57-1.62 (m, 2H, H-2), 2.31-2.38 (m, 1H, H-15A), 2.43-
2.95 (m, 1H, H-15B), 2.53-2.57 (m, 2H, H-1), 3.59 (ABX3, 2H, JAB= 10.3 Hz, JAX= JBX= 7.1 Hz, Δγ= 
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70 Hz, H-10A and H-10B), 3.78 (s, 3H, H-19), 3.79 (s, 3H, H-20), 3.97 (m, 1H, H-6), 4.65 (AB, 2H, 
JAB= 6.9 Hz, Δν= 30 Hz, H-9A and H-9B), 5.07-5.17 (m, 4H, H-8 and H-17), 5.18-5.23 (m, 1H, H-
14), 5.74 ( A1B1X1, 1H, JAX = 17.4 Hz, JBX = 9.2 Hz, JAB = 10.3 Hz, H-7), 5.83 ( A2B2X2, 1H, JAX = 17 Hz, 
JBX = 10 Hz, H-16), 6.30 ( s, 2H, H-12 and H-13) 
 
13C NMR (100 MHz, CDCl3): δ= 15.17 (C-11), 19.60 (C-25), 25.30 (C-4), .29.61 (C-3), 31.36 (C-2), 
33.89 (C-1), 35.41 (C-5), 40.33 (C-22), 55.41 (C-19), 55.86 (C-20), 63.31 (C-10), 71.00 (C-21), 
77.34 (C-6), 92.35 (C-9), 96.27 (C-12 or C-14), 105.81 (C-14 or C-12), 113.96 (C-16), 117.12 (C-
8), 138.53 (C-7), 145.97 (C-17), 158.89 (C-15), 161.95 (C-13), 170.08 (C-18) 
 
HRMS (ESI+): calcd for (M-H)+: 435.2747, found: 435.2751 
 
 
Chemical Formula: C23H34O6 
Molecular Weight: 406.51 g.mol-1 
 
(3S,Z)-7-(ethoxymethoxy)-14,16-dimethoxy-3-methyl-3,4,7,8,9,10,11,12-octahydro-1H-
benzo[c][1]oxacyclotetradecin-1-one (644) 
 
To a solution of (S)-pent-4-en-2-yl 2-(6-(ethoxymethoxy)oct-7-en-1-yl)-4,6-
dimethoxybenzoate (643) (1.0 g, 2.3 mmol, 1.0 equiv.) in degassed dry toluene (230 mL) at RT 
was added the 2nd  Grubbs’ catalyst (97.6 mg, 0.12 mmol, 0.05 equiv.). The colorless solution 
became orange then brown after 4h at 80°C then allowed to cool down to 40°C. Another 
portion of catalyst (97.6 mg, 0.12 mmol, 0.05 equiv.) was added at this temperature and the 
solution stirred at 80°C overnight. The reaction was cooled to RT before the filtration on a 
Celite® pad to separate the residual solid and washed with toluene (15 mL).  The filtrate was 
evaporated under reduced pressure and purified by silica gel flash chromatography (Cy/EtOAC: 
90/10  85/15) to afford a E/Z : 2/1 mixture of 644 (0.75 g, 80%) as a colorless oil. 
 
Rf = 0.5 (Cy/EtOAC: 4/1) 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (C6D6): (major isomer) δ= 1.08 (t, ABX3, 3H, JAX= JBX= 7 Hz, H-15), 1.27 (d, J= 5.9 Hz, H-
18), 1.21-1.54 (m, 6H, H-3, H-4 and H-5), 1.55-1.74 (m, 2H, H-2), 2.06-2.18 (m, 2H, H-9), 2.56-
2.65 (m, 1H, H-1A), 2.75-2.87 (m, 1H, H-1B), 3.24 (s, 3H, H-16), 3.25(s, 3H, H-17), 3.37-3.42  (m, 
1H, H-14A), 3.52-3.62 (m, 1H, H-14B), 3.97 (dt, 1H, JH6-H7= 3 Hz, JH6-H5= 7 Hz, H-6), 4.61 (AB, 2H, 
JAB= 6.6 Hz, Δν= 75 Hz, H-13A and H-13B), 5.08-5.23 (m, 1H, H-8), 5.20-5.34 (m, 1H, H-10), 5.55-
5.62 (m, 1H, H-7), 6.20 (AB, 2H, JAB= 2.1 Hz, Δν= 55 Hz, H-11 and H-12) 
 
13C NMR (C6D6): (major isomer) δ= 15.22 (C-20), 20.48 (C-23), 24.33 (C-4), 26.67 (C-3), 28.65 (C-
2), 30.53 (C-1), 34.71 (C-5), 39.53 (C-22), 54.53 (C-21), 54.85 (C-22), 62.83 (C-19), 70.48 (C-10), 
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77.14 (C-6), 91.81 (C-18), 96.37 (C-14 or C-16), 104.36 (C-16 or C-14), 118.76 (C-12), 130.17 (C-
8), 134.59 (C-7), 141.82 (C-17), 158.35 (C-13), 161.43 (C-15), 167.85 (C-11) 
 
MS (ESI+): calcd for (M-H)+: 407.2434, found: 407.2411 
 
 
 
Chemical Formula: C23H36O6 
Molecular Weight: 408.53 g.mol-1 
 
(3S)-7-(ethoxymethoxy)-14,16-dimethoxy-3-methyl-3,4,5,6,7,8,9,10,11,12-decahydro-1H-
benzo[c][1]oxacyclotetradecin-1-one (642) 
 
To a solution of (3S,Z)-7-(ethoxymethoxy)-14,16-dimethoxy-3-methyl-3,4,7,8,9,10,11,12-
octahydro-1H-benzo[c][1]oxacyclotetradecin-1-one (644) (0.75 g, 1.84 mmol, 1.0 equiv.) in 
degassed dry EtOAc (180 mL) was added PtO2.H2O (44.3 mg, 0.18  mmol, 0.1 equiv.). The 
solution was continuously submitted to a bubbling source of hydrogen overnight at RT. The 
residual solid was filtrated through a Celite® pad and washed with EtOAc (20 mL) and the 
obtained filtrate evaporated under reduced pressure. The resulting mixture was purified by 
silica gel flash chromatography (Cy/EtOAC: 90/10  85/15 80/20) to afford afford a 60/40 
diastereomeric mixture of 642 (0.74 g, 99%) as a colorless oil. 
 
Rf = 0.46 (Cy/EtOAC: 3/1) 
 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (C6D6): δ= 1.08 (t, ABX3, 3H, JAX= JBX= 7.1 Hz, H-15), 1.28 (d, J= 6.6 Hz, H-18), 1.21-1.68 
(m, 10 H, H-2, H-3, H-4, H-5, H-6, H-7 and H-8), 2.38-2.48 (m, 1H, H-1A), 2.86-2.97 (m, 1H, H-
1B), 3.16 (s, 3H, H-16), 3.27 (s, 3H, H-17), 3.43-3.51  (m, 2H, H-14), 3.57-3.68 (m, 1H, H-6), 4.61 
(AB, 2H, JAB= 6.9 Hz, Δν= 10 Hz, H-13A and H-13B), 5.27-5.34 (m, 1H, H-10), 5.20-5.34 (m, 1H, 
H-10), 5.55-5.62 (m, 1H, H-7), 6.20 (AB, 2H, JAB= 2.1 Hz, Δν= 55 Hz,H-11 and H-12) 
 
13C NMR (C6D6): δ= 15.18 (C-20), 17.80 (C-8), 20.63 (C-23), 23.04 (C-4), 27.28 (C-3), 30.31 (C-2), 
30.91 (C-9), 31.31 (C-5), 32.55 (C-1), 35.34 (C-7), 54.58 (C-21), 55.05 (C-22), 62.85 (C-19), 69.45 
(C-10), 75.07 (C-6), 93.18 (C-18), 96.52 (C-14 or C-16), 105.32 (C-16 or C-14), 118.39 (C-12), 
142.72 (C-17), 158.43 (C-13), 161.38 (C-13), 167.77 (C-11) 
 
MS (ESI+): calcd for (M-H)+: 409.2590, found: 409.2565 
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Chemical Formula: C18H26O5 
Molecular Weight: 322.40 g.mol-1 
 
(3S)-7,14,16-trihydroxy-3-methyl-3,4,5,6,7,8,9,10,11,12-decahydro-1H-
benzo[c][1]oxacyclotetradecin-1-one (611) 
 
To a solution of (3S)-7-(ethoxymethoxy)-14,16-dimethoxy-3-methyl-3,4,5,6,7,8,9,10,11,12-
decahydro-1H-benzo[c][1]oxacyclotetradecin-1-one (642) (0.74 g, 1.8 mmol, 1 equiv.) in DCM 
(20 mL) at 0°C was added dropwise a 1 M solution of BBr3 (10.9 mL, 10.9 mmol, 6 equiv.). The 
solution turned yellow after 5 min at 0°C and was stirred for 1h at 0°C then overnight after the 
temperature reached RT. The reaction was quenched at 0°C with a saturated solution of 
NaHCO3 (30 mL) then methanol (10 mL). The aqueous phase was extracted by DCM (3 x 20 
mL). The combined organic phases were washed by a saturated brine (150 mL), dried over 
anhydrous MgSO4 and concentrated under reduced pressure. The crude product was purified 
by silica gel flash chromatography (Cy/EtOAC: 90/10  60/40) to afford a 60/40 
diastereomeric mixture of 611 (0.46 g, 80% yield) as a light-yellow solid. 
 
Rf = 0.6 (EtOAC) 
 
The analytical data are identical to those from the literature.10 
 
mp= 169-171°C 
 
 
Numbering for the hydrogens                   Numbering for the carbons 
 
1H NMR (400 MHz, CDCl3):δ= 1.36 (d, 3H, J= 2.1 Hz, H-13), 1.37-2.15 (m, 14H, H-2, H-3, H-4, H-
5, H-7, H-8 and H-9), 2.25-2.64 (m, 1H, H-1), 3.22-3.30 (m, 2H, H-6), 5.13-5.20 (m, 1H, H-10), 
5.32-5.53 (m, 1H, OH), 6.26 (AB, 2H, JAB= 2.5 Hz, Δγ= 25 Hz,H-11 and H-12) 
 
13C NMR (100 MHz, CDCl3): δ= 14.2 (C-8), 20.41 (C-18), 22.98 (C-4), 24.71 (C-3), 27.90 (C-2), 
29.78 (C-1), 37.20 (C-9), 37.45 (C-5), 38.08 (C-7), 73.42 (C-6), 101.60 (C-14), 110.85 (C-16), 
148.86 (C-17), 164.82 (C-13), 165.95 (C-15), 171.75 (C-11) 
 
HRMS (ESI+): calcd for (M-Na)+: 345.1677, found: 345.1602 
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Afterword  
 
 
 
 
 
 
 
 
 
The true splendor of science is not so much that it names and classifies, records and predicts, 
but that it observes and desires to know the facts, whatever they may turn out to be. However 
much it may confuse facts with conventions, and reality with arbitrary divisions, in this 
openness and sincerity of mind it bears some resemblance to religion, understood in its other 
and deeper sense. The greater the scientist, the more he is impressed with his ignorance of 
reality, and the more he realizes that his laws and labels, descriptions and definitions, are the 
products of his own thought. They help him to use the world for purposes of his own devising 
rather than to understand and explain it. 
 
Alan Watts (1915-1973)  
 
